glucagon has been researched along with c-peptide in 1306 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (c-peptide) | Trials (c-peptide) | Recent Studies (post-2010) (c-peptide) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 9,053 | 1,632 | 2,445 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 407 (31.16) | 18.7374 |
1990's | 412 (31.55) | 18.2507 |
2000's | 239 (18.30) | 29.6817 |
2010's | 193 (14.78) | 24.3611 |
2020's | 55 (4.21) | 2.80 |
Authors | Studies |
---|---|
Bratusch-Marrain, P; Dudczak, R; Kleinberger, G; Korn, A; Nowotny, P; Waldhäusl, W | 1 |
Alford, FP; Chisholm, DJ; Larkins, RG; Martin, FI | 1 |
Baratono, S; Sacchetti, C | 1 |
Bretzel, RG; Dobroschke, J; Federlin, K; Langhoff, G; Laube, H; Schwemmle, K | 1 |
De Nutte, N; De Vroede, M; Gepts, W; Pipeleers, D; Somers, G | 1 |
Vaisrub, S | 1 |
Fujiya, H; Kokubo, T; Ohneda, A; Ohtani, H; Otsuki, M; Yaginuma, N | 1 |
Inui, K; Ishida, M; Kodama, H; Okada, S; Seino, Y; Yabuuchi, H; Yutaka, T | 1 |
Binder, C; Faber, OK | 1 |
Binder, C; Drejer, J; Faber, OK; Hendriksen, C | 1 |
Hansson, BG; Heding, LG; Hökfelt, B; Nilsson, KO | 1 |
Sato, K | 1 |
Binder, C; Elliot, HL; Faber, OK; Frier, BM | 1 |
Emmanouel, DS; Katz, AI | 1 |
Aldor, TA; Baetens, D; Collins, SM; Conlon, JM; Davis, GR; Krejs, GJ; McCarthy, DM; Orci, L; Raskin, P; Ravazzola, M; Rubenstein, A; Unger, RH | 1 |
Binder, C; Faber, OK; Pyke, DA; Smith, RB; Watkins, PJ | 1 |
Ichihara, K; Kumahara, Y; Morishita, S; Sawazaki, N; Shima, K; Tanaka, R; Yanaihara, N | 1 |
Horwitz, DL; Rubenstein, AH | 1 |
Baldus, WP; Go, VL; Nelson, RL; Rubenstein, AH; Service, FJ | 1 |
Ziegler, M | 1 |
Albertini, A; Mantovanelli, F; Rigosa, C; Valentini, A; Zamboni, G; Zoppi, G | 1 |
Faber, OK; Kühl, C; Lenz, S; Mølsted-Pedersen, L; Orskov, H; Wang, P | 1 |
Buysschaert, M; Lambert, AE; Lambotte, L | 1 |
Angeletti, G; Bolli, G; Brunetti, P; Calabrese, G; Massi-Benedetti, M; Puxeddu, A; Santeusanio, F; Scionti, L | 1 |
Ratzmann, KP; Witt, S | 1 |
Horwitz, DL; Kaplan, E; Langer, B; Moossa, AR; Ribeiro, G; Rubenstein, AH; Schwartz, SS; Zehfus, B | 1 |
Smith-Laing, G | 1 |
Andreani, D; Caccamo, C; de Gado, F; Fallucca, F; Lamalfa, G; Maldonato, A; Pachi, A; Russo, A | 1 |
Chiba, T; Fukami, T; Kondo, T; Nakayama, K; Yamazoe, A | 1 |
Heding, LG; Ludvigsson, J | 1 |
Binder, C; Faber, OK; Kehlet, H; Madsbad, S | 1 |
Kanno, R | 1 |
Leonova, LN; Smirnova, GI; Zubovskiĭ, GA | 1 |
Takeda, S | 1 |
Goto, A; Ishida, T; Kawamura, K; Nishina, Y; Takahara, J | 1 |
Horwitz, DL; Jiang, NS; Molnar, GD; Reynolds, C; Rubenstein, AH; Taylor, WF | 1 |
Goto, A; Kawamura, K; Kawanishi, K; Nishina, Y; Okada, S | 1 |
Kumahara, Y; Morishita, S; Shima, K; Tanaka, R; Tarui, S | 1 |
Heding, LG; Joffe, BI; Seftel, HC; Shires, R | 1 |
Kuzuya, T; Matsuda, A | 1 |
Aydin, I; Nakabayashi, H; Raskin, P; Srikant, CB; Unger, RH | 1 |
Borth, F; Bruce, R; Crook, D; Devenport, M; Ghatei, M; Godsland, I; Stevenson, J; Whitehead, M; Wynn, V | 1 |
Beaufrère, B; Beylot, M; Broussolle, C; Chassard, D; Riou, JP | 1 |
d'Onofrio, F; de Riu, S; Lefèbvre, P; Marrazzo, G; Paolisso, G; Sgambato, S; Varricchio, M | 1 |
Ahrén, B; Efendic, S; Gutniak, M; Holst, JJ; Orskov, C | 1 |
Huang, HS; Huang, MJ; Juang, JH | 1 |
Battezzati, A; Bianchi, E; Ferrari, G; La Rocca, E; Luzi, L; Perseghin, G; Secchi, A; Spotti, D; Staudacher, C; Vergani, S | 1 |
Hanafusa, T; Itoh, N; Katsura, H; Kono, N; Tarui, S | 1 |
Chune, G; Elias, AN; Gordon, I; Gwinup, G; Pandian, MR; Vaziri, ND; Wesley, R | 1 |
Anisimov, KIu; Egorov, VM; Iakushev, AM; Kulikov, AV; Kuznetsov, NN; Vershinina, GA | 1 |
Creutzfeldt, W; Liess, H; Nauck, MA; Niedmann, PD; Siegel, EG | 1 |
Cherrington, AD; Moore, MC; Neal, DW; Pagliassotti, MJ | 1 |
Burmeister, LA; Gannon, MC; Lane, JT; Nuttall, FQ | 1 |
Haymond, MW; Horber, FF; Mauras, N | 1 |
Beastall, GH; Chita, BS; Fisher, BM; Gray, R; Jauhar, P; MacCuish, AC; Quin, JD | 1 |
Bosquet, F; Cesselin, F; Champigneulle, A; Grimaldi, A; Khalifa, L; Sachon, C; Troupel, S | 1 |
Fernlund, P; Gottsäter, A; Gullberg, B; Landin-Olsson, M; Lernmark, A; Sundkvist, G | 1 |
Büchler, M; Duntas, L; Glasbrenner, B; Malfertheiner, P; Pieramico, O; Wolf, C | 1 |
Beaufrère, B; Beylot, M; Broussolle, C; Chassard, D | 1 |
Garg, A; Grundy, SM; Koffler, M | 1 |
Fyhrquist, F; Koivisto, VA; Pelkonen, R; Sane, T | 1 |
LeBlanc, J; Mercier, I | 1 |
Fujii, S; Komatsu, R; Matsuyama, T; Miki, H; Nishioeda, Y; Omae, T | 1 |
Kobayashi, K; Miyakoshi, H; Miyamoto, I; Nagai, Y; Nishimura, Y; Noto, Y; Ohsawa, K | 1 |
Basin, C; De Rouge, B; Kuhn, JM; Mollard, M; Schatz, B; Wolf, LM | 1 |
Basabe, JC; Capucchio, M; Cardoso, AI; Fabiano de Bruno, LE; Fainboim, L; Mota, AH; Poskus, E; Zavala, AV | 1 |
Ceriello, A; D'Onofrio, F; Giugliano, D; Paolisso, G; Saccomanno, F; Torella, R; Varricchio, M | 1 |
Brunetti, P; Misericordia, P; Santeusanio, F; Santucci, A; Scionti, L | 1 |
Birkeland, KI; Chatzipanagiotou, F; Hanssen, KF; Vaaler, S | 1 |
Alberti, KG; Hockaday, TD; Kanitkar, SV; Naik, SS; Orskov, H; Shelgikar, KM; Yajnik, CS | 1 |
Cortinovis, F; Lepore, G; Maglio, ML; Nosari, I; Pagani, G | 1 |
Clutter, WE; Cryer, PE; Marker, JC | 1 |
Burmeister, LA; Gannon, MC; Lane, JT; Nuttall, FQ; Pyzdrowski, KL | 1 |
D'Onofrio, F; Gambardella, A; Paolisso, G; Pizza, G; Sgambato, S; Tesauro, P; Varricchio, M | 1 |
Bech, K; Drejer, K; Hansen, P; Mygind, N; Sørensen, AR; Vaag, A | 1 |
Bolli, GB; Brunetti, P; De Feo, P; Fanelli, CG; Perriello, G; Porcellati, F; Santeusanio, F; Torlone, E | 1 |
Falholt, K; Holst, JJ; Jensen, SL; Orbaek Andersen, H; Rahimi-Saber, S; Shokouh-Amiri, MH | 1 |
Kolácný, I; Weber, P | 1 |
Cottrell, DA; Ferguson, RM; Henry, ML; O'Dorisio, TM; Osei, K; Tesi, RJ | 1 |
Funahashi, M; Koons, J; Winter, WE | 1 |
Arnqvist, HJ; Lindström, T; Ludvigsson, J; von Schenck, HH | 1 |
Barreca, T; Cataldi, A; Franceschini, R; Rolandi, E | 1 |
Cryer, PE; Hirsch, IB; Holloszy, JO; Marker, JC; Parvin, CA; Smith, LJ | 1 |
Busch-Sørensen, M; Holst, JJ; Lyngsøe, J | 1 |
Deltour, L; Dubois, P; Jami, J; Leduque, P; Paldi, A; Ripoche, MA | 1 |
Adamson, U; Kollind, M; Lins, PE; Liu, D; Moberg, E | 1 |
Abadjieva, Z; Borissova, AM; Javorska, N; Kirilov, G | 1 |
Ahrén, B | 1 |
Ferrari, C; Fiaccadori, F; Orlandi, N; Pedretti, G; Pezzarossa, A; Pizzaferri, P; Riggio, O | 1 |
Boivin, M; DiMagno, EP; Jain, NK; Zinsmeister, AR | 1 |
Bosello, O; Bovo, P; Brocco, G; Cavallini, G; Chiavenato, A; Filippini, M; Pelle, C; Riela, A; Rossi, L; Zamboni, M | 1 |
Bicz, B; Kaciuba-Uscilko, H; Kruk, B; Nazar, K; Opaszowski, B; Stupnicka, E; Szczpaczewska, M | 1 |
Jørgensen, JO; Møller, J; Møller, N; Pørksen, N; Schmitz, O | 1 |
Ceriello, A; Cozzolino, D; D'Onofrio, F; Franchimont, P; Giugliano, D; Lefebvre, PJ; Salvatore, T; Torella, R | 1 |
Greulich, B; Mahon, J; Mandrup-Poulsen, T; Martin, S; Pawlowski, B; Ziegler, AG | 1 |
Bailey, DJ; Blackard, WG; Clore, JN; Nestler, JE; Post, EP | 1 |
Maezawa, H; Sugiyama, H; Uchimura, I; Watanabe, T | 1 |
Jeanprêtre, N; Jéquier, E; Schneeberger, D; Tappy, L; Temler, E | 1 |
Benassi, L; Orlandi, N; Pezzarossa, A; Tridenti, G | 1 |
Brown, R; Clark, BA; Elahi, D; Flanagan, TL; Gingerich, R; McAloon-Dyke, M; Minaker, KL; Pruett, T; Shapiro, M; Wong, G | 1 |
Borisova, AM; Georgieva, R | 1 |
Creutzfeldt, W; Nauck, MA; Siegel, EG | 1 |
Fält, K; Hahn, HJ; Madsen, O; Reiher, H; von Dorsche, HH | 1 |
Alberti, KG; Fulcher, GR; Marsiaj, H; Orskov, H; Walker, M | 1 |
Dorofeeva, SD; Fabrikov, AP; Shishkina, SN | 1 |
Abdenur, JE; Basabe, JC; Cresto, JC; Ramos, O; Sires, JM | 1 |
Borkman, M; Bruce, DG; Chisholm, DJ; Kraegen, EW; Storlien, LH | 1 |
Hinds, A; Machida, H; Parsons, HG; Sheehan, AG | 1 |
Chi, Z; Kan, Y | 1 |
Eeftinck Schattenkerk, JK; Endert, E; Hommes, MJ; Romijn, JA; Sauerwein, HP | 1 |
Yao, SC | 1 |
Johansson, BL; Ostman, J; Sjöberg, S; Wahren, J | 1 |
Alberti, KG; Mengel, A; Møller, N; Orskov, L; Pedersen, O; Rasmussen, O; Schmitz, O; Seefeldt, T | 1 |
Diem, P; Robertson, RP; Sutherland, DE | 1 |
Bentdal, OH; Berg, KJ; Brekke, IB; Djøseland, O; Fauchald, P; Ganes, T; Gjellestad, A; Hartmann, A; Holdaas, H; Jervell, J | 1 |
Dela, F; Galbo, H; Mikines, KJ; von Linstow, M | 2 |
Davis, MR; Shamoon, H | 1 |
Bendtson, I; Binder, C; Gade, J; Rosenfalck, AM; Thomsen, CE; Wildschiødtz, G | 1 |
Arslanian, S; Becker, DJ; Drash, AL; Ohki, Y | 1 |
Shamoon, H; Shilo, S; Sotsky, M | 1 |
Acheson, KJ; Burger, AG; Jequier, E; Müller, MJ | 1 |
Brechtel, G; Henry, RR; Lim, KH | 1 |
Kung, AW; Lam, KS; Pun, KK; Wang, C; Yeung, RT | 1 |
D'Onofrio, F; Paolisso, G; Salvatore, T; Sgambato, S; Torella, R; Varricchio, M | 1 |
Acheson, KJ; Burger, AG; Jeanprêtre, N; Jéquier, E; Müller, MJ; Piolino, V | 1 |
Caruso, M; Divertie, GD; Jensen, MD; Miles, JM | 1 |
Besenthal, I; Eggstein, M; Jakober, B; Nordt, TK | 1 |
Heiling, VJ; Jensen, MD; Miles, JM | 1 |
Blackman, J; Bosson, D; Copinschi, G; Lewis, G; Polonsky, KS; Shapiro, ET; Tillil, H; Van Cauter, E | 1 |
Bolli, GB; Brunetti, P; De Feo, P; Fanelli, C; Gerich, JE; Perriello, G; Santeusanio, F; Torlone, E; Ventura, MM | 2 |
Albert, A; D'Onofrio, F; Giugliano, D; Lefèbvre, PJ; Paolisso, G; Scheen, AJ; Sgambato, S; Varricchio, M | 1 |
Cozzolino, D; D'Onofrio, F; Franchimont, P; Giugliano, D; Lefebvre, PJ; Torella, R | 1 |
Boyle, PJ; Cryer, PE | 1 |
Boesby, S; Hansen, CP; Kirkegaard, P | 1 |
Harju, E; Nordback, I | 1 |
Butler, P; Kryshak, E; Rizza, R | 1 |
Diem, P; Klein, DJ; Levitt, MD; Moran, A; Robertson, RP | 1 |
Dupre, J; Jenner, MR; Mahon, JL; Purdon, C; Rodger, NW; Stiller, CR | 1 |
Binder, C; Lassen, LH; Rosenfalck, AM; Snorgaard, O | 1 |
Faber, OK; Gjessing, HJ; Pedersen, O; Reinholdt, B | 1 |
Cryer, PE; Hirsch, IB; Holloszy, JO; Marker, JC; Parvin, CA; Smith, LJ; Spina, RJ | 1 |
Iakhontova, OI; Pomazovskaia, VA | 1 |
Born, J; Fehm, HL; Kern, W; Kerner, W | 1 |
Matsuda, A | 1 |
Komi, N; Muñoz, NA; Nishi, M; Takehara, H | 1 |
Geller, LI; Obukhova, GG; Pashko, MM | 2 |
Castellino, P; DeFronzo, RA; Del Prato, S; Luzi, L | 1 |
Abdulkadir, J; Bekele, A; Gebre, P; Keen, H; Mengesha, B; Taddesse, AS; Urga, K; Welde Gebriel, Z; Worku, Y | 1 |
Gerich, J; Greenawalt, K; Mitrakou, A; Stanko, RT | 1 |
Aslan, SM; Atiea, JA; Luzio, S; Owens, DR | 1 |
Krans, HM; Nijs, HG; Poorthuis, BJ; Radder, JK | 1 |
Reckless, JP; Simpson, HC; Stirling, CA; Sturley, R | 1 |
Attvall, S; Fowelin, J; Lager, I; Smith, U; von Schenck, H | 2 |
Ayzac, L; Charrie, A; Fleury, MC; Jouve, M; Rebattu, B; Sabot, O; Tourniaire, J | 1 |
Elstein, M; Golland, IM; Laing, I; Shalet, SM; Vaughan-Williams, CA | 1 |
Jávor, T; Mózsik, G; Rinfel, J; Ruzsa, C | 1 |
Cho, K; Moattari, AR; Vinik, AI | 1 |
Andersen, T; Astrup, A; Breum, L; Bülow, J; Christensen, NJ; Madsen, J; Quaade, F | 1 |
Aitken, PM; Alford, FP; Best, JD; Walters, JM; Ward, GM | 1 |
Bolli, G; Gerich, J; Lecavalier, L | 1 |
Keilacker, H; Kohnert, KD; Michaelis, D; Rjasanowski, I; Woltanski, KP; Ziegler, B; Ziegler, M | 1 |
Karasová, L; Lánská, V; Malý, J; Petrásek, R; Skála, I; Stastná, R; Svácek, J; Winkler, L | 1 |
Fujiyama, K; Hoshino, T; Ikeda, T; Mashiba, H; Takeuchi, T; Tominaga, M | 1 |
Assan, R; Boitard, C; Du Rostu, H; Feutren, G; Figoni, M; Laborie, C; Rodier, M; Sirmai, J; Vague, P; Vexiau, P | 1 |
Kaku, K; Kaneko, T; Nagasaka, Y | 1 |
Boylan, JM; Schwartz, R; Sehgal, P; Susa, JB | 1 |
Blickle, JF; Bockel, R; Doffoel, M; Fratte, S; Hirsch, E; Pinget, M; Reville, M; Roze, F; Vetter, D; Winiszewski, P | 1 |
Gannon, MC; Nuttall, FQ | 1 |
Gannon, MC; Nuttall, FQ; Westphal, SA | 1 |
Buonocore, S; D'Onofrio, F; Gentile, S; Lefèbvre, PJ; Paolisso, G; Scheen, A; Sgambato, S; Varricchio, M | 1 |
Aguilar, M; Escobar-Jiménez, F; Gómez-Villalba, R; Herrera Pombo, JL; Nuñez del Carril, J; Rovira, A | 1 |
Consoli, A; Gerich, JE; Jenssen, T; Nurjhan, N | 1 |
Ferguson, RM; Henry, ML; O'Dorisio, TM; Osei, K; Sommer, BG; Tesi, RJ | 1 |
Bach, JF; Boisson, C; Boitard, C; Bougnères, PF; Carel, JC; Chaussain, JL; Frament, N; Landais, P | 1 |
Chew, LS; Rajasoorya, C; Tan, YT | 1 |
Barr, D; Butler, PC; Kryshak, EJ; Marsh, C; Miller, A; Perkins, JD; Polonsky, K; Rizza, RA | 1 |
Flynn, T; Gumbiner, B; Henry, RR; Thorburn, AW | 1 |
Ditschuneit, H; Glasbrenner, B; Kerner, W; Malfertheiner, P; Scherbaum, WA | 1 |
Efendic, S; Giacca, A; Khan, A; Vranic, M; Wajngot, A | 1 |
Balasse, EO; d'Attellis, NP; Fery, F | 1 |
Andersen, BB; Gjessing, HJ; Jensen, BG; Kvetny, J; Matzen, LE; Sindrup, SH | 1 |
Azad, AK; Bennish, ML; Phillips, RE; Rahman, O | 1 |
Frisk, B; Hedman, L; Nordén, G; Nyberg, G; von Schenck, H | 1 |
Berg, KJ; Brekke, IB; Fauchald, P; Flatmark, A; Hartmann, A; Holdaas, H; Jervell, J; Sødal, G | 1 |
Lütjens, A; Nauta, EH; Vahlkamp, T | 1 |
Abendroth, D; Illner, WD; Land, W; Landgraf, R; Landgraf-Leurs, MM; Loy, A; Nusser, J | 1 |
al-Attas, OS; al-Dress, AZ; Khan, MS; Laajam, MA | 1 |
Istomin, IuP; Khodina, TV; Lappo, SP; Nodel'son, SE; Prokhorova, VI; Rubanova, VZ; Zhavrid, EA | 1 |
Alberti, KG; Christiansen, J; Jørgensen, JO; Møller, J; Møller, N; Orskov, H; Schmitz, O | 1 |
Ahrén, B; Hedner, P; Lundquist, I; Scherstén, B; Valdemarsson, S | 1 |
Bertrand, J; Demidem, A; Durand, A; Haftek, M; Thivolet, CH | 1 |
Hegedüs, V; Hilsted, J; Myhre, J; Philipsen, E; Staffeldt, H; Tronier, B; Worning, H | 1 |
Marsh, HM; McMahon, M; Rizza, RA | 1 |
Jeppsson, B; Lunderquist, A; Magnússon, J; Tranberg, KG | 1 |
Bouma, DJ; Hart, JS; Phillipson, BE; Riddle, MC; Youker, G | 1 |
De Leeuw, I; Nobels, F; Rillaerts, E; Van Gaal, L | 1 |
Bernal, M; Lassmann-Vague, V; Picq, R; Vague, P; Vialettes, B | 1 |
Fischer, HR; Hackeng, WH; Lems, WF; Naafs, MA; Stehouwer, CD | 1 |
Abildgaard, N; Alberti, KG; Arnfred, J; Christiansen, JS; Jørgensen, JO; Orskov, H; Orskov, L; Schmitz, O | 1 |
Antonelli, A; Baschieri, L; del Guerra, P; Fialdini, A; Gasperini, L | 1 |
Bolli, GB; Brunetti, P; De Feo, P; Gerich, JE; Perriello, G; Santeusanio, F; Torlone, E; Ventura, MM | 1 |
Bier, DM; Cryer, PE; Matthews, DE; Staten, MA | 1 |
Elahi, D; Hartl, WH; Miyoshi, H; Wolfe, RR | 1 |
Caruso, M; Heiling, V; Jensen, MD; Miles, JM | 1 |
Casamitjana, R; Goday, A; Gomis, R; Montaña, E; Rosel, P; Soler, J | 1 |
Bell, PM; Firth, RG; Rizza, RA | 3 |
Hillebrand, G; Kampik, A; Lachenmayr, B; Landgraf, R; Landgraf-Leurs, MM; Müller, W; Nusser, J; Schleibner, S; Thurau, S; Ulbig, M | 1 |
Blackard, WG; Clore, JN; Nestler, JE | 1 |
Bonora, E; Cacciatori, V; Cigolini, M; Corgnati, A; Moghetti, P; Muggeo, M; Querena, M; Zancanaro, C | 1 |
Marsh, H; McMahon, M; Rizza, R | 1 |
Kallio, V; Laakso, M; Pyörälä, K; Rönnemaa, T; Sarlund, H | 1 |
Helve, E; Karonen, SL; Nikkilä, EA; Sane, T; Taskinen, MR; Yki-Järvinen, H | 1 |
Cantell, K; Koivisto, VA; Pelkonen, R | 1 |
Kawai, K; Murayama, Y; Watanabe, Y; Yamashita, K; Yoshikawa, H | 1 |
Boyle, PJ; Cryer, PE; Shah, SD | 1 |
Alejandro, R; Bloom, AD; Feldman, EC; Kenyon, NS | 1 |
Aitken, PM; Alford, FP; Best, JD; Marangou, AG; Ward, GM | 1 |
Hutton, JC; Larsson, LI; Madsen, OD; Nielsen, JH | 1 |
Faber, OK; Frøland, A; Gjessing, HJ; Matzen, LE | 1 |
Bisacchi, U; Gianni, R; Maggi, L; Santoro, E; Tomassini, CR | 1 |
Bougnères, PF; Chaussain, JL; Walker, J | 1 |
Jandrain, BJ; Lacroix, M; Lefebvre, PJ; Mosora, F; Pirnay, F; Scheen, AJ | 1 |
DeFronzo, RA; Luzi, L | 1 |
Gannon, MC; Neil, BJ; Nuttall, FQ; Seaquist, ER; Westphal, SA | 1 |
Cravarezza, P; Giustina, A; Romanelli, G; Spandrio, S; Zuccato, F | 1 |
Huang, BY; Huang, HS; Huang, MJ; Juang, JH; Lin, JD | 1 |
Luca, M; Noto, R; Privitera, P; Sfogliano, L | 1 |
Alberti, KG; Beckwith, R; Butler, PC; Christensen, NJ; Møller, N; Orskov, H | 1 |
Gillet, J; Guiot, J; Henrivaux, P; Jandrain, B; Lefèbvre, PJ; Rosenthaler, J; Scheen, AJ | 1 |
Heaton, DA; Lazarus, NR; Leslie, RD; Pyke, DA | 1 |
Ishii, H; Murozono, S; Picazo, J; Sato, K | 1 |
Funakoshi, N; Innami, R; Murayama, F; Nagaoka, H; Satoh, M; Watanabe, M | 1 |
Gjessing, HJ; Pedersen, O; Reinholdt, B | 1 |
Bottazzo, GF; Casamitjana, R; Ercilla, G; Gomis, R; Peig, M; Pujol-Borrell, R | 1 |
Cavallini, M; Stipa, F; Stipa, S; Tersigni, R | 1 |
Ho, PW; Pun, KK; Tam, CF; Wang, C; Young, RT | 1 |
Ho, PW; Pun, KK; Yeung, RT | 1 |
Dubitskiĭ, AE; Furmanenko, ED; Kozhara, SP | 1 |
Araki, E; Fukushima, H; Kishikawa, H; Nakamura, N; Sakakida, M; Shirotani, T; Takahashi, T; Ueno, S; Uzawa, H; Yamaguchi, K | 1 |
Cutfield, RG; Kyriakides, G; Miller, J; Mintz, DH; Olson, L; Polonsky, K | 1 |
Cryer, P; Dimitriadis, G; Gerich, J | 1 |
Bieger, WP; Michel, G; Schwarz, W | 1 |
Fukushima, H; Kishikawa, H; Maeda, H; Nakamura, N; Sakakida, M; Shimada, M; Suzaki, K; Uzawa, H | 1 |
Efendić, S; Grill, V; Gutniak, M | 1 |
Bolli, GB; Brunetti, P; Campbell, PJ; De Cosmo, S; De Feo, P; Gerich, JE; Perriello, G; Ventura, MM | 1 |
Cagliero, E; Carini, G; Maccario, M; Massara, F; Orzan, F | 1 |
Cavalie, G; Lachkar, H; Mirouze, J; Monnier, L; Orsetti, A; Richard, JL; Rodier, M | 1 |
Acheson, KJ; Christin, L; Jéquier, E; Nacht, CA; Ravussin, E; Vernet, O | 1 |
Jaspan, JB; Lever, E; Polonsky, KS; Van Cauter, E | 1 |
Polonsky, K; Pugh, W; Samols, E; Stagner, J | 1 |
Chen, JJ; Chen, YD; Ho, LT; Reaven, GM; Wu, MS | 1 |
Baron, AD; Kolterman, OG; Schaeffer, L; Shragg, P | 1 |
Ho, PW; Lam, KS; Lam, SK; Yeung, RT | 1 |
Nair, KS | 1 |
Bolli, GB; Brunetti, P; De Feo, P; Gerich, JE; Perriello, G; Santeusanio, F; Ventura, MM | 1 |
D'Onofrio, F; Franchimont, P; Giugliano, D; Lefèbvre, PJ; Paolisso, G; Scheen, AJ | 1 |
du Toit, DF; Wolfe-Coote, SA | 1 |
Burrow, GN; George, SR; Hegele, RA | 1 |
Elahi, D; Meneilly, GS; Minaker, KL; Rowe, JW | 2 |
Schmitz, O | 1 |
Hilsted, J; Larsen, S; Tronier, B; Worning, H | 2 |
Adachi, Y; Aoki, N; Chikugo, T; Hajiro, K; Higashizawa, T; Nakano, K; Suzuki, T; Takahashi, H; Yamamoto, T | 1 |
Berger, W; Keller, U; Müller, R | 1 |
Beastall, GH; Cohen, HN; MacCuish, AC; Small, M | 1 |
Ceriello, A; Cozzolino, D; D'Onofrio, F; Giugliano, D; Salvatore, T; Torella, R | 1 |
Bauman, A; Jeffrey, J; Jonasson, O; Jones, C; Lands, W; Takimoto, G | 1 |
Cozzolino, D; D'Onofrio, F; Franchimont, P; Giugliano, D; Lefebvre, PJ; Salvatore, T; Torella, R | 1 |
Cozzolino, D; D'Onofrio, F; Giugliano, D; Salvatore, T; Torella, R | 1 |
Milton, A; Odlind, B | 1 |
Hiraoka, T; Murata, E; Tashiro, S | 1 |
Asp, NG; Björck, I; Hagander, B; Lundquist, I; Nilsson-Ehle, P; Scherstén, B; Schrezenmeir, J | 1 |
Carlo Stella, C; De Caro, L; Ghizzi, A; Gorini, M | 1 |
Ide, T; Nagashima, H; Nakata, K; Shimamura, J; Taketa, K | 1 |
Barnett, AH; Chiodini, PL; Farrell, ID; Geddes, AM; Gilbert, J; Odugbesan, O; Toop, MJ | 1 |
Cabrerizzo Garcia, L; Lassmann, V; Vague, P; Vialettes, B | 1 |
Cabezas-Cerrato, J; De la Fuente, A; García López, JM; Gaudiero, GJ; Mato Mato, JA; Odriozola, A; Tomé, MA | 1 |
Kurihara, Y | 1 |
Behme, MT; Chamberlain, MJ; Dupre, J; Rodger, NW | 1 |
Irjala, KM; Koskinen, PJ; Viikari, JS | 1 |
Hashimoto, N; Iwaoka, H; Kanatsuka, A; Makino, H; Sakurada, M; Taira, M; Yamaguchi, T; Yoshida, A; Yoshida, S | 1 |
D'Onofrio, F; Gentile, S; Giugliano, D; Memoli, P; Paolisso, G; Sgambato, S; Varricchio, M | 1 |
Creutzfeldt, W; Ebert, R; Nauck, MA; Stöckmann, F; Thiery, J | 1 |
Hayakawa, N; Nimura, Y; Ohtsuka, K; Takaesu, Y; Yasui, K | 1 |
Ellyin, FE; Gilden, JL; Kumar, Y; Singh, SP; Snyder, AK | 1 |
D'Onofrio, F; Giugliano, D; Mignano, S; Paolisso, G; Passariello, N; Sgambato, S; Torella, R; Varricchio, M | 1 |
Keller, U; Luzio, S; Owens, DR; Tronier, B; Turkes, A; Vora, JP | 1 |
Akgün, S; Ertel, NH; Samanta, A | 1 |
Bruining, GJ; de Beaufort, CE; den Boer, NC; Eilers, GA; van Strik, R; Weterings, T | 1 |
Bicknell, EJ; Gulliford, MC; Scarpello, JH | 1 |
Damsgaard, EM; Faber, OK; Frøland, A; Gjessing, HJ; Matzen, LE | 1 |
Fujishima, M; Iwase, M; Kikuchi, M; Maki, Y; Nunoi, K; Wada, M; Wakisaka, M | 1 |
Ho, LT; Jap, TS; Tai, WH | 1 |
Iversen, J; Tygstrup, N; Vilstrup, H | 1 |
Beastall, GH; Buchanan, KD; Omile, C; Paterson, KR; Semple, CG | 1 |
Altemeyer, KH; Dölp, R; Konrad, F; Schmitz, JE; Seeling, W; Wiedeck, H | 1 |
Alberti, KG; Hanning, I; Leslie, RD; Orskov, H; Poncher, M; Volkmann, HP | 1 |
Buch, I; Buschard, K; Hougaard, P; Kühl, C; Mølsted-Pedersen, L | 1 |
Borisova, AM; Kirilov, G; Koev, D | 1 |
Berger, M; Kemmer, FW; Tacken, M | 1 |
Haymond, MW; Schwenk, WF | 1 |
DeFronzo, RA; Groop, L; Groop, PH; Luzi, L; Melander, A; Ratheiser, K; Simonson, DC | 1 |
Lockwood, D; Nair, KS; Welle, S | 1 |
Galione, A; Hopps, V; Sorrentino, MC; Vaccaro, F; Vetri, P; Woodrow, ME | 1 |
Brown, CB; Hanning, I; Johnston, DG; Smith, WG | 1 |
Hosoi, H; Kagoshima, T; Ohki, Y; Teshirogi, T | 1 |
Boine, L; Bruno, A; Cassader, M; Cavallo-Perin, P; Lenti, G; Pagano, G | 1 |
Khristov, V; Petkova, M; Tsanev, A; Zlateva, S | 1 |
Fukuda, M; Ikegami, H; Kumahara, Y; Shima, K; Tahara, Y; Tanaka, A; Yamamoto, Y | 1 |
Bottazzo, GF; Groop, L; Groop, PH; Koskimies, S; Meri, S; Miettinen, A | 1 |
Hakala, P; Korhonen, T; Laakso, M; Majander, H; Pyörälä, K; Sarlund, H; Uusitupa, M; Voutilainen, E | 1 |
Brechtel, G; Griver, K; Henry, RR | 1 |
Farrell, PA; Galbo, H; Mikines, KJ; Sonne, B; Tronier, B | 1 |
Abasov, IT; Gidaiatov, AA; Isaev, EG | 1 |
D'Onofrio, F; Lefèbvre, PJ; Paolisso, G; Scheen, A; Sgambato, S; Torella, R; Varricchio, M | 1 |
Hasselstrøm, K; Lumholtz, IB; Siersbaek-Nielsen, K; Snorgaard, O; Thorsteinsson, B | 1 |
Bruce, DG; Chisholm, DJ; Kraegen, EW; Storlien, LH | 1 |
Efendic, S; Karlander, S; Vranic, M | 2 |
Fang, VS; Polonsky, KS; Rubenstein, AH; Shapiro, ET; Tillil, H; Van Cauter, E | 1 |
Härkonen, M; Koivisto, VA; Kolaczynski, JW; Ylikahri, R | 1 |
Binder, C; Cerasi, E; Glaser, B; Hartling, S; Leibovich, G; Nesher, R | 1 |
Kawakami, K | 1 |
Koh, CS; Lee, HK; Lee, KU; Min, HK | 1 |
Ahrén, B; Nobin, A; Scherstén, B | 1 |
Blickle, JF; Brogard, JM; Cohen, B; Paris-Bockel, D; Pinget, M; Stahl, A | 1 |
Kunihiro, K | 1 |
Baraldi, G; Capelli, M; Melchionda, N; Pasquali, R; Patrono, D | 1 |
Laakso, M; Penttilä, I; Pyörälä, K; Sarlund, H | 2 |
Fahrenkrug, J; Hökfelt, T; Lundberg, JM; Ottesen, B; Pedersen, JH; Yamashita, Y | 1 |
Fyhrquist, F; Groop, LC; Groop, PH; Tötterman, KJ | 1 |
Koskinen, P; Rönnemaa, T; Viikari, J | 1 |
Hsieh, SD; Iwamoto, Y; Kuzuya, T; Matsuda, A | 2 |
Solov'eva, NE; Trusov, VV; Vakhrushev, IaM | 1 |
Aussel, C; Coudray-Lucas, C; Cynober, L; Giboudeau, J; Lioret, N; Saizy, R; Vaubourdolle, M | 1 |
Economou, E; Felber, JP; Fotiadou-Pappa, H; Livadas, DP; Sofroniadou, K; Temler, E; Van Melle, GD | 1 |
Castillo, M; Fernández, JM; Gualda, P; Molina-Font, JA; Osuna, JI; Rubio, R | 1 |
Hökfelt, B; Hulthén, UL; Katzman, PL | 1 |
Hirota, M; Mizuno, A; Ohboshi, C; Shima, K; Shimizu, I | 1 |
Bosch, J; Casamitjana, R; Gomis, R; Mastai, R; Navasa, M; Rivera, F; Rodés, J; Silva, G | 1 |
Kääpä, P; Knip, M; Viinikka, L; Ylikorkala, O | 2 |
Clutter, WE; Cryer, PE; Dalsky, GP; Hoelzer, DR; Holloszy, JO; Shah, SD | 1 |
Bantle, JP; Francis, R; Gaenslen, HE; Goetz, FC; Greenberg, BZ; Hoogwerf, BJ; Senske, BJ | 1 |
Astrup, A; Bülow, J; Christensen, NJ; Madsen, J; Quaade, F | 1 |
Chisholm, DJ; Furler, SM; Jenkins, AB; Kraegen, EW | 1 |
Borciani, E; Braverman, LE; d'Amato, L; Gardini, E; Maestri, D; Montermini, M; Pezzarossa, A; Robuschi, G; Roti, E; Salvi, M | 1 |
Adner, N; Nygren, A | 1 |
Bell, PM; Firth, RG; Hansen, I; Marsh, HM; Rizza, RA | 1 |
Adamson, U; Clausen, N; Efendić, S; Hamberger, B; Lins, PE | 1 |
Lefebvre, PJ; Luyckx, AS; Paolisso, G; Scheen, AJ; Verdin, EM | 1 |
Besch, W; Keilacker, H; Michaelis, D; Rjasanowski, I; Woltanski, KP; Ziegler, M | 1 |
Gerich, JE | 1 |
Harnthong, S; Nitiyanant, W; Ploybutr, S; Vannasaeng, S; Vichayanrat, A | 1 |
Jørgensen, HS; Urdahl, P | 1 |
Fyhrquist, F; Groop, L; Groop, PH; Tötterman, KJ | 2 |
Ahrén, B; Lundquist, I; Scherstén, B | 1 |
Gall, FP; Gebhardt, C; Schaller, P; Schwille, PO | 1 |
Arachi, S; Fallucca, F; Fiore, R; Gargiulo, P; Maldonato, A; Pachi, A; Pimpinella, G; Tinelli, FP; Zicari, D | 1 |
Fallucca, F; Gargiulo, P; Gerlini, G; Gori, G; Pachi, A; Pimpinella, G; Sciullo, E; Troili, F; Zicari, D | 1 |
Spangler, RS; Triebwasser, KC; Wilson, ML | 1 |
Irjala, K; Kaihola, HL; Koskinen, P; Seppälä, P; Viikari, J | 2 |
Bartosh, NH; Gannon, MC; Krezowski, PA; Nuttall, FQ | 1 |
Holland, GC; Osei, K | 1 |
Lefebvre, PJ; Luyckx, AS; Paolisso, G; Scheen, AJ | 1 |
Besch, W; Keilacker, H; Kohnert, KD; Woltanski, KP | 1 |
Angel, A; Jimenez, J; Zinman, B; Zuniga-Guajardo, S | 1 |
Clutter, WE; Cryer, PE; Schwartz, NS; Shah, SD | 1 |
Doeden, B; Rizza, R | 1 |
Hirota, M; Ikegami, H; Kumahara, Y; Shima, K; Tahara, Y; Tanaka, A | 2 |
Bezwoda, WR; Bothwell, TH; Joffe, BI; Kalk, WJ; Rumbak, MJ; Seftel, HC | 1 |
Biso, P; Buratti, P; Capelli, M; Melchionda, N; Pasquali, R; Pasqui, F; Patrono, D | 1 |
Olefsky, JM; Prager, R; Wallace, P | 1 |
Elfving, S; Kyllästinen, M | 1 |
Laakso, M; Pyörälä, K; Sarlund, H; Siitonen, O | 1 |
Laakso, M; Pyörälä, K; Sarlund, H | 1 |
Mohan, V | 1 |
Krarup, T; Kühl, C; Madsbad, S; Møller-Jensen, B; Sauerbrey, N | 1 |
Rönnemaa, T | 1 |
Andres, J; Maclaren, NK; Riley, WJ; Rosenbloom, AL; Toskes, PP; Winter, WE | 1 |
Iakhontova, OI; Pomazovskaia, A; Zaĭchik, AM | 1 |
Brodows, RG | 1 |
Harno, K; Välimäki, M; Verho, M | 1 |
Albrecht, G; Besch, W; Förster, F; Menzel, R; Pusch, H; Ratzmann, GW; Ruhnke, R | 1 |
Joffe, BI; Seftel, HC; Shires, R | 1 |
Schwartz, R; Susa, JB | 1 |
Fyhrquist, F; Groop, LC; Groop, PH | 1 |
Dimitriadis, GD; Gerich, JE; Pehling, GB | 1 |
Cryer, PE; Hansen, IL; Rizza, RA | 1 |
Avogaro, A; Baccaglini, U; Del Prato, S; Duner, E; Nosadini, R; Tiengo, A; Tremolada, C; Trevisan, R; Vigili de Kreutzenberg, S | 1 |
Capelli, M; Cassarani, S; Checchia, GA; Marchesini, G; Mattioli, L; Melli, A; Pisi, E; Zoli, M | 1 |
Aro, A; Laakso, M; Penttilä, I; Pyörälä, K; Sarlund, H; Voutilainen, E | 1 |
Colman, PG; Harrison, LC; Tait, BD | 1 |
Campisi, R; Carducci Artenisio, A; Consolo, F; Forte, F; Lettina, G; Perrone, G; Ragonese, F; Saitta, G | 1 |
Conde Yagüe, R; González Coterillo, T; Gutiérrez-Cortines Corral, MD; Ledesma Castaño, F; Ortiz Ortiz, M; Ramos Fernández, R | 1 |
Casamitjana, R; Coves, MJ; Figuerola, D; Guillén, M; Peig, M; Soriano, G | 1 |
Isakova, ZS; Karepova, ME; Logimov, AS; Vysotskaia, RA | 1 |
Cucinotta, D; De Leo, A; Di Benedetto, A; Giannetti, C; Giunta, E; Lamberti, C; Mancini, F; Tarzia, I | 1 |
Buzzelli, G; Cotrozzi, G; Gentilini, P; Matassi, L; Orioli, S; Relli, P; Simondi, P | 1 |
Frölich, M; Geelhoed-Duyvestijn, PH; Looij, BJ; Nieuwenhuijzen Kruseman, AC; Roelfsema, F | 1 |
Iwamoto, Y; Kamata, I; Kuzuya, T; Matsuda, A; Sakamoto, Y | 1 |
Groop, L; Harno, K; Nikkilä, EA; Pelkonen, R; Tolppanen, EM | 1 |
Fyhrqvist, F; Groop, L; Groop, PH; Melander, A; Tolppanen, EM; Tötterman, KJ; Wåhlin-Boll, E | 1 |
Herbertz, L; Langenbeck, U; Schauder, P | 1 |
Billesbølle, P; Kølendorf, K; Poulsen, S; Thorsteinsson, B | 2 |
Alberti, KG; Beck-Nielsen, H; Hjøllund, E; Orskov, H; Schmitz, O | 1 |
Kowarski, AA; Levin, PA; McLaughlin, J | 1 |
Besser, GM; Dawson, AM; Marks, V; Medbak, S; Penman, E; Rees, LH; Tsiolakis, D; Wass, JA | 1 |
Nagai, K; Yanaihara, N | 1 |
Coppola, L; D'Onofrio, F; Giugliano, D; Misso, L; Passariello, N; Tirelli, A | 1 |
Coppola, L; D'Onofrio, F; Giugliano, D; Misso, L; Sgambato, S; Tirelli, A | 1 |
Blanc-Brunat, N; Devonec, M; Dubernard, JM; Faure, JL; Martin, X; Traeger, J | 1 |
Alberti, KG; Del Prato, S; Duner, E; Johnston, DG; Marescotti, C; Nosadini, R | 1 |
Besch, W; Ratzmann, KP; Schulz, B; Witt, S | 2 |
Alexandre, J; Assan, R; Bessioud, M; Delprato, S; Tabbi-Anneni, A; Tiengo, A; Valverde, I | 1 |
Lunetta, M; Maugeri, D; Papalia, D; Tribulato, A; Trovato, G | 1 |
Hansen, BC; Jen, KL; Schielke, GP; Vinik, A | 1 |
Beylot, M; Chayvialle, JA; Cohen, R; Mornex, R; Rambliere, R; Riou, JP; Souquet, JC | 1 |
Efendić, S; Luft, R; Wajngot, A | 1 |
del Balzo, P; Fallucca, F; Ghirlanda, G; Giangrande, L; Marinelli, M; Pimpinella, G; Stipa, S; Tersigni, R; Zicari, D | 1 |
Cohen, DM; Jaspan, JB; Lever, EG; Moossa, AR; Polonsky, KS | 1 |
Besch, W; Heinke, P; Ratzmann, KP; Schulz, B | 1 |
Kommerell, B; Limberg, B | 1 |
Knip, M | 1 |
Hübinger, A; Müller, HJ; Vogelberg, KH | 1 |
Faber, OK; Hagen, C; Krarup, T; Nyboe Andersen, B; Thorsgaard Pedersen, NT; Worning, H | 1 |
Modnikov, OP | 1 |
Blickle, JF; Brogard, JM; Dorner, M; Pinget, M; Stahl, A | 1 |
Bockel, R; Doffoël, M; Doffoël, S; Sapin, R; Schlienger, JL; Vetter, D | 1 |
Fujisaki, K; Hashimoto, S; Kamibeppu, A; Nagahama, J; Tsubouchi, H | 1 |
Grosman, BE; Iagoda, AV; Mosin, VI | 1 |
Fukushima, H; Kitoh, M; Konno, T; Takemiya, M; Uzawa, H; Yamaguchi, K | 1 |
Landgraf, R; Spelsberg, F; Wirsching, R | 1 |
Dalle-Furnari, MA; Garraud, JC; Lefebvre, J; Lelièvre, G; Linquette, M; Luyckx, A; Mazzuca, M; Proye, C | 1 |
Kobayashi, T; Nihei, J; Ohneda, A; Sakai, T | 2 |
Bloom, SR; Polak, JM; Wood, SM | 1 |
DeFronzo, RA; Ferrannini, E; Hendler, R; Juhlin-Dannfelt, A; Koivisto, V; Sherwin, RS; Simonson, DC | 1 |
Kajikawa, K; Katsuda, S; Konishi, K; Miwa, K; Nakanishi, I; Yonemura, Y | 1 |
Chan, MK; Ho, PW; Lin, HJ; Pun, KK; Yeung, CK; Yeung, RT | 1 |
Chenon, D; Colette, C; Mirouze, J; Monnier, LH; Orsetti, A; Phaka, M | 1 |
Angeletti, G; Bolli, G; Brunetti, P; Cartechini, MG; Compagnucci, P; de Feo, P; Gerich, JE; Santeusanio, F | 1 |
Campbell, LV; Kraegen, EW; Lazarus, L | 1 |
Hollingsworth, DR | 1 |
Branca, S; Coco, R; Damante, G; Del Campo, F; Di Vincenzo, S; Ferlito, S; Fichera, C | 1 |
Ahnefeld, FW; Altemeyer, KH; Beischer, W; Breucking, E; Feist, H; Schmitz, JE; Seeling, W | 1 |
Kober, G; Rainer, OH | 1 |
Bobal, MA; Duckworth, WC; Gray, S; Himmelstein, S; Iyer, RS; Jerkins, T; Shankar, TP; Solomon, SS | 1 |
Ansorge, S; Bernstein, HG; Dorn, A; Hahn, HJ; Rinne, A; Ziegler, M | 1 |
Benito Zaballos, F; Carbajosa Herrero, T; García González, P; Pedraz García, C; Pedraz García, MJ; Salazar Villalobos, V; Soler Ripoll, JJ | 1 |
Gunnarsson, R; Ostman, J; Sjöberg, S | 1 |
Bratusch-Marrain, P; Gasić, S; Nowotny, P; Waldhäusl, WK | 1 |
Cossel, L; Lohmann, D; Mättig, H; Schade, J; Verlohren, HJ | 1 |
Hidaka, H; Klimes, I; Nagulesparan, M; Unger, RH; Vasquez, B | 1 |
Bolli, G; Brunetti, P; Compagnucci, P; De Cosmo, S; De Feo, P; Perriello, G; Santeusanio, F; Unger, RH | 1 |
Huupponen, R | 1 |
Asplin, CM; Hollander, PM; Palmer, JP | 1 |
Krzentowski, G; Lacroix, M; Lefebvre, PJ; Luyckx, AS; Mosora, F; Pirnay, F | 1 |
Bonora, E; Bosello, O; Butturini, U; Capretti, L; Cigolini, M; Coscelli, C; Zancanaro, C; Zavaroni, I | 1 |
Brogard, JM; Dorner, M; Pinget, M | 1 |
Groop, L; Taskinen, MR | 1 |
Gyr, K; Keller, U; Szöllösy, E; Varga, L | 1 |
Alberti, KG; Cook, D; Francis, AJ; Hanning, I; Heine, RJ; Orskov, H; Pernet, A; Ponchner, M | 1 |
Berger, M; Creutzfeldt, W; Ebert, R; Niederau, C; Siegel, E; Starke, A; Stremmel, W; Strohmeyer, G | 1 |
Groop, L; Tolppanen, EM | 1 |
Acosta, AM; Arteaga, A; Foradori, A; López, G; Pellegrino, MR; Szegedi, AM; Velasco, N | 1 |
Krarup, T; Madsbad, S; Tronier, B | 1 |
Castillo, M; Lefebvre, PJ; Luyckx, AS; Verdin, E | 1 |
Golubiatnikova, GA; Goriaĭnova, II; Zhumatova, MG | 1 |
Fink, M; Frisch, H; Schernthaner, G; Schober, E | 1 |
Giugliano, D | 1 |
Arias, P; Kerner, W; Navascués, I; Pfeiffer, EF; Schäfauer, G | 1 |
Besch, W; Dorn, A; Heinzmann, B; Kostmann, G; Lippert, H; Lorenz, D; Schulz, B; Wolff, H; Zander, E; Ziegler, B | 1 |
Acosta, AM; Arteaga, A; Costamaillere, L; Foradori, A; López, G; Pellegrino, MR; Velasco, N | 1 |
Diamantopoulos, E; Enzmann, F; Hadjidakis, D; Raptis, A; Raptis, S | 1 |
Landgraf, R; Landgraf-Leurs, MM | 1 |
Ametov, AS; Toritsina, LK | 1 |
Jandrain, B; Krzentowski, G; Lacroix, M; Lefebvre, P; Luyckx, A; Mosora, F; Pirnay, F | 1 |
Carey, RM; Kaiser, DL; Malchoff, CD; Pohl, SL | 1 |
Bratusch-Marrain, P; Ferenci, P; Korn, A; Nowotny, P; Waldhäusl, WK | 1 |
Baldissera, F; Holst, JJ; Pedersen, JH; Stadil, F | 1 |
Molitvoslovova, NN | 1 |
Efendić, S; Luft, R; Roovete, A; Vranić, M; Wajngot, A | 1 |
Shima, K; Tanaka, A | 1 |
Capelli, M; Ciavarella, A; Cocchi, V; Flammini, M; Forlani, G; Vannini, P | 1 |
Ceriello, A; D'Onofrio, F; Guigliano, D; Passariello, N; Sgambato, S; Torella, R | 1 |
Ratzmann, KP; Schulz, B; Witt, S | 1 |
Amamiya, N; Asayama, K; Kato, K | 1 |
Chisholm, DJ; James, DE; Jenkins, AB; Kraegen, EW | 1 |
Chiumello, G; di Natale, B; Jankovic, M; Masera, G; Meschi, F; Rondanini, GF; Uderzo, C | 1 |
Frankel, BJ; Freedman, ZR; Fujiya, H; Grodsky, GM; Karam, JH; Lewitt, PA; Nowlain, RE; Young, CW | 1 |
Emmanouel, DS; Katz, AI; Lindheimer, MD | 1 |
Anderson, GE; Francis, RS; Goetz, FC; Greenberg, BZ; Najarian, JS; Senske, BJ; Sutherland, DE | 1 |
Bernstein, HG; Dorn, A; Hahn, HJ; Rinne, A; Ziegler, M | 1 |
Asmal, AC; Omar, MA | 1 |
Agren, A; Andersson, A; Björkén, C; Groth, CG; Gunnarsson, R; Hellerström, C; Lindmark, G; Lundqvist, G; Petersson, B; Swenne, I | 1 |
Arapova, SD; Marova, EI; Zavadskiĭ, PS | 1 |
Gerich, JE; Go, VL; Nelson, RL; Rizza, RA; Service, FJ; Verdonk, CA | 1 |
Cooper, MJ; Gelder, F; Go, VL; Hall, AW; Mackie, CR; Moossa, AR; Noble, G; Rubenstein, AH; Sizemore, G; Waldmann, T; Wood, RA | 1 |
Giugliano, D; Lefebvre, PJ; Luyckx, AS | 1 |
Albisser, AM; Hanna, AK; Leibel, BS; Marliss, EB; Minuk, HL; Nakhooda, AF; Stokes, EF; Zinman, B | 1 |
Assoian, RK; Blix, PM; Rubenstein, AH; Tager, HS | 1 |
Brennan, MD; Carpenter, AM; Edis, AJ; Rubenstein, AH; Service, FJ | 1 |
Donald, RA; Ellis, MJ; Espiner, EA; Scott, RS | 1 |
Aune, S; Kåresen, R; Tronier, B | 1 |
Ginsberg-Fellner, F; Horwitz, DL; Mirel, RD; Rayfield, EJ | 1 |
Gragnoli, G; Signorini, AM; Tanganelli, I | 1 |
Kumahara, Y; Matsuyama, T; Sawazaki, N; Shima, K; Tanaka, R; Yanaihara, N | 1 |
Czyzyk, A; Heding, LG; Jayyab, AK; Krókewski, AS; Malczewski, B | 1 |
Häger, A; Heding, LG; Larsson, Y; Ludvigsson, J; Trygstad, O | 1 |
Kleinberger, G | 1 |
Alford, FP; Larkins, RG; Prince, RL | 1 |
Hanafusa, T; Nonaka, K; Tarui, S; Toyoshima, H | 1 |
Ashby, JP; Baird, JD; Frier, BM; Nairn, IM | 1 |
Ash, S; Granger, JF; Horwitz, DL; Martin, MJ; Nattrass, M; Rochman, H | 1 |
Bianchi, E; Brossa, C; Bruni, B; D'Alberto, M; Gamba, S; Regis, G; Segre, G; Turco, G | 1 |
D'Onofrio, F; Giugliano, D; Passariello, N; Sgambato, S; Torella, R | 1 |
Asplin, CM; Palmer, JP; Paquette, TL | 1 |
Ashby, JP; Frier, BM | 1 |
Bonser, AM; Garcia-Webb, P | 1 |
Berger, M; Keck, E; Starke, A; Zimmermann, H | 1 |
Lefebvre, PJ; Luyckx, AS; Mendoza, E | 1 |
Binder, C; Christiansen, C; Faber, OK; Krarup, T; Madsbad, S; McNair, P; Transbøl, I | 1 |
Krzentowski, G; Lacroix, M; Lefèbvre, PJ; Luyckx, AS; Mosora, F; Pallikarakis, N; Pirnay, F | 1 |
Borsey, DQ; Clarke, BF; Duncan, LJ; Elton, RA; Gray, RS; Kurtz, A; Rainbow, S; Smith, AF | 1 |
Cherrington, AD; Lacy, WW; Lewis, SB; Liljenquist, JE; Sinclair-Smith, BC | 1 |
Bockel, R; Doffoël, M; Imler, M; Marescarux, J; Raul, F; Schlienger, JL; Zarski, JP | 1 |
Frasier, SD; Nicoloff, JT; Penny, R; Stein, RB; Zeidler, A | 1 |
Martín Gómez, R; Roca Martínez, FJ; Rubio Rubio, JM; Zamora Madaria, E | 1 |
Agardh, CD; Ahrén, B; Lundquist, I; Scherstén, B | 1 |
Czyzyk, A; Heding, LG; Jayyab, AK; Królewski, AS; Malczewski, B | 1 |
Andres, R; Blix, PM; Elahi, D; Hershcopf, RJ; Muller, DC; Nagulesparan, M; Rubenstein, AH; Tobin, JD; Unger, RH | 1 |
Casamitjana, R; Figuerola, D; Gomis, R; Millán, M; Peig, M; Reynals, E | 1 |
Cappelletti, G; Cavagnini, F; Dubini, A; Invitti, C; Pinto, M; Polli, EE | 1 |
Beaven, DW; Donald, RA; Espiner, EA; Glatthaar, C; Smith, JR | 1 |
Barbara, L; Benfenati, F; Capelli, M; Cornia, G; Giacomoni, P; Marini, A; Miglioli, M; Pironi, L; Salera, M | 1 |
Gerich, JE; Go, VL; Haymond, MW; Ternand, C | 1 |
Hayakawa, T; Katada, N; Kato, K; Kondo, T; Noda, A; Okumura, N; Sakakibara, A; Takeici, M | 1 |
Epshteĭn, EV | 1 |
Bohannon, NV; Grodsky, GM; Karam, JH; Lorenzi, M | 1 |
Cerciello, T; Giugliano, D; Passariello, N; Sgambato, S; Torella, R; Varricchio, M | 1 |
Imagawa, K; Kodaira, T; Kumahara, Y; Nishino, T; Shima, K; Shimomura, Y; Tanaka, R | 1 |
Kubo, SH; Redmon, JB; Robertson, RP | 1 |
Badet, C; Carreau, A; Chayvialle, JA; Laville, M; Mornex, R; Riou, JP; Rousset, H | 1 |
Koivisto, V | 1 |
Bonetti, F; Cortona, L; De Stefano, P; Locatelli, F; Lorini, R; Scaramuzza, A; Severi, F | 1 |
Berger, W; Girard, J; Keller, U; Laager, R; Winiger, G | 1 |
Prasanna, BM; Shah, P; Sidhu, SS; Srikanta, SS; Tandon, RK | 1 |
Alberti, KG; Ashworth, LA; Cooper, BG; Gibson, GJ; White, JE | 1 |
Creutzfeldt, W; Holst, JJ; Nauck, MA; Orskov, C; Qualmann, C | 1 |
Hasumi, S; Kawai, K; Kuroki, H; Maruyama, A; Miyazono, Y; Omori, Y; Owada, K; Wasada, T; Yano, K; Yoshino, H | 1 |
Gama, R; Marks, V; Teale, JD; Wright, J | 1 |
Campbell, LV; Chisholm, DJ; Furler, SM; Jenkins, AB; Kraegen, EW; Markovic, TP | 1 |
Bonfatti, D; Caldara, R; Caumo, A; Di Carlo, V; Monti, LD; Pozza, G; Secchi, A | 1 |
Blomqvist, BI; Hammarqvist, F; von der Decken, A; Wernerman, J | 1 |
Hasegawa, H; Iwasaki, Y; Kondo, K; Oiso, Y | 1 |
Alberti, KG; Berrish, TS; Hetherington, CS; Walker, M | 1 |
Holst, JJ; Nauck, MA; Orskov, C; Ritzel, R | 1 |
Agostini, G; Brambilla, P; Caumo, A; Cobelli, C; Galli-Kienle, M; Magni, F; Monti, LD; Poma, R; Stefani, I; Tomasini, L | 1 |
Abiru, N; Akazawa, S; Ishibasi, M; Kawasaki, E; Matsumoto, K; Matsuo, H; Uotani, S; Yamamoto, H; Yamasaki, H; Yano, M | 1 |
Bloom, SR; Ghatei, MA; Kruszynska, YT; McIntyre, N | 1 |
de Boer, H; Groeneveld, AB; Nauta, JP; Strack van Schijndel, RJ; Thijs, LG; Voerman, BJ | 1 |
Araki, S; Hashiramoto, M; Ishida, Y; Kanda, E; Kasuga, M; Kazumi, T; Kishimoto, M | 1 |
Finegold, M; Kolodka, TM; Moss, L; Woo, SL | 1 |
Fouque, D; Kopple, JD; Peng, SC | 1 |
Ebener, K; Federlin, K; Laube, H; Linn, T; Raptis, G | 1 |
Abildgaard, N; Alberti, KG; Møller, N; Orskov, L; Petersen, JA; Schmitz, O | 1 |
Bornscheuer, A; Brabant, G; Kiuchi, T; Kuse, ER; Okamoto, S; Oldhafer, KJ; Pichlmayr, R; Ringe, B; Yamaoka, Y | 1 |
Alberti, KG; Bagger, JP; Jørgensen, JO; Møller, J; Møller, N; Orskov, H; Ovesen, P; Schmitz, O | 1 |
Behme, MT; Dupre, J; Hramiak, IM; McDonald, TJ; McFarlane, P; Williamson, MP; Zabel, P | 1 |
Casals, MM; Clark, WS; Gebhart, SP; Mixon, PS; Phillips, LS; Umpierrez, GE | 1 |
Bednarczyk-Kałuzny, M; Jonderko, G; Krzewiński, W; Kucharz, EJ; Straszecka, J | 1 |
Beljic, T; Miric, M | 1 |
Hinds, A; Parsons, HG; Sheehan, AG | 1 |
Beck-Nielsen, H; Henriksen, JE; Holm, N; Madsbad, S; Vaag, A | 1 |
Coggan, AR; Habash, DL; Kien, CL; Mendenhall, LA; Swanson, SC | 1 |
Berlin, I; Blacker, C; Cesselin, F; Chalon, S; Fuseau, E; Landault, C; Puech, AJ; Rosenzweig, P | 1 |
Baruffaldi, L; Caumo, A; Cobelli, C; Costa, S; Garbetta, F; Monti, LD; Piatti, PM; Pontiroli, AE; Pozza, G; Santambrogio, G | 1 |
Blostein, AC; Craig, BW; Edwards, BA; Goodpaster, B; Hickey, MS; Trappe, SW | 1 |
Arutiunova, MV; Khalmuratova, RA; Sativoldyev, MM | 1 |
Gabbe, SG; Landon, MB; O'Dorisio, T; Osei, K; Platt, M; Samuels, P | 1 |
Andreani, D; Baroni, MG; Boccuni, ML; Buzzetti, R; Cavallo, MG; Fioriti, E; Lucentini, L; Pozzilli, P; Signore, A; Visalli, N | 1 |
Mason, GF; Price, TB; Rothman, DL; Shulman, GI; Shulman, RG; Taylor, R | 1 |
Huisman, WM; Jacobs, ML; van der Linden, WH; Verhoog, S; Wallenburg, HC; Weber, RF | 1 |
Efendić, S; Gutniak, MK; Holst, JJ; Linde, B | 1 |
Duckworth, WC; Frisbie, K; Larsen, JL; Miller, SA; Ruby, EI; Stratta, RJ; Taylor, RJ; Tran, MP | 1 |
Annibale, B; Ciofetta, M; Di Vincenzo, A; Epifano, L; Fanelli, C; Lalli, C; Lepore, M; Modarelli, F; Pampanelli, S; Rambotti, AM | 1 |
Basso, D; Briani, G; Burlina, A; D'Angeli, F; Del Favero, G; Ferrara, C; Fogar, P; Meggiato, T; Panozzo, MP; Plebani, M | 1 |
D'Alessandro, B; Esposito, D; Esposito, V; Lo Iudice, G; Rispoli, C; Verrillo, A | 1 |
Colzi, G; Cresci, B; Galli, G; Giannini, S; Mannucci, E; Messeri, G; Piani, F; Rizzello, SM; Rotella, CM; Vannini, R | 1 |
Blankenstein, MA; Hackeng, WH; Höppener, JW; Lips, CJ; Nieuwenhuis, MG; van Hulst, KL; van Jaarsveld, BC | 1 |
Andreasen, JJ; Holst, JJ; Orskov, C | 1 |
Kowalska, K; Kowalski, D; Piestrak, J; Przybyłowski, J; Siedlecki, J | 1 |
Cathelineau, G; Gautier, JF; Jandrain, B; Lacroix, M; Lefèbvre, PJ; Mosora, F; Pirnay, F; Scheen, AJ | 1 |
Kääpä, P; Knip, M; Koivisto, M | 1 |
Bagger, JP; Bøtker, HE; Mengel, A; Møller, N; Orskov, H; Ovesen, P; Schmitz, O | 1 |
Beger, HG; Bittner, R; Büchler, M; Butters, M; Nägele, S; Roscher, R | 1 |
Bruno, A; Cassader, M; Cavallo-Perin, P; Gruden, G; Pagano, G; Scaglione, L | 1 |
Boyle, PJ; Comstock, E; Hoffman, C; Krentz, AJ; Nagy, RJ; Scott, JC | 1 |
De Sio, G; Ippoliti, M; Monteburini, T; Recchioni, A; Refe, A; Testa, I; Testa, R | 1 |
Boulware, SD; Gesundheit, N; Rennert, NJ; Sherwin, RS; Tamborlane, WV | 1 |
Cavallero, E; Dachet, C; Jacotot, B; Mathe, D; Neufcour, D; Wirquin, E | 1 |
Barrou, Z; Robertson, RP; Seaquist, ER | 1 |
Orwoll, E; Prince, M; Riddle, M | 1 |
O'Dorisio, TM; Osei, K; Schuster, D | 1 |
Boulware, SD; Caprio, S; Kerr, D; Rennert, NJ; Sherwin, RS; Tamborlane, WV | 1 |
Cryer, PE; Dagogo-Jack, S; Rattarasarn, C; Zachwieja, JJ | 1 |
Cherrington, AD; Davis, SN; Goldstein, RE; Price, L | 1 |
Guan, RJ | 1 |
Cozzolino, D; D'Onofrio, F; Di Maro, G; Lefebvre, PJ; Paolisso, G; Scheen, A; Varricchio, M | 1 |
Ahnefeld, FW; Anhäupl, T; Ensinger, H; Geisser, W; Georgieff, M; Träger, K; Vogt, J | 1 |
Alzaid, A; Dinneen, S; Miles, J; Rizza, R | 1 |
de Boer, H; Groeneveld, AB; Nauta, JP; Strack van Schijndel, RJ; Thijs, LG; van der Veen, EA; Voerman, HJ | 1 |
Craft, S; Cryer, P; Havlin, CE; Towler, DA | 1 |
Keller, U; Laager, R | 1 |
Ercan, N; Gannon, MC; Nuttall, FQ; Redmon, JB; Sheridan, KJ | 1 |
Chauvet, D; Darmaun, D; Leblanc, H; Robert, JJ | 1 |
Balázsi, I; Hargitai, G; Takács, J | 1 |
Duckworth, WC; Hirst, K; Larsen, JL; Miller, SA; Ozaki, C; Stratta, RJ; Taylor, RJ | 1 |
Cersosimo, E; Coppack, S; Jensen, M | 1 |
Elahi, D; Fukagawa, NK; McAloon-Dyke, M; Miles, JM; Minaker, KL; Rubenstein, AH; Sclater, AL; Shannon, RP; Vandepol, CJ; Wong, GA | 1 |
Caumo, A; Cobelli, C; Homan, M; Jensen, M; Katz, H; Rizza, R | 1 |
Boyle, PJ; Krentz, AJ; Macdonald, LM; Schade, DS | 1 |
De Fronzo, RA; Petrides, AS | 1 |
Sadokov, VM; Vinokurova, LV | 1 |
Frier, BM; Hepburn, DA; MacLeod, KM | 1 |
Laitinen, J; Pyörälä, K; Siitonen, O; Uusitupa, M; Vanninen, E | 1 |
Ercan, N; Gannon, MC; Nuttall, FQ; Westphal, SA | 1 |
Fernlund, P; Gottsäter, A; Landin-Olsson, M; Lernmark, A; Sundkvist, G | 1 |
Abourizk, NN; Lyons, RW; Madden, GM | 1 |
Balint-Peric, LA; Prelevic, GM; Sönksen, PH; Wheeler, M; Wurzburger, MI | 1 |
Arnqvist, H; Asplund, J; Olsson, PO | 1 |
Gautier, JF; Jandrain, BJ; Lacroix, M; Mosora, F; Normand, S; Pachiaudi, C; Pallikarakis, N; Pirnay, F; Riou, JP; Scheen, AJ | 1 |
Matthews, DE; Petrides, AS; Schulze-Berge, D; Strohmeyer, G; Vogt, C | 1 |
O'Brien, PC; O'Brien, T; Service, FJ | 1 |
Ditzler, TM; Gumbiner, B; Henry, RR; Joyce, M; Murata, C; Song, YM; Suh, KI | 1 |
Hirsch, L; Levitt, NS; Polonsky, KS; Rubenstein, AH | 1 |
Ekstrand, A; Eriksson, J; Forsblom, C; Groop, L; Groop, PH; Teppo, AM; Widén, E | 1 |
Cryer, PE; Wiethop, BV | 2 |
Goriya, Y; Iwama, N; Kajimoto, Y; Kamada, T; Katsura, M; Kawamori, R; Kubota, M; Shichiri, M; Yamasaki, Y | 1 |
Inoue, S; Numata, K; Saito, M; Shishido, T; Tanaka, K | 1 |
Ahlfors, K; Ivarsson, SA; Lindberg, B; Nilsson, KO; Svanberg, L | 1 |
Johansson, BL; Kernell, A; Sjöberg, S; Wahren, J | 1 |
Aoki, TT; Foss, MC | 1 |
Kerr, D; Rife, F; Sherwin, RS; Tamborlane, WV | 1 |
Creutzfeldt, W; Ebert, R; Heimesaat, MM; Holst, JJ; Nauck, MA; Orskov, C | 1 |
Boldt, J; Dapper, F; Dünnes, S; Hempelmann, G; Knothe, C; Zickmann, B | 1 |
Erkelens, DW; Hoekstra, JB; van der Feltz, M | 1 |
Kerp, L; Rössle, M; Storch, MJ | 1 |
Christiansen, E; Madsbad, S; Rasmussen, K; Tibell, A; Tydén, G | 1 |
Ceriello, A; Consoli, G; D'Onofrio, F; De Rosa, N; Giugliano, D; Minei, A; Quatraro, A | 1 |
Caprio, S; Gerow, K; Sherwin, RS; Tamborlane, WV; Zych, K | 1 |
Birkenhäger, JC; Docter, R; Fauser, BC; Jacobs, ML; Loriaux, DL; Pache, TD; Weber, RF | 1 |
Alberti, KG; Berrish, TS; Cooper, BG; Elliott, C; Orskov, H; Reed, JW; Walker, M | 1 |
Butler, P; Caumo, A; Cobelli, C; Homan, M; Katz, H; Rizza, R; Zerman, A | 1 |
Alberti, KG; Møller, N; Ovesen, P; Pørksen, N | 1 |
Holst, JJ; Koch, C; Lanng, S; Nerup, J; Orskov, C; Røder, ME; Thorsteinsson, B | 1 |
Holst, JJ; Orskov, C; Wettergren, A | 1 |
Alford, FP; Best, JD; Galvin, P; Pestell, RG; Ward, GM | 1 |
Alberti, KG; Farrer, M; Fulcher, GR; Johnson, AS; Walker, M | 1 |
Akimoto, K; Hayakawa, K; Matsukura, S; Nakazato, M | 1 |
Erkelens, DW; Hackeng, WH; Lips, CJ; van Jaarsveld, BC | 1 |
Arnold, R; Fuder, H; Göke, B; Kleist, P; Littke, T; Lücker, PW; Stridde, E; Theiss, U; Wieckhorst, G | 1 |
Brkić, S; Dimitrijević, V; Dordević, PB; Dragasević, M; Jotić, A; Lalić, K; Lalić, NM; Paunović, I; Popović, S; Zamaklar, M | 1 |
Arnold, R; Göke, B; Katschinski, M; Schäfer, T; Schirra, J; Wank, U; Weidmann, C | 1 |
Arai, M; Funatomi, H; Hatta, Y; Kaneko, K; Mitamura, K | 1 |
Cline, GW; Gerow, K; Hwang, JH; Perseghin, G; Petersen, KF; Roden, M; Rothman, DL; Shulman, GI | 1 |
Grossman, EB; Gumbiner, B; Low, CC | 1 |
Andreasen, F; Bak, JF; Møller, N; Orskov, L; Richter, EA; Schmitz, O; Skjaerbaek, C | 1 |
Cozzolino, D; Giugliano, D; Lefebvre, PJ; Salvatore, T; Sasso, FC; Sessa, G; Torella, R | 1 |
Battezzati, A; Bianchi, E; Brambilla, E; Brandhorst, D; Brandhorst, H; Bretzel, RG; Di Carlo, V; Falqui, L; Federlin, K; Gennari, L; Hering, BJ; Luzi, L; Maffi, P; Mazzaferro, V; Perseghin, G; Pozza, G; Raptis, G; Regalia, E; Secchi, A; Socci, C; Terruzzi, I | 1 |
Holst, JJ; Nauck, MA; Orskov, C; Siemsglüss, J | 1 |
Bier, D; Bucci, A; Dailey, G; Gerich, J; Jansson, PA; Jenssen, T; Nurjhan, N; Perriello, G; Stumvoll, M; Welle, S | 1 |
Craft, S; Cryer, PE; Fanelli, CG; Hershey, T; Hvidberg, A; Terkamp, C | 1 |
Cheli, V; Ciuchi, E; Giusti, R; Melga, P; Odetti, P; Prando, R | 1 |
Clodi, M; Klauser, R; Kotzmann, H; Linkesch, M; Ludvik, B; Luger, A; Prager, R; Schernthaner, G | 1 |
Bartocci, L; Bolli, GB; Brunetti, P; Ciofetta, M; Del Sindaco, P; Ialli, C; Lepore, M; Pampanelli, S; Torlone, E | 1 |
Assan, R; Boitard, C; Deschamps, I; Jos, J; Laborde, K; Rakotoambinina, B; Robert, JJ; Timsit, J | 1 |
Camisasca, R; Pacchioni, M; Pontiroli, AE; Pozza, G | 1 |
Creutzfeldt, WO; Holst, JJ; Kleine, N; Nauck, MA; Orskov, C; Willms, B | 1 |
Engelman, K; Teff, KL | 1 |
Gudat, U; Heinemann, L | 1 |
Beattie, GM; Hayek, A; Mally, MI; Otonkoski, T; Rubin, JS | 1 |
Bolli, GB; Brunetti, P; Cruciani, G; De Feo, P; Lucidi, P; Monacchia, F; Reboldi, G; Volpi, E | 1 |
Becker, HD; Benz, S; Büsing, M; Gwodzinski, A; Hopt, UT; Nauck, MA; Pfeffer, F; Zink, R | 1 |
Gama, R; Hampton, S; Marks, V; Morgan, L; Norris, F; Watkins, S; Wright, J | 1 |
Carroll, R; Chan, SJ; Gong, Q; Martin, S; Rouillé, Y; Steiner, DF | 1 |
Berne, C; Björk, E; Kämpe, O; Karlsson, FA; Oskarsson, P; Wibell, L | 1 |
Bedford, C; George, E; Hardisty, CA; Harris, N; Heller, SR; Macdonald, IA; Peacey, SR; Rostami-Hodjegan, A; Tucker, GT | 1 |
Albert, SG; Bernbaum, M; Mooradian, AD; Plummer, S | 1 |
Birkenholz, M; Kabadi, M; Kabadi, UM; McCoy, S | 1 |
Bolli, G; Brunetti, P; Del Sindaco, P; Di Vincenzo, A; Epifano, L; Kassi, G; Lalli, C; Modarelli, F; Pampanelli, S; Perriello, G; Rambotti, AM; Torlone, E | 1 |
Alberti, KG; Holst, JJ; Møller, J; Møller, N; Orskov, C; Orskov, L; Schmitz, O | 1 |
Erbaş, T; Gedik, O; Gürlek, A; Sayinalp, S | 1 |
Bizzarro, A; Capaldo, B; Corigliano, G; De Bellis, A; Di Bonito, P; Pace, E; Turco, S | 1 |
Efendic, S; Gutniak, M; Hamsten, A; Juntti-Berggren, L; Karpe, F; Pigon, J; Vignati, L | 1 |
Edelman, SV; Henry, RR; Kelley, DE | 1 |
Geyer, R; Laube, H; Linn, T; Prassek, S | 1 |
Creutzfeldt, W; Holst, JJ; Nauck, MA; Orskov, C; Werner, J; Willms, B; Wollschläger, D | 1 |
Corssmit, EP; Endert, E; Romijn, JA; Sauerwein, HP | 1 |
Castillo, MJ; Lefèbvre, PJ; Scheen, AJ | 2 |
Furmanenko, ED; Kozhara, SP; Lifshits, IuZ; Usenko, AIu | 1 |
Bonicki, W; Kasperska-Dworak, A; Lewandowski, Z; Piniewska-Hułas, D | 1 |
Alberti, KG; Bhat, DS; Hockaday, TD; Naik, SS; Orskov, H; Raut, KN; Sardesai, BS; Shelgikar, KM; Yajnik, CS | 1 |
Arai, Y; Imamura, K; Ishii, M; Machida, K; Nakamura, T; Suda, T; Takebe, K; Tandoh, Y; Terada, A; Yamada, N | 1 |
Atkinson, P; Behme, MT; Dupré, J; Guan, J; Zhong, R; Zucker, PF | 1 |
Holst, JJ; Keller, U; Shalev, A | 1 |
Behme, MT; Dupré, J; Hramiak, IM; McDonald, TJ | 1 |
Caprio, S; Limb, C; Pederson, R; Sherwin, RS; Tamborlane, WV | 1 |
Amiel, SA; Cranston, I; Evans, M; Lomas, J; Macdonald, I; Matyka, K | 1 |
Dyck, PJ; Melton, LJ; O'Brien, PC; Rizza, RA; Service, FJ; Zimmerman, BR | 1 |
Giacca, A; Lewis, GF; Vranic, M | 1 |
Bier, DM; Bucci, A; Dailey, G; Gerich, JE; Jenssen, TG; Nurjhan, N; Perriello, G; Stumvoll, M; Toft, I; Welle, S | 1 |
Johansson, BL; Leclercq-Meyer, V; Malaisse, WJ; Wahren, J | 1 |
Zalewski, L | 1 |
George, E; Heller, SR; Peacey, SR; Rostami-Hodjegan, A; Tucker, GT | 1 |
Kuikka, JT; Turpeinen, AK; Uusitupa, MI; Vanninen, E | 1 |
Emoto, M; Oka, Y; Sato, Y | 1 |
Nielsen, M; Rizza, R; Wise, S | 1 |
Giacca, A; Harley, P; Lewis, GF; Vranic, M | 1 |
Birkeland, K; Bjørgaas, M; Jorde, R; Sager, G; Sand, T; Vea, H; Vik, T | 1 |
Christiansen, E; Holst, JJ; Madsbad, S; Rasmussen, K; Schäffer, L; Tibell, A; Vølund, AA | 1 |
Aarsen, M; Draeger, KE; Heine, RJ; Martini, C; van der Wal, PS; van Iperen, AM | 1 |
Becker, YT; Blair, KT; Bradley, AL; Chapman, WC; Donovan, KL; Drougas, JG; Flakoll, PJ; Jabbour, K; Pinson, CW; Sika, M; Van Buren, DH; Williams, PE; Wright, JK | 1 |
Berneis, K; Frey, BM; Girard, J; Keller, U; Ninnis, R | 1 |
Brismar, K; Ekberg, K; Fernqvist-Forbes, E; Hilding, A | 1 |
Baratti, D; Battezzati, A; Bozzetti, F; Luzi, L; Mazzaferro, V; Perseghin, G; Pulvirenti, A; Regalia, E; Terruzzi, I; Vergani, S | 1 |
Adamson, U; Johansson, BL; Lins, PE; Oskarsson, P | 1 |
Ahrén, B; Filipsson, K; Holst, J; Tornøe, K | 1 |
Angelopoulos, TJ; Fatouros, IG; Gao, J; Goldfarb, AH; Jamurtas, AZ | 1 |
Ihm, SH; Lee, KU; Park, JY; Park, SW; Yoo, HJ | 1 |
Basu, TK; McBurney, MI; Ooraikul, B; Rajotte, RV; Reimer, RA; Thomson, AB | 1 |
DeFronzo, RA; Haywood, JR; Koopmans, SJ; Mandarino, LJ; Ohman, L | 1 |
Eisfelder, B; Schnell, O; Standl, E; Ziegler, AG | 1 |
Ettler, R; Holst, JJ; Nauck, MA; Niedereichholz, U; Orskov, C; Ritzel, R; Schmiegel, WH | 1 |
Basu, A; Dinneen, SF; Nielsen, MF; Rizza, RA; Schwenk, WF; Wise, S | 1 |
Chrousos, GP; Defensor, R; Kyrou, I; Mitsiadis, CS; Papanicolaou, DA; Tsigos, C | 1 |
Baloga, J; Bell, JM; Joyce, M; Ludvik, B; Nolan, JJ; Olefsky, JM; Roberts, A | 1 |
Kinalska, I; Kinalski, M; Zarzycka, B; Zarzycki, W | 1 |
Butler, PC; Grøfte, B; Holst, JJ; Nyholm, B; Pincus, SM; Pørksen, N; Schmitz, O; Veldhuis, JD | 1 |
Adner, N; Gutniak, M; Holst, JJ; Svartberg, J | 1 |
Alford, FP; Arackal, R; Barton, J; Best, JD; Boston, RC; Walters, JM; Ward, GM | 1 |
Camilleri, M; Dinneen, SF; Frank, JW; Rizza, RA; Thomforde, GM | 1 |
Bouillon, R; Coulie, B; Janssens, J; Peeters, T; Tack, J | 1 |
Arnold, R; Byrne, MM; Göke, B; Katschinski, M; Pluntke, K; Schirra, J; Wank, U | 1 |
Goulas, S; Kruszynska, YT; McIntyre, N; Wollen, N | 1 |
Arnold, R; Göke, B; Katschinski, M; Leicht, P; Schirra, J; Sturm, K | 1 |
Berne, C; Björk, E; Karlsson, FA | 1 |
Aiache, JM; Cardot, JM; Saffar, F | 1 |
Bungert, S; Gudat, U; Heinemann, L; Kemmer, F | 1 |
Bouwens, L; Delvaux, G; Gorus, FK; Grupping, A; Hendrieckx, C; Keymeulen, B; Ling, Z; Pipeleers, DG; Pipeleers-Marichal, M; Salmela, K; Van Schravendijk, C | 1 |
Armstrong, E; Blackshaw, PE; Buchanan, KD; King, P; Kong, MF; Macdonald, IA; Perkins, AC; Tattersall, RB | 1 |
Keller, U; Ninnis, R; Shalev, A | 1 |
Binder, C; Christiansen, E; Kjems, LL; Madsbad, S; Tibell, A; Vølund, A | 1 |
Alford, FP; Beck-Nielsen, H; Henriksen, JE; Hew, LF; Rantzau, C; Vaag, A; Ward, GM | 1 |
Creutzfeldt, W; Holst, JJ; Idowu, K; Nauck, MA; Willms, B | 1 |
Akai, H; Chiba, M; Hinokio, Y; Hirai, A; Hirai, M; Kasuga, S; Ohtomo, M; Satoh, Y; Suzuki, S; Toyota, T | 1 |
Bergmann, J; Holst, JJ; Nauck, MA; Ritzel, R; Schmiegel, W; Seifarth, C | 1 |
Cuttitta, F; Martínez, A; Teitelman, G | 1 |
Atkison, P; Behme, MT; Dupré, J; Guan, J; Hramiak, I; Zhong, R; Zucker, P | 1 |
Hirshberg, B; Raz, I; Trelezky, V | 1 |
Cryer, PE; Nielsen, MF; Rizza, RA; Wise, SD | 1 |
Cseh, K; Salamon, D; Salamon, F; Simon, K; Speer, G; Winkler, G | 1 |
Brismar, K; Efendic, S; Karpe, F; Ljungqvist, O; Nair, KS; Nygren, JO; Soop, M; Thorell, A | 1 |
Caffarri, G; Caiazza, A; Capretti, L; Chiodera, P; Coiro, V; Giuliani, N; Volpi, R | 1 |
Aharon, Y; Giacca, A; Hawkins, M; Mevorach, M; Rossetti, L; Shamoon, H | 1 |
Gutniak, M; Hellström, PM; Näslund, E; Rössner, S; Skogar, S | 1 |
Ahrén, B; Pacini, G | 1 |
Alzaid, A; Basu, A; Basu, R; Dinneen, S; Nielsen, MF; Rizza, RR | 1 |
Barreca, T; Bruno, E; Cataldi, A; Corsini, G; Franceschini, R; Robaudo, C; Rolandi, E; Russo, R | 1 |
Couch, RM; Elliott, JF; Marlin, KL | 1 |
Basu, R; Caumo, A; Cobelli, C; Nielsen, MF; Rizza, RA; Wise, S | 1 |
Holst, JJ; Madsbad, S; Toft-Nielsen, M | 1 |
Holst, JJ; Nauck, MA; Ritzel, R; Sauerwald, A; Schmiegel, W | 1 |
Cryer, PE; Fanelli, CG; Paramore, DS; Shah, SD | 1 |
Askari, H; Dagogo-Jack, S; Franklin, SC; Liu, J; Miller, SB; Vijayan, A | 1 |
Bach, I; Holst, JJ; Nauck, MA; Orskov, C; Richter, S; Schmiegel, W; Weber, I | 1 |
Cseh, K; Hajós, P; Harmos, G; Kovács, M; Salamon, D; Salamon, F; Simon, K; Speer, G; Szekeres, O; Winkler, G | 1 |
Edvell, A; Lindström, P | 1 |
Carpentier, A; Giacca, A; Lewis, GF; Vranic, M | 1 |
Barazzoni, R; Tessari, P; Tiengo, A; Zanetti, M | 1 |
Armstrong, E; Blackshaw, PE; Buchanan, KD; Horowitz, M; King, P; Kong, MF; Macdonald, IA; Perkins, AC; Tattersall, RB | 1 |
Frayn, KN; Levy, JC; Manley, SE; Morris, RJ; Turner, RC; Widjaja, A | 1 |
Binder, C; Dinesen, B; Hartling, SG; Houssa, P; Røder, ME; Sodoyez-Goffaux, F; Vestergaard, H | 1 |
Barkeling, B; Blundell, JE; Gutniak, M; Hellström, PM; Holst, JJ; King, N; Näslund, E; Rössner, S | 1 |
Hiroyoshi, M; Ikeda, S; Maeshiro, K; Matsuoka, Y; Ono, J; Tateishi, K; Yasunami, Y | 1 |
Isotani, H; Kameoka, K | 1 |
Hamaguchi, T; Hanafusa, T; Higashiyama, S; Horikawa, Y; Imagawa, A; Iwahashi, H; Matsuzawa, Y; Miyagawa, J; Miyazaki, J; Nakajima, H; Namba, M; Okita, K; Oue, T; Satoh, T; Yamagata, K; Yamamoto, K; Yamasaki, T; Yang, Q; Yoshiuchi, I | 1 |
Adeghate, E | 1 |
Holst, JJ; Madsbad, S; Toft-Nielsen, MB | 2 |
Basu, A; Basu, R; Nielsen, M; Rizza, RA; Shah, P | 1 |
Brandão-Neto, J; da Cunha, NF; da Silva, CA; Dourado, FB; Figueiredo, NB; Naves, LA; Shuhama, T | 1 |
Bohrer, A; Cryer, PE; Dagogo-Jack, S; Halban, PA; Powderly, WG; Sigmund, C; Tebas, P; Turk, J; Yarasheski, KE | 1 |
Franzese, A; Laforenza, U; Patrini, C; Poggi, V; Tenore, A; Valerio, G | 1 |
Basu, A; Basu, R; Rizza, R; Shah, P | 1 |
Adamson, U; Landstedt-Hallin, L; Lins, PE | 1 |
Alvarsson, M; Clauson, P; Grill, V | 1 |
Abbott, DH; Dumesic, DA; Eisner, JR; Nair, KS; Nielsen, MF; Rizza, RA | 1 |
Alberti, KG; Gravholt, CH; Holst, JJ; Nyholm, B; Schmitz, O; Shearing, PA; Sturis, J; Walker, M | 1 |
Hedetoft, C; Holst, JJ; Larsen, S; Sheikh, SP | 1 |
Adamson, UC; Lins, PE; Oskarsson, PR; Wallberg Henriksson, H | 1 |
Carlsson, A; Groop, L; Sundkvist, G; Tuomi, T | 1 |
Brand-Miller, JC; Colagiuri, S; Gan, ST | 1 |
Chhibber, VL; Soriano, C; Tayek, JA | 1 |
Alevizaki, CC; Alevizaki, M; Anastasiou, E; Beis, C; Grigorakis, SI; Souvatzoglou, A | 1 |
Andereggen, E; Bühler, L; Crétin, N; Fournier, B; Goumaz, C; Lou, J; Mage, R; Morel, P; Oberholzer, J; Philippe, J; Triponez, F | 1 |
Bruining, HA; Buscher, HC; Jacobs, ML; Ong, GL; van Goor, H; Weber, RF | 1 |
Battezzati, A; Caumo, A; Di Carlo, V; Luzi, L; Perseghin, G; Terruzzi, I; Zerbi, A | 1 |
Fritsche, A; Hardt, E; Häring, H; Schützenauer, S; Stefan, N; Stumvoll, M | 1 |
Chan, JC; Cockram, CS; Li, JK; Mackay, IR; Rowley, MJ; Zimmet, PZ | 1 |
Dinesen, B; Holst, JJ; Krarup, T; Madsbad, S; Toft-Nielsen, MB; Vilsbøll, T | 1 |
Ackermans, MT; Bisschop, PH; Endert, E; Kuipers, F; Meijer, AJ; Pereira Arias, AM; Pijl, H; Romijn, JA; Sauerwein, HP | 1 |
Holst, JJ; Juhl, CB; Pincus, S; Pørksen, N; Schmitz, O; Veldhuis, J | 1 |
Bell, GI; D'Souza, E; Fajans, SS; Herman, WH; Ilag, LL; Tabaei, BP; Zawacki, CM | 1 |
Basu, A; Basu, R; Holst, JJ; Rizza, RA; Shah, P; Vella, A | 1 |
Brabant, G; Frayn, KN; Horn, R; Humphreys, SM; Levy, JC; Morris, RJ; Turner, RC; von zur Mühlen, A; Widjaja, A | 1 |
Birkeland, K; Dejgaard, A; Hanssen, KF; Kjems, L; Madsbad, S; Rosenfalck, AM; Thorsby, P | 1 |
Benz, S; Erb, M; Hopt, U; Müller, T; Nauck, MA; Pfeffer, F; Schmiegel, W | 1 |
Fritsche, A; Hardt, E; Häring, H; Stefan, N; Stumvoll, M | 1 |
Hansen, JB; Hornum, L; Mandrup-Poulsen, T; Markholst, H; Rasmussen, SB; Sørensen, TS | 1 |
Brostrom, L; Brunicardi, FC; Colonna, J; Dyen, Y; Gelabert, H; Gingerich, R; Kleinman, R | 1 |
Brunengraber, H; Chandramouli, V; Efendic, S; Landau, BR; Schumann, WC; Wajngot, A | 1 |
Chin, GA; Clarke, WL; Clocquet, AR; Egan, JM; Elahi, D; Habener, JF; Hanks, JB; Muller, DC; Stoffers, DA; Wideman, L | 1 |
Basu, A; Basu, R; Rizza, RA; Schwenk, WF; Shah, P; Vella, A | 1 |
Beck-Nielsen, H; Eshøj, O; Hojlund, K; Holst, JJ; Koldkjaer, O; Møller Jensen, D; Skjaerbaek, C; Wildner-Christensen, M | 1 |
Denisova, TP; Malinov, IA | 1 |
Bischof, MG; Fürnsinn, C; Krebs, M; Krssák, M; Nowotny, P; Roden, M; Shulman, GI; Stingl, H; Waldhäusl, W | 1 |
Askari, H; Dagogo-Jack, S; Kim, B; Lehner, LL; Morrill, B; Sha, X | 1 |
Damberg, G; Gannon, MC; Gupta, V; Nuttall, FQ; Nuttall, JA | 1 |
Basu, A; Basu, R; Camilleri, M; Holst, JJ; Rizza, RA; Schwenk, FW; Shah, P; Vella, A | 1 |
Deacon, CF; Holst, JJ; Krarup, T; Madsbad, S; Vilsbøll, T | 1 |
Holst, JJ; Krarup, T; Madsbad, S; Vilsbøll, T | 3 |
Bernroider, E; Bischof, MG; Krebs, M; Krssak, M; Roden, M; Stingl, H; Waldhäusl, W | 1 |
AvRuskin, TW; Banerji, MA; Bastian, W; Castells, S; Taha, D; Umpaichitra, V | 1 |
Choi, CS; Kim, SK; Koh, JJ; Lee, HK; Lee, KU; Park, DJ; Park, KS; Shin, CS; Song, JH | 1 |
Holst, JJ; Madsbad, S; Taskiran, M; Toft-Nielsen, MB; Zander, M | 1 |
Alford, FP; Barton, J; Boston, RC; Walters, JM; Ward, GM | 1 |
Efendic, S; Kindmark, H; Pigon, J | 1 |
Christiansen, JS; Gravholt, CH; Jensen, MD; Møller, N; Schmitz, O | 1 |
Egan, JM; Elahi, D; Gingerich, R; Habener, JF; McIntosh, CH; Meneilly, GS; Pederson, RA | 2 |
Brandão-Neto, J; Oba, L; Shuhama, T; Silva, CA; Silva, JA | 1 |
Bonner-Weir, S; Lopez-Avalos, MD; Sharma, A; Tatarkiewicz, K; Weir, GC | 1 |
Beck-Nielsen, H; Holst, JJ; Hother-Nielsen, O; Levin, K; Staehr, P | 1 |
Contesse, J; Reinhart, WH; Rohrer, A; Schnyder, L; Walter, R | 1 |
Blount, ED; Jain, K; Magariños, AM; McEwen, BS; Reagan, L; Smith, BH | 1 |
Cobelli, C; Golling, M; Klar, E; Konrad, T; Mahon, A; Toffolo, G; Usadel, K; Vicini, P; Wittman, M | 1 |
Brändle, M; Lehmann, R; Maly, FE; Schmid, C; Spinas, GA | 1 |
Clark, SJ; Croos, P; Miell, J; Seed, PT; Shojaee-Moradie, F; Umpleby, AM; Wendon, JA | 1 |
Arnold, R; Brandt, A; Byrne, MM; Göke, B; Katschinski, M; Polonsky, KS | 1 |
Borg, H; Fernlund, P; Gottsäter, A; Landin-Olsson, M; Sundkvist, G | 1 |
Hansen , AP; Juhl, CB; Pincus, SM; Pørksen, N; Schmitz, O; Veldhuis, JD | 1 |
Aarnio, P; Dela, F; Lauritsen, T | 1 |
Carlés, C; Carmona, E; Fajardo, C; Merino, JF; Piñón, F; Sánchez-Cuenca, JM | 1 |
Damholt, MB; Hilsted, LM; Holst, JJ; Hughes, TE; Madsbad, S; Michelsen, BK; Toft-Nielsen, MB | 1 |
Huang, HW; Larpadisorn, K; Lesser, II; Volpe, SL | 1 |
Aliberti, G; Arzilla, R; Cigognetti, L; Giovanni, CD; Miraldi, F; Proietta, M; Pulignano, I; Toscano, M; Tritapepe, L; Vecci, E | 1 |
Ackermans, MT; Arias, AM; Bisschop, PH; Endert, E; Nijpels, G; Romijn, JA; Sauerwein, HP | 1 |
Barilli, AL; Dei Cas, A; Gnudi, A; Iotti, M; Lugari, R; Marani, B; Orlandini, A; Ugolotti, D; Zandomeneghi, R | 1 |
Hardy, KJ; McNulty, SJ | 1 |
Becker, C; Bühler, L; Caulfield, A; Cretin, N; Fournier, B; Morel, P; Philippe, J | 1 |
Bergeron, R; Bülow, J; Galbo, H; Howlett, K; Kjaer, M; Simonsen, L; Skovgaard, D | 1 |
Crino, A; Gross, TM; Jeng, LM; Mesturino, CA; Pozzilli, P; Visalli, N | 1 |
Ackermans, MT; Dekker, E; Endert, E; Kager, PA; Le, T; Romijn, JA; Sauerwein, HP; Thanh Chien, VO; van Thien, H | 1 |
Haymond, MW; Sunehag, A; Tigas, S | 1 |
Banerji, MA; Bastian, W; Castells, S; Taha, DR; Umpaichitra, V | 1 |
Cryer, PE; Paramore, DS; Segel, SA | 1 |
Abdulkadir, J; Faiman, C; Hammel, JP; Reddy, SS; Scherbaum, WA; Siraj, ES | 1 |
Battezzati, A; Benedini, S; Del Maschio, A; Fiocchi, R; Gamba, A; Luzi, L; Mammana, C; Perseghin, G; Scifo, P; Sereni, LP | 1 |
Banarer, S; Cryer, PE; McGregor, VP | 1 |
Andersen, V; Hamberg, O; Larsen, S; Sonne, J; Vilstrup, H | 1 |
Ericsson, UB; Groop, L; Hallengren, B; Lethagen, AL; Tuomi, T | 1 |
Holst, JJ; Madsbad, S; Madsen, JL; Zander, M | 1 |
Gaspard, UJ; Jaminet, C; Lefebvre, PJ; Scheen, AJ; Wery, OJ | 1 |
Born, J; Fehm, HL; Fruehwald-Schultes, B; Kern, W; Oltmanns, KM; Peters, A; Sopke, S; Toschek, B | 1 |
Gabriely, I; Hawkins, M; Rossetti, L; Shamoon, H; Vilcu, C | 1 |
Castro, A; Fernández-Real, JM; García-Bragado, F; Hernández-Aguado, I; Peñarroja, G; Ricart, W | 1 |
Dela, F; Holst, JJ; Jensen, CB; Madsbad, S; Storgaard, H; Vaag, AA | 2 |
Cooper, BP; Fucetola, R; Haupt, DW; Melson, AK; Newcomer, JW; Schweiger, JA; Selke, G | 1 |
Bunc, M; Rozman, J; Zitko, M; Zorko, B | 1 |
Richardson, AP; Tayek, JA | 1 |
AvRuskin, TW; Juan, CS | 1 |
Banerji, MA | 1 |
Bilz, S; Bloesch, D; Keller, U; Laager, R; Turkalj, I | 1 |
Gallwitz, B; Meier, JJ; Nauck, MA; Schmidt, WE | 1 |
Egan, JM; Elahi, D; Habener, JF; Meneilly, GS | 1 |
Christiansen, JS; Dall, R; Gravholt, CH; Møller, N; Schmitz, O | 1 |
Kato, Y; Miura, Y; Oiso, Y; Sato, I; Suzuki, A | 1 |
Bernroider, E; Bischof, MG; Krssak, M; Lahousen, T; Pacini, G; Roden, M; Schnedl, WJ; Stingl, H | 1 |
Ahrén, B; Bolinder, J; Sjöberg, S | 1 |
Adkins, AS; Basu, R; Reed, AS; Rizza, RA; Shah, P; Vella, A | 1 |
Nowotny, P; Raffesberg, W; Roden, M; Stingl, H; Waldhäusl, W | 1 |
Lakey, JR; Paty, BW; Robertson, RP; Ryan, EA; Shapiro, AM | 1 |
Egan, JM; Elahi, D; Meneilly, GS | 1 |
Bjerve, KS; Grill, VE; Mostad, IL; Qvigstad, E | 1 |
Holst, JJ; Kjems, LL; Madsbad, S; Vølund, A | 1 |
Altuntas, Y | 1 |
Abbatecola, AM; Grella, R; Manzella, D; Paolisso, G; Ragno, E | 1 |
Egan, JM; Ehlers, MR; Elahi, D; Habener, JF; McIntosh, CH; Meneilly, GS; Pederson, RA | 1 |
Bélanger, P; Couturier, K; Fillion, Y; Gauthier, MS; Lavoie, JM | 1 |
Ahrén, B; Thorsson, O | 1 |
Basu, A; Basu, R; Charkoudian, N; Joyner, MJ; Reed, AS; Rizza, RA; Shah, P; Vella, A | 1 |
Dostou, JM; Gerich, JE; Mariuz, PR; Meyer, C; Popa, EM; Reichman, RC; Welle, SL; Woerle, HJ | 1 |
Holmbäck, U | 1 |
Holst, JJ; Juul, AG; Krarup, T; Madsbad, S; Sonne, J; Vilsbøll, T; Vølund, A | 1 |
Arora, P; Basu, A; Basu, R; Breda, E; Cobelli, C; Dalla Man, C; Jensen, MD; Klee, GG; Oberg, AL; Powell, CC; Rizza, RA; Toffolo, G; Vittone, JL | 1 |
Arora, P; Basu, R; Camilleri, M; Rizza, RA; Shah, P; Zangeneh, F | 1 |
Alvarsson, M; Berntorp, K; Fernqvist-Forbes, E; Grill, V; Henricsson, M; Lager, I; Orn, T; Steen, L; Sundkvist, G; Westermark, G; Westermark, P | 1 |
Atkinson, AB; Bell, PM; Courtney, CH; Ennis, CN; Sheridan, B | 1 |
Bollheimer, LC; Buettner, R; Landauer, H; Schölmerich, J; Troll, S; Wrede, CE | 1 |
Holst, JJ; Knop, FK; Krarup, T; Larsen, S; Madsbad, S; Vilsbøll, T | 1 |
Adkins, A; Basu, R; Dicke, B; Persson, M; Rizza, R; Schwenk, WF; Shah, P; Vella, A | 1 |
Chen, CL; Chen, PJ; Chuang, LM; Jeng, YM; Kao, JH; Lai, MY; Lee, CZ; Lee, HS; Lu, JY; Tai, TY | 1 |
Beck-Nielsen, H; Hojlund, K; Holst, JJ; Hother-Nielsen, O; Staehr, P | 1 |
Egan, JM; Elahi, D; Greig, N; Habener, JF; Meneilly, GS; Tildesley, H | 1 |
Ahrén, B; Holst, JJ; Mari, A | 1 |
Holst, JJ; Hücking, K; Meier, S; Nauck, MA; Ritzel, R; Schmiegel, WH | 1 |
Ernsberger, P; Velliquette, RA | 1 |
Hansen, T; Holst, JJ; Johansen, A; Knop, FK; Krarup, T; Larsen, S; Madsbad, S; Pedersen, O; Vilsbøll, T | 1 |
Autio, K; Holst, JJ; Juntunen, KS; Laaksonen, DE; Liukkonen, KH; Mykkänen, HM; Niskanen, LK; Poutanen, KS; Savolainen, KE | 1 |
Brissova, M; Cherrington, AD; Farmer, B; Gustavson, SM; Neal, D; Nishizawa, M; Powers, AC | 1 |
Carr, RD; Degn, KB; Gall, MA; Rizza, RA; Schmitz, O; Thomsen, MK; Veldhuis, JD; Østergård, T | 1 |
Clements, RH; Gonzalez, QH; Laws, HL; Long, CI; Wittert, G | 1 |
Ahrén, B; Holst Jj, Jj; Olsson, T; Pacini, G; Rask, E; Söderberg, S; Tura, A | 1 |
Meier, JJ; Nauck, MA | 1 |
Andersen, O; Dela, F; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Nielsen, JO; Storgaard, H | 1 |
Amato, M; Averna, MR; Barbagallo, CM; Cefalù, AB; Citarrella, R; Galluzzo, A; Giordano, C; Noto, D; Pugliese, A; Rizzo, M | 1 |
Bordenave, B; Claxton, S; Henry, K; Kane, E; Klebert, M; Powderly, WG; Tebas, P; Yarasheski, K | 1 |
Dotta, F; Vendrame, F; Zappaterreno, A | 1 |
Basu, A; Basu, R; Johnson, CM; Rizza, RA; Schwenk, WF | 1 |
Jahoor, F; Shangraw, RE | 1 |
Caselli, D; Ferrari, E; Maccabruni, A; Maghnie, M; Minoli, L; Rondanelli, M; Solerte, SB; Trotti, R | 1 |
Eppler, E; Jevdjovic, T; Maake, C; Reinecke, M; Zapf, J; Zoidis, E | 1 |
Brock, B; Degn, KB; Djurhuus, CB; Fineman, M; Grubert, J; Han, J; Juhl, CB; Kim, D; Schmitz, O; Taylor, K | 1 |
Chang, CC; Ferber, S; Linning, KD; Madhukar, BV; Olson, LK; Reed, DN; Tai, MH; Trosko, JE | 1 |
Jimenez-Feltstrom, J; Lundquist, I; Obermuller, S; Salehi, A | 1 |
Ferrannini, E; Gastaldelli, A; Mari, A; Natali, A; Ostergard, T; Schmitz, O | 1 |
Atouf, F; Choi, Y; Lumelsky, N; Ta, M | 1 |
Atsumi, Y; Matsuoka, K; Murata, C; Oka, Y; Suzuki, Y; Taniyama, M | 1 |
Bromberg, JS; Keller, G; Ku, HT; Kubo, A; Mao, M; O'Connor, R; Zhang, N | 1 |
Byström, B; Hirschberg, AL; Holtet, J; Naessén, S; Stridsberg, M | 1 |
Holst, JJ; Hücking, K; Kostic, Z; Nauck, MA; Pox, C; Ritzel, R; Schmiegel, W | 1 |
Andersen, O; Andersen, UB; Deacon, CF; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Nielsen, JO | 1 |
Cryer, PE; Gerich, JE; Gosmanov, NR; Israelian, Z; Meyer, C; Smith, T; Szoke, E | 1 |
Deacon, CF; Holst, JJ; Jensen, CB; Madsbad, S; Pilgaard, K; Schou, JH; Vaag, AA; Vilsbøll, T; Vølund, A | 1 |
Buchwald, A; Nolte, W; Raddatz, D; Ramadori, G; Rossbach, C; Scholz, KH | 1 |
Albareda, M; Caballero, A; Cabezas, R; Carreras, G; Chico, A; Pérez, A; Rigla, M; Rodríguez-Espinosa, J | 1 |
Holst, JJ; Kemmeries, G; Meier, JJ; Nauck, MA | 2 |
Carey, PE; Cline, GW; Cobelli, C; Dalla Man, C; English, PT; Firbank, MJ; Gerrard, J; Taylor, R | 1 |
Jenssen, T; Toft, I | 1 |
Bai, L; Meredith, G; Tuch, BE | 1 |
Bracho-Blanchet, E; Dávila-Pérez, R; Dorantes, LM; Elliott, RB; Garibay, GN; Mendez, AJ; Terán, L; Valdés-González, RA; White, DJ | 1 |
Bergstrom, C; Ipp, E; Linfoot, P | 1 |
Hill, M; Pelikánová, T; Stanická, S; Vlcek, P; Vondra, K; Zamrazil, V | 1 |
Gutniak, M; Malmberg, K; Olsson, A; Rydén, L; Thrainsdottir, I | 1 |
Bock, T; Bogdani, M; In't Veld, P; Pipeleers, D; Pipeleers-Marichal, M; Suenens, K | 1 |
Behie, LA; Bodnar, CA; Kallos, MS; Petropavlovskaia, M; Rosenberg, L; Sen, A | 1 |
Deacon, CF; Holst, JJ; Madsbad, S; Zander, M | 1 |
Beauvieux, MC; Gallis, JL; Gin, H; Rigalleau, V; Schneiter, P; Tappy, L | 2 |
Groop, LC; Honkanen, EH; Isomaa, B; Sarelin, L; Tuomi, T | 1 |
Andersen, O; Deacon, CF; Dela, F; Haugaard, SB; Holst, JJ; Iversen, J; Madsbad, S; Pedersen, SB | 1 |
Makino, H; Nakatsuka, A; Wada, J | 1 |
Rogatsky, E; Stein, DT | 1 |
Damjanovic, SS; Djukic, VB; Djurovic, M; Jotic, A; Lalic, KS; Lalic, NM; Lukic, L; Miljic, D; Pesko, PM; Petakov, MS | 1 |
Ae Park, S; Cho, SY; Choi, MS; Jung, UJ; Kim, MJ; Lee, MK; Park, YB; Seo, JS; Sung, MK | 1 |
Choi, MS; Jung, UJ; Kim, HJ; Kim, MJ; Lee, JS; Lee, MK; Noh, HJ; Park, HM; Park, KK; Park, SA; Park, YB | 1 |
Banasch, M; Bulut, K; Hagemann, D; Holst, JJ; Meier, JJ; Schmidt, WE; Schrader, H | 1 |
Holst, JJ; Højberg, PV; Knop, FK; Krarup, T; Larsen, S; Madsbad, S; Vilsbøll, T; Vølund, A | 2 |
Bizzarri, C; Buzzetti, R; Cappa, M; Crinò, A; Gentilucci, UV; Guglielmi, C; Lauria, A; Manfrini, S; Merola, MK; Picardi, A; Pitocco, D; Pozzilli, P; Suraci, C; Visalli, N | 1 |
Basu, R; Bock, G; Campioni, M; Chittilapilly, E; Cobelli, C; Dalla Man, C; Rizza, R; Toffolo, G | 2 |
Bolli, GB; Busciantella Ricci, N; Fanelli, CG; Lucidi, P; Marzotti, S; Pampanelli, S; Porcellati, F; Rossetti, P; Santeusanio, F | 1 |
Cao, XY; Ding, H; He, LJ; Liu, M; Ma, SL; Ma, XG; Ma, XW; Wang, XH; Wang, XQ; Yang, XJ | 1 |
Bryan, J; Harmon, JS; Robertson, RP; Zhang, T; Zhou, H | 1 |
Abdul-Ghani, M; DeFronzo, RA | 1 |
Baetge, E; Beattie, GM; Flores, LE; Hao, E; Hayek, A; Kayali, AG; Kitamura, R; Kutlu, B; Lopez, AD | 1 |
Basu, A; Basu, R; Campioni, M; Cobelli, C; Dalla Man, C; Jensen, MD; Khosla, S; Klee, G; Nair, KS; Rizza, RA; Toffolo, G | 1 |
Berková, Z; Dovolilová, E; Girman, P; Karasová, L; Koblas, T; Mindlová, M; Saudek, F; Zacharovová, K | 1 |
Anderwald, C; Artwohl, M; Bischof, M; Brehm, A; Brunmair, B; Fürnsinn, C; Krebs, M; Nowotny, P; Promintzer, M; Roden, M; Roth, E; Szendroedi, J | 1 |
Harmon, J; Oseid, E; Robertson, RP; Tonooka, N; Zhang, T; Zhou, H | 1 |
Basu, R; Bock, G; Chandramouli, V; Chittilapilly, E; Cobelli, C; Landau, BR; Rizza, RA; Toffolo, G | 1 |
Alvarsson, M; Berntorp, K; Fernqvist-Forbes, E; Grill, V; Holberg, MA; Kirksaether, N; Lager, I; Orn, T; Steen, L; Sundkvist, G | 1 |
Dejgaard, A; Gredal, C; Hilsted, J; Rosenfalck, AM | 1 |
Chen, S; Ding, J; Grayburn, PA; Wood, DR; Yang, B; Yu, C | 1 |
Brooks-Worrell, B; Chiu, H; Felton, J; Goel, A; Palmer, JP | 1 |
Chiarelli, F; Hansen, L; Holst, JJ; Hougaard, P; Kaas, A; Kocova, M; Mortensen, HB; Nielsen, LB; Orskov, C; Ploug, KB; Pörksen, S | 1 |
Bandorf, N; Born, J; Hallschmid, M; Jauch-Chara, K; Schmid, SM; Schultes, B | 1 |
Chiarelli, F; de Beaufort, C; Gammeltoft, S; Hansen, L; Holl, R; Holst, JJ; Hougaard, P; Jansen-Olesen, I; Mortensen, HB; Nielsen, LB; Ploug, KB; Pörksen, S; Rorsman, P; Swift, P; Ørskov, C | 1 |
Arbelaez, AM; Breckenridge, SM; Cooperberg, BA; Cryer, PE; Patterson, BW | 1 |
Bollheimer, LC; Buettner, R; Ottinger, I; Wobser, H; Wrede, CE | 1 |
Davidovic, M; Despotovic, N; Erceg, P; Milosevic, D; Stevic, R; Zivkovic, TB | 1 |
Bollyky, J; Greenbaum, CJ | 1 |
Kocić, G; Kocić, R; Pavlović, D; Pesić, M | 1 |
Holst, JJ; Højberg, PV; Knop, FK; Krarup, T; Larsen, S; Madsbad, S; Vilsbøll, T | 1 |
El-Ouaghlidi, A; Foley, J; Holmes, D; Holst, JJ; Nauck, MA; Rehring, E; Schweizer, A | 1 |
Hsiao, PH; Lee, JS; Tsai, WY; Tung, YC | 1 |
Baz-Hecht, M; Bernier, R; Devine, E; Goldfine, AB; Holst, JJ; Jones, DB; Mun, EC; Patti, ME; Schneider, BE | 1 |
Basu, A; Basu, R; Chandramouli, V; Cohen, O; Dicke, B; Landau, BR; Norby, B; Rizza, RA; Shah, P | 2 |
Baron, MA; Deacon, CF; Foley, JE; Holst, JJ; Landin-Olsson, M; Rendell, M; Rochotte, E; Rosenstock, J | 1 |
Balamurugan, AN; Bottino, R; Campanile, N; Casu, A; Cooper, DK; Hara, H; Smetanka, C; Trucco, M; van der Windt, DJ | 1 |
Charpentier, G; Gautier, JF; German, MS; Guillausseau, PJ; Kevorkian, JP; Louet, JF; Mauvais-Jarvis, F; Molokhia, M; Smith, SB; Urbanek, M; Vaisse, C; Vexiau, P; Virally, ML | 1 |
Asgharian, H; Dorkhan, M; Groop, L; Malm, G; Tripathy, D; Tuomi, T | 1 |
Büsing, M; Frystyk, J; Klempnauer, J; Lück, R; Maubach, J; Nauck, MA; Ritzel, RA; Schmiegel, W | 1 |
Boyd, AS; Higashi, Y; Wood, KJ; Wu, DC | 1 |
Banks, MR; Klein, S; Patterson, BW; Polonsky, KS; Villareal, DT | 1 |
Bolli, GB; Busciantella Ricci, N; Candeloro, P; Cioli, P; Fanelli, CG; Nair, KS; Porcellati, F; Rossetti, P; Santeusanio, F | 1 |
Gao, F; Hu, YH; Jin, GX; Li, FJ; Li, GD; Sun, TW; Wu, DQ | 1 |
Cobelli, C; Dalla Man, C; English, PT; Firbank, MJ; Gerrard, J; Lane, A; Ravikumar, B; Taylor, R | 1 |
Brown, RJ; Rother, KI; Sinaii, N | 1 |
Alejandro, R; Baidal, DA; Cure, PE; Faradji, RN; Froud, T; Mendez, A; Messinger, S; Monroy, K; Pileggi, A; Ponte, GM; Ricordi, C; Selvaggi, G | 1 |
Battelino, T; Greenbaum, CJ; Haastert, B; Kolb, H; Lachin, JM; Ludvigsson, J; Mandrup-Poulsen, T; McGee, PF; Pozzilli, P | 1 |
Li, WH; Sun, Q; Wang, H; Wang, T; Xiao, XH; Yang, GH; Yuan, T | 1 |
Gao, F; Hu, YH; Jin, GX; Wu, DQ | 1 |
Ahlgren, KM; Fall, T; Holm, B; Kämpe, O; Karlsson, A; von Euler, H | 1 |
Li, J; Lin, G; Lu, GX; Ou-Yang, Q; Zhou, J; Zhou, XY | 1 |
Kitatani, N; Kuroe, A; Kurose, T; Ohya, M; Oku, M; Seino, Y; Watanabe, K; Yabe, D | 1 |
Bock, G; Camilleri, M; Cobelli, C; Dalla Man, C; Foley, JE; Giesler, PD; Ligueros Saylan, M; Rizza, RA; Serra, DB; Toffolo, G; Vella, A | 1 |
Born, J; Hallschmid, M; Jauch-Chara, K; Oltmanns, KM; Peters, A; Schmid, SM; Schultes, B | 1 |
Deacon, CF; Gardiwal, H; Goetze, O; Holst, JJ; Meier, JJ; Menge, BA; Schmidt, WE; Vollmer, K | 1 |
Almeida, MH; Barone, B; Campos, F; Dantas, JR; Kupfer, R; Milech, A; Oliveira, JE; Rodacki, M; Zajdenverg, L | 1 |
Basu, A; Basu, R; Chandramouli, V; Landau, BR; Rizza, RA; Schumann, W | 1 |
Gerrard, J; Jovanovic, A; Taylor, R | 1 |
Ahrén, B; Carr, RD; Deacon, CF; Lindgren, O; Mari, A; Vikman, J; Winzell, MS | 1 |
Dufour, S; Lebon, V; Petersen, KF; Shulman, GI | 1 |
Breuer, TG; Holst, JJ; Meier, JJ; Menge, BA; Ritter, PR; Schmidt, WE; Schrader, H; Uhl, W | 1 |
Miyamoto, M | 1 |
Cui, MH; Gabriely, I; Leu, J; Shamoon, H | 1 |
Amiel, SA; Choudhary, P; Emery, CJ; Heller, SR; Lonnen, K; MacDonald, IA; MacLeod, KM | 1 |
Chacko, SK; Haymond, MW; Maningat, PD; Mohammad, MA; Pontius, AS; Sunehag, AL | 1 |
Chen, ZX; Duan, HY; Lin, CJ; Lin, SD | 1 |
Basu, S; Bjerve, KS; Frayn, KN; Grill, V; Mostad, IL; Sutton, P | 1 |
Cooperberg, BA; Cryer, PE | 1 |
Kolb, H; Meierhoff, G; Pfleger, C; Schloot, NC | 1 |
Hallschmid, M; Jauch-Chara, K; Schmid, SM; Schultes, B | 1 |
Asmar, M; Deacon, CF; Hare, KJ; Holst, JJ; Knop, FK; Madsbad, S; Vilsbøll, T | 1 |
Dirksen, C; Hansen, DL; Holst, JJ; Hvolris, LE; Madsbad, S; Naver, LS; Worm, D | 1 |
Alejandro, R; Faradji, RN; Froud, T; Mendez, AJ; Messinger, S; Mineo, D; Monroy, K; Pileggi, A; Ricordi, C; Tharavanij, T | 1 |
Bigelow, ML; Irving, BA; Klaus, K; Nair, KS; Short, KR; Tatpati, LL; Tom, A | 1 |
Hare, KJ; Holst, JJ; Knop, FK; Vilsbøll, T | 1 |
Cobelli, C; Dalla Man, C; Micheletto, F; Rizza, RA; Sathananthan, A; Vella, A | 1 |
Asmar, M; Bache, M; Holst, JJ; Knop, FK; Madsbad, S | 1 |
Asmar, M; Holst, JJ; Kielgast, U; Madsbad, S | 1 |
Bellmann, K; Blanchard, PG; Brûlé, S; Deshaies, Y; Festuccia, WT; Houde, VP; Marette, A | 1 |
Briscoe, VJ; Davis, SN; Gogitidze Joy, N; Hedrington, MS; Nicholson, W; Richardson, MA; Tate, DB; Wang, Z; Younk, L | 1 |
Fuskevåg, OM; Gjessing, PF; Hagve, M; Irtun, Ø; Revhaug, A | 1 |
Dietzen, DJ; Green, RP; Hollander, AS; Thevis, M; Thomas, A | 1 |
Bagger, JI; Hansen, KB; Holst, JJ; Knop, FK; Vilsbøll, T | 3 |
Grønbaek, H; Holland-Fischer, P; Mengel, A; Nielsen, MF; Schmitz, O; Tønner-Nielsen, D; Vilstrup, H | 1 |
Deacon, CF; Holst, JJ; Jacob, A; Meier, JJ; Menge, BA; Nauck, MA; Ritter, PR; Schmidt, WE | 1 |
Balasubramanian, R; Cobelli, C; Dalla Man, C; English, PT; Firbank, MJ; Gerrard, J; Lane, A; Taylor, R | 1 |
Degerblad, M; Edholm, T; Efendic, S; Grybäck, P; Hellström, PM; Hilsted, L; Holst, JJ; Jacobsson, H; Schmidt, PT | 1 |
Baughman, R; Boss, A; Cassidy, J; Costello, D; Damico, C; Marino, MT; Richardson, PC; van Marle, S; van Vliet, A | 1 |
Lele, RD | 1 |
Almeida, MH; Campos, F; Dantas, JR; Duarte, JD; Kupfer, R; Milech, A; Oliveira, JE; Rodacki, M; Serfaty, FM; Zajdenverg, L | 1 |
Ellard, S; Flanagan, SE; Gilbert, C; Hussain, K; Kapoor, RR; Moyo, Y; Padidela, R | 1 |
Caprio, S; D'Adamo, E; Hershkop, K; Santoro, N; Weiss, R | 1 |
Chang, CM; Chang, YL; Chen, SJ; Chen, YJ; Chiou, SH; Kao, CL; Ku, HH; Li, HY; Liao, CY; Lo, WL; Tseng, LM; Twu, NF; Yang, DM | 1 |
Barosa, C; Basu, A; Basu, R; Jones, J; Pattan, V; Rizza, R; Saad, A | 1 |
Li, F; Liu, S; Luo, B; Ren, Z; Wang, S; Zhang, Y; Zhang, YA; Zou, C | 1 |
Landin-Olsson, M; Petersson, C; Thorgeirsson, H; Thunander, M; Törn, C | 1 |
Arnqvist, H; Berne, C; Björk, E; Bolinder, J; Karlsson, FA; Nyström, L; Schölin, A | 1 |
Diamant, M; Eekhoff, EM; Garretsen, MK; Ghatei, MA; Heijboer, AC; Holst, JJ; Ligthart-Melis, GC; Richir, MC; Uitdehaag, BM; van Leeuwen, PA; van Schie, A; Vermeulen, MA | 1 |
Castracane, VD; Francois, MR; Kraemer, RR; Sehgal, K; Sirikul, B; Valverde, RA | 1 |
Barbot-Trystram, L; Benabadji, S; Boitard, C; Larger, E; Philippe, MF; Vadrot, D | 1 |
Basu, R; Khosla, S; Peterson, J; Rizza, R | 1 |
Bertera, S; Drain, P; Esni, F; Nicholls, RD; Simmons, RA; Stefan, M; Trucco, M | 1 |
Born, J; Hallschmid, M; Jauch-Chara, K; Lehnert, H; Schmid, SM; Schultes, B; Wilms, B | 1 |
Arbeláez, AM; Cryer, PE; Ramanathan, RP | 1 |
Bagger, JI; Holst, JJ; Knop, FK; Lund, A; Vilsbøll, T | 1 |
Alvarsson, M; Berntorp, K; Fernqvist-Forbes, E; Grill, V; Lager, I; Orn, T; Steen, L | 1 |
Holst, JJ; Kielgast, U; Madsbad, S | 1 |
Chisholm, DJ; Douglas, A; Greenfield, JR; Gribble, FM; Holst, JJ; Piyaratna, N; Samocha-Bonet, D; Synnott, EL; Wong, O | 1 |
Buhl, M; Clasen, BF; Jørgensen, JO; Krusenstjerna-Hafstrøm, T; Møller, N; Nielsen, R; Nielsen, S; Pedersen, SB; Vestergaard, ET | 1 |
Baxter, R; Brugts, M; Coopmans, W; Gielen, M; Janssen, JA; Lamberts, S; Mesotten, D; Van den Berghe, G; Van Herck, E; Vanhorebeek, I | 1 |
Hitman, GA | 1 |
Besser, RE; Bowman, P; Hattersley, AT; Hope, SV; Jones, AG; Knight, BA; McDonald, TJ; Oram, RA; Shields, BM | 1 |
Błazik, M; Groele, L; Pańkowska, E | 1 |
Ader, M; Bunnell, DJ; Harlan, DM; Hirshberg, B; Remaley, AT; Rickels, MR; Rother, KI; Soleimanpour, SA; Sumner, AE | 1 |
Andersen, ML; Buschard, K; de Beaufort, C; Fredheim, S; Hansen, L; Hougaard, P; Kaas, A; Mortensen, HB; Nielsen, LB; Petersen, JS; Robertson, KJ | 1 |
Aaboe, K; Holst, JJ; Knop, FK; Krarup, T; Madsbad, S; Vilsbøll, T; Vølund, A | 1 |
Ding, Z; Hwang, J; Ivy, JL; Kammer, LM; Lassiter, DG; Nelson, JL; Wang, B | 1 |
Almdal, T; Bojsen-Møller, KN; Clausen, TR; Dirksen, C; Hansen, DL; Holst, JJ; Hvolris, LE; Jacobsen, SH; Jørgensen, NB; Kielgast, U; Madsbad, S; Naver, LS; Olesen, SC; Rehfeld, JF; Worm, D; Wulff, BS | 1 |
Gjedsted, J; Juhl, CB; Nielsen, MF; Schmitz, O | 1 |
Cobelli, C; Dalla Man, C; Micheletto, F; Sathananthan, A; Sathananthan, M; Smushkin, G; Vella, A; Zinsmeister, AR | 1 |
Bandsma, RH; Dash, S; Lewis, GF; Szeto, L; Xiao, C | 1 |
Crimmins, DL; Dunai, J; Ladenson, JH; Patterson, BW; Polonsky, KS; Reeds, DN; Tran, HD; Villareal, DT; Wallendorf, MJ; Wice, BM | 1 |
Bojsen-Møller, KN; Clausen, TR; Dirksen, C; Holst, JJ; Hvolris, L; Jacobsen, SH; Jørgensen, NB; Lindqvist Hansen, D; Madsbad, S; Naver, L; Worm, D; Wulff, BS | 1 |
Litwinowicz, M; Niedźwiecki, P; Rogowicz-Frontczak, A; Wierusz-Wysocka, B; Zozulińska-Ziółkiewicz, D | 1 |
Bianchi, L; Bonaventura, A; Carbone, A; Cicero, AF; Derosa, G; Fogari, E; Franzetti, I; Maffioli, P; Querci, F; Romano, D | 1 |
Cang, J; Ge, SJ; Xue, ZG; Zhong, J; Zhuang, XF | 1 |
Ericsson, H; Hompesch, M; Leonsson-Zachrisson, M; Morrow, LA; Norjavaara, E; Sjöberg, F; Sjöstrand, M | 1 |
Bredenbröker, D; Brose, M; Fabbri, LM; Göke, B; Rabe, KF; Teichmann, P; Wouters, EF | 1 |
Cree-Green, M; Mizokami-Stout, K; Nadeau, KJ | 1 |
Blondeau, B; Boudou, P; Calvo, F; Choukem, SP; Fetita, LS; Gautier, JF; Ibrahim, F; Mauvais-Jarvis, F; Porcher, R; Sobngwi, E; Vexiau, P | 1 |
Hashimoto, N; Hirota, Y; Matsuda, T; Nakamura, T; Ogawa, W; Sakaguchi, K; Seino, S; Takabe, M | 1 |
Anděl, M; Dlouhý, P; Kraml, P; Potočková, J; Rambousková, J; Smejkalová, V; Wildová, E | 1 |
Cobelli, C; Dalla Man, C; Law, JH; Piccinini, F; Rizza, RA; Sathananthan, M; Smushkin, G; Vella, A; Zinsmeister, AR | 1 |
Hare, KJ; Holst, JJ; Knop, FK; Martens, P; Rehfeld, JF; Sonne, DP; Vilsbøll, T | 1 |
Anderwald, CH; Baumgartner-Parzer, SM; Bischof, M; Göbl, C; Haidinger, M; Jankovic, D; Korbonits, M; Krebs, M; Krššák, M; Luger, A; Mühlbacher, F; Pacini, G; Prager, R; Saemann, M; Stadler, M; Winhofer, Y | 1 |
Barosa, C; Basu, A; Basu, R; Carter, R; Dube, S; Jones, J; Rizza, RA | 1 |
Casamitjana, R; Jiménez, A; Lacy, A; Viaplana-Masclans, J; Vidal, J | 1 |
Coester, HV; Forst, T; Hincelin-Méry, A; Kapitza, C; Poitiers, F; Ruus, P | 1 |
Fukui, T; Hara, N; Hirano, T; Nagashima, M; Naito, H; Oono, K; Yamamoto, T | 1 |
Calanna, S; Di Pino, A; Maria Rabuazzo, A; Maria Zagami, R; Piro, S; Purrello, F; Urbano, F | 1 |
Cho, YM; Kim, MY; Kim, S; Lee, JC; Oh, TJ; Park, KS; Shin, JY | 1 |
Bagger, JI; Bonde, L; Holst, JJ; Knop, FK; Larsen, S; Nielsen, T; Svare, JA; Vilsbøll, T | 1 |
Bound, MJ; Horowitz, M; Jones, KL; Rayner, CK; Standfield, SD; Wu, T | 1 |
Albernaz, M; Almeida, MH; Barone, B; Bencke, MR; Dantas, JR; Kupfer, R; Oliveira, JE; Rodacki, M; Serfaty, FM; Zajdenverg, L | 1 |
Imagawa, A; Iwahashi, H; Kozawa, J; Okita, K; Shimomura, I; Yamagata, K | 1 |
Casamitjana, R; Delgado, S; Flores, L; Jiménez, A; Lacy, A; Vidal, J | 1 |
Honda, K; Kumagai, N; Muroya, Y; Shimodaira, M; Tsuzawa, K | 1 |
Becker, RH; Horowitz, M; Lorenz, M; Pfeiffer, C; Rütten, H; Ruus, P; Steinsträsser, A | 1 |
Gao, H; Hu, J; Sun, R; Wang, F; Wang, L; Wang, Y; Wang, Z; Yan, S; Yu, X; Zhao, W | 1 |
Castracane, VD; Daniel Castracane, V; Francois, M; Kraemer, RR; Norman, RL; Rogers, SN; Shah, U; Webb, ND; Worley, JR | 1 |
Cheng, Y; Dong, L; Fu, X; Han, W; Hao, H; Hou, Q; Liu, H; Liu, J; Mu, Y; Shen, J; Ti, D; Tong, C; Zhao, Y | 1 |
Ahrén, B; Alba, M; Goldstein, BJ; Guan, Y; Inzucchi, SE; Kaufman, KD; Mallick, M; O'Neill, EA; Williams-Herman, DE; Xu, L | 1 |
Beglinger, C; Keller, S; Malarski, A; Meyer-Gerspach, AC; Schulte, FH; Steinert, RE | 1 |
Otto-Buczkowska, E | 1 |
Basu, A; Basu, R; Carter, R; Cobelli, C; Dalla Man, C; Hinshaw, L; Johnson, M; Kudva, Y; Mallad, A; Schiavon, M; Sparacino, G | 1 |
Balas, B; Balena, R; Boldrin, M; Bolli, GB; Charbonnel, B; Gastaldelli, A; Ratner, R; Rosenstock, J | 1 |
Ghazi, T; Herold, KC; Rink, L; Sherr, JL; Wurtz, A | 1 |
Chowdhury, S; Crimmins, DL; Dunai, J; Griest, TA; Laciny, E; Ladenson, JH; Patterson, BW; Polonsky, KS; Reeds, DN; Rometo, DA; Tran, HD; Wallendorf, MJ; Wang, S; Wice, BM | 1 |
Cho, SH; Gu, N; Jang, IJ; Kim, J; Lee, H; Lim, KS; Seol, E; Shin, D; Shin, SG; Yu, KS | 1 |
Avron, A; Cohen, IR; Dagan, S; Elias, D; Eren, R; Peled, D; Pozzilli, P; Raz, I; Tamir, M | 1 |
Calanna, S; Di Pino, A; Knop, FK; Piro, S; Purrello, F; Rabuazzo, AM; Scicali, R | 1 |
Bae, JC; Choi, DW; Choi, SH; Heo, JS; Jin, SM; Kim, JH; Kim, KW; Lee, MK; Lee, MS; Suh, S | 1 |
Chen, MJ; Hou, JY; Lin, GF; Liu, TC; Ren, ZQ; Wu, YS | 1 |
Bound, M; Checklin, H; Horowitz, M; Jones, KL; Lange, K; Marathe, CS; Rayner, CK; Standfield, S; Wishart, J | 1 |
Apseloff, G; Atiee, G; Bush, MA; Collins, DA; Corsino, L; Feldman, PL; Gillmor, D; McMullen, SL; Morrow, L; Nunez, DJ | 1 |
Ishida, H; Katsuta, H; Nishida, S; Ozawa, S; Sumitani, Y; Suzuki, K; Takahashi, K; Tanaka, T; Yoshimoto, K | 1 |
Fukami, N; Hirai, H; Hiratsuka, I; Hoshinaga, K; Itoh, M; Itoh, T; Kenmochi, T; Kondo-Ando, M; Kusaka, M; Maeda, Y; Makino, M; Sasaki, H; Sekiguchi-Ueda, S; Shibata, M; Suzuki, A; Takayanagi, T | 1 |
Belinova, L; Dezortova, M; Hajek, M; Hill, M; Kahleova, H; Kazdova, L; Malinska, H; Oliyarnyk, O; Pelikanova, T; Skop, V; Trnovska, J; Tura, A | 1 |
Ai, J; Azami, M; Ebrahimi-Barough, S; Karimi, R; Lotfibakhshaiesh, N; Niknamasl, A; Ostad, SN; Roozafzoon, R; Salmani, MK; Soleimani, M | 1 |
Hirshberg, B; Iqbal, N; Lu, J; Sjöstrand, M | 1 |
Holst, JJ; Knop, FK; Rehfeld, JF; Sonne, DP; Vilsbøll, T | 1 |
Ang, M; Linn, T | 1 |
Balamurugan, AN; Beilman, G; Bellin, MD; Bogachus, LD; Dunn, T; Hering, B; Oseid, E; Parazzoli, S; Patti, ME; Pruett, T; Robertson, RP; Schuetz, C; Sutherland, DE | 1 |
Calanna, S; Christensen, M; Faber, J; Holst, JJ; Knop, FK; Kristensen, PL; Purrello, F; Rosenkilde, MM; Sparre-Ulrich, AH; van Hall, G; Vilsbøll, T | 1 |
Basu, A; Basu, R; Bharucha, AE; Carter, RE; Cobelli, C; Hinshaw, L; Kudva, YC; Mallad, A; Man, CD; Schiavon, M | 1 |
Bokhari, S; Emmerson, P; Gupta, A; Meyer, C; Plummer, E | 1 |
Calle, RA; Fryburg, DA; Ghosh, A; Lee, DS; Raymond, RH; Robertson, RP; Savage, PJ; Shankar, SS; Vassileva, MT; Weir, GC | 1 |
Basu, A; Basu, R; Brett, J; Johnson, C; Joyner, M; Nandy, D; Svendsen, CB | 1 |
Arpa, M; Deyneli, O; Gunes, M; Haklar, G; Imeryuz, N; Sirikci, O; Temizkan, S; Yasar, M; Yavuz, DG; Yazici, D | 1 |
Ebdrup, BH; Holst, JJ; Knop, FK; Lublin, H; Madsen, A; Mortensen, HB; Szecsi, PB; Søgaard, B | 1 |
Ahrén, B; Alsalim, W; Bizzotto, R; Mari, A; Omar, B; Pacini, G | 1 |
Deng, Y; Gu, W; Gu, Y; Hong, J; Liu, T; Ning, G; Shi, J; Sun, Z; Wang, C; Wang, W; Yao, S; Zhang, Y; Zheng, S | 1 |
Almokayyad, RM; Gannon, MC; Nuttall, FQ | 1 |
Baker, RK; Gage, BK; Kieffer, TJ | 1 |
Ahrén, B; Deacon, CF; Holst, JJ; Lindgren, O; Pacini, G; Tura, A | 1 |
Gyldenløve, M; Holst, JJ; Knop, FK; Skov, L; Storgaard, H; Vilsbøll, T | 1 |
Fujimoto, K; Hamamoto, Y; Hamasaki, A; Honjo, S; Ikeda, H; Koshiyama, H; Okamura, E; Tokumoto, S; Wada, Y; Yamaguchi, E | 1 |
Holst, JJ; Lehrskov-Schmidt, L; Møller, K; Nielsen, ST; Solomon, TP | 1 |
Bolze, S; Fouqueray, P; Mari, A; Pacini, G; Roden, M | 1 |
Heden, TD; Kanaley, JA; Leidy, HJ; Liu, Y; Nyhoff, LM; Park, YM; Thyfault, JP | 1 |
Bangert, AM; Daniel, H; Gedrich, K; Hoefle, AS; Lee, YM; Rist, MJ; Skurk, T; Stamfort, A | 1 |
Eguchi, H; Fujita, Y; Imagawa, A; Iwahashi, H; Kozawa, J; Nagano, H; Okita, K; Shimomura, I; Uno, S; Yoneda, S; Yoshikawa, A | 1 |
Davis, SN; Joy, NG; Tate, DB | 1 |
Becker, RH; Golor, G; Pellissier, F; Stechl, J; Steinstraesser, A | 1 |
Abadpour, S; Foss, A; Gorman, T; Hoeyem, M; Johansson, L; Korsgren, O; Sahraoui, A; Scholz, H; Skrtic, S; Smith, DM; Winzell, MS | 1 |
Ahmed, L; Bantle, JP; Bessler, M; Billington, CJ; Connett, JE; Ikramuddin, S; Inabnet, WB; Korner, J; Nguyen, KT; Thomas, A; Vella, A; Wang, Q | 1 |
Cho, WK; Jung, MH; Park, MS; Park, SH; Suh, BK | 1 |
Bindels, LB; Burkart, V; Hartmann, B; Henrich, B; Holst, JJ; Hwang, JH; Kolb, H; MacKenzie, C; Martinez, I; Nowotny, B; Nowotny, P; Pacini, G; Roden, M; Schloot, NC; Simon, MC; Stehle, P; Strassburger, K; Walter, J; Zivehe, F | 1 |
Bocchio-Chiavetto, L; Cattaneo, A; Gennarelli, M; Maina, G; Rosso, G; Zanardini, R | 1 |
Hansen, HS; Hansen, KB; Hartmann, B; Holst, JJ; Mandøe, MJ; Rehfeld, JF | 1 |
Ahren, B; Bar-Dayan, Y; Froy, O; Jakubowicz, D; Landau, Z; Wainstein, J | 1 |
Choi, H; Connelly, PW; Kramer, CK; Retnakaran, R; Zinman, B | 1 |
Camilleri, M; Cobelli, C; Edens, KL; Farrugia, LP; Grothe, KB; Man, CD; Micheletto, F; Piccinini, F; Rizza, RA; Sathananthan, M; Shah, M; Vella, A | 1 |
Hara, K; Kaku, H; Kato, T; Mitsuzaki, K; Muraishi, K; Nakayama, H; Nakayama, S; Ohki, T; Tajiri, Y; Tanaka, K; Tokubuchi, I; Tsuruta, M; Wada, N; Yamada, K | 1 |
Ahrén, B; Alsalim, W; Bizzotto, R; Mari, A; Omar, B; Pacini, G; Tura, A | 1 |
Anthony, DF; Davies, RW; MacDonald, AI; MacIntyre, A; McGuinness, D; Moulisova, V; Nag, A; Shiels, PG; Thomson, J | 1 |
Chen, H; Luo, N; Wang, Y; Zhang, Z; Zhu, Y | 1 |
Chrenova, J; Dedik, L; Mojto, V; Rausova, Z | 1 |
Benatti, FB; Harder-Lauridsen, NM; Krogh-Madsen, R; Lyngbæk, MP; Møller, K; Nielsen, ST; Pedersen, BK; Wedell-Neergaard, AS | 1 |
Iwasaki, M; Kurose, T; Kuwata, H; Maeda, H; Minami, K; Murotani, K; Nakada, K; Nosaka, C; Seino, S; Seino, Y; Shimizu, S; Yabe, D | 1 |
Holst, JJ; Madsbad, S; Nørgaard, K; Ranjan, A; Schmidt, S | 1 |
Adams-Huet, B; Bouza, B; Dart, L; Franklin, B; Mitchell, J; Phillips, M; Shah, M | 1 |
Bendtsen, F; Bojsen-Møller, KN; Dirksen, C; Hartmann, B; Holst, JJ; Jørgensen, NB; Kristiansen, VB; Madsbad, S; Nielsen, S; Svane, MS | 1 |
Cogne, M; Gérard, P; Jarlet, E; Maiza, JC; Rollot, O; Schneebeli, S | 1 |
Beilman, GJ; Bellin, MD; Berry, KL; Dunn, TB; Freeman, ML; Lundberg, R; Moran, A; Pruett, TL; Ptacek, PE; Robertson, RP | 1 |
Beglinger, C; Cajacob, L; Drewe, J; Herzog, R; Meyer-Gerspach, AC; Riva, D; Wölnerhanssen, BK | 1 |
Dincer, F; Farr, OM; Gavrieli, A; Hamnvik, OP; Mantzoros, CS; Sahin-Efe, A; Vamvini, MT | 1 |
de la Peña, A; Del Prato, S; Karanikas, CA; Ludvik, B; Mari, A; Milicevic, Z; Pechtner, V; Shurzinske, L | 1 |
Bergman, A; Erion, DM; Kazierad, DJ; Lee, DS; Rolph, T; Somayaji, V; Tan, B | 1 |
Carrera-Bastos, P; Chanrai, M; Fontes-Villalba, M; Granfeldt, Y; Jönsson, T; Knop, FK; Lindeberg, S; Memon, AA; Picazo, Ó; Sundquist, K; Sunquist, J | 1 |
Cicciò, F; Ciresi, A; Giordano, C; Radellini, S | 1 |
Arslanian, S; Bacha, F; Hannon, T; Hughan, KS; Kim, JY; Lee, S; Michaliszyn, SF; Nasr, A; Tfayli, H | 1 |
Chowdhury, S; Dunai, J; Kilpatrick, R; Oestricker, LZ; Patterson, BW; Reeds, DN; Wallendorf, MJ; Wang, S; Wice, BM | 1 |
Cuchel, M; De Leon, DD; Gudipaty, L; Hadjiliadis, D; Kelly, A; Kubrak, C; Malik, S; Nyirjesy, SC; Peleckis, AJ; Rickels, MR; Rosenfeld, NK; Rubenstein, RC; Sheikh, S; Stefanovski, D | 1 |
Brede, S; Cobelli, C; Hallschmid, M; Klement, J; Lehnert, H; Ott, V; Piccinini, F; Rapp, K | 1 |
Broadbent, RS; Medlicott, NJ; Reith, DM; Salis, ER; Wheeler, BJ | 1 |
Feinle-Bisset, C; Fitzgerald, PC; Horowitz, M; Schober, G; Steinert, RE; Ullrich, SS | 1 |
Bartoszewicz, Z; Grodzicki, M; Kalinowski, P; Krawczyk, M; Paluszkiewicz, R; Remiszewski, P; Wróblewski, T | 1 |
Baranov, O; Deacon, CF; Holst, JJ; Kahle, M; Nauck, MA | 1 |
Cui, X; de la Peña, A; Kapitza, C; Kelly, RP; Loghin, C; Zhang, X | 1 |
Ahrén, B; D'Argenio, DZ; Pacini, G; Song, G | 1 |
Abadie, J; Bach, JM; Blancho, G; Bosch, S; Brouard, S; Conchon, S; Concordet, JP; Cozzi, E; Danna, C; Duchi, R; Gaide, N; Galli, C; Gauthier, O; Guicheux, J; Hervouet, J; Jégou, D; Judor, JP; Lagutina, I; Lazzari, G; Le Bas-Bernardet, S; Le Berre, L; Lévêque, X; Minault, D; Mosser, M; Mouré, A; Perota, A; Pogu, S; Riochet, D; Salama, A; Soulillou, JP; Weiss, P | 1 |
Grunewald, ZI; Heden, TD; Kanaley, JA; Liu, Y; Nyhoff, LM; Winn, NC | 1 |
Bojsen-Moller, KN; Clausen, TR; Holst, JJ; Kristiansen, VB; Kuhre, RE; Madsbad, S; Nielsen, S; Rehfeld, JF; Svane, MS | 1 |
Fujimori, N; Igarashi, H; Ito, T; Jensen, RT; Kawabe, K; Lee, L; Oda, Y; Tachibana, Y; Takayanagi, R; Ueda, K | 1 |
Angeletti, S; Cappelli, A; Del Toro, R; Fallucca, S; Guglielmi, C; Lachin, JM; Lauria, A; Maurizi, AR; Pozzilli, P | 1 |
Bell, GI; Gregersen, S; Hjørringgaard, CU; Olsen, J; Park, SY; Støy, J | 1 |
Fujioka, Y; Izawa, S; Kato, M; Matsumoto, K; Matsuzawa, K; Nakamura, R; Okura, T; Shoji, K; Sumi, K; Taniguchi, S; Yamamoto, K | 1 |
Cobelli, C; Dalla Man, C; Laurenti, MC; Matveyenko, A; Rizza, RA; Sharma, A; Varghese, RT; Vella, A | 1 |
Anděl, M; Gojda, J; Plíhalová, A; Polák, J; Potočková, J; Straková, R; Tůma, P | 1 |
Bruce, CR; Hamley, S; Kowalski, GM; Moore, SM; Selathurai, A | 1 |
Breuer, TGK; Holst, JJ; Meier, JJ; Menge, BA; Mumme, L; Nauck, MA; Rohrer, S; Schenker, N | 1 |
Kadowaki, T; Muto, S; Ouchi, Y; Seino, Y; Shimazaki, R | 1 |
Harada, N; Ikeda, K; Inagaki, N; Joo, E; Mano, F; Yamane, S | 1 |
Fukui, K; Imagawa, A; Iwahashi, H; Kozawa, J; Shimomura, I; Uno, S | 1 |
Bódis, K; Bönhof, G; Burkart, V; Markgraf, DF; Müssig, K; Püttgen, S; Roden, M; Strom, A; Szendroedi, J; Ziegler, D | 1 |
Bailey, KR; Cobelli, C; Man, CD; Rizza, RA; Shah, M; Sharma, A; Varghese, RT; Vella, A | 1 |
Augustin, T; Boulgaropoulos, B; Brunner, M; Eller, P; Korsatko, S; Mader, JK; Magnes, C; Narath, SH; Pieber, TR; Raml, R; Regittnig, W; Zenz, S | 1 |
Bäckhed, F; Brønden, A; Gabe, MN; Hansen, M; Holst, JJ; Knop, FK; Mikkelsen, K; Rehfeld, JF; Rosenkilde, M; Sonne, DP; Tremaroli, V; Våben, C; Vilsbøll, T; Wu, H | 1 |
Feinle-Bisset, C; Fitzgerald, PCE; Giesbertz, P; Horowitz, M; Steinert, RE; Ullrich, SS | 1 |
Chujo, D; Kajio, H; Takahashi, N; Tsujimoto, T | 1 |
Gu, DY; Gu, P; Li, K; Lu, B; Shao, JQ; Song, WJ; Wu, X; Zang, P | 1 |
Clarke, SD; Feinle-Bisset, C; Heruc, GA; Horowitz, M; Kohn, MR; Little, TJ; Madden, S | 1 |
He, Z; Hou, X; Hu, C; Jia, W; Jiang, F; Wang, J; Wang, S; Zhang, R | 1 |
Basu, A; Basu, R; Carter, RE; Joshi, N; Miles, J; Rizza, RA | 1 |
Chikh, K; Marchand, L; Thivolet, C | 1 |
Hu, Y; Lee, KO; Li, HQ; Li, Z; Liu, BL; Ma, JH; Su, XF; Sun, R; Wang, J; Ye, L | 1 |
Bergsten, P; Eriksson, J; Gustafsson, J; Kristinsson, H; Moazzami, AA; Müllner, E; Östman, JR; Witthöft, C | 1 |
Abdul-Ghani, M; Basu, R; DeFronzo, RA; Merovci, A; Tripathy, D | 1 |
Fujita, Y; Fukui, K; Hosakawa, Y; Ishibashi, C; Iwahashi, H; Kimura, T; Kozawa, J; Shimomura, I; Yoneda, S | 1 |
Ahlers, M; Laferrère, B; Levesque, K; Mark, V; Patel, K; Pierini, E; Rojas, B; Shah, A | 1 |
Christensen, B; Dollerup, OL; Gillum, MP; Hartmann, B; Holst, JJ; Jessen, N; Møller, N; Trammell, SAJ; Treebak, JT | 1 |
De Leon, DD; Hadjiliadis, D; Kelly, A; Kilberg, MJ; Kubrak, C; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D | 1 |
Bocchio-Chiavetto, L; Bonetto, C; Bruschi, C; D'Agostino, A; Faravelli, C; Furlato, K; Gennarelli, M; Imbesi, M; Lasalvia, A; Minelli, A; Preti, A; Ruggeri, M; Scocco, P; Tomassi, S; Tosato, S; Zanardini, R | 1 |
Adams, JD; Andrade, MDH; Bailey, KR; Cobelli, C; Dalla Man, C; Laurenti, MC; Rizza, RA; Vella, A | 1 |
Bojsen-Møller, KN; Dirksen, C; Fenger, M; Holst, JJ; Kristiansen, VB; Madsbad, S; Martinussen, C; Svane, MS; van Hall, G; Veedfald, S; Wewer Albrechtsen, NJ | 1 |
Fels, JJ; Gradel, AKJ; Kildegaard, J; Ludvigsen, TP; Lykkesfeldt, J; Porsgaard, T; Refsgaard, HHF; Schou-Pedersen, AMV | 1 |
Chen, P; Guan, W; Ji, H; Lai, J; Sun, Y; Wang, Q; Yang, Q; Yin, J; Zhang, S | 1 |
Cuchel, M; Hadjiliadis, D; Harris, C; Kelly, A; Kilberg, MJ; Kubrak, C; Rickels, MR; Rubenstein, RC; Sheikh, S; Stefanovski, D | 1 |
Cai, HL; Chen, T; Cheng, M; Cheng, XB; Huang, HY; Lu, Y; Su, JB; Wang, X; Wang, XH; Wang, XQ; Xu, F; Zhang, DM; Zhang, XL; Zhao, LH | 1 |
Cui, X; Feng, J; Gu, L; Hong, T; Lang, S; Le, Y; Liu, J; Wang, H; Wei, R; Wei, T; Yang, J; Yang, K | 1 |
Morioka, I; Urakami, T; Yoshida, K | 1 |
Holst, JJ; Hædersdal, S; Knop, FK; Lund, A; Maagensen, H; Nielsen-Hannerup, E; van Hall, G; Vilsbøll, T | 1 |
Kadowaki, S; Kaga, H; Kawamori, R; Nakagata, T; Sato, M; Satoh, H; Someya, Y; Sugimoto, D; Tamura, Y; Watada, H; Yamasaki, N | 1 |
Ali Mondal, S; Anne M, B; Basu, M; Chakrabarti, P; Das, K; Ghosh, I; Ghosh, S; Mukhopadhyay, P; Nargis, T; Pandit, K | 1 |
Benítez-Pérez, R; Chávez-Alderete, J; Del-Río-Hidalgo, R; Gochicoa-Rangel, L; Guerrero-Zúñiga, S; Mora-Romero, U; Rodríguez-Moreno, L; Torre-Bouscoulet, L; Vargas, MH | 1 |
Abiru, N; Akazawa, S; Haraguchi, A; Horie, I; Ito, A; Kamada, A; Kawakami, A; Miwa, M; Nakashima, Y; Natsuda, S; Niri, T; Sako, A; Shigeno, R | 1 |
Elovaris, RA; Feinle-Bisset, C; Hajishafiee, M; Heilbronn, LK; Horowitz, M; Jones, KL; Poppitt, SD | 1 |
Alarcon Ramos, GC; Bharmal, SH; Cameron-Smith, D; Cho, J; Ko, J; Petrov, MS | 1 |
Chen, S; Chowdhury, KH; Dean, ED; Efanov, AM; Gimeno, RE; Holland, WL; Lee, Y; Leonard, DC; Li, N; McCorkle, SK; Poffenberger, G; Powers, AC; Quittner-Strom, E; Scherer, PE; Schlegel, A; Sloop, KW; Unger, RH; Von Deylen, A; Wang, MY; Ye, R; Yu, X; Zhang, Y; Zhang, Z; Zhao, S; Zhu, Y | 1 |
Gradel, AKJ; Kildegaard, J; Lykkesfeldt, J; Porsgaard, T; Refsgaard, HHF | 1 |
Beaumont, M; Grathwohl, D; Macé, K; Monnard, C; Sauser, J; Shahkhalili, Y; Zufferey, CA | 1 |
Bagger, JI; Becker, U; Bergmann, SS; Dalsgaard, NB; Demant, M; Foghsgaard, S; Gasbjerg, LS; Gether, L; Gillum, MP; Grønbæk, H; Grøndahl, MFG; Holst, JJ; Knop, FK; Knop, J; Kønig, MJ; Lanng, AR; Strandberg, C; Suppli, MP; Thomasen, M; Vilsbøll, T; Wewer Albrechtsen, NJ | 1 |
Cason, RL; Cherrington, AD; Dai, Y; Farmer, B; Moore, MC; Sheanon, N; Smith, M; Warner, SO; Winnick, JJ | 1 |
Ghislain, J; Maachi, H; Poitout, V; Tremblay, C | 1 |
Agah, S; Bitarafan, V; Elovaris, RA; Feinle-Bisset, C; Horowitz, M; Lange, K; Ullrich, SS | 1 |
Bojsen-Møller, KN; Clausen, TR; Holst, JJ; Jonsson, I; Kristiansen, VB; Kuhre, RE; Madsbad, S; Rehfeld, JF; Svane, MS; Veedfald, S; Wewer Albrechtsen, NJ | 1 |
Bain, SC; Bracken, RM; Eckstein, ML; McCarthy, O; Moser, O; Pitt, J | 1 |
Allerton, DM; Bowden Davies, KA; Brunsgaard, LH; Smith, K; Stevenson, EJ; Taylor, GS; West, DJ | 1 |
Binkowski, S; Davis, EA; Harray, AJ; Horowitz, M; Jones, T; Keating, BL; King, BR; Paramalingam, N; Smart, CEM; Smith, G; Standfield, S | 1 |
Holst, JJ; Rehfeld, JF; Svendsen, LB; van Hall, G; Veedfald, S | 1 |
Bao, J; Li, L; Liu, D; Lv, Y; Ni, M; Qi, L; Sj, P; Su, J; Wang, L; Wang, Q; Wei, Q; Xia, H | 1 |
Ahrén, B; Alsalim, W; Göbl, C; Kahleova, H; Morettini, M; Salvatori, B; Tura, A | 1 |
Feinle-Bisset, C; Hajishafiee, M; Horowitz, M; Lange, K; McVeay, C; Rehfeld, JF | 1 |
Angelidi, AM; Gavrieli, A; Kalra, B; Kumar, A; Mantzoros, CS; Perakakis, N; Yannakoulia, M | 1 |
Bao, J; Cheng, H; Li, L; Liu, D; Lv, Y; Qi, L; Qiu, Y; Su, J; Su, X; Sun, J; Wei, Q; Ye, Z; Yu, X; Zhang, Y | 1 |
Azlan, A; Ebadi, S; Kannar, D; Mahmood, Z; Othman, NMH; Sultana, S; Yusof, BNM | 1 |
Cheng, Z; Dong, S; Hu, S; Rayner, C; Wang, K; Wu, T; Zhang, G; Zhang, X; Zhong, M | 1 |
Bellin, MD; Chen, YC; Dai, L; Klimek-Abercrombie, AM; Pallo, LP; Potter, KJ; Soukhatcheva, G; Verchere, CB | 1 |
Barbot, M; Basso, D; Ceccato, F; Giordano, C; Guarnotta, V; Mondin, A; Regazzo, D; Scaroni, C | 1 |
Dan, K; Fushimi, Y; Iwamoto, H; Iwamoto, Y; Kaku, K; Kaneto, H; Katakura, Y; Kimura, T; Kubo, M; Mune, T; Nakanishi, S; Nakao, E; Sanada, J; Shimoda, M; Sugisaki, T; Takahashi, K; Tatsumi, F; Wamata, R | 1 |
Anderlova, K; Bendlova, B; Krejci, H; Pacini, G; Sladek, M; Sumova, A; Tura, A; Vankova, M; Vcelak, J; Vejrazkova, D | 1 |
Billeter, AT; Israel, B; Kopf, S; Müller-Stich, BP; Nawroth, PP; Scheurlen, KM; Schirmacher, P; Straub, BK | 1 |
Essaouiba, A; Gakière, B; Gilard, F; Jellali, R; Kim, SH; Leclerc, E; Legallais, C; Poulain, S; Sakai, Y; Tokito, F | 1 |
Bøgh, IB; Fels, JJ; Jensen, VFH; Lykkesfeldt, J; Mølck, AM; Nowak, J | 1 |
Aida, N; Go, H; Hasegawa, M; Hiratsuka, I; Ishihara, T; Ito, T; Kenmochi, T; Kurihara, K; Kusaka, M; Matsushima, H; Shibata, M; Shintani, A; Suzuki, A; Yabusaki, K | 1 |
Buralkina, NA; Chuprynin, VD; Chursin, VV; Krasnyi, AM; Pavlovich, SV; Sadekova, AA; Smolnova, TY; Sukhikh, GT; Yarotskaya, E | 1 |
Eguchi, H; Fujita, Y; Horii, T; Ishibashi, C; Kawata, S; Kozawa, J; Miyagawa, JI; Nammo, T; Ozawa, H; Shimomura, I; Yoneda, S | 1 |
Kashtanova, EV; Khudiakova, AD; Polonskaya, YV; Ragino, YI; Shcherbakova, LV; Shramko, VS; Striukova, EV | 1 |
Gulati, S; Misra, A; Pandey, RM; Sati, HC; Sharma, M; Tiwari, R; Upadhyay, AD | 1 |
Babu, S; Gowshika, K; Kumar, NP; Lakshan Raj, S; Mittal, R; Pandiarajan, AN; Putlibai, S; Rajamanickam, A; Ramanan, PV; Sasidaran, R; Selvaraj, N; Venkataraman, A | 1 |
Faggionato, E; Laurenti, MC; Man, CD; Vella, A | 1 |
Deane, A; Horowitz, M; Jalleh, RJ; Jones, KL; Plummer, MP; Umapathysivam, MM | 1 |
Boll, KK; Bundgaard, CJ; Christoffersen, BØ; Fels, JJ; Hjøllund, KR; Lyhne, MK; Olsen, LH | 1 |
Horowitz, M; Huang, W; Jones, KL; Rayner, CK; Sang, M; Sun, Z; Wewer Albrechtsen, NJ; Wu, T; Xie, C | 1 |
30 review(s) available for glucagon and c-peptide
Article | Year |
---|---|
Metabolism of polypeptide hormones by the normal kidney and in uremia.
Topics: Animals; Antigens; C-Peptide; Erythropoietin; Glucagon; Gonadotropins, Pituitary; Humans; Insulin; Kidney; Kidney Failure, Chronic; Luteinizing Hormone; Metabolic Clearance Rate; Molecular Weight; Pancreatic Hormones; Proinsulin; Prolactin; Uremia | 1978 |
Evaluation of insulin secretory capacity in diabetes mellitus.
Topics: Adult; Animals; Blood Glucose; C-Peptide; Child, Preschool; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Antibodies; Insulin Secretion; Islets of Langerhans; Rats | 1979 |
[Radioimmunological methods for the highly specialized diagnosis and clinical study of diabetes mellitus].
Topics: Antigens; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Insulin; Insulin Antibodies; Radioimmunoassay | 1979 |
[Methods for the characterization of glucose turnover and the peripheral insulin resistance in human prediabetic conditions].
Topics: C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Insulin Resistance; Liver; Prediabetic State; Tritium | 1979 |
[Hormonal changes during administration of dietary fibers in patients with decreased glucose tolerance].
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Dietary Fiber; Gastrins; Glucagon; Glucose Tolerance Test; Humans; Insulin; Intestinal Absorption; Triticum | 1990 |
Insulin-dependent diabetes mellitus: pathophysiology.
Topics: Autoimmune Diseases; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Diagnosis, Differential; Glucagon; Humans; Insulin; Insulin Resistance | 1986 |
[Pancreatic paraneurons and their hormones].
Topics: Animals; C-Peptide; Dogs; Glucagon; Guinea Pigs; Humans; Insulin; Pancreas; Pancreatic Hormones; Pancreatic Polypeptide; Somatostatin; Vasoactive Intestinal Peptide | 1980 |
[Islet cell cancer with organic hyperinsulinism. Clinical aspects, diagnosis and therapy].
Topics: Adenoma; Adenoma, Islet Cell; C-Peptide; Diagnosis, Differential; Diazoxide; Female; Glucagon; Humans; Hyperinsulinism; Liver Neoplasms; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Prognosis; Proinsulin; Streptozocin | 1982 |
Gut hormone secreting tumours.
Topics: Adenoma, Islet Cell; Bombesin; Bronchial Neoplasms; C-Peptide; Carcinoma, Small Cell; Diagnosis, Differential; Endocrine System Diseases; Erythema; Gastrointestinal Hormones; Glucagon; Glucagonoma; Humans; Insulin; Insulin Secretion; Insulinoma; Male; Neoplasms; Neurotensin; Pancreatic Hormones; Pancreatic Neoplasms; Pancreatic Polypeptide; Somatostatinoma; Vasoactive Intestinal Peptide; Zollinger-Ellison Syndrome | 1983 |
Alterations of maternal metabolism in normal and diabetic pregnancies: differences in insulin-dependent, non-insulin-dependent, and gestational diabetes.
Topics: Blood Glucose; C-Peptide; Child; Circadian Rhythm; Female; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Resistance; Lipoproteins, HDL; Maternal-Fetal Exchange; Placenta; Postpartum Period; Pregnancy; Pregnancy in Diabetics; Prolactin; Time Factors; Triglycerides; Uterus | 1983 |
C-peptide and free insulin determinations in type I diabetes; relationships with metabolic control and insulin therapy.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Humans; Insulin; Islets of Langerhans | 1984 |
[Radioimmunoassay in endocrinology].
Topics: Adrenal Gland Diseases; C-Peptide; Diabetes Mellitus; Dwarfism; Glucagon; Growth Hormone; Humans; Insulin; Parathyroid Diseases; Radioimmunoassay; Thyroglobulin; Thyroid Diseases; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine; Triiodothyronine, Reverse | 1983 |
Pathogenesis of endocrine abnormalities in uremia.
Topics: Animals; C-Peptide; Calcitriol; Clomiphene; Dihydroxycholecalciferols; Female; Follicle Stimulating Hormone; Glomerular Filtration Rate; Glucagon; Gonadotropin-Releasing Hormone; Hormones; Humans; Insulin; Kidney; Kidney Failure, Chronic; Luteinizing Hormone; Male; Metabolic Clearance Rate; Mineralocorticoids; Parathyroid Hormone; Proinsulin; Prolactin; Sexual Dysfunction, Physiological; Thyroid Hormones; Uremia | 1980 |
[Influence of insulinfree rehydration on diabetic derangements (author's transl)].
Topics: Acidosis; Adolescent; Adult; Aged; Aldosterone; Blood Glucose; C-Peptide; Diabetes Mellitus; Electrolytes; Epinephrine; Female; Glucagon; Gluconeogenesis; Glycosuria; Humans; Hydrocortisone; Hydrogen-Ion Concentration; Infusions, Parenteral; Insulin; Male; Middle Aged; Osmotic Pressure; Renin; Water-Electrolyte Balance | 1980 |
Circulating C peptide: measurement and clinical application.
Topics: C-Peptide; Drug Stability; Glucagon; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Peptides; Radioimmunoassay | 1981 |
C-peptide measurement and its clinical usefulness: a review.
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Hypoglycemia; Infant, Newborn; Insulin; Insulinoma; Islets of Langerhans; Kidney Function Tests; Middle Aged; Peptides; Radioimmunoassay | 1981 |
[Role of C-peptide determination in the diagnosis of diabetes mellitus].
Topics: C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Prognosis; Radioimmunoassay | 1993 |
The role of prohormone convertases in insulin biosynthesis: evidence for inherited defects in their action in man and experimental animals.
Topics: Animals; Aspartic Acid Endopeptidases; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Islets of Langerhans; Obesity; Organ Specificity; Proinsulin; Proprotein Convertase 2; Proprotein Convertases; Subtilisins | 1996 |
Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
Topics: Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion | 1996 |
[Insulin secretion--assay method and its significance].
Topics: C-Peptide; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Leucine | 1997 |
Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Brief Psychiatric Rating Scale; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Hydrocortisone; Insulin; Male; Obesity; Schizophrenia | 2002 |
Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
Topics: Adolescent; Adult; Black People; Body Mass Index; C-Peptide; Child; Diabetes Mellitus, Type 2; Food; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Puberty | 2002 |
Gastric inhibitory polypeptide: the neglected incretin revisited.
Topics: Adipose Tissue; Amino Acid Sequence; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Lipids; Models, Biological; Molecular Sequence Data; Pancreatic Hormones; Peptide Fragments; Postprandial Period; Protein Precursors; Secretin; Sequence Homology, Amino Acid; Stomach | 2002 |
The potential role of glucagon-like peptide 1 in diabetes.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Injections, Intravenous; Injections, Subcutaneous; Insulin; Peptide Fragments; Protein Precursors | 2004 |
Markers of beta cell function in type 1 diabetes mellitus.
Topics: Age Factors; Autoantibodies; Biomarkers; C-Peptide; Cell Death; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Diabetic Retinopathy; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans | 2004 |
[Molecular biology of regulation in renal functions; biosynthesis, metabolism, and action of insulin and glucagon].
Topics: C-Peptide; Glomerular Filtration Rate; Glucagon; Humans; Insulin; Kidney; Kidney Glomerulus; Kidney Tubules; Renal Circulation; Sclerosis; Sodium | 2006 |
Pro-insulin, C peptide, glucagon, adiponectin, TNF alpha, AMPK: neglected players in type 2 diabetes mellitus.
Topics: Adipocytes; Adiponectin; AMP-Activated Protein Kinases; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Tumor Necrosis Factor-alpha | 2010 |
Insulin resistance in type 2 diabetic youth.
Topics: Adolescent; Body Mass Index; C-Peptide; Child; Diabetes Mellitus, Type 2; Exercise Tolerance; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Metformin; Obesity; Phenotype; Young Adult | 2012 |
[Type LADA diabetes--interrogation points].
Topics: Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Disease Progression; Glucagon; Humans; Insulin; Islets of Langerhans | 2013 |
Postprandial plasma GLP-1 levels are elevated in individuals with postprandial hypoglycaemia following Roux-en-Y gastric bypass - a systematic review.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Insulin | 2023 |
296 trial(s) available for glucagon and c-peptide
Article | Year |
---|---|
Effect of insulin induced hypoglycaemia on the blood levels of catecholamines, glucagon, growth hormone, cortisol, C-peptide and proinsulin before and during medication with the cardioselective beta-receptor blocking agent metoprolol in man.
Topics: Adult; C-Peptide; Catecholamines; Clinical Trials as Topic; Glucagon; Growth Hormone; Half-Life; Humans; Hydrocortisone; Hypertension; Hypoglycemia; Insulin; Male; Metoprolol; Middle Aged; Peptides; Proinsulin; Propanolamines | 1978 |
Danazol induces resistance to both insulin and glucagon in young women.
Topics: Adult; Blood Glucose; C-Peptide; Cholesterol; Danazol; Endometriosis; Female; Glucagon; Humans; Insulin; Insulin Resistance; Models, Biological | 1992 |
Effects of the new somatostatin analogue (BIM 23014) on blood glucose homeostasis in normal men.
Topics: Adult; Amino Acid Sequence; Blood Glucose; C-Peptide; Digestive System; Glucagon; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Insulin; Male; Molecular Sequence Data; Peptides, Cyclic; Somatostatin | 1992 |
Nicardipine does not cause deterioration of glucose homoeostasis in man: a placebo controlled study in elderly hypertensives with and without diabetes mellitus.
Topics: Aged; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Homeostasis; Humans; Hypertension; Insulin; Male; Nicardipine; Reproducibility of Results | 1992 |
The metabolic response to various doses of fructose in type II diabetic subjects.
Topics: Aged; Amino Acids; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Fructose; Glucagon; Humans; Insulin; Middle Aged; Nitrogen; Osmolar Concentration | 1992 |
Daily magnesium supplements improve glucose handling in elderly subjects.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; Blood Viscosity; Body Mass Index; C-Peptide; Double-Blind Method; Erythrocytes; Female; Glucagon; Homeostasis; Humans; Insulin; Insulin Resistance; Lactates; Magnesium; Male; Pyruvates | 1992 |
Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects.
Topics: Absorption; Administration, Intranasal; Adult; Blood Glucose; C-Peptide; Drug Carriers; Glucagon; Humans; Insulin; Male; Phospholipids; Reference Values | 1992 |
C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Food; Glucagon; Humans; Hypoglycemic Agents; Insulin; Kinetics; Male | 1992 |
Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.
Topics: Adult; Aged; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Growth Hormone; Humans; Injections, Intravenous; Insulin; Middle Aged; Somatostatin; Time Factors | 1991 |
Natural course of remission in IDDM during 1st yr after diagnosis.
Topics: Adult; Autoantibodies; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Antibodies; Islets of Langerhans; Male; Probability; Remission, Spontaneous | 1992 |
Meal-time intranasal insulin delivery in type 2 diabetes.
Topics: Administration, Intranasal; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Kinetics; Male; Time Factors | 1991 |
Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Infusion Systems; Kinetics; Male; Pancreatic Hormones; Pulsatile Flow | 1991 |
Comparison between a glucose-fructose-xylitol solution and a sole glucose solution for surgical patients with glucose tolerance impairment.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructose; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Postoperative Care; Randomized Controlled Trials as Topic; Surgical Procedures, Operative; Xylitol | 1990 |
Effect of dihydroxyacetone and pyruvate on plasma glucose concentration and turnover in noninsulin-dependent diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dihydroxyacetone; Female; Food, Formulated; Glucagon; Glucose Tolerance Test; Humans; Insulin; Isotope Labeling; Middle Aged; Pyruvates | 1990 |
Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glucagon; Glucose Clamp Technique; Glyburide; Glycated Hemoglobin; Humans; Insulin; Lipoproteins; Male; Middle Aged; Sulfonylurea Compounds | 1990 |
Influence of danazol and goserelin on insulin and glucagon in non-obese women with endometriosis.
Topics: Adult; Androgens; Blood Glucose; Buserelin; C-Peptide; Danazol; Endometriosis; Female; Follicle Stimulating Hormone; Glucagon; Glucose Tolerance Test; Goserelin; Humans; Insulin; Luteinizing Hormone; Testosterone | 1990 |
Plasma C-peptide levels and clinical remissions in recent-onset type I diabetic patients treated with cyclosporin A and insulin.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Clinical Trials as Topic; Cyclosporins; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Eating; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Reference Values | 1990 |
Metabolic response to glucose ingested with various amounts of protein.
Topics: Adult; Blood Glucose; C-Peptide; Dietary Proteins; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Nitrogen | 1990 |
Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.
Topics: Blood Glucose; C-Peptide; Calorimetry; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Lipid Metabolism; Male; Middle Aged; Obesity; Oxidation-Reduction | 1990 |
[Effect of pancreatin on diabetes mellitus in chronic pancreatitis].
Topics: Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 1; Glucagon; Humans; Insulin; Pancreatic Function Tests; Pancreatic Polypeptide; Pancreatin; Pancreatitis | 1990 |
Enteral versus parenteral glucose as the sole nutritional support after colorectal resection. A prospective, randomized comparison.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Enteral Nutrition; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Parenteral Nutrition; Postoperative Care; Prospective Studies; Random Allocation | 1989 |
Efficacy of bedtime NPH insulin with daytime sulfonylurea for subpopulation of type II diabetic subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Eating; Fasting; Glucagon; Glyburide; Humans; Insulin, Isophane; Middle Aged; Random Allocation | 1989 |
Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; HLA-DR Antigens; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Niacinamide | 1989 |
Effects of short-term pulsatile and continuous insulin delivery on glucagon secretion and insulin secretion and action.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Pulsatile Flow | 1989 |
[Comparison of biosynthetic human insulin and purified pork insulin. Studies in insulin-resistant obese patients using the insulin suppression test].
Topics: Adult; Aged; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Insulin, Regular, Pork; Male; Middle Aged; Obesity; Recombinant Proteins; Somatostatin; Swine | 1986 |
Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; C-Peptide; Child; Clinical Trials as Topic; Cyclosporins; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Random Allocation; Regression Analysis | 1988 |
Hormonal and metabolic responses to breakfast meals in niddm: comparison of white and whole-grain wheat bread and corresponding extruded products.
Topics: Adult; Aged; Blood Glucose; Bread; C-Peptide; Diabetes Mellitus, Type 2; Dietary Fiber; Female; Gastric Inhibitory Polypeptide; Glucagon; Glycerol; Humans; Insulin; Male; Middle Aged; Triglycerides; Triticum | 1985 |
Sulbactam/ampicillin: effects on glucose metabolism in diabetics with soft tissue infection.
Topics: Ampicillin; Bacterial Infections; Blood Glucose; C-Peptide; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combination; Floxacillin; Glucagon; Humans; Middle Aged; Penicillanic Acid; Sulbactam; Time Factors | 1985 |
Metabolic effects of continuous subcutaneous insulin infusion: evidence that a rise and fall of portal vein insulin concentration with each major meal facilitates post-absorptive glycemic control.
Topics: Adult; Body Composition; C-Peptide; Cholesterol; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Eating; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Infusion Systems; Middle Aged; Random Allocation; Triglycerides | 1988 |
Effect of guar on amino acid absorption and the blood glucose, insulin, C-peptide and glucagon responses to jejunal amino acid and glucose perfusion in man.
Topics: Absorption; Adult; Amino Acids; Blood Glucose; C-Peptide; Galactans; Glucagon; Glucose; Humans; Insulin; Jejunum; Mannans; Middle Aged; Plant Gums | 1988 |
Effect of oral verapamil on glibenclamide stimulated insulin secretion.
Topics: Adult; C-Peptide; Glucagon; Glucose; Glyburide; Humans; Hypoglycemia; Insulin; Insulin Secretion; Male; Verapamil | 1986 |
Insulin resistance in Graves' disease: a quantitative in-vivo evaluation.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Graves Disease; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Male; Middle Aged | 1988 |
Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Insulin Infusion Systems; Islets of Langerhans; Male; Pulsatile Flow; Reference Values | 1988 |
Relationship between changes in GIP concentrations and changes in insulin and C-peptide concentrations after guar gum therapy.
Topics: Adult; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Female; Galactans; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Lipids; Male; Mannans; Middle Aged; Plant Gums; Random Allocation | 1986 |
The effect of protein ingestion on the metabolic response to oral glucose in normal individuals.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Dietary Carbohydrates; Dietary Proteins; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged | 1986 |
Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Topics: Adult; Blood Glucose; C-Peptide; Drug Administration Schedule; Glucagon; Glucose; Humans; Infusions, Intravenous; Insulin; Kinetics; Liver; Male | 1987 |
Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone.
Topics: Blood Glucose; Body Weight; C-Peptide; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glucagon; Glyburide; Glycated Hemoglobin; Glycosuria; Humans; Insulin; Lipids; Male; Middle Aged | 1985 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Platelet Aggregation; Somatostatin | 1980 |
[The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication].
Topics: Adult; Bezafibrate; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Insulin Resistance; Somatostatin; Time Factors | 1984 |
Effects of dietary fiber on postprandial glycemic profiles in diabetic patients submitted to continuous programmed insulin infusion.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Dietary Fiber; Glucagon; Humans; Insulin; Insulin Infusion Systems; Male; Middle Aged; Random Allocation | 1984 |
[The stress reaction in knee operations under continuous peridural anesthesia in comparison with neuroleptanalgesia].
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Anesthesia, Epidural; Blood Glucose; C-Peptide; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Knee; Middle Aged; Neuroleptanalgesia; Stress, Physiological; Time Factors | 1983 |
Blood glucose and serum C-peptide after a single chlorpropamide dose.
Topics: Adult; Blood Glucose; C-Peptide; Chlorpropamide; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Sulfonylurea Compounds | 1984 |
Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Hyperinsulinism; Insulin; Male; Metabolic Clearance Rate | 1984 |
Semisynthetic human insulin and purified pork insulin do not differ in their biological potency.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin, Regular, Pork; Male; Norepinephrine; Prolactin | 1984 |
Effects of mild hyperinsulinemia on the metabolic response to exercise.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Humans; Hydroxybutyrates; Insulin; Kinetics; Lactates; Lactic Acid; Male; Physical Exertion | 1981 |
Calcitonin, a diabetogenic hormone?
Topics: Adult; Blood Glucose; C-Peptide; Calcitonin; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Kinetics; Male; Middle Aged; Peptides | 1981 |
Effects of gamma aminobutyric acid (GABA) and muscimol on endocrine pancreatic function in man.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Female; gamma-Aminobutyric Acid; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Muscimol; Oxazoles | 1982 |
Protein content of the evening meal and nocturnal plasma glucose regulation in type-I diabetic subjects.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Dietary Fats; Dietary Proteins; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hydrocortisone; Middle Aged | 1995 |
Importance of early insulin levels on prandial glycaemic responses and thermogenesis in non-insulin-dependent diabetes mellitus.
Topics: Aged; Basal Metabolism; Blood Glucose; Body Temperature Regulation; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Food; Glucagon; Humans; Insulin; Male; Middle Aged; Time Factors | 1995 |
Glutamine and alpha-ketoglutarate prevent the decrease in muscle free glutamine concentration and influence protein synthesis after total hip replacement.
Topics: Amino Acids; Blood Glucose; C-Peptide; Glucagon; Glutamine; Hip Prosthesis; Humans; Hydrocortisone; Insulin; Ketoglutaric Acids; Muscles; Parenteral Nutrition, Total; Postoperative Complications; Protein Biosynthesis; Ribosomes | 1995 |
Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7-36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships.
Topics: Adult; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Dose-Response Relationship, Drug; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Injections, Subcutaneous; Insulin; Kinetics; Male; Peptide Fragments; Random Allocation; Reference Values; Time Factors | 1995 |
Insulin response after treatment depends on fasting plasma glucose level in NIDDM.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Fasting; Female; Gliclazide; Glucagon; Glucose Tolerance Test; Glyburide; Humans; Insulin; Male; Middle Aged | 1994 |
Effects of human growth hormone in critically ill nonseptic patients: results from a prospective, randomized, placebo-controlled trial.
Topics: Blood Glucose; C-Peptide; Critical Illness; Double-Blind Method; Energy Metabolism; Glucagon; Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Lipids; Methylhistidines; Minerals; Nitrogen; Oxygen Consumption; Prospective Studies | 1995 |
Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Case-Control Studies; Female; Glucagon; Humans; Injections, Subcutaneous; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Recombinant Proteins; Renal Dialysis | 1995 |
Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Forearm; Glucagon; Glucose Clamp Technique; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Infusions, Intra-Arterial; Insulin; Male; Somatostatin | 1995 |
[Effect of misoprostol, a synthetic prostaglandin E analog, on levels of serum C-peptide in serum and glucose tolerance].
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Duodenal Ulcer; Glucagon; Humans; Male; Misoprostol; Radioimmunoassay; Stomach Ulcer | 1994 |
Improved metabolic control does not reverse left ventricular filling abnormalities in newly diagnosed non-insulin-dependent diabetes patients.
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Chlorpropamide; Cholesterol; Diabetes Mellitus, Type 2; Diet, Diabetic; Echocardiography, Doppler; Female; Follow-Up Studies; Glucagon; Glyburide; Glycated Hemoglobin; Heart Rate; Humans; Male; Middle Aged; Reference Values; Triglycerides; Ventricular Function, Left | 1994 |
Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
Topics: Age of Onset; Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Liver; Middle Aged; Obesity; Reference Values; Triglycerides; Tritium; Twins, Monozygotic | 1995 |
Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Glipizide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Indoles; Insulin; Male; Pyrroles; Reference Values | 1994 |
Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.
Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male; Niacinamide; Pregnenediones | 1994 |
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Injections, Subcutaneous; Insulin; Male; Middle Aged; Peptide Fragments; Protein Precursors; Radioimmunoassay; Time Factors | 1994 |
Anti-insulin antibodies are a cause of hypoglycemia following pancreas transplantation.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Female; Food, Formulated; Glucagon; Humans; Hypoglycemia; Insulin Antibodies; Male; Pancreas Transplantation; Precipitin Tests; Proinsulin; Sucrose | 1994 |
Availability of glucose ingested during muscle exercise performed under acipimox-induced lipolysis blockade.
Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Calorimetry, Indirect; Carbohydrate Metabolism; Energy Metabolism; Glucagon; Glucose; Glycerol; Humans; Hypolipidemic Agents; Insulin; Lipid Metabolism; Lipolysis; Male; Oxidation-Reduction; Physical Exertion; Pyrazines | 1994 |
Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Calcifediol; Calcitriol; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged | 1994 |
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocytes; Female; Glucagon; Glucose; Humans; Insulin; Magnesium; Male; Oxidation-Reduction | 1994 |
Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Hormones; Humans; Hydrocortisone; Insulin; Insulin-Like Growth Factor I; Kinetics; Leucine; Male; Middle Aged; Norepinephrine; Recombinant Proteins | 1993 |
The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins B; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diet, Diabetic; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Male; Middle Aged; Sex Factors; Triglycerides | 1993 |
Glycemic actions of alanine and terbutaline in IDDM.
Topics: Administration, Oral; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Humans; Injections, Subcutaneous; Insulin; Kinetics; Lactates; Random Allocation; Reference Values; Terbutaline | 1993 |
Alanine and terbutaline in treatment of hypoglycemia in IDDM.
Topics: 3-Hydroxybutyric Acid; Administration, Oral; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Hypoglycemia; Injections, Subcutaneous; Insulin; Lactates; Pancreatic Polypeptide; Terbutaline; Time Factors | 1993 |
Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1.
Topics: Adolescent; Adult; Albuminuria; Blood Glucose; Blood-Retinal Barrier; C-Peptide; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fructosamine; Glomerular Filtration Rate; Glucagon; Glycated Hemoglobin; Growth Hormone; Hexosamines; Humans; Insulin; Insulin Infusion Systems; Kidney; Male; Norepinephrine; Pilot Projects | 1993 |
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Peptide Fragments; Protein Precursors; Reference Values; Time Factors | 1993 |
Influence of different glucose-insulin-potassium regimes on glucose homeostasis and hormonal response in cardiac surgery patients .
Topics: Animals; Blood Glucose; C-Peptide; Cattle; Coronary Artery Bypass; Epinephrine; Glucagon; Glucose; Growth Hormone; Homeostasis; Hormones; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged; Norepinephrine; Potassium; Prolactin | 1993 |
Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.
Topics: Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Homeostasis; Humans; Islets of Langerhans; Lipids; Male; Metformin; Middle Aged; Obesity; Prospective Studies; Risk Factors; Single-Blind Method | 1993 |
The role of plasma non-esterified fatty acids during exercise in type 2 diabetes mellitus.
Topics: 3-Hydroxybutyric Acid; Blood Glucose; C-Peptide; Calorimetry; Carbon Dioxide; Diabetes Mellitus, Type 2; Energy Metabolism; Exercise; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Hypolipidemic Agents; Insulin; Lactates; Male; Middle Aged; Nitrogen; Oxygen Consumption; Pyrazines; Reference Values | 1993 |
Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterified fatty acid concentration and whole-body lipid oxidation rate.
Topics: Adult; Alanine; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Hypolipidemic Agents; Insulin; Lactates; Lipid Metabolism; Male; Oxidation-Reduction; Pyrazines; Pyruvates; Radioimmunoassay; Time Factors | 1993 |
Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cyclohexanols; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Insulin; Male; Peptide Fragments; Protein Precursors | 1995 |
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans.
Topics: Adult; Amino Acids; C-Peptide; Fatty Acids, Nonesterified; Gastrointestinal Agents; Glucagon; Glucose; Glucose Clamp Technique; Glycogen; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Lactates; Lactic Acid; Liver; Male; Models, Biological | 1996 |
Potentiation of effects of weight loss by monounsaturated fatty acids in obese NIDDM patients.
Topics: Analysis of Variance; Blood Glucose; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Monounsaturated; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Obesity; Time Factors; Triglycerides; Weight Loss | 1996 |
Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in nondiabetic humans.
Topics: Adolescent; Adult; Blood Glucose; Body Composition; C-Peptide; Circadian Rhythm; Cognition; Female; Glucagon; Humans; Hypoglycemia; Insulin; Male; Norepinephrine; Pancreatic Polypeptide; Time Factors | 1996 |
Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients.
Topics: Adolescent; Adult; Arginine; Blood Glucose; C-Peptide; Cyclosporine; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Reference Values | 1995 |
Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Male; Peptide Fragments; Protein Precursors; Time Factors | 1996 |
Ø[The effect of physical exercise on glycemia on healthy subjects following administration of glimepiride].
Topics: Adult; Blood Glucose; C-Peptide; Exercise; Exercise Test; Female; Glucagon; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Lactates; Lactic Acid; Male; Sulfonylurea Compounds | 1996 |
Diazoxide treatment at onset preserves residual insulin secretion in adults with autoimmune diabetes.
Topics: Adult; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Diazoxide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon; Glutamate Decarboxylase; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Placebos; Time Factors | 1996 |
The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
Topics: Amyloid; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Fasting; Female; Glipizide; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Male; Middle Aged; Placebos; Postprandial Period; Single-Blind Method | 1996 |
More uniform diurnal blood glucose control and a reduction in daily insulin dosage on addition of glibenclamide to insulin in type 1 diabetes mellitus: role of enhanced insulin sensitivity.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Circadian Rhythm; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Glucagon; Glyburide; Glycated Hemoglobin; Glycosuria; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Placebos; Triglycerides | 1995 |
GLP-1 does not not acutely affect insulin sensitivity in healthy man.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Analysis of Variance; Blood Glucose; C-Peptide; Calorimetry, Indirect; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Insulin Secretion; Lactates; Male; Neurotransmitter Agents; Peptide Fragments; Reference Values; Somatostatin; Time Factors | 1996 |
The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients.
Topics: Blood Glucose; C-Peptide; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperlipoproteinemias; Hypoglycemic Agents; Insulin; Lipoproteins, VLDL; Male; Middle Aged; Peptide Fragments; Protein Precursors; Time Factors; Triglycerides | 1996 |
Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucose; Homeostasis; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Insulin; Insulin Infusion Systems; Insulin, Regular, Pork; Kinetics; Male; Middle Aged; Recombinant Proteins; Time Factors | 1996 |
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cohort Studies; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Emptying; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Injections, Subcutaneous; Insulin; Male; Middle Aged; Peptide Fragments; Peptides | 1996 |
[Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
Topics: Acromegaly; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Child; Fasting; Female; Glucagon; Hormones; Human Growth Hormone; Humans; Insulin; Male; Middle Aged; Regression Analysis | 1996 |
Ketosis resistance in fibrocalculous pancreatic diabetes: II. Hepatic ketogenesis after oral medium-chain triglycerides.
Topics: Adipose Tissue; Administration, Oral; Adult; Blood Glucose; C-Peptide; Carnitine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Fatty Acids; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Ketones; Liver; Male; Triglycerides | 1997 |
Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man.
Topics: Adult; Blood Glucose; C-Peptide; Calorimetry, Indirect; Energy Metabolism; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Glycerol; Humans; Insulin; Leucine; Male; Pancreas; Peptide Fragments; Peptides; Proteins | 1997 |
Subcutaneous glucagon-like peptide I combined with insulin normalizes postcibal glycemic excursions in IDDM.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Middle Aged; Pancreatic Polypeptide; Peptide Fragments; Time Factors | 1997 |
Acute incretin response to oral glucose is associated with stimulation of gastric inhibitory polypeptide, not glucagon-like peptide in young subjects.
Topics: Administration, Oral; Adolescent; Adult; C-Peptide; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Peptide Fragments; Peptides; Secretory Rate; Stimulation, Chemical | 1997 |
[Long-term follow up of acute and chronic pancreatitis during insulin and peptide C secretion and carbohydrate tolerance].
Topics: Adult; C-Peptide; Chronic Disease; Dietary Carbohydrates; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreatitis | 1996 |
Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production.
Topics: Blood Glucose; C-Peptide; Carbon Dioxide; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glycogen; Humans; Insulin; Lipid Metabolism; Liver; Male; Osmolar Concentration; Oxidation-Reduction | 1997 |
Counterregulatory hormone and symptom responses to hypoglycaemia in diabetic children.
Topics: Adolescent; Blood Glucose; Body Mass Index; C-Peptide; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Growth Hormone; Hormones; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Norepinephrine; Time Factors | 1997 |
Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Middle Aged; Pharmaceutical Preparations; Proinsulin; Sulfonylurea Compounds | 1997 |
Effects of insulin-like growth factor I combined with growth hormone on glucocorticoid-induced whole-body protein catabolism in man.
Topics: Adult; Blood Glucose; C-Peptide; Double-Blind Method; Fatty Acids, Nonesterified; Glucagon; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Kinetics; Leucine; Male; Methylprednisolone; Placebos; Proteins | 1997 |
Regulation of glucose homeostasis in humans with denervated livers.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Central Nervous System; Denervation; Glucagon; Glucose Clamp Technique; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Hyperglycemia; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Resistance; Liver; Liver Transplantation; Middle Aged; Models, Biological; Somatostatin; Time Factors | 1997 |
Effects of C-peptide on insulin-induced hypoglycaemia and its counterregulatory responses in IDDM patients.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Male; Pilot Projects; Radioimmunoassay | 1997 |
Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Cohort Studies; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Injections, Subcutaneous; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Reference Values | 1997 |
High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM.
Topics: Adolescent; Adult; C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Food; Glucagon; Glycated Hemoglobin; Humans; Infusions, Intravenous; Insulin; Islets of Langerhans; Male | 1997 |
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.
Topics: Adult; Blood Glucose; C-Peptide; Eating; Fasting; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Peptide Fragments; Peptides; Postprandial Period; Protein Precursors; Reference Values; Time Factors | 1997 |
[Peptide C and insulin after delivery in women with gestational diabetes].
Topics: Adult; Biomarkers; C-Peptide; Diabetes, Gestational; Female; Glucagon; Glucose Tolerance Test; Humans; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Radioimmunoassay; Retrospective Studies | 1997 |
Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors; Pulsatile Flow; Time Factors | 1998 |
The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: no evidence for a role of glucagon-like peptide-1 (GLP-1).
Topics: Adult; C-Peptide; Calcium Channel Blockers; Ethanol; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Nifedipine; Peptide Fragments; Protein Precursors | 1998 |
The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Catecholamines; Computer Simulation; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Models, Biological; Neurotransmitter Agents; Norepinephrine; Time Factors | 1997 |
5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Pancreatic Polypeptide; Postprandial Period; Receptors, Serotonin; Serotonin Receptor Agonists; Somatostatin; Sumatriptan | 1998 |
Inhibitory effects of hyperglycaemia on fed jejunal motility: potential role of hyperinsulinaemia.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Drug Combinations; Gastrointestinal Motility; Gastrointestinal Transit; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Jejunum; Male; Pancreatic Polypeptide; Peptide Fragments; Perfusion; Phospholipids; Protein Precursors; Sorbitol | 1998 |
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
Topics: Adult; C-Peptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Insulin; Male; Peptide Fragments; Protein Precursors; Receptors, Glucagon; Time Factors | 1998 |
Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide.
Topics: Adult; Antihypertensive Agents; Blood Glucose; C-Peptide; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Diazoxide; Female; Food; Glucagon; Glycated Hemoglobin; Hormones; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Octreotide; Postprandial Period | 1998 |
Influence of food on glycemia, insulin, C-peptide and glucagon levels in diabetic patients treated with antidiabetic metformin at steady-state.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged | 1997 |
The blood glucose lowering effects of exercise and glibenclamide in patients with type 2 diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Exercise; Glucagon; Glyburide; Humans; Hypoglycemic Agents; Insulin; Lactic Acid; Middle Aged | 1998 |
Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft.
Topics: Adolescent; Adult; Autoantibodies; Blood Glucose; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glucagon; Glutamate Decarboxylase; Glycated Hemoglobin; Histocompatibility Testing; Humans; Islets of Langerhans Transplantation; Kidney Transplantation; Liver; Male; Middle Aged; Tissue Donors; Transplantation, Heterotopic | 1998 |
Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Peptide Fragments; Postprandial Period; Protein Precursors; Single-Blind Method; Time Factors; Treatment Outcome | 1998 |
The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.
Topics: Adult; C-Peptide; Coenzymes; Deafness; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; DNA, Mitochondrial; Family Health; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hearing; Humans; Lactic Acid; Male; Middle Aged; Mothers; Point Mutation; Time Factors; Treatment Outcome; Ubiquinone | 1998 |
Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients.
Topics: Acarbose; Administration, Oral; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptide Fragments; Sucrose; Time Factors; Trisaccharides | 1998 |
Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Norepinephrine; Oxidation-Reduction | 1998 |
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men.
Topics: Adult; Blood Glucose; C-Peptide; Double-Blind Method; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hunger; Infusions, Intravenous; Insulin; Male; Obesity; Pain Measurement; Peptide Fragments; Postprandial Period; Protein Precursors; Radioimmunoassay; Satiation | 1998 |
Effect of bacille Calmette-Guérin vaccination on C-peptide secretion in children newly diagnosed with IDDM.
Topics: Adolescent; BCG Vaccine; C-Peptide; Child; Diabetes Mellitus, Type 1; Double-Blind Method; Fasting; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Time Factors | 1998 |
Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
Topics: Aged; Blood Glucose; C-Peptide; Calorimetry, Indirect; Cholesterol; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptide Fragments; Postprandial Period; Proinsulin; Protein Precursors; Sulfonylurea Compounds; Triglycerides | 1998 |
Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
Topics: Age of Onset; Aged; Blood Glucose; C-Peptide; Calorimetry, Indirect; Cholesterol; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged; Peptide Fragments; Peptides; Triglycerides | 1998 |
Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.
Topics: Adult; Appetite; Blood Glucose; Body Mass Index; C-Peptide; Cross-Over Studies; Double-Blind Method; Eating; Energy Intake; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hunger; Infusions, Intravenous; Insulin; Male; Obesity; Peptide Fragments; Peptide YY; Protein Precursors | 1999 |
Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients.
Topics: Adult; Aged; Appetite; Appetite Depressants; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Drug Delivery Systems; Energy Intake; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Infusion Pumps; Insulin; Lipids; Middle Aged; Peptide Fragments; Peptides; Pilot Projects; Postprandial Period; Protein Precursors | 1999 |
Lipophilic thiamine treatment in long-standing insulin-dependent diabetes mellitus.
Topics: Adolescent; Age of Onset; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Double-Blind Method; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Placebos; Reference Values; Thiamine; Thiamine Monophosphate; Time Factors | 1999 |
Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis.
Topics: Aged; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combination; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Pancreatitis; Peptide Fragments | 2000 |
Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA).
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Male | 2000 |
Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Carbon Isotopes; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Growth Hormone; Humans; Hydrocortisone; Insulin; Liver; Male | 2000 |
Hormonal parameters in gestational diabetes mellitus during the third trimester: high glucagon levels.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes, Gestational; Female; Glucagon; Hormones; Humans; Insulin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, Third; Reference Values; Sensitivity and Specificity; Statistics, Nonparametric | 2000 |
Effect of hemipancreatectomy and of pancreatic diversion on the tolerance to a glucose load in humans.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Feedback; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hydrocortisone; Hyperglycemia; Immunosuppression Therapy; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Pancreas Transplantation; Pancreatectomy | 2000 |
A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors; Reproducibility of Results | 2000 |
Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Middle Aged; Peptide Fragments; Periodicity; Protein Precursors | 2000 |
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Food; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Kinetics; Peptide Fragments; Somatostatin | 2000 |
Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Aspart; Insulin, Regular, Pork; Male; Middle Aged; Postprandial Period | 2000 |
Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine.
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Norepinephrine; Recombinant Proteins; Reference Values | 2000 |
Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes.
Topics: Adult; Aged; Animals; Blood Glucose; C-Peptide; Cattle; Circadian Rhythm; Diabetes Mellitus, Type 2; Dietary Proteins; Drinking; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin; Male; Meat; Middle Aged; Triglycerides; Uric Acid | 2001 |
Additive glucose-lowering effects of glucagon-like peptide-1 and metformin in type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Infusions, Parenteral; Insulin; Insulin Secretion; Kinetics; Male; Metformin; Middle Aged; Peptide Fragments; Placebos; Research Design | 2001 |
Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Models, Biological | 2001 |
GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors; White People | 2001 |
Acute and short-term administration of a sulfonylurea (gliclazide) increases pulsatile insulin secretion in type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Entropy; Fatty Acids, Nonesterified; Gliclazide; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Middle Aged; Placebos; Prospective Studies; Time Factors | 2001 |
Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program.
Topics: Adult; Basal Metabolism; Blood Glucose; Blood Proteins; Body Composition; C-Peptide; Cholesterol; Chromium; Diet; Dietary Supplements; Double-Blind Method; Exercise; Fasting; Female; Glucagon; Humans; Insulin; Iron; Lipids; Middle Aged; Obesity; Patient Compliance; Placebos; Zinc | 2001 |
Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus.
Topics: Aged; Aminophylline; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged; Norepinephrine; Purinergic P1 Receptor Antagonists | 2001 |
Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.
Topics: Aged; Biological Transport, Active; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Clamp Technique; Humans; Insulin; Peptide Fragments; Peptides | 2001 |
Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Black or African American; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glycated Hemoglobin; Hispanic or Latino; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Islets of Langerhans; Male; Metformin; Pancreatic Function Tests | 2002 |
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Peptide Fragments; Pilot Projects; Protein Precursors | 2002 |
Short-term treatment with metformin decreases serum leptin concentration without affecting body weight and body fat content in normal-weight healthy men.
Topics: Adipose Tissue; Adult; Blood Pressure; Body Weight; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Leptin; Male; Metformin; Obesity; Reference Values | 2002 |
Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function.
Topics: Analysis of Variance; Area Under Curve; Blood Glucose; Blood Pressure; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 2; Ferritins; Glucagon; Glycated Hemoglobin; Hematocrit; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Phlebotomy; Smoking; Transferrin | 2002 |
Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in man.
Topics: Adult; C-Peptide; Carbon Isotopes; Fatty Acids; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Keto Acids; Lactic Acid; Leucine; Liver; Male; Oxidation-Reduction; Proteins; Reference Values; Triglycerides | 2002 |
Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Obesity; Peptide Fragments; Protein Precursors | 2002 |
Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans.
Topics: Abdomen; Adipose Tissue; Adult; Blood Glucose; C-Peptide; Calorimetry, Indirect; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Fasting; Fatty Acids, Nonesterified; Femur; Glucagon; Glycerol; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Lipolysis; Male; Microdialysis; Placebos; Prednisolone | 2002 |
Effects of 1-mo bolus subcutaneous administration of exendin-4 in type 2 diabetes.
Topics: Aged; Blood Glucose; Body Composition; C-Peptide; Diabetes Mellitus, Type 2; Exenatide; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Peptides; Venoms | 2003 |
Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Hyperinsulinism; Insulin; Liver; Male; Neurotransmitter Agents; Peptide Fragments; Peptides | 2003 |
Insulin secretion and cellular glucose metabolism after prolonged low-grade intralipid infusion in young men.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Oxidation-Reduction | 2003 |
Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients.
Topics: Adult; Aged; Amyloid; Blood Glucose; Body Weight; C-Peptide; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Follow-Up Studies; Glucagon; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Islets of Langerhans; Male; Middle Aged; Proinsulin; Quality of Life | 2003 |
Comparison of the priming effects of pulsatile and continuous insulin delivery on insulin action in man.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Fatty Acids; Female; Gastrointestinal Agents; Glucagon; Glycerol; Human Growth Hormone; Humans; Hyperinsulinism; Hypoglycemic Agents; Insulin; Male; Octreotide | 2003 |
No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Injections, Subcutaneous; Insulin; Kinetics; Middle Aged; Pancreatitis; Peptide Fragments; Protein Precursors | 2003 |
Higher insulin concentrations are required to suppress gluconeogenesis than glycogenolysis in nondiabetic humans.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Gluconeogenesis; Glucose; Glycogen; Hormones; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Male; Somatostatin; Tritium; Uridine Diphosphate Glucose; Water | 2003 |
Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Implants; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Injections, Subcutaneous; Insulin; Male; Peptide Fragments; Protein Precursors; Treatment Outcome | 2003 |
Characterization of GLP-1 effects on beta-cell function after meal ingestion in humans.
Topics: Aged; Blood Glucose; C-Peptide; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Peptide Fragments; Postprandial Period; Protein Precursors | 2003 |
Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Fasting; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptides; Reference Values | 2003 |
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Humans; Hyperglycemia; Insulin; Islets of Langerhans; Male; Middle Aged; Neurotransmitter Agents; Nuclear Proteins; Pancreatitis; Peptide Fragments; Phenotype; Protein Precursors; Transcription Factors | 2003 |
Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread.
Topics: Blood Glucose; Bread; C-Peptide; Dietary Fiber; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hydrolysis; Insulin; Kinetics; Microscopy; Middle Aged; Peptide Fragments; Protein Precursors; Secale; Starch; Triticum | 2003 |
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Glyburide; Growth Hormone-Releasing Hormone; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Piperidines; Placebos; Potassium Channel Blockers; Somatostatin | 2004 |
Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.
Topics: Adipose Tissue; Adult; Alanine; Anthropometry; Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Feedback; Glucagon; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Triglycerides | 2004 |
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Blood Glucose; Body Composition; Bone Density; C-Peptide; Cyclopropanes; Drug Therapy, Combination; Female; Glucagon; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Insulin; Insulin Resistance; Lipids; Lipoproteins; Male; Nevirapine; Oxazines; Pilot Projects; RNA, Viral; Viral Load | 2004 |
Mechanism of dichloroacetate-induced hypolactatemia in humans with or without cirrhosis.
Topics: Adult; Alanine; C-Peptide; Dichloroacetic Acid; Female; Gas Chromatography-Mass Spectrometry; Glucagon; Humans; Insulin; Kinetics; Lactates; Liver; Liver Cirrhosis; Male; Oxidation-Reduction; Pyruvic Acid | 2004 |
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Exenatide; Fatty Acids, Nonesterified; Glucagon; Humans; Hydrocortisone; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Male; Peptides; Venoms | 2004 |
alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients.
Topics: Acarbose; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptide Fragments; Postprandial Period; Protein Precursors | 2005 |
Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Somatostatin | 2005 |
Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight.
Topics: Adult; Blood Glucose; C-Peptide; Eating; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hyperglycemia; Infant, Low Birth Weight; Infant, Newborn; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Protein Precursors | 2005 |
Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 2005 |
Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Homeostasis; Human Growth Hormone; Humans; Insulin; Liver; Male; Middle Aged; Sodium Bicarbonate; Sodium Lactate | 2005 |
Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study.
Topics: Adolescent; Animals; Animals, Newborn; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Graft Rejection; Graft Survival; Humans; Immunohistochemistry; Insulin; Islets of Langerhans Transplantation; Male; Sertoli Cells; Specific Pathogen-Free Organisms; Swine; Transplantation, Heterologous | 2005 |
Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Exercise Test; Glucagon; Glucagon-Like Peptide 1; Heart; Heart Failure; Humans; Infusions, Parenteral; Injections, Subcutaneous; Insulin; Male; Myocardial Contraction; Pilot Projects; Recombinant Proteins; Time Factors | 2004 |
The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Enzyme Activation; Enzyme Inhibitors; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Nitriles; Peptides; Pyrrolidines | 2006 |
Effects of hyperglycemia on glucose metabolism before and after oral glucose ingestion in normal men.
Topics: Administration, Oral; Blood Glucose; C-Peptide; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Time Factors | 2006 |
Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Cyclohexanes; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise Test; Female; Glucagon; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Nateglinide; Phenylalanine; Postprandial Period | 2006 |
Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
Topics: Adiponectin; Adult; Blood Glucose; Body Mass Index; C-Peptide; Double-Blind Method; Fatty Acids, Nonesterified; Female; Gastrectomy; Ghrelin; Glucagon; Glucose Clamp Technique; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Secretion; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Kinetics; Leptin; Male; Middle Aged; Peptide Hormones; Placebos | 2006 |
Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.
Topics: Aged; Amylases; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Lipase; Male; Middle Aged; Pancreas; Pancreatitis, Chronic; Peptide Hydrolases; Postprandial Period; Steatorrhea; Triglycerides | 2007 |
Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women.
Topics: Adjuvants, Immunologic; Aged; Body Composition; C-Peptide; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Double-Blind Method; Drug Administration Schedule; Estrogens; Female; Gastrointestinal Motility; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Secretion; Liver; Male; Postprandial Period; Sex Characteristics; Testosterone; Time Factors | 2007 |
Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Fasting; Female; Follow-Up Studies; Glucagon; Glyburide; Glycated Hemoglobin; Health Status Indicators; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Insulin, Long-Acting; Lipids; Male; Middle Aged; Proinsulin; Quality of Life | 2008 |
Sleep loss alters basal metabolic hormone secretion and modulates the dynamic counterregulatory response to hypoglycemia.
Topics: 3-Hydroxybutyric Acid; Adrenocorticotropic Hormone; Adult; C-Peptide; Cross-Over Studies; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Hormones; Human Growth Hormone; Humans; Hunger; Hydrocortisone; Hypoglycemia; Lactic Acid; Male; Neurosecretory Systems; Norepinephrine; Sleep Deprivation | 2007 |
The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
Topics: Adamantane; Adult; Algorithms; C-Peptide; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glyburide; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Nitriles; Pyrrolidines; Vildagliptin | 2007 |
Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.
Topics: Adolescent; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Evaluation Studies as Topic; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Infant; Islets of Langerhans; Male; ROC Curve; Taiwan | 2008 |
Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glycerol; Glycogenolysis; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Metformin; Middle Aged; Pioglitazone; Placebos; Thiazolidinediones | 2008 |
Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance.
Topics: Adamantane; Blood Glucose; C-Peptide; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Humans; Inulin; Kinetics; Male; Nitriles; Placebos; Postprandial Period; Pyrrolidines; Vildagliptin | 2008 |
Weight loss therapy improves pancreatic endocrine function in obese older adults.
Topics: Aged; Aging; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet, Reducing; Exercise; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Obesity; Risk Factors; Weight Loss | 2008 |
Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.
Topics: Abdominal Fat; Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Oxidation-Reduction; Pioglitazone; Postprandial Period; Sulfonylurea Compounds; Thiazolidinediones; Triglycerides | 2008 |
Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes.
Topics: Adamantane; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Digestion; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Nitriles; Placebos; Postprandial Period; Pyrrolidines; Satiety Response; Vildagliptin | 2009 |
Lactate overrides central nervous but not beta-cell glucose sensing in humans.
Topics: Adult; Blood Glucose; C-Peptide; Central Nervous System; Double-Blind Method; Epinephrine; Glucagon; Glucose; Glucose Clamp Technique; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Lactic Acid; Male; Placebos; Young Adult | 2008 |
Regulation of net hepatic glycogenolysis and gluconeogenesis by epinephrine in humans.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Gluconeogenesis; Glycogenolysis; Humans; Insulin; Lactic Acid; Liver; Male; Young Adult | 2009 |
[Effects of glucagon on plasma ghrelin level in type 2 diabetes mellitus].
Topics: Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Ghrelin; Glucagon; Humans; Male; Middle Aged | 2009 |
Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus.
Topics: Adult; Aged; Biomarkers; Body Composition; C-Peptide; Calorimetry, Indirect; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Dinoprost; Double-Blind Method; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Female; Glucagon; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Isoprostanes; Male; Middle Aged; Oxidative Stress | 2009 |
Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients.
Topics: Adolescent; Adult; Autoantigens; C-Peptide; Cells, Cultured; Child; Cytokines; Diabetes Mellitus, Type 1; Disease Progression; Female; Follow-Up Studies; Glucagon; Humans; Insulin-Secreting Cells; Male; T-Cell Antigen Receptor Specificity; Th1 Cells; Th2 Cells | 2010 |
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged | 2009 |
Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
Topics: Adult; Amyloid; Area Under Curve; C-Peptide; Demography; Diabetes Mellitus, Type 1; Exenatide; Female; Glucagon; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Middle Aged; Peptides; Primary Graft Dysfunction; Prospective Studies; Transplantation, Homologous; Venoms | 2009 |
Do the actions of glucagon-like peptide-1 on gastric emptying, appetite, and food intake involve release of amylin in humans?
Topics: Adult; Amyloid; Appetite; Body Mass Index; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 1; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Reference Values; Single-Blind Method | 2010 |
Dose-response effects of insulin glargine in type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Insulin Glargine; Insulin, Long-Acting; Male; Middle Aged | 2010 |
Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis.
Topics: Adult; Appetite; Blood Glucose; C-Peptide; Cross-Over Studies; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Hunger; Immunoassay; Incretins; Insulin; Male; Peptide YY; Satiety Response | 2010 |
Pharmacokinetics and pharmacodynamics of inhaled GLP-1 (MKC253): proof-of-concept studies in healthy normal volunteers and in patients with type 2 diabetes.
Topics: Administration, Inhalation; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Delivery Systems; Energy Intake; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptide Fragments | 2010 |
Gastric emptying, glucose metabolism and gut hormones: evaluation of a common preoperative carbohydrate beverage.
Topics: Adult; Beverages; Blood Glucose; C-Peptide; Carbohydrates; Citrus; Cross-Over Studies; Dietary Carbohydrates; Female; Fruit; Gastric Emptying; Gastrointestinal Contents; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Polysaccharides; Preoperative Care | 2011 |
Amylin and selective glucoregulatory peptide alterations during prolonged exercise.
Topics: Adult; Blood Glucose; C-Peptide; Exercise; Glucagon; Humans; Hydrocortisone; Insulin; Islet Amyloid Polypeptide; Lactic Acid; Leptin; Male; Oxygen Consumption; Postprandial Period; Young Adult | 2011 |
Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia.
Topics: Adult; Blood Glucose; C-Peptide; Diazoxide; Female; Glucagon; Glucose Intolerance; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; KATP Channels; Male; Sulfonylurea Compounds; Young Adult | 2011 |
Effects of insulin versus sulphonylurea on beta-cell secretion in recently diagnosed type 2 diabetes patients: a 6-year follow-up study.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucagon; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged | 2010 |
Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.
Topics: Adult; Blood Glucose; C-Peptide; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Postprandial Period; Tachyphylaxis; Young Adult | 2011 |
Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Peptide Fragments; Triglycerides; Young Adult | 2011 |
Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glutamine; Humans; Hyperglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Triazoles | 2011 |
Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.
Topics: Adult; Biopsy; Blood Glucose; C-Peptide; Gene Expression; Glucagon; Glucose Clamp Technique; GTPase-Activating Proteins; Human Growth Hormone; Humans; Hyperinsulinism; Infusions, Intra-Arterial; Insulin Resistance; Insulin-Like Growth Factor I; Leg; Lipids; Male; Muscle, Skeletal; Somatostatin; STAT5 Transcription Factor; Suppressor of Cytokine Signaling Proteins; Young Adult | 2011 |
Effect of intensive insulin therapy on the somatotropic axis of critically ill children.
Topics: Adolescent; C-Peptide; Case-Control Studies; Child; Child, Preschool; Critical Illness; Female; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Infant; Infant, Newborn; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Intensive Care Units, Pediatric; Male; Prospective Studies | 2011 |
Does the fat-protein meal increase postprandial glucose level in type 1 diabetes patients on insulin pump: the conclusion of a randomized study.
Topics: Adolescent; Blood Glucose; Blood Glucose Self-Monitoring; C-Peptide; Child; Diabetes Mellitus, Type 1; Dietary Fats; Dietary Proteins; Female; Glucagon; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Postprandial Period | 2012 |
Amino acid mixture acutely improves the glucose tolerance of healthy overweight adults.
Topics: Adult; Amino Acids; Area Under Curve; Blood Glucose; C-Peptide; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Overweight; Young Adult | 2012 |
Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Incretins; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Male; Severity of Illness Index; Young Adult | 2012 |
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans.
Topics: Adult; Apolipoprotein B-100; Apolipoprotein B-48; Apolipoproteins B; Blood Glucose; C-Peptide; Down-Regulation; Exenatide; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Insulin; Intestinal Mucosa; Intestines; Kinetics; Liver; Male; Models, Biological; Ontario; Peptides; Postprandial Period; Receptors, Glucagon; Reference Values; Triglycerides; Venoms | 2012 |
Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Neurotensin | 2012 |
Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Topics: Adult; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hyperglycemia; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Obesity, Morbid; Postprandial Period; Time Factors | 2012 |
Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin resistance in type 2 diabetic patients.
Topics: Blood Glucose; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Exercise; Fasting; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin-Secreting Cells; Italy; Male; Metformin; Middle Aged; Pyrazines; Sitagliptin Phosphate; Treatment Outcome; Triazoles | 2012 |
Effect of intraoperative amino acid infusion on blood glucose under general anesthesia combined with epidural block.
Topics: Adolescent; Adult; Amino Acids; Anesthesia, Epidural; Anesthesia, General; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Hypothermia; Infusions, Intravenous; Insulin; Insulin Secretion; Isotonic Solutions; Male; Middle Aged; Ringer's Lactate; Young Adult | 2012 |
Glucokinase activators AZD6370 and AZD1656 do not affect the central counterregulatory response to hypoglycemia in healthy males.
Topics: Adult; Azetidines; Benzamides; Body Mass Index; C-Peptide; Cross-Over Studies; Enzyme Activators; Epinephrine; Glucagon; Glucokinase; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Norepinephrine; Pyrazines; Sulfones; Young Adult | 2012 |
Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus.
Topics: Adult; Aged; Aminopyridines; Area Under Curve; Benzamides; Blood Glucose; Body Weight; C-Peptide; Cyclopropanes; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycated Hemoglobin; Glycerol; Homeostasis; Humans; Insulin; Male; Middle Aged; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Sample Size | 2012 |
Orally administered whey proteins have comparable effect on C-peptide secretion in healthy subjects as standard C-peptide stimulation tests.
Topics: Adult; Area Under Curve; Arginine; Blood Glucose; C-Peptide; Cross-Over Studies; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Milk Proteins; Stimulation, Chemical; Whey Proteins; Young Adult | 2013 |
The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.
Topics: Allylamine; Anticholesteremic Agents; Blood Glucose; C-Peptide; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Double-Blind Method; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Postprandial Period | 2013 |
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patients.
Topics: Adult; Aged; Bile Acids and Salts; Blood Glucose; C-Peptide; Cholecystectomy; Female; Gastric Emptying; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Postprandial Period | 2013 |
Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Resistance; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hyperinsulinism; Hypoglycemic Agents; Incretins; Injections, Subcutaneous; Liraglutide; Male; Metformin; Middle Aged; Peptides | 2013 |
Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans.
Topics: Adult; Blood Glucose; C-Peptide; Cholagogues and Choleretics; Double-Blind Method; Glucagon; Glucagon-Like Peptide 1; Glucose; Health; Humans; Infusion Pumps; Insulin; Intestine, Small; Male; Taurocholic Acid | 2013 |
Early postprandial glucagon surge affects postprandial glucose levels in obese and non-obese patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Meals; Middle Aged; Obesity; Postprandial Period; Up-Regulation | 2013 |
Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Gastric Emptying; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Peptides; Postprandial Period | 2013 |
No effect of menstrual cycle phase on glucose and glucoregulatory endocrine responses to prolonged exercise.
Topics: Adult; Blood Glucose; C-Peptide; Endocrine Cells; Exercise; Female; Glucagon; Glucose; Homeostasis; Hormones; Humans; Hydrocortisone; Insulin; Islet Amyloid Polypeptide; Leptin; Menstrual Cycle; Pancreas; Young Adult | 2013 |
Sitagliptin and pioglitazone provide complementary effects on postprandial glucose and pancreatic islet cell function.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucagon; Glucagon-Secreting Cells; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Middle Aged; Pioglitazone; Postprandial Period; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles | 2013 |
Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans.
Topics: Adult; Bile Acids and Salts; C-Peptide; Chenodeoxycholic Acid; Cholecystokinin; Dipeptides; Double-Blind Method; Fibroblast Growth Factors; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Young Adult | 2013 |
A direct comparison of long- and short-acting GLP-1 receptor agonists (taspoglutide once weekly and exenatide twice daily) on postprandial metabolism after 24 weeks of treatment.
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Exenatide; Female; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Meals; Metformin; Middle Aged; Peptides; Postprandial Period; Receptors, Glucagon; Treatment Outcome; Venoms | 2014 |
Characterization of residual β cell function in long-standing type 1 diabetes.
Topics: Adolescent; Adult; C-Peptide; Child; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Disease Progression; Down-Regulation; Female; Glucagon; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Postprandial Period; Young Adult | 2014 |
Xenin-25 delays gastric emptying and reduces postprandial glucose levels in humans with and without type 2 diabetes.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Male; Middle Aged; Missouri; Neurotensin; Postprandial Period; Receptors, Neurotensin; Time Factors; Treatment Outcome | 2014 |
Pharmacokinetic properties and effects of PT302 after repeated oral glucose loading tests in a dose-escalating study.
Topics: Adult; Blood Glucose; C-Peptide; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Exenatide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Male; Middle Aged; Peptides; Venoms; Young Adult | 2014 |
Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal.
Topics: Adolescent; Adult; Area Under Curve; Blood Glucose; C-Peptide; Chaperonin 60; Diabetes Mellitus, Type 1; Double-Blind Method; Fasting; Female; Food; Gastrointestinal Agents; Glucagon; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Meals; Middle Aged; Peptide Fragments; Young Adult | 2014 |
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies.
Topics: Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Insulin; Male; Mesylates; Metformin; Middle Aged; Oxadiazoles; Peptide YY; Prognosis; Pyrazines; Receptors, G-Protein-Coupled; Sitagliptin Phosphate; Triazoles | 2014 |
Estimated proinsulin processing activity of prohormone convertase (PC) 1/3 rather than PC2 is decreased in pancreatic β-cells of type 2 diabetic patients.
Topics: Administration, Intravenous; Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin-Secreting Cells; Middle Aged; Proinsulin; Proprotein Convertase 1; Proprotein Convertase 2; Protein Processing, Post-Translational; Statistics as Topic | 2014 |
Eating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover study.
Topics: Adult; Aged; Blood Glucose; Breakfast; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Reducing; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Lunch; Male; Meals; Middle Aged; Treatment Outcome | 2014 |
Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes.
Topics: Adamantane; Asian People; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Postprandial Period | 2014 |
Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
Topics: Adult; Aged; Area Under Curve; Bile; Biomarkers; Blood Glucose; C-Peptide; Case-Control Studies; Cholecystokinin; Denmark; Diabetes Mellitus, Type 2; Dietary Fats; Female; Gallbladder Emptying; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrins; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Postprandial Period; Receptors, G-Protein-Coupled | 2014 |
Comparison of the effects of slowly and rapidly absorbed carbohydrates on postprandial glucose metabolism in type 2 diabetes mellitus patients: a randomized trial.
Topics: Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Double-Blind Method; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Insulin; Isomaltose; Male; Middle Aged; Postprandial Period; Sucrose | 2014 |
Glucose-dependent insulinotropic polypeptide augments glucagon responses to hypoglycemia in type 1 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Synergism; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycerol; Hormones; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Treatment Outcome | 2015 |
Glucose counterregulation in advanced type 2 diabetes: effect of β-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; C-Peptide; Case-Control Studies; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Single-Blind Method | 2014 |
The effect of liraglutide on endothelial function in patients with type 2 diabetes.
Topics: Acetylcholine; Aged; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hypoglycemic Agents; Insulin; Lipids; Liraglutide; Male; Middle Aged; Nitroprusside; Plethysmography | 2014 |
Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in patients with type 2 diabetes.
Topics: Adult; Area Under Curve; Aspartame; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Healthy Volunteers; Humans; Insulin; Male; Middle Aged; Sucrose; Sweetening Agents | 2015 |
Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; C-Peptide; China; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Male; Middle Aged; Postprandial Period; Predictive Value of Tests; Time Factors; Young Adult | 2015 |
Comparison of a carbohydrate-free diet vs. fasting on plasma glucose, insulin and glucagon in type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Caloric Restriction; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet, Carbohydrate-Restricted; Diet, Reducing; Fasting; Glucagon; Hospitals, Veterans; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Weight Loss | 2015 |
Incretin effect after oral amino acid ingestion in humans.
Topics: Administration, Oral; Adult; Amino Acids; Blood Glucose; C-Peptide; Eating; Electrolytes; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Insulin Secretion; Male; Solutions; Young Adult | 2015 |
The effects of TNF-α on GLP-1-stimulated plasma glucose kinetics.
Topics: Adult; Blood Glucose; Body Temperature; C-Peptide; Cross-Over Studies; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Interleukin-6; Kinetics; Male; Recombinant Proteins; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucose Clamp Technique; Hepatobiliary Elimination; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Triazines | 2015 |
A high-protein breakfast induces greater insulin and glucose-dependent insulinotropic peptide responses to a subsequent lunch meal in individuals with type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Breakfast; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Diet Records; Dietary Carbohydrates; Dietary Proteins; Energy Intake; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Insulin; Lunch; Male; Middle Aged; Postprandial Period; Single-Blind Method; Young Adult | 2015 |
Metabolic responses of healthy or prediabetic adults to bovine whey protein and sodium caseinate do not differ.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Carnitine; Caseins; Dietary Carbohydrates; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Healthy Volunteers; Humans; Insulin; Male; Milk Proteins; Postprandial Period; Prediabetic State; Single-Blind Method; Whey Proteins | 2015 |
Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Leptin; Male; Pancreatic Polypeptide; Single-Blind Method; Sulfonylurea Compounds | 2015 |
Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects.
Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Blood Glucose; C-Peptide; Cross-Over Studies; Dose-Response Relationship, Drug; Female; Gastric Emptying; Gastrointestinal Agents; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Insulin Secretion; Intestinal Absorption; Male; Peptides; Postprandial Period; Young Adult | 2015 |
Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
Topics: Adiponectin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Obesity; Treatment Outcome; Weight Loss | 2015 |
Intake of Lactobacillus reuteri improves incretin and insulin secretion in glucose-tolerant humans: a proof of concept.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Limosilactobacillus reuteri; Male; Middle Aged; Obesity; Oxidative Stress; Pilot Projects; Probiotics; Prospective Studies; Protein Precursors | 2015 |
The 2-monoacylglycerol moiety of dietary fat appears to be responsible for the fat-induced release of GLP-1 in humans.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Cholecystokinin; Cross-Over Studies; Daucus carota; Dietary Fats; Fats; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glycerides; Humans; Insulin; Male; Monoglycerides; Neurotensin; Oleic Acid; Olive Oil; Peptide YY; Receptors, G-Protein-Coupled; Single-Blind Method; Triglycerides; Young Adult | 2015 |
Fasting until noon triggers increased postprandial hyperglycemia and impaired insulin response after lunch and dinner in individuals with type 2 diabetes: a randomized clinical trial.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; Breakfast; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Follow-Up Studies; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Lunch; Male; Meals; Middle Aged; Postprandial Period | 2015 |
The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Liraglutide; Male; Middle Aged; Treatment Outcome | 2015 |
[Clinical observation on the combined therapy of sitagliptin with insulin for patients with brittle diabetes].
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Drug Therapy, Combination; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Sitagliptin Phosphate | 2015 |
Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
Topics: Adult; Aged; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Japan; Male; Meals; Middle Aged; Postprandial Period | 2016 |
Effects of subcutaneous, low-dose glucagon on insulin-induced mild hypoglycaemia in patients with insulin pump treated type 1 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Female; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Injections, Subcutaneous; Insulin Antagonists; Insulin Aspart; Insulin Infusion Systems; Male; Middle Aged; Severity of Illness Index; Single-Blind Method; Young Adult | 2016 |
Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects.
Topics: Adolescent; Adult; Aged; Appetite; Blood Glucose; Body Mass Index; C-Peptide; Cross-Over Studies; Exercise; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Male; Meals; Mental Recall; Middle Aged; Obesity; Overweight; Postprandial Period; Young Adult | 2017 |
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Enzyme-Linked Immunosorbent Assay; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Linear Models; Male; Obesity; Peptide Fragments; Postprandial Period; Single-Blind Method; Sitagliptin Phosphate | 2016 |
Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Topics: Adult; Blood Glucose; Body Mass Index; Body Weight; C-Peptide; Case-Control Studies; Diabetes Mellitus; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Young Adult | 2016 |
Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Aspartate Aminotransferases; beta-Alanine; Blood Glucose; C-Peptide; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrazoles; Receptors, Glucagon; Sulfonylurea Compounds | 2016 |
Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Leptin; Male; Middle Aged | 2016 |
Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
Topics: Administration, Oral; Adult; Bethanechol; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Hormones; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Muscarinic Agonists; Neurotensin; Non-Randomized Controlled Trials as Topic; Pancreatic Polypeptide; Postprandial Period | 2016 |
Intragastric administration of leucine or isoleucine lowers the blood glucose response to a mixed-nutrient drink by different mechanisms in healthy, lean volunteers.
Topics: Adult; Beverages; Blood Glucose; Body Mass Index; C-Peptide; Cholecystokinin; Cross-Over Studies; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Energy Intake; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Healthy Volunteers; Humans; Insulin; Isoleucine; Leucine; Male; Young Adult | 2016 |
Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass-results of a randomized clinical trial.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Female; Gastrectomy; Gastric Bypass; Ghrelin; Glucagon; Glycated Hemoglobin; Homeostasis; Humans; Insulin Resistance; Laparoscopy; Leptin; Male; Middle Aged; Obesity, Morbid; Operative Time; Prospective Studies; Weight Loss; Young Adult | 2017 |
Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Liraglutide; Male; Metformin; Middle Aged; Sitagliptin Phosphate; Treatment Outcome | 2017 |
Once-weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Schedule; Female; Glucagon; Glucagon-Like Peptides; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Infusions, Intravenous; Injections, Subcutaneous; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Recombinant Fusion Proteins; Treatment Outcome | 2017 |
Chenodeoxycholic acid stimulates glucagon-like peptide-1 secretion in patients after Roux-en-Y gastric bypass.
Topics: Administration, Oral; Adult; Bile Acids and Salts; Blood Glucose; C-Peptide; Chenodeoxycholic Acid; Cross-Over Studies; Female; Fibroblast Growth Factors; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Ursodeoxycholic Acid | 2017 |
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes.
Topics: Adult; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Diagnostic Techniques, Endocrine; Eating; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin-Secreting Cells; Male; Meals; Stimulation, Chemical | 2017 |
Glucose metabolism during rotational shift-work in healthcare workers.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Health Personnel; Humans; Insulin; Male; Postprandial Period; Shift Work Schedule; Young Adult | 2017 |
Efficacy and safety of saxagliptin in combination with insulin in Japanese patients with type 2 diabetes mellitus: a 16-week double-blind randomized controlled trial with a 36-week open-label extension.
Topics: Adamantane; Aged; Blood Glucose; C-Peptide; Deoxyglucose; Diabetes Mellitus, Type 2; Dipeptides; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Japan; Male; Middle Aged; Placebo Effect; Treatment Outcome | 2017 |
Glucose-lowering effects and mechanisms of the bile acid-sequestering resin sevelamer.
Topics: Aged; Area Under Curve; Bile Acids and Salts; Blood Glucose; C-Peptide; Chelating Agents; Cholecystokinin; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Double-Blind Method; Energy Metabolism; Female; Fibroblast Growth Factors; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrointestinal Microbiome; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; RNA, Ribosomal, 16S; Sequestering Agents; Sevelamer; Triglycerides | 2018 |
Effects of Intragastric Administration of Tryptophan on the Blood Glucose Response to a Nutrient Drink and Energy Intake, in Lean and Obese Men.
Topics: Administration, Oral; Adult; Appetite Depressants; Beverages; Biomarkers; Blood Glucose; C-Peptide; Cholecystokinin; Double-Blind Method; Energy Intake; Food, Formulated; Gastric Emptying; Glucagon; Humans; Male; Obesity; Postprandial Period; South Australia; Time Factors; Treatment Outcome; Tryptophan | 2018 |
Glucose Appearance Rate Rather than the Blood Glucose Concentrations Explains Differences in Postprandial Insulin Responses between Wholemeal Rye and Refined Wheat Breads-Results from A Cross-Over Meal Study.
Topics: Adolescent; Adult; Blood Glucose; Bread; C-Peptide; Chromatography, High Pressure Liquid; Cross-Over Studies; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Mass Spectrometry; Postprandial Period; Secale; Triticum | 2019 |
Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity.
Topics: Blood Glucose; C-Peptide; Double-Blind Method; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Niacinamide; Obesity; Pyridinium Compounds | 2019 |
The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Topics: Blood Glucose; C-Peptide; Canagliflozin; Cross-Over Studies; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Middle Aged; Pancreatic Polypeptide; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: A cross-over randomized trial.
Topics: 3-Hydroxybutyric Acid; Area Under Curve; Blood Glucose; C-Peptide; Cross-Over Studies; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Intolerance; Glucose Tolerance Test; Glycemic Control; Humans; Insulin; Ketones; Male; Middle Aged | 2021 |
Effects of intragastric administration of L-tryptophan on the glycaemic response to a nutrient drink in men with type 2 diabetes - impacts on gastric emptying, glucoregulatory hormones and glucose absorption.
Topics: 3-O-Methylglucose; Aged; Beverages; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Administration Routes; Gastric Emptying; Glucagon; Glucose; Humans; Insulin; Intestinal Absorption; Male; Middle Aged; Nutrients; Obesity; Postprandial Period; Tryptophan | 2021 |
Acute Nutritional Ketosis and Its Implications for Plasma Glucose and Glucoregulatory Peptides in Adults with Prediabetes: A Crossover Placebo-Controlled Randomized Trial.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Blood Glucose; C-Peptide; Cross-Over Studies; Dietary Supplements; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Islet Amyloid Polypeptide; Ketosis; Male; Middle Aged; Prediabetic State; Single-Blind Method | 2021 |
Comparison of the acute metabolic effect of different infant formulas and human milk in healthy adults: a randomized trial.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Dietary Proteins; Double-Blind Method; Female; Glucagon; Glucagon-Like Peptide 1; Healthy Volunteers; Humans; Infant; Infant Formula; Insulin; Lipids; Male; Milk, Human; Postprandial Period; Triglycerides; Whey Proteins; Young Adult | 2021 |
Effects of Manipulating Circulating Bile Acid Concentrations on Postprandial GLP-1 Secretion and Glucose Metabolism After Roux-en-Y Gastric Bypass.
Topics: Adult; Bile Acids and Salts; Blood Glucose; C-Peptide; Colesevelam Hydrochloride; Female; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Male; Middle Aged; Neurotensin; Obesity, Morbid; Postprandial Period; Single-Blind Method | 2021 |
Pancreatic β-Cell Function Is Associated with Augmented Counterregulation to In-Exercise Hypoglycemia in Type 1 Diabetes.
Topics: Adult; Biomarkers; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 1; Exercise; Female; Glucagon; Humans; Hypoglycemia; Insulin-Secreting Cells; Male; Middle Aged; Young Adult | 2021 |
The Postprandial Glycaemic and Hormonal Responses Following the Ingestion of a Novel, Ready-to-Drink Shot Containing a Low Dose of Whey Protein in Centrally Obese and Lean Adult Males: A Randomised Controlled Trial.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Eating; England; Food, Formulated; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Obesity, Abdominal; Postprandial Period; Thinness; Whey Proteins; Young Adult | 2021 |
Effects of Dietary Fat and Protein on Glucoregulatory Hormones in Adolescents and Young Adults With Type 1 Diabetes.
Topics: Adult; Australia; Biomarkers; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 1; Dietary Fats; Dietary Proteins; Female; Follow-Up Studies; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hyperglycemia; Insulin; Male; Meals; Prognosis | 2022 |
Temporal Patterns of Glucagon and Its Relationships with Glucose and Insulin following Ingestion of Different Classes of Macronutrients.
Topics: Area Under Curve; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Meals; Middle Aged; Nutrients; Time Factors | 2022 |
Effects of intraduodenal infusion of lauric acid and L-tryptophan, alone and combined, on glucoregulatory hormones, gastric emptying and glycaemia in healthy men.
Topics: Adult; Blood Glucose; C-Peptide; Cholecystokinin; Double-Blind Method; Energy Intake; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Lauric Acids; Male; Tryptophan; Young Adult | 2022 |
Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial.
Topics: C-Peptide; Caffeine; Coffee; Glicentin; Glucagon; Glucagon-Like Peptide 1; Humans; Oxyntomodulin; Peptides; Proglucagon; Water | 2022 |
Effects of ileal glucose infusion on enteropancreatic hormone secretion in humans: relationship to glucose absorption.
Topics: 3-O-Methylglucose; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Ileum; Insulin; Peptide Fragments | 2022 |
Gastric Bypass Resolves Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) in Low-BMI Patients: A Prospective Cohort Study.
Topics: Adipokines; Adolescent; Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Gastric Bypass; Gastrointestinal Hormones; Glucagon; Glycated Hemoglobin; Humans; Insulin; Liver Diseases; Middle Aged; Obesity, Morbid; Prospective Studies; Sirtuin 1; Young Adult | 2022 |
Beneficial effects of premeal almond load on glucose profile on oral glucose tolerance and continuous glucose monitoring: randomized crossover trials in Asian Indians with prediabetes.
Topics: Blood Glucose; Blood Glucose Self-Monitoring; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Postprandial Period; Prediabetic State; Prunus dulcis | 2023 |
980 other study(ies) available for glucagon and c-peptide
Article | Year |
---|---|
Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose concentration.
Topics: Adolescent; Adult; Aged; Aldosterone; Blood Glucose; C-Peptide; Dehydration; Diabetic Ketoacidosis; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Male; Middle Aged; Norepinephrine; Pancreatic Polypeptide; Parathyroid Hormone; Prolactin | 1979 |
Relationship between alpha and beta cell function before and after metabolic control in ketotic diabetic subjects.
Topics: Adolescent; Adult; C-Peptide; Diabetic Ketoacidosis; Female; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Tolbutamide | 1978 |
[Infantile diabetes mellitus. Metabolic problems and therapeutic prospects].
Topics: Blood Coagulation Disorders; C-Peptide; Child; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Ketoacidosis; Diabetic Retinopathy; Glucagon; Hemoglobin A; Humans; Insulin; Insulin Secretion | 1979 |
[Autotransplantation of Langerhans' islets in a case of total duodenopancreatectomy (author's transl)].
Topics: Adult; C-Peptide; Chronic Disease; Duodenum; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Liver; Male; Pancreatectomy; Pancreatitis; Transplantation, Autologous | 1979 |
Plasma pancreatic hormone levels in a case of somatostatinoma: diagnostic and therapeutic implications.
Topics: C-Peptide; Diabetes Complications; Female; Glucagon; Humans; Middle Aged; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioimmunoassay; Somatostatin; Streptozocin; Tolbutamide | 1979 |
Connecting (C)-peptide--a spin-off of insulin secretion.
Topics: Adenoma, Islet Cell; C-Peptide; Glucagon; Humans; Insulin; Insulin Secretion; Pancreatic Neoplasms; Peptides; Stimulation, Chemical | 1976 |
A malignant insulinoma transformed into a glucagonoma syndrome.
Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; C-Peptide; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Neoplasms; Male; Middle Aged; Somatostatin; Streptozocin | 1979 |
Insulin and glucagon secretion in hepatic glycogenoses.
Topics: Blood Glucose; C-Peptide; Child; Child, Preschool; Female; Glucagon; Glucose Tolerance Test; Glycogen Storage Disease; Glycogen Storage Disease Type I; Glycogen Storage Disease Type III; Humans; Infant; Insulin; Insulin Secretion; Male | 1979 |
C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Fasting; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Peptides | 1977 |
Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Fasting; Glucagon; Humans; Insulin; Islets of Langerhans; Peptides; Time Factors | 1977 |
[Studies on pancreatic endocrine function and changes of the eye-ground in workers exposed to carbon disulphide (author's transl)].
Topics: Adult; Blood Glucose; C-Peptide; Carbon Disulfide; Glucagon; Growth Hormone; Humans; Insulin; Islets of Langerhans; Middle Aged; Occupational Medicine; Retina | 1978 |
The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus.
Topics: Adolescent; Adult; Amylases; Bicarbonates; C-Peptide; Cholecystokinin; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Pancreas; Secretin; Trypsin | 1978 |
Somatostatinoma syndrome. Biochemical, morphologic and clinical features.
Topics: C-Peptide; Celiac Disease; Cholelithiasis; Diabetes Complications; Glucagon; Hormones, Ectopic; Humans; Hypothalamus; Islets of Langerhans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Pituitary Gland; Radioimmunoassay; Somatostatin; Syndrome | 1979 |
C-peptide response to glucagon in diabetics with and without complications.
Topics: Adult; C-Peptide; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Peptides | 1979 |
Secretory function of pancreatic beta cell during insulin-induced hypoglycemia evaluated by C-peptide immunoreactivity (CPR) determination.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Peptides | 1978 |
Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
Topics: Adult; Aged; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Hemochromatosis; Humans; Insulin; Islets of Langerhans; Middle Aged; Pancreatectomy | 1979 |
Pancreatic endocrine response to the first feed in term newborn infants.
Topics: Blood Glucose; C-Peptide; Glucagon; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Insulin; Islets of Langerhans; Time Factors | 1979 |
The effect of ritodrine on carbohydrate and lipid metabolism in normal and diabetic pregnant women.
Topics: Bicarbonates; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Electrolytes; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Lactates; Lipid Metabolism; Pregnancy; Pregnancy in Diabetics; Propanolamines; Ritodrine | 1979 |
Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
Topics: Artificial Organs; Blood Glucose; C-Peptide; Diabetes Mellitus; Eating; Feedback; Glucagon; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Infusions, Parenteral; Insulin; Islets of Langerhans | 1979 |
Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration.
Topics: Arginine; Artificial Organs; Blood Glucose; C-Peptide; Catecholamines; Diabetes Mellitus; Diphosphoglyceric Acids; Erythrocytes; Glucagon; Glycosides; Growth Hormone; Hemoglobin A; Infusions, Parenteral; Insulin; Islets of Langerhans | 1979 |
Use of a glucose controlled insulin infusion system (artificial beta cell) to control diabetes during surgery.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Monitoring, Physiologic; Prolactin; Surgical Procedures, Operative | 1979 |
The glucoregulatory hormones in cirrhosis of the liver.
Topics: C-Peptide; Carbohydrate Metabolism; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperinsulinism; Insulin; Liver Cirrhosis; Pancreas | 1979 |
[Insulin, C peptide and glucagon in amniotic fluid in normal and diabetic pregnancy].
Topics: Amniotic Fluid; Arginine; C-Peptide; Female; Glucagon; Humans; Insulin; Peptides; Pregnancy; Pregnancy in Diabetics | 1979 |
[Clinical studies of pancreatic endocrine function in liver cirrhosis].
Topics: Adult; Aged; C-Peptide; Female; Glucagon; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Peptides | 1977 |
C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children.
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Male; Peptides | 1977 |
Kinetics of human C-peptide in man.
Topics: C-Peptide; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Kinetics; Peptides; Proinsulin | 1978 |
[Influence of renal function on the kinetics of pancreatic hormones in chronic renal disorders (author's transl)].
Topics: Adult; Blood Glucose; C-Peptide; Chronic Disease; Female; Glucagon; Humans; Kidney; Kidney Diseases; Kinetics; Male; Middle Aged; Pancreatic Hormones | 1978 |
[Glucagon, C-peptide and insulin content in the blood of healthy children].
Topics: Adolescent; Basal Metabolism; Blood Glucose; C-Peptide; Child; Glucagon; Glucose Tolerance Test; Humans; Insulin; Peptides | 1978 |
[The acute effect of the human growth hormone under hyperglycemic conditions in man (author's transl)].
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Growth Hormone; Humans; Hyperglycemia; Insulin; Male | 1978 |
Comparison studies of neurotensin and xenopsin upon pancreatic secretion in the dog [proceedings].
Topics: Animals; C-Peptide; Dogs; Gastrins; Glucagon; Insulin; Islets of Langerhans; Pancreatic Hormones; Peptides; Pituitary Gland | 1976 |
Abnormalities of endogenous glucagon and insulin in unstable diabetes.
Topics: Adult; Antigens; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose; Growth Hormone; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Sodium Chloride | 1977 |
Successful immunosuppressive therapy in insulin resistant diabetes caused by anti-insulin receptor autoantibodies.
Topics: Autoantibodies; C-Peptide; Cyclophosphamide; Diabetes Complications; Diabetes Mellitus; Female; Glucagon; Humans; Immunosuppressive Agents; Insulin; Insulin Antibodies; Insulin Resistance; Middle Aged; Prednisolone; Receptor, Insulin; Sjogren's Syndrome | 1977 |
Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve.
Topics: Adult; Aged; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; In Vitro Techniques; Insulin; Insulin Antibodies; Insulin Secretion; Middle Aged; Pancreas | 1977 |
Plasma insulin, C-peptide, and glucagon levels in acute phase of ethanol-induced hypoglycaemia.
Topics: Adult; C-Peptide; Ethanol; Female; Glucagon; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Peptides | 1977 |
Disappearance rate of endogenous human C-peptide from blood.
Topics: C-Peptide; Glucagon; Glucose; Half-Life; Humans; Insulin; Peptides | 1976 |
The effects of glucagon administration to nondiabetics and diabetics.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Insulin | 1976 |
Effects of D-beta-hydroxybutyrate and long- and medium-chain triglycerides on leucine metabolism in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Bicarbonates; C-Peptide; Carbon Isotopes; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Insulin; Kinetics; Leucine; Male; Oxidation-Reduction; Reference Values; Sodium; Sodium Bicarbonate; Structure-Activity Relationship; Triglycerides | 1992 |
Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly.
Topics: Adult; Age Factors; Aged; Blood Glucose; C-Peptide; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Metabolic Clearance Rate; Severity of Illness Index; Time Factors | 1992 |
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Middle Aged; Obesity; Peptide Fragments; Peptides; Somatostatin | 1992 |
C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hypoglycemic Agents; Male; Middle Aged | 1992 |
Lack of feedback inhibition of insulin secretion in denervated human pancreas.
Topics: 3-Hydroxybutyric Acid; Adult; Analysis of Variance; Blood Glucose; C-Peptide; Denervation; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Epinephrine; Fatty Acids, Nonesterified; Feedback; Follow-Up Studies; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Hormones; Humans; Hydroxybutyrates; Insulin; Insulin Secretion; Kidney Transplantation; Lactates; Pancreas; Pancreas Transplantation; Pancreatic Polypeptide; Somatostatin; Uremia | 1992 |
Demonstration of islet cell antibodies in apparently non-insulin dependent diabetic patients; a marker for the later development of insulin dependency.
Topics: Autoantibodies; Biomarkers; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Prognosis | 1991 |
Effective portal insulin delivery with enzyme-protected capsules in pancreatectomized pigs.
Topics: Animals; Aprotinin; Blood Flow Velocity; Blood Glucose; C-Peptide; Capsules; Female; Glucagon; Hepatic Artery; Insulin; Liver Circulation; Methacrylates; Pancreatectomy; Portal Vein; Swine | 1992 |
[Blood platelet as a test system in the evaluation of neurohormonal imbalance in pregnant women with diabetes mellitus].
Topics: Adrenocorticotropic Hormone; Blood Platelets; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Humans; Hydrocortisone; Metaproterenol; Pregnancy; Pregnancy in Diabetics; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical | 1992 |
Critical evaluation of the 'heated-hand-technique' for obtaining 'arterialized' venous blood: incomplete arterialization and alterations in glucagon responses.
Topics: Adult; Arteries; Blood Gas Analysis; Blood Glucose; Blood Specimen Collection; Body Temperature; C-Peptide; Evaluation Studies as Topic; Glucagon; Hand; Hormones; Hot Temperature; Humans; Insulin; Male; Norepinephrine; Oxygen Consumption; Skin Temperature; Veins | 1992 |
Insulin is required for the liver to respond to intraportal glucose delivery in the conscious dog.
Topics: Alanine; Analysis of Variance; Animals; Blood Glucose; C-Peptide; Dogs; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Insulin; Kinetics; Lactates; Liver; Male; Mathematics; Models, Biological; Pancreatectomy; Portal System | 1992 |
Metabolic response to cottage cheese or egg white protein, with or without glucose, in type II diabetic subjects.
Topics: Aged; Amino Acids; Blood Glucose; Blood Urea Nitrogen; C-Peptide; Cheese; Diabetes Mellitus, Type 2; Egg Proteins; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Triglycerides | 1992 |
Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Female; Glucagon; Humans; Insulin; Insulin-Like Growth Factor I; Islets of Langerhans; Leucine; Male; Proteins; Recombinant Proteins | 1992 |
Failure to induce reactive hypoglycaemia by drinking whisky and a mixer in Glaswegian alcoholic patients.
Topics: Alcohol Drinking; Alcoholism; Blood Glucose; C-Peptide; Glucagon; Humans; Hypoglycemia; Insulin; Radioimmunoassay | 1992 |
Does glucagon preserve its insulinogenic effect during tolbutamide-induced hypoglycemia?
Topics: Adult; C-Peptide; Glucagon; Humans; Hypoglycemia; Insulin; Tolbutamide | 1992 |
Pancreatic beta-cell function evaluated by intravenous glucose and glucagon stimulation. A comparison between insulin and C-peptide to measure insulin secretion.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Female; Glucagon; Glucose; Glycated Hemoglobin; Humans; Injections, Intravenous; Insulin; Islets of Langerhans; Kinetics; Male; Middle Aged | 1992 |
TRH-immunoreactivity in chronic pancreatitis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chronic Disease; Fluoresceins; Glucagon; Glucose; Humans; Insulin; Middle Aged; Pancreatitis; Radioimmunoassay; Thyrotropin-Releasing Hormone; Thyroxine | 1992 |
Effects of different lipid substrates on glucose metabolism in normal postabsorptive humans.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Male; Oxidation-Reduction; Pancreas; Triglycerides | 1992 |
Effect of high carbohydrate intake on hyperglycemia, islet function, and plasma lipoproteins in NIDDM.
Topics: Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Monounsaturated; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Lipoproteins; Male; Middle Aged; Triglycerides | 1992 |
Fuel and fluid homeostasis during long-term exercise in healthy subjects and type I diabetic patients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Electrolytes; Energy Metabolism; Exercise; Glucagon; Growth Hormone; Homeostasis; Hormones; Humans; Hydrocortisone; Insulin; Male; Reference Values; Renin; Skiing; Sports; Water-Electrolyte Balance | 1992 |
Cold wind stimulation reflex.
Topics: Adult; Blood Glucose; Bradycardia; C-Peptide; Cold Temperature; Eating; Glucagon; Heart Rate; Humans; Insulin; Insulin Secretion; Male; Norepinephrine; Pancreas; Reflex; Respiratory Mechanics; Trigeminal Nerve; Vagus Nerve; Wind | 1992 |
Glucagon-glucose (GG) test for the estimation of the insulin reserve in diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diet, Diabetic; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Middle Aged; Prediabetic State | 1992 |
Characterization of the insulin resistance in liver cirrhosis: a comparison with non-insulin dependent diabetes mellitus.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Receptor, Insulin | 1992 |
Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure.
Topics: Analysis of Variance; Animals; Antibody Formation; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; HLA Antigens; HLA-DQ Antigens; HLA-DR Antigens; Humans; Hypoglycemic Agents; Immunity, Cellular; Insulin; Insulin Antibodies; Insulin Secretion; Islets of Langerhans; Lymphocytes; Male; Middle Aged; Rats; Reference Values; Treatment Failure | 1992 |
A simple clinical approach to discriminate between "true" and "pseudo" secondary failure to oral hypoglycaemic agents.
Topics: Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 1992 |
Relationship between blood pressure and in vivo action of insulin in type II (non-insulin-dependent) diabetic subjects.
Topics: Antihypertensive Agents; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 2; Diet, Diabetic; Female; Glucagon; Glucose Clamp Technique; Glyburide; Glycated Hemoglobin; Humans; Hypertension; Infusions, Intravenous; Insulin; Male; Metformin; Middle Aged; Regression Analysis | 1992 |
The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance test.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Male; Multivariate Analysis; Pancreas; Reference Values; Triglycerides | 1992 |
The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Male; Middle Aged | 1992 |
Attenuated glucose recovery from hypoglycemia in the elderly.
Topics: 3-Hydroxybutyric Acid; Adult; Age Factors; Aged; Alanine; Analysis of Variance; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Lactates; Middle Aged; Norepinephrine | 1992 |
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Kinetics; Lactates; Lipolysis; Male; Oxidation-Reduction | 1992 |
Pancreas endocrine function in pigs after segmental pancreas autotransplantation with either systemic or portal venous drainage.
Topics: Animals; Blood Glucose; C-Peptide; Female; Glucagon; Insulin; Insulin Secretion; Ischemia; Islets of Langerhans; Kinetics; Pancreas Transplantation; Pancreatic Polypeptide; Portal Vein; Swine; Time Factors; Transplantation, Autologous | 1992 |
[Glucose tolerance in the elderly--changes in insulin, C-peptide and glucagon secretion].
Topics: Adult; Aged; Aged, 80 and over; Aging; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Reference Values | 1992 |
Sequential metabolic studies of pancreas allograft function in type 1 diabetic recipients.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Eating; Female; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Kidney Transplantation; Male; Pancreas Transplantation; Regression Analysis; Transplantation, Homologous | 1992 |
Encainide-induced diabetes: analysis of islet cell function.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet; Encainide; Glucagon; Humans; Hyperglycemia; Insulin Resistance; Islets of Langerhans; Male | 1992 |
Plasma somatostatin response to an oral mixed test meal in cirrhotic patients.
Topics: Administration, Oral; Aged; Blood Glucose; C-Peptide; Fasting; Female; Food, Formulated; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Male; Middle Aged; Somatostatin; Time Factors | 1991 |
Catecholamines in prevention of hypoglycemia during exercise in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Infusions, Intravenous; Insulin; Kinetics; Male; Phentolamine; Physical Exertion; Propranolol; Reference Values; Somatostatin; Time Factors | 1991 |
Polyclonal origin of pancreatic islets in aggregation mouse chimaeras.
Topics: Animals; C-Peptide; Cell Aggregation; Chimera; Glucagon; Immunohistochemistry; Insulin; Islets of Langerhans; Mice; Mice, Transgenic; Somatostatin; Stem Cells | 1991 |
A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Kinetics; Male; Norepinephrine; Pancreatic Polypeptide; Somatostatin; Time Factors | 1991 |
Increased somatostatin response to glucagon in insulin-dependent diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cross Reactions; Diabetes Mellitus, Type 1; Female; Gastrins; Glucagon; Humans; Insulin; Radioimmunoassay; Somatostatin | 1991 |
Effects of galanin and calcitonin gene-related peptide on insulin and glucagon secretion in man.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Calcitonin Gene-Related Peptide; Drug Synergism; Female; Galanin; Glucagon; Humans; Insulin; Insulin Secretion; Kinetics; Male; Peptides | 1990 |
Insulin and glucagon levels in fulminant hepatic failure in man.
Topics: Adult; Alanine; alpha-Fetoproteins; Amino Acids, Branched-Chain; Blood Glucose; C-Peptide; Female; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Liver Diseases; Male | 1991 |
The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans.
Topics: Adult; Amylases; Bile Acids and Salts; Bile Ducts; C-Peptide; Carbohydrate Metabolism; Carbohydrates; Feedback; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrins; Glucagon; Humans; Ileum; Male; Motilin; Neurotensin; Pancreas; Pancreatic Polypeptide; Peptide YY; Peptides; Trypsin | 1991 |
Exocrine and endocrine functional reserve in the course of chronic pancreatitis as studied by maximal stimulation tests.
Topics: Adult; Alcoholism; C-Peptide; Ceruletide; Chronic Disease; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Pancreas; Pancreatic Function Tests; Pancreatitis; Secretin | 1992 |
Metabolic, body temperature and hormonal responses to repeated periods of prolonged cycle-ergometer exercise in men.
Topics: Adult; Blood Glucose; Body Temperature; C-Peptide; Catecholamines; Exercise; Exercise Test; Fatty Acids, Nonesterified; Glucagon; Glycogen; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Insulin; Lactates; Male; Osmolar Concentration; Oxygen Consumption; Respiration; Time Factors; Ventilation-Perfusion Ratio | 1992 |
Dose-response studies on the metabolic effects of a growth hormone pulse in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Energy Metabolism; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hydroxybutyrates; Insulin; Kinetics; Lactates; Male; Reference Values; Time Factors | 1992 |
Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
Topics: Adult; beta-Endorphin; Blood Glucose; Body Weight; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Kinetics; Male; Obesity; Reference Values | 1992 |
Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Liver Glycogen; Male; Obesity; Reference Values | 1992 |
Serum ketone response to glucagon as a marker of insulin dependency in diabetics.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Fructosamine; Glucagon; Hexosamines; Humans; Hydroxybutyrates; Ketone Bodies; Kinetics; Male; Middle Aged; Regression Analysis | 1991 |
Effects of muscarinic blockade on the thermic effect of oral or intravenous carbohydrate.
Topics: Administration, Oral; Adult; Atropine; Blood Glucose; Body Temperature Regulation; C-Peptide; Energy Metabolism; Fatty Acids, Nonesterified; Female; Fructose; Glucagon; Humans; Injections, Intravenous; Insulin; Male; Parasympatholytics; Pulmonary Gas Exchange | 1991 |
Glucose tolerance and insulin release in adolescent female.
Topics: Adolescent; Adult; Arginine; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Puberty | 1991 |
Islet cell responses to glucose in human transplanted pancreas.
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Peptides | 1991 |
[Tobacco smoking and beta-cell secretion].
Topics: Adult; C-Peptide; Female; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Reference Values; Smoking; Time Factors | 1991 |
Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Secretion; Insulinoma; Male; Pancreatic Neoplasms; Proinsulin; Tolbutamide | 1991 |
Detection of proinsulin, C-peptide, insulin-A-chain, and glicentin in pancreatic islet cells of early human fetogenesis.
Topics: Antibodies; C-Peptide; Gestational Age; Glicentin; Glucagon; Glucagon-Like Peptides; Humans; Immunoenzyme Techniques; Insulin; Islets of Langerhans; Peptide Fragments; Proinsulin; Protein Precursors | 1991 |
The independent effect of ketone bodies on forearm glucose metabolism in normal man.
Topics: Adult; Bicarbonates; C-Peptide; Fatty Acids, Nonesterified; Forearm; Glucagon; Glucose; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Insulin; Ketone Bodies; Male; Muscles; Reference Values; Regional Blood Flow | 1991 |
[The functional status of the endocrine pancreas in patients with acute intestinal infections].
Topics: Acute Disease; C-Peptide; Dysentery, Bacillary; Foodborne Diseases; Glucagon; Humans; Insulin; Intestinal Diseases; Islets of Langerhans; Shigella boydii; Shigella flexneri; Shigella sonnei | 1991 |
[Insulin/glucagon relationship in spontaneous diabetic remission].
Topics: Adolescent; Blood Glucose; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Remission Induction | 1991 |
Postprandial hyperglycemia and pancreatic function in cystic fibrosis patients.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Cystic Fibrosis; Eating; Female; Forced Expiratory Flow Rates; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Reference Values; Time Factors | 1991 |
[Clinical significance of measuring serum c-peptide before and after glucagon injection].
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Male; Middle Aged | 1991 |
Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Glucagon; Glucose; Growth Hormone; HIV Infections; Humans; Hydrocortisone; Insulin; Insulin Infusion Systems; Insulin Resistance; Male; Metabolic Clearance Rate; Middle Aged; Norepinephrine; Reference Values | 1991 |
[Clinical study on changes in insulin, C-peptide and glucagon during cardiopulmonary bypass].
Topics: Adolescent; C-Peptide; Cardiopulmonary Bypass; Female; Glucagon; Heart Septal Defects; Humans; Insulin; Male; Tetralogy of Fallot | 1991 |
Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Catecholamines; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Infusions, Intravenous; Insulin; Kidney; Male; Norepinephrine; Sodium Chloride; Spleen | 1991 |
Decreased hepatic glucagon responses in type 1 (insulin-dependent) diabetes mellitus.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Lactates; Liver; Male; Reference Values; Time Factors | 1991 |
Time-related, cross-sectional and prospective follow-up of pancreatic endocrine function after pancreas allograft transplantation in type 1 (insulin-dependent) diabetic patients.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Follow-Up Studies; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Pancreas Transplantation; Prospective Studies; Transplantation, Homologous | 1991 |
Long-term metabolic control in recipients of combined pancreas and kidney transplants.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Transplantation; Pancreas Transplantation; Reference Values; Uremia | 1991 |
Twenty-four-hour profile of plasma glucose and glucoregulatory hormones during normal living conditions in trained and untrained men.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Creatinine; Fatty Acids, Nonesterified; Glucagon; Glycerol; Homeostasis; Humans; Insulin; Male; Physical Fitness; Reference Values | 1991 |
Counterregulatory adaptation to recurrent hypoglycemia in normal humans.
Topics: Acclimatization; Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Norepinephrine; Reference Values; Time Factors | 1991 |
Nocturnal electroencephalogram registrations in type 1 (insulin-dependent) diabetic patients with hypoglycaemia.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 1; Electrocardiography; Electroencephalography; Epinephrine; Glucagon; Glycated Hemoglobin; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin Antibodies; Norepinephrine | 1991 |
Demonstration of a dawn phenomenon in normal adolescents.
Topics: Adolescent; Adrenocorticotropic Hormone; Blood Glucose; C-Peptide; Circadian Rhythm; Female; Glucagon; Growth Hormone; Hormones; Humans; Hydrocortisone; Insulin; Insulin Secretion; Male; Puberty; Reference Values | 1990 |
Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Exercise; Female; Glucagon; Glucose; Homeostasis; Humans; Insulin; Insulin Infusion Systems; Islets of Langerhans; Male; Norepinephrine; Somatostatin | 1990 |
Thyroid hormone action on lipid metabolism in humans: a role for endogenous insulin.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Fatty Acids; Glucagon; Glycerol; Humans; Hydroxybutyrates; Hyperthyroidism; Insulin; Lipid Metabolism; Oxidation-Reduction; Oxygen Consumption; Pancreatic Hormones; Somatostatin; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 1990 |
Effects of ketone bodies on carbohydrate metabolism in non-insulin-dependent (type II) diabetes mellitus.
Topics: Acetoacetates; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Ketone Bodies; Liver; Male; Middle Aged; Radioisotope Dilution Technique; Somatostatin; Tritium | 1990 |
Circulating somatostatin after oral glucose in hypothyroidism.
Topics: Adult; Aged; C-Peptide; China; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hypothyroidism; Insulin; Male; Middle Aged; Somatostatin; Thyrotropin; Thyroxine; Triiodothyronine | 1990 |
Metabolic effects of pulsatile insulin infusion in the elderly.
Topics: Aged; Apolipoproteins B; Blood Glucose; C-Peptide; Cholesterol, HDL; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin; Kinetics; Lipids; Male; Periodicity; Somatostatin; Triglycerides | 1990 |
Thermogenic effect of thyroid hormones: interactions with epinephrine and insulin.
Topics: Adult; Blood Pressure; Body Temperature Regulation; C-Peptide; Energy Metabolism; Epinephrine; Glucagon; Heart Rate; Humans; Insulin; Lipid Peroxidation; Male; Norepinephrine; Reference Values; Respiration; Somatostatin; Thyroxine | 1990 |
Lack of effect of hyperglycemia on lipolysis in humans.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glycated Hemoglobin; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Lipolysis; Male; Palmitic Acid; Palmitic Acids; Reference Values; Somatostatin | 1990 |
Influence of breakfasts with different nutrient contents on glucose, C peptide, insulin, glucagon, triglycerides, and GIP in non-insulin-dependent diabetics.
Topics: Aged; Analysis of Variance; Blood Glucose; C-Peptide; Carbohydrates; Diabetes Mellitus, Type 2; Diet, Diabetic; Dietary Fats; Dietary Proteins; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Male; Triglycerides | 1991 |
Effect of training on response to a glucose load adjusted for daily carbohydrate intake.
Topics: Adult; Blood Glucose; Blood Proteins; C-Peptide; Dietary Carbohydrates; Eating; Epinephrine; Exercise; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Humans; Insulin; Insulin Secretion; Male; Norepinephrine; Oxygen Consumption; Reference Values | 1991 |
Effects of glucagon on free fatty acid metabolism in humans.
Topics: Adipose Tissue; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Kinetics; Lipolysis; Male; Palmitic Acid; Palmitic Acids | 1991 |
Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Secretion; Male; Metabolic Clearance Rate; Middle Aged | 1991 |
Evidence against important catecholamine compensation for absent glucagon counterregulation.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Kinetics; Lactates; Male; Time Factors | 1991 |
Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity.
Topics: Adult; beta-Endorphin; Blood Glucose; Body Weight; C-Peptide; Female; Glucagon; Humans; Insulin; Kinetics; Male; Obesity | 1991 |
Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Hypopituitarism; Insulin; Norepinephrine; Recombinant Proteins; Reference Values | 1991 |
Glucose homeostasis after orthotopic liver transplantation in the pig.
Topics: Animals; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Homeostasis; Insulin; Liver; Liver Transplantation; Swine | 1991 |
Immediate effect of vagotomy on pancreatic insulin secretion.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Gastrectomy; Glucagon; Humans; Insulin; Insulin Secretion; Intraoperative Period; Male; Middle Aged; Pancreas; Secretory Rate; Stomach Neoplasms; Stomach Ulcer; Time Factors; Vagotomy, Truncal | 1991 |
Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Humans; Hydroxybutyrates; Insulin; Lactates; Male; Reference Values; Time Factors | 1991 |
Pancreatic endocrine function in cystic fibrosis.
Topics: Adult; Arginine; C-Peptide; Cystic Fibrosis; Fasting; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemia; Insulin; Pancreas; Pancreatic Polypeptide; Time Factors | 1991 |
Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporine.
Topics: Adolescent; Adult; Arginine; Blood Glucose; C-Peptide; Child; Cyclosporins; Diabetes Mellitus, Type 1; Eating; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Humans; Male; Reference Values | 1991 |
Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Catecholamines; Cognition; Evoked Potentials, Visual; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Male; Middle Aged; Reaction Time | 1991 |
The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus.
Topics: Acute Disease; Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Female; Food; Glucagon; Humans; Hyperglycemia; Injections, Intravenous; Islets of Langerhans; Male | 1991 |
Insulin and glucagon in prevention of hypoglycemia during exercise in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Analysis of Variance; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Male; Norepinephrine; Physical Exertion; Reference Values | 1991 |
[Hormonal mechanisms of carbohydrate metabolism disorders in chronic pancreatitis].
Topics: Blood Glucose; C-Peptide; Carbohydrates; Chronic Disease; Glucagon; Humans; Insulin; Islets of Langerhans; Pancreatitis; Radioimmunoassay | 1991 |
Sustained oscillatory insulin secretion after pancreas transplantation.
Topics: Activity Cycles; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Kidney Transplantation; Male | 1990 |
[Clinical significance of plasma C-peptide analysis and the analytical method in the diagnosis of diabetes related diseases].
Topics: C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Glucagon; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Radioimmunoassay; Reference Values | 1990 |
[The indices of pancreatic incretory activity in patients with chronic pancreatitis and disordered carbohydrate metabolism].
Topics: C-Peptide; Carbohydrate Metabolism; Cholecystokinin; Chronic Disease; Diabetes Mellitus; Glucagon; Humans; Insulin; Islets of Langerhans; Pancreatitis; Recurrence | 1990 |
Dissociation of the effects of epinephrine and insulin on glucose and protein metabolism.
Topics: Adult; Amino Acids; Bicarbonates; Blood Glucose; C-Peptide; Carbon Dioxide; Carbon Radioisotopes; Epinephrine; Glucagon; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Infusion Systems; Leucine; Oxidation-Reduction; Proteins; Radioisotope Dilution Technique; Respiration | 1990 |
The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus.
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Ethiopia; Female; Glucagon; Humans; Male; Middle Aged; Nutritional Physiological Phenomena; Protein-Energy Malnutrition; Reference Values | 1990 |
Early morning hyperglycaemia "dawn phenomenon" in non-insulin dependent diabetes mellitus (NIDDM): effects of cortisol suppression by metyrapone.
Topics: Aged; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glycated Hemoglobin; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Male; Metyrapone; Norepinephrine | 1990 |
Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Glycerol; Humans; Insulin; Insulin Antibodies; Insulin Resistance; Ketone Bodies; Male; Reference Values | 1990 |
Postprandial hyperglycaemia following a morning hypoglycaemia in type 1 diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Eating; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Hypoglycemia; Insulin; Male | 1990 |
[C-peptide assays of the urine and plasma at baseline and under stimulation with glucagon in healthy subjects and diabetics].
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Humans; Middle Aged; Reference Values; Stimulation, Chemical | 1990 |
Somatostatin analogue in treatment of coexisting glucagonoma and pancreatic pseudocyst: dissociation of responses.
Topics: Adenoma, Islet Cell; Arginine; Blood Glucose; C-Peptide; Eosinophilia; Follow-Up Studies; Glucagon; Glucagonoma; Humans; Male; Middle Aged; Octreotide; Pancreatic Cyst; Pancreatic Neoplasms; Pancreatic Pseudocyst | 1990 |
Impaired glucose-induced thermogenesis and arterial norepinephrine response persist after weight reduction in obese humans.
Topics: Adult; Blood Glucose; Body Temperature Regulation; C-Peptide; Energy Metabolism; Epinephrine; Female; Glucagon; Glucose; Humans; Insulin; Male; Middle Aged; Norepinephrine; Obesity; Sympathetic Nervous System; Weight Loss | 1990 |
Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity.
Topics: Adult; Blood Glucose; C-Peptide; Computer Simulation; Drug Administration Schedule; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Norepinephrine; Time Factors | 1990 |
Glucagon-cortisol interactions on glucose turnover and lactate gluconeogenesis in normal humans.
Topics: Acetates; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Humans; Hydrocortisone; Insulin; Kinetics; Lactates; Male; Reference Values | 1990 |
Autoantibodies against insulin (IAA), C-peptide (CAA), and glucagon (GAA) in new-onset type 1 diabetic patients.
Topics: Age Factors; Autoantibodies; Body Weight; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Sex Factors | 1990 |
Endocrine pancreatic secretion in patients after acute pancreatitis.
Topics: Acute Disease; Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Pancreatitis; Time Factors | 1990 |
Oral and intravenous glucose-induced insulin secretion in hyperthyroid patients.
Topics: Administration, Oral; Adult; C-Peptide; Carbohydrates; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperthyroidism; Injections, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged | 1990 |
[Plasma C-peptide assay and the clinical significance].
Topics: Autoimmune Diseases; C-Peptide; Diabetes Mellitus; Diagnosis, Differential; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Radioimmunoassay; Specimen Handling | 1990 |
Impaired insulin secretion in the neonatal rhesus monkey after chronic hyperinsulinemia in utero.
Topics: Animals; Animals, Newborn; Blood Glucose; C-Peptide; Female; Fetal Diseases; Glucagon; Hyperinsulinism; Infusion Pumps, Implantable; Insulin; Insulin Secretion; Islets of Langerhans; Macaca mulatta; Pregnancy; Pregnancy in Diabetics | 1990 |
[Consequences of hyperglycemia on glucose and nitrogen metabolism in liver cirrhosis. A study using a hyperglycemic clamp].
Topics: Adult; Aged; Amino Acids; Ammonia; C-Peptide; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Insulin Infusion Systems; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Nitrogen | 1990 |
Metabolic response to egg white and cottage cheese protein in normal subjects.
Topics: Adult; Aminoacetonitrile; Blood Glucose; Blood Urea Nitrogen; C-Peptide; Dairy Products; Dietary Proteins; Egg Proteins; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin; Kinetics; Male; Starvation; Urea | 1990 |
Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.
Topics: 3-Hydroxybutyric Acid; Adult; Age Factors; Aged; Aging; Blood Glucose; C-Peptide; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucagon; Glycerol; Humans; Hydroxybutyrates; Hyperglycemia; Infusions, Intravenous; Insulin; Ketone Bodies; Kinetics; Lipolysis; Reference Values | 1990 |
Characterization of the late posthypoglycemic insulin resistance in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycated Hemoglobin; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin Resistance; Male; Random Allocation | 1990 |
Standard breakfast test: an alternative to glucagon testing for C-peptide reserve?
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Food, Formulated; Glucagon; Humans; Islets of Langerhans; Middle Aged | 1990 |
Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration.
Topics: Alanine; Bicarbonates; Blood Glucose; C-Peptide; Glucagon; Gluconeogenesis; Growth Hormone; Homeostasis; Humans; Hydrogen-Ion Concentration; Insulin; Lactates; Liver | 1990 |
Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Reference Values; Transplantation, Homologous | 1990 |
Limited duration of remission of insulin dependency in children with recent overt type I diabetes treated with low-dose cyclosporin.
Topics: Adolescent; Autoantibodies; C-Peptide; Child; Cyclosporins; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male | 1990 |
The value of C-peptide level measurements in diabetes mellitus.
Topics: Administration, Oral; Adolescent; Adult; Aged; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Prospective Studies; Radioimmunoassay; Time Factors | 1990 |
Pattern of postprandial carbohydrate metabolism and effects of portal and peripheral insulin delivery.
Topics: Animals; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Dogs; Female; Glucagon; Glucose; Insulin; Lipid Metabolism; Pancreas; Time Factors | 1990 |
Dexamethasone increases glucose cycling, but not glucose production, in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Dexamethasone; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Kinetics; Male; Radioisotope Dilution Technique; Reference Values; Tritium | 1990 |
Mechanisms of starvation diabetes: a study with double tracer and indirect calorimetry.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Fasting; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Insulin; Lactates; Male; Starvation | 1990 |
Different short-term effect of protein and carbohydrate intake on TSH, growth hormone (GH), insulin, C-peptide, and glucagon in humans.
Topics: Adult; C-Peptide; Dietary Carbohydrates; Dietary Proteins; Female; Glucagon; Growth Hormone; Hormones; Humans; Insulin; Kinetics; Male; Thyrotropin | 1990 |
Hypoglycemia during diarrhea in childhood. Prevalence, pathophysiology, and outcome.
Topics: Adolescent; Alanine; Aspartate Aminotransferases; Bilirubin; Blood Glucose; C-Peptide; Child; Child, Preschool; Diarrhea; Female; Fluid Therapy; Glucagon; Gluconeogenesis; Hormones; Humans; Hydroxybutyrates; Hypoglycemia; Lactates; Male | 1990 |
Glucagon-stimulated serum C-peptide levels in the early period following pancreas transplantation.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glucagon; Graft Rejection; Humans; Kidney Transplantation; Male; Pancreas Transplantation | 1990 |
Metabolic control in recipients of duct-occluded segmental pancreatic grafts: a four-year follow-up.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Graft Survival; Humans; Immunosuppression Therapy; Kidney Transplantation; Pancreas Transplantation; Pancreatic Ducts; Postoperative Complications | 1990 |
The glucagon-stimulated C-peptide test: an aid in classification of patients with diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glycated Hemoglobin; Humans; Longitudinal Studies; Male; Middle Aged | 1990 |
Metabolic studies of type I diabetics after successful segmental pancreas and kidney transplantation.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Glucagon; Growth Hormone; Humans; Kidney Transplantation; Norepinephrine; Pancreas Transplantation; Reference Values | 1990 |
Endogenous insulin secretion in newly diagnosed diabetic patients in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus; Fasting; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Saudi Arabia | 1990 |
[Effects of induced hyperglycemia on the activity of pancreatic and gastrointestinal secretion of hormones in oncologic patients].
Topics: Antineoplastic Agents; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Combined Modality Therapy; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Lung Neoplasms; Stomach Neoplasms | 1990 |
Effects of a growth hormone pulse on total and forearm substrate fluxes in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Analysis of Variance; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Forearm; Glucagon; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Injections, Intravenous; Insulin; Kinetics; Male; Regional Blood Flow; Time Factors | 1990 |
Glucose tolerance and insulin and C-peptide responses after various insulin secretory stimuli in hyper- and hypothyroid subjects before and after treatment.
Topics: Adolescent; Adult; Antithyroid Agents; Blood Glucose; C-Peptide; Eating; Female; Glucagon; Glucose; Humans; Hyperthyroidism; Hypothyroidism; Insulin; Insulin Secretion; Iodine Radioisotopes; Male; Middle Aged; Secretory Rate; Terbutaline; Thyroid Hormones; Thyroxine | 1985 |
Structure, function, and immunogenicity of human insulinoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Adenoma, Islet Cell; Adult; C-Peptide; Fluorescent Antibody Technique; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Insulinoma; Lymphocyte Culture Test, Mixed; Lymphocytes; Microscopy, Electron; Pancreatic Neoplasms; Tolbutamide; Tumor Cells, Cultured | 1988 |
Monitoring of celiac plexus block in chronic pancreatitis.
Topics: Blood Pressure; C-Peptide; Celiac Plexus; Glucagon; Heart Rate; Humans; Insulin; Middle Aged; Palliative Care; Pancreatic Polypeptide; Pancreatitis; Posture; Somatostatin; Vascular Resistance | 1989 |
Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
Topics: Blood Glucose; C-Peptide; Carbon Dioxide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Glucose; Humans; Insulin; Insulin, Long-Acting; Lipid Metabolism; Liver; Male; Middle Aged; Obesity | 1989 |
Effect of oral antidiabetic drug withdrawal in type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male | 1989 |
Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
Topics: Adenoma, Islet Cell; Aged; C-Peptide; Female; Glucagon; Humans; Hypoglycemia; Insulin; Insulinoma; Octreotide; Pancreatic Neoplasms | 1989 |
Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Growth Hormone; Humans; Insulin; Insulin Infusion Systems; Male; Somatostatin | 1989 |
Somatostatin effect in postprandial hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Female; Food; Glucagon; Glucose; Humans; Hypoglycemia; Insulin; Middle Aged; Somatostatin | 1989 |
Demonstration of a role for growth hormone in glucose counterregulation.
Topics: Adult; Alanine; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Metyrapone; Norepinephrine; Reference Values; Somatostatin | 1989 |
Epinephrine's effect on metabolic rate is independent of changes in plasma insulin or glucagon.
Topics: Adult; Basal Metabolism; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Insulin Secretion; Islets of Langerhans; Lactates; Male; Norepinephrine; Somatostatin | 1989 |
Glucagon and hepatic glucose production: modulation by low-dose bradykinin infusion.
Topics: Adult; Bradykinin; C-Peptide; Glucagon; Glucose; Hemodynamics; Hormones; Humans; Insulin; Liver; Male; Somatostatin | 1989 |
Insulin regulation of lipolysis in nondiabetic and IDDM subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Kinetics; Lipolysis; Male; Palmitic Acid; Palmitic Acids; Reference Values; Somatostatin | 1989 |
Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
Topics: Adolescent; Autoantibodies; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Humans; Male; Prognosis | 1989 |
Assessment of the postprandial pattern of glucose metabolism in nondiabetic subjects and patients with non-insulin-dependent diabetes mellitus using a simultaneous infusion of [2(3)H] and [3(3)H] glucose.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Glucose; Glycogen; Humans; Insulin; Liver; Male; Middle Aged; Random Allocation; Time Factors | 1989 |
Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Female; Glucagon; Humans; Insulin; Kidney Transplantation; Male; Microcirculation; Pancreas Transplantation; Prospective Studies | 1989 |
Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events.
Topics: Adult; Alanine; Blood Glucose; Body Temperature; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Insulin; Lactates; Liver; Male; Sleep | 1989 |
Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Infusion Systems; Insulin Resistance; Male; Norepinephrine; Obesity | 1989 |
Comparison of the pattern of postprandial carbohydrate metabolism after ingestion of a glucose drink or a mixed meal.
Topics: Adult; Blood Glucose; C-Peptide; Diet; Dietary Carbohydrates; Eating; Female; Glucagon; Glucose; Humans; Insulin; Liver; Male; Middle Aged; Oxidation-Reduction | 1989 |
Factors associated with fasting and postglucagon plasma C-peptide levels in middle-aged insulin-treated diabetic patients.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Finland; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Sex Factors | 1989 |
Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM.
Topics: Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Lactates; Lactic Acid; Liver; Male; Middle Aged | 1989 |
Effect of interferon on glucose tolerance and insulin sensitivity.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Insulin Resistance; Interferon Type I; Male | 1989 |
Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Middle Aged | 1989 |
Insulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting.
Topics: Adult; Blood Glucose; C-Peptide; Catecholamines; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Lactates; Lactic Acid; Male | 1989 |
Effects of cyclosporin on insulin and C-peptide secretion in healthy beagles.
Topics: Animals; C-Peptide; Cyclosporins; Dogs; Female; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Insulin Secretion; Kinetics; Male; Reference Values | 1989 |
Pancreatic hormones are expressed on the surfaces of human and rat islet cells through exocytotic sites.
Topics: Animals; C-Peptide; Cell Membrane; Chromogranins; Exocytosis; Glucagon; Humans; Immunohistochemistry; Insulin; Islets of Langerhans; Microscopy, Electron; Pancreatic Hormones; Rats; Rats, Inbred Strains | 1989 |
Contribution of cortisol to glucose counterregulation in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Kinetics; Lactates; Lactic Acid; Male; Portal Vein | 1989 |
Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male | 1989 |
[Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Islets of Langerhans; Middle Aged | 1989 |
Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal.
Topics: Body Height; C-Peptide; Child; Dwarfism, Pituitary; Female; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Islets of Langerhans; Liver; Male | 1989 |
Effect of osmolality on availability of glucose ingested during prolonged exercise in humans.
Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Dietary Carbohydrates; Exercise; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Insulin; Male; Osmolar Concentration; Oxidation-Reduction | 1989 |
Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Liver; Male; Reference Values | 1989 |
Effects of dose of ingested glucose on plasma metabolite and hormone responses in type II diabetic subjects.
Topics: Aged; Amino Acids; Blood Glucose; Blood Urea Nitrogen; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Food; Glucagon; Glucose; Humans; Insulin; Lactates; Male; Middle Aged; Nitrogen; Pancreatic Hormones | 1989 |
Effect of age on beta-cell response to exogenous glucagon in man.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Injections, Intravenous; Islets of Langerhans; Male | 1989 |
C-peptide response to glucagon in young diabetics.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged | 1989 |
[Plasma lipids, insulin, C-peptide, and glucagon levels in cirrhosis: personal observations].
Topics: Adult; Aged; C-Peptide; Female; Glucagon; Humans; Insulin; Lipids; Liver Cirrhosis; Male; Middle Aged | 1989 |
Metabolic and hormonal responses to exogenous hyperthermia in man.
Topics: Adult; Alanine; C-Peptide; Epinephrine; Fever; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Hormones; Hot Temperature; Humans; Immersion; Insulin; Lactates; Lactic Acid; Lipid Metabolism; Male | 1989 |
Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Administration Schedule; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Humans; Hydroxybutyrates; Insulin; Insulin Infusion Systems; Male; Octreotide | 1989 |
B-cell responses to intravenous glucose and glucagon in non-diabetic twins of patients with type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Autoantibodies; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 1; Diseases in Twins; Female; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreatitis; Reference Values; Risk Factors; Twins, Monozygotic | 1989 |
Measurement of proinsulin in human pancreatic juice.
Topics: Adolescent; Adult; C-Peptide; Chromatography, Affinity; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Pancreatic Juice; Proinsulin; Radioimmunoassay | 1989 |
Preservation of pancreatic beta cell function with pulsatile cardiopulmonary bypass.
Topics: Blood Glucose; C-Peptide; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Glucagon; Humans; Hyperglycemia; Insulin; Intraoperative Care; Islets of Langerhans; Lactates; Lactic Acid; Male; Middle Aged; Pulsatile Flow | 1989 |
The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Glucagon; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Time Factors | 1989 |
Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study.
Topics: Adolescent; Adult; Autoantibodies; C-Peptide; Child; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Parietal Cells, Gastric; Thyroid Gland | 1989 |
Pylorus-preserving total pancreatectomy and segmental pancreas autotransplantation.
Topics: Adult; Aged; Biliary Tract; Biliary Tract Neoplasms; Blood Glucose; C-Peptide; Female; Gastric Emptying; Glucagon; Humans; Insulin; Liver; Male; Middle Aged; Pancreas Transplantation; Pancreatectomy; Pancreatic Neoplasms; Pyloric Antrum; Radionuclide Imaging; Stomach; Transplantation, Autologous | 1989 |
[The effect of pharmacological agents on pancreatic incretory activity in patients with chronic pancreatitis].
Topics: Aminophylline; C-Peptide; Calcium Gluconate; Chronic Disease; Diabetes Mellitus; Glucagon; Gluconates; Glucose Tolerance Test; Humans; Insulin; Isoproterenol; Pancreas; Pancreatitis; Recurrence | 1989 |
The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
Topics: Adenoma, Islet Cell; Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Carcinoma, Hepatocellular; Female; Glucagon; Humans; Hypoglycemia; Insulin; Insulinoma; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms | 1988 |
C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carcinoma, Hepatocellular; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged | 1988 |
[Features of incretory function of the pancreas in patients with insulinoma].
Topics: Adenoma, Islet Cell; Adolescent; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Insulinoma; Male; Middle Aged; Pancreatic Hormones; Pancreatic Neoplasms; Predictive Value of Tests | 1988 |
[Inhibitory effects of somatostatin analog (SMS 201-995) on pancreatic hormones in patients with malignant islet-cell carcinoma].
Topics: Adenoma, Islet Cell; Adult; Blood Glucose; C-Peptide; Depression, Chemical; Female; Gastrins; Glucagon; Growth Hormone; Humans; Middle Aged; Octreotide; Pancreatic Hormones; Pancreatic Neoplasms | 1988 |
Long-term follow-up of canine segmental pancreatic autografts.
Topics: Animals; C-Peptide; Dogs; Fasting; Follow-Up Studies; Glucagon; Glucose; Insulin; Islets of Langerhans; Pancreas Transplantation; Pancreatectomy; Somatostatin; Transplantation, Autologous | 1985 |
Prolonged hyperglycaemia during infusion of glucose and somatostatin impairs pancreatic A- and B-cell responses to decrements in plasma glucose in normal man: evidence for induction of altered sensitivity to glucose.
Topics: Adult; Blood Glucose; C-Peptide; Drug Resistance; Epinephrine; Female; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Hyperglycemia; Insulin; Islets of Langerhans; Male; Somatostatin; Time Factors | 1985 |
Exercise-induced regulation of insulin receptor affinity: role of circulating metabolites.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Erythrocytes; Fatty Acids, Nonesterified; Glucagon; Glycerol; Growth Hormone; Humans; Hydrocortisone; Hydrogen-Ion Concentration; Insulin; Ketone Bodies; Lactates; Lactic Acid; Male; Monocytes; Physical Exertion; Prostaglandins; Pyruvates; Pyruvic Acid; Receptor, Insulin; Somatostatin | 1985 |
Effect of simultaneous infusion of a somatostatin analogue, insulin and glucose on serum triglycerides and blood glucose levels in man.
Topics: Adult; Blood Glucose; C-Peptide; Cholesterol; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Lipoproteins, VLDL; Male; Middle Aged; Somatostatin; Time Factors; Triglycerides | 1985 |
Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Feedback; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Hyperglycemia; Insulin; Insulin Infusion Systems; Male; Middle Aged; Somatostatin | 1986 |
Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans.
Topics: Adult; Alanine; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Humans; Hypoglycemia; Insulin; Lactates; Lactic Acid; Male; Norepinephrine; Somatostatin | 1986 |
Pathophysiological doses of glucagon cause a transient increase of the hepatic vein potassium concentration in man.
Topics: Adult; Aged; Aorta; Blood Glucose; C-Peptide; Female; Glucagon; Hepatic Veins; Humans; Insulin; Male; Middle Aged; Potassium; Somatostatin | 1986 |
Insulin. Its role in the thermic effect of glucose.
Topics: Adult; Body Temperature Regulation; Breath Tests; C-Peptide; Energy Metabolism; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Heart Rate; Hot Temperature; Humans; Insulin; Male; Mathematics; Norepinephrine; Oxidation-Reduction; Somatostatin | 1986 |
In vivo pulsatility of pancreatic islet peptides.
Topics: Animals; Blood Glucose; C-Peptide; Dogs; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Pancreatic Hormones; Pancreatic Polypeptide; Papio; Radioimmunoassay; Somatostatin; Time Factors | 1986 |
Lack of direct inhibition of insulin secretion by exogenous insulin in the canine pancreas.
Topics: Animals; Arginine; C-Peptide; Dogs; Female; Glucagon; Homeostasis; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Perfusion; Somatostatin | 1986 |
Somatostatin potentiation of insulin-induced glucose uptake in normal individuals.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Insulin; Kinetics; Male; Middle Aged; Reference Values; Somatostatin | 1986 |
Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Liver; Middle Aged; Somatostatin | 1987 |
Glucose intolerance in thyrotoxicosis roles of insulin, glucagon and somatostatin.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Somatostatin; Thyrotoxicosis | 1987 |
Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.
Topics: Adult; Basal Metabolism; Blood Glucose; C-Peptide; Energy Metabolism; Female; Glucagon; Humans; Insulin; Kinetics; Male; Oxygen Consumption; Somatostatin | 1987 |
The pancreatic-adrenocortical-pituitary clamp technique for study of counterregulation in humans.
Topics: 3-Hydroxybutyric Acid; Adrenal Cortex; Adult; Alanine; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Insulin Secretion; Islets of Langerhans; Lactates; Male; Metyrapone; Pituitary Gland; Somatostatin | 1987 |
Primary role of glucagon release in the effect of beta-endorphin on glucose homeostasis in normal man.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Endorphins; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Homeostasis; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Male; Norepinephrine; Somatostatin | 1987 |
Morphology and endocrine production of cells in the islets of Langerhans of the Chacma baboon.
Topics: Animals; C-Peptide; Cytoplasmic Granules; Female; Glucagon; Histocytochemistry; Insulin; Islets of Langerhans; Male; Microscopy, Electron; Pancreatic Polypeptide; Papio; Peptide Biosynthesis; Proglucagon; Protein Precursors; Somatostatin | 1987 |
The somatostatin analogue SMS 201-995 in acromegaly: prolonged, preferential suppression of growth hormone but not pancreatic hormones.
Topics: Acromegaly; Adult; Aged; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Humans; Insulin; Middle Aged; Octreotide; Pancreatic Hormones; Somatostatin | 1987 |
The effects of hyperglycaemia on isotopic measurement of glucose utilisation using [2(3)H], [3(3)H] and [6(14)C] glucose in patients with type 1 (insulin-dependent) diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Carbon Radioisotopes; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose; Growth Hormone; Humans; Hyperglycemia; Insulin; Kinetics; Male; Radioisotope Dilution Technique; Reference Values; Somatostatin; Tritium | 1987 |
Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Liver; Male; Somatostatin | 1988 |
Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
Topics: Adult; Aged; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Kinetics; Liver; Male; Middle Aged; Somatostatin; Uremia | 1988 |
Pancreatic hormone secretion in chronic pancreatitis without residual beta-cell function.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 1; Food; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Pancreatic Polypeptide; Pancreatitis; Somatostatin | 1988 |
Multiple nonfunctional pancreatic islet cell tumor in multiple endocrine neoplasia type I. A case report.
Topics: Adenoma, Islet Cell; Adult; C-Peptide; Female; Gastrins; Glucagon; Growth Hormone-Releasing Hormone; Humans; Immunohistochemistry; Insulin; Microscopy, Electron; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Pancreatic Polypeptide; Radioimmunoassay; Somatostatin; Vasoactive Intestinal Peptide | 1988 |
Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lipolysis; Liver; Male; Metabolic Clearance Rate; Middle Aged; Sulfonylurea Compounds | 1986 |
Comparison of oral glucose loading and intravenous glucagon injection as stimuli to C-peptide secretion in normal men.
Topics: Adult; C-Peptide; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male | 1985 |
Sensitivity to beta-endorphin as a cause of human obesity.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Naloxone; Obesity | 1987 |
Biochemical changes in rhesus monkey during the first days after streptozotocin administration are indicative of selective beta cell destruction.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Free Radicals; Glucagon; Glycated Hemoglobin; Islets of Langerhans; Macaca mulatta; Streptozocin | 1988 |
Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Humans; Infusions, Intravenous; Insulin; Male; Obesity | 1988 |
Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Insulin Secretion; Kinetics; Male; Reference Values | 1988 |
Renal peritubular versus luminal uptake of biologically active small proteins.
Topics: Animals; Atrial Natriuretic Factor; beta 2-Microglobulin; C-Peptide; Chickens; Glucagon; Insulin; Iodine Radioisotopes; Kidney Tubules; Molecular Weight; Parathyroid Hormone; Proteins; Serum Albumin | 1988 |
Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
Topics: Adenoma, Islet Cell; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Insulinoma; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Serotonin; Streptozocin | 1985 |
[Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
Topics: Adenoma, Islet Cell; Adult; Aged; Blood Glucose; C-Peptide; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulinoma; Male; Middle Aged; Tolbutamide | 1985 |
Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
Topics: Adult; Blood Glucose; C-Peptide; Cyclic AMP; Female; Glucagon; Hepatitis, Viral, Human; Humans; Insulin; Kinetics; Liver Cirrhosis; Liver Diseases; Male; Middle Aged | 1985 |
Impaired pancreatic polypeptide response to insulin hypoglycemia in obese subjects.
Topics: Adrenocorticotropic Hormone; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Male; Obesity; Pancreatic Polypeptide | 1985 |
Acromegaly and insulin resistance: a case study.
Topics: Acromegaly; Adenoma, Acidophil; Bromocriptine; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Resistance; Middle Aged; Pituitary Neoplasms; Tomography, X-Ray Computed | 1986 |
[Studies on the diagnosis of insulinoma].
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Insulin Secretion; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Tolbutamide | 1987 |
Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Eating; Fasting; Glucagon; Humans; Insulin; Insulin Secretion; Middle Aged | 1988 |
First-phase insulin response to glucose in nonobese or obese subjects with glucose intolerance: analysis by C-peptide secretion rate.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity | 1988 |
Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Infusion Systems; Lipids; Lipoproteins; Male; Middle Aged; Pulsatile Flow; Triglycerides | 1988 |
Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments.
Topics: Adult; C-Peptide; Drug Interactions; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Hormones; Humans; Infusions, Intravenous; Insulin; Kinetics; Proinsulin | 1988 |
[Influence of total pancreatectomy on the secretion of human growth hormone and the endocrine pancreas].
Topics: Adult; Aged; Arginine; Blood Glucose; C-Peptide; Female; Glucagon; Growth Hormone; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Pancreatectomy | 1988 |
Effect of alcohol on glucose tolerance in normal and noninsulin-dependent diabetic subjects.
Topics: Alcohol Drinking; C-Peptide; Diabetes Mellitus, Type 2; Erythrocytes; Ethanol; Glucagon; Glucose Tolerance Test; Humans; Insulin; Receptor, Insulin | 1988 |
Pharmacological doses of oxytocin affect plasma hormone levels modulating glucose homeostasis in normal man.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Glucagon; Growth Hormone; Homeostasis; Hormones; Humans; Hydrocortisone; Insulin; Male; Norepinephrine; Oxytocin | 1988 |
Hormonal counterregulatory responses to human (semi-synthetic and recombinant DNA) and porcine insulin induced hypoglycaemia.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Glucagon; Growth Hormone; Hormones; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin, Regular, Pork; Male; Prolactin; Reference Values | 1988 |
Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.
Topics: Adult; Ascitic Fluid; Blood Glucose; C-Peptide; Glucagon; Glucose; Humans; Insulin; Kinetics; Liver Cirrhosis, Alcoholic; Male; Middle Aged | 1988 |
Urinary C-peptide: a useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood.
Topics: C-Peptide; Child; Cohort Studies; Diabetes Mellitus, Type 1; Glucagon; Glycosuria; Humans; Insulin; Ketone Bodies; Longitudinal Studies | 1988 |
The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Food; Glucagon; Humans; Insulin; Islets of Langerhans | 1988 |
Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diabetic Retinopathy; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged | 1988 |
Comparison of glucose, glucagon and standard meal-induced insulin release in patients with newly onset non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Food; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged | 1988 |
Glucoregulation in acute liver failure.
Topics: Acute Disease; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Liver; Liver Diseases; Male; Middle Aged | 1986 |
[Behavior of insulin, glucagon, cortisol and thyroid hormones in plasma in the early post-traumatic phase with and without modification by nutritional therapy adapted to metabolism].
Topics: Amino Acids; Betamethasone; Brain Injuries; C-Peptide; Energy Metabolism; Fructose; Glucagon; Glucose Solution, Hypertonic; Humans; Hydrocortisone; Insulin; Nutritional Requirements; Parenteral Nutrition; Thyroid Hormones; Wounds and Injuries; Xylose | 1986 |
Metabolic abnormalities in children of non-insulin dependent diabetics.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 2; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male | 1986 |
Increased incidence of true type I diabetes acquired during pregnancy.
Topics: Adult; Blood Glucose; C-Peptide; Denmark; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Longitudinal Studies; Pregnancy; Pregnancy in Diabetics; Prospective Studies; Seasons | 1987 |
[Possibility of transferring patients with type-II diabetes mellitus treated with small doses of sulfonylurea preparations to diet therapy].
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus, Type 2; Female; Glucagon; Glyburide; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds | 1987 |
Mechanism of exercise-induced hypoglycemia during sulfonylurea treatment.
Topics: Adult; C-Peptide; Glucagon; Glyburide; Humans; Hypoglycemia; Insulin; Kinetics; Lactates; Lactic Acid; Male; Physical Exertion | 1987 |
Effects of leucine, isoleucine, or threonine infusion on leucine metabolism in humans.
Topics: Analysis of Variance; Breath Tests; C-Peptide; Carbon Dioxide; Demography; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Isoleucine; Keto Acids; Leucine; Male; Oxidation-Reduction; Reference Values; Threonine | 1987 |
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glucose; Glyburide; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Liver; Sulfonylurea Compounds | 1987 |
Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus.
Topics: Blood Glucose; Blood Urea Nitrogen; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Energy Metabolism; Epinephrine; Female; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Male; Middle Aged; Norepinephrine; Obesity | 1988 |
Glybenclamide and cyclosporine A: an interaction on glucose metabolism.
Topics: Animals; C-Peptide; Cyclosporins; Drug Interactions; Glucagon; Glucose; Glyburide; Glycogen; Insulin; Rats | 1988 |
Pancreatic beta-cell function in CAPD.
Topics: C-Peptide; Cross Reactions; Glucagon; Humans; Insulin; Islets of Langerhans; Peritoneal Dialysis, Continuous Ambulatory; Proinsulin; Uremia | 1988 |
Classification of diabetes mellitus by studies of C-peptide secretory capacity.
Topics: Adolescent; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Injections, Intravenous; Islets of Langerhans | 1987 |
[Effect of biostator control on levels of contra-insulin hormones].
Topics: Adolescent; Adult; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 1; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin Antagonists; Insulin Infusion Systems; Middle Aged | 1988 |
Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Islets of Langerhans; Kinetics; Male; Middle Aged; Norepinephrine | 1988 |
Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Topics: Autoantibodies; Autoimmune Diseases; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Heterozygote; HLA-D Antigens; HLA-DR Antigens; HLA-DR3 Antigen; HLA-DR4 Antigen; Humans; Insulin; Islets of Langerhans; Male; Parietal Cells, Gastric; Thyroid Gland | 1988 |
Stopping insulin treatment in middle-aged diabetic patients with high postglucagon plasma C-peptide. Effect on glycaemic control, serum lipids and lipoproteins.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Lipids; Lipoproteins; Male; Middle Aged | 1988 |
Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
Topics: Basal Metabolism; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Liver; Male; Middle Aged; Obesity; Pancreas | 1988 |
Postexercise dose-response relationship between plasma glucose and insulin secretion.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; Blood Pressure; C-Peptide; Calorimetry; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Substances; Heart Rate; Humans; Hydrocortisone; Hydroxybutyrates; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Lactates; Male; Norepinephrine; Physical Exertion; Proinsulin | 1988 |
[Pancreatic endocrine function of patients with nonspecific ulcerative colitis].
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Colitis, Ulcerative; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Pancreas | 1988 |
Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male | 1988 |
Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Administration Schedule; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged | 1988 |
Mild type II diabetes markedly increases glucose cycling in the postabsorptive state and during glucose infusion irrespective of obesity.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Infusions, Intravenous; Insulin; Liver; Male; Middle Aged; Obesity | 1988 |
Oscillations in insulin secretion during constant glucose infusion in normal man: relationship to changes in plasma glucose.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Female; Glucagon; Glucose; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Secretory Rate | 1988 |
The acute effect of ethanol on counterregulatory response and recovery from insulin-induced hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Ethanol; Fasting; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Male; Norepinephrine | 1988 |
Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Infusion Systems; Islets of Langerhans; Male; Middle Aged; Proinsulin | 1988 |
[Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Topics: C-Peptide; Diabetes Complications; Diabetes Mellitus; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Liver Cirrhosis; Middle Aged; Pancreatic Hormones; Pancreatic Polypeptide; Radioimmunoassay | 1988 |
Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man.
Topics: Adult; Blood Glucose; C-Peptide; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glycerol; Heparin; Humans; Insulin; Insulin Resistance; Kinetics; Lipolysis; Male; Triglycerides | 1988 |
Insulin and C-peptide secretory responses to glucagon in man: studies on the dose-response relationships.
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Glucagon; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Middle Aged; Secretory Rate | 1987 |
Semisynthetic human insulin: biological and pharmacokinetic effects in normal subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Kinetics; Male | 1987 |
[An evaluation of insulin requirement of diabetic patients by glucagon test].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; C-Peptide; Diabetes Mellitus; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Middle Aged | 1987 |
Interrelationships between dietary carbohydrates, B cell function and rate of ketogenesis during underfeeding in obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Diet, Reducing; Dietary Carbohydrates; Energy Intake; Fasting; Female; Glucagon; Humans; Insulin; Ketone Bodies; Male; Obesity | 1987 |
Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Secretion; Lipids; Lipoproteins; Male; Middle Aged; Obesity | 1987 |
Occurrence of VIP and peptide HM in human pancreas and their influence on pancreatic endocrine secretion in man.
Topics: Adult; C-Peptide; Female; Fluorescent Antibody Technique; Glucagon; Histocytochemistry; Humans; Insulin; Insulin Secretion; Male; Pancreas; Peptide PHI; Tissue Distribution; Vasoactive Intestinal Peptide | 1987 |
Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis.
Topics: Adult; C-Peptide; Chronic Disease; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Pancreatitis | 1987 |
The effect of dexamethasone on the enteroinsular axis.
Topics: Adult; Blood Glucose; C-Peptide; Dexamethasone; Female; Food; Gastric Inhibitory Polypeptide; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged | 1987 |
Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Food; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Prospective Studies | 1987 |
Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Sulfonylurea Compounds | 1987 |
[Pancreatic function of chronic pancreatitis patients].
Topics: Adult; C-Peptide; Chronic Disease; Fasting; Food; Glucagon; Humans; Insulin; Middle Aged; Pancreas; Pancreatitis; Trypsin | 1987 |
Influence of enterally administered ornithine alpha-ketoglutarate on hormonal patterns in burn patients.
Topics: Adolescent; Adult; Blood Glucose; Burns; C-Peptide; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Kinetics; Male; Middle Aged; Ornithine | 1987 |
A study of beta-cell function after glucagon stimulation in thalassaemia major treated by high transfusion programme.
Topics: Adolescent; Adult; Blood Glucose; Blood Transfusion; C-Peptide; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Thalassemia | 1987 |
[Biological significance of the endogenous secretion of insulin in response to breakfast in diabetic children].
Topics: Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glycated Hemoglobin; Growth Hormone; Humans; Insulin; Male | 1987 |
Glucose tolerance and secretion and clearance of insulin during long term felodipine treatment.
Topics: Adult; Antihypertensive Agents; C-Peptide; Felodipine; Glucagon; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Male; Middle Aged; Nitrendipine | 1987 |
Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man.
Topics: Administration, Oral; Adult; Arginine; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged | 1987 |
Hyperglucagonism and glucagon resistance in cirrhosis. Paradoxical effect of propranolol on plasma glucagon levels.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Drug Resistance; Female; Glucagon; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Propranolol | 1988 |
Increased platelet thromboxane B2 production in newborn infants of diabetic mothers.
Topics: Blood Glucose; Blood Platelets; C-Peptide; Diabetes Mellitus, Type 1; Female; Fetal Blood; Glucagon; Humans; Infant, Newborn; Pancreas; Thromboxane B2 | 1986 |
Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; C-Peptide; Chromaffin System; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycerol; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Islets of Langerhans; Lactates; Lactic Acid; Male; Norepinephrine; Physical Exertion | 1986 |
Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Male; Time Factors | 1986 |
Facultative thermogenesis induced by carbohydrate: a skeletal muscle component mediated by epinephrine.
Topics: Adult; Blood Glucose; Body Temperature Regulation; C-Peptide; Carbohydrates; Epinephrine; Female; Forearm; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Muscles; Oxygen Consumption; Pancreas | 1986 |
Regulation of hepatic glucose output during exercise by circulating glucose and insulin in humans.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose; Humans; Insulin; Liver; Male; Mathematics; Physical Exertion | 1986 |
Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients.
Topics: Adult; Analysis of Variance; Arginine; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperthyroidism; Insulin; Islets of Langerhans; Male; Middle Aged; Proinsulin | 1986 |
Insulin secretion in alcoholics in a withdrawal state.
Topics: Adult; Aged; Alcoholism; Blood Glucose; C-Peptide; Ethanol; Female; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Substance Withdrawal Syndrome; Time Factors | 1986 |
Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Eating; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Hyperglycemia; Insulin; Liver; Male; Middle Aged; Tritium | 1986 |
Counterregulation of insulin-induced hypoglycaemia in primary hypothyroidism.
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypothyroidism; Insulin; Male; Middle Aged; Norepinephrine; Pulse | 1986 |
Effects of hyperglycemia on glucose production and utilization in humans. Measurement with [23H]-, [33H]-, and [614C]glucose.
Topics: Adult; Blood Glucose; C-Peptide; Carbon Radioisotopes; Female; Glucagon; Glucose; Glucose-6-Phosphate; Glucosephosphates; Growth Hormone; Humans; Hyperglycemia; Insulin; Liver Glycogen; Male; Middle Aged; Tritium | 1986 |
Insulin oscillations per se do not affect glucose turnover parameters in normal man.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose; Humans; Infusions, Parenteral; Insulin; Kinetics; Male | 1986 |
The role of insulin antibodies in insulin treatment of type I diabetes.
Topics: Adolescent; C-Peptide; Child; Diabetes Mellitus, Type 1; Glucagon; Glucose; Humans; Insulin; Insulin Antibodies; Mathematics | 1986 |
C-peptide secretion in calcific tropical pancreatic diabetes.
Topics: Adult; C-Peptide; Calcinosis; Diabetes Mellitus; Female; Glucagon; Humans; Islets of Langerhans; Male; Pancreatic Diseases; Tropical Climate | 1986 |
[Glucagon-stimulated plasma c-peptide in diabetics. Clinical parameters in the choice of therapy?].
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Male; Middle Aged | 1986 |
Effects of acarbose on the relationship between changes in GIP and insulin responses to meals in normal subjects.
Topics: Acarbose; Adult; Blood Glucose; Body Weight; C-Peptide; Double-Blind Method; Female; Food; Gastric Inhibitory Polypeptide; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Random Allocation; Trisaccharides | 1986 |
Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Interactions; Female; Food; Glipizide; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds; Terbutaline | 1986 |
Intravenous glucose tolerance after Whipple's procedure in patients with chronic pancreatitis--relative influence of occlusion of the pancreatic duct.
Topics: Adult; Aged; C-Peptide; Chronic Disease; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Methods; Middle Aged; Pancreatitis; Postoperative Complications | 1986 |
Endocrine pancreatic function in insulin-dependent diabetic pregnant women.
Topics: Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Islets of Langerhans; Pregnancy; Pregnancy in Diabetics | 1986 |
Gastro-entero-pancreatic hormones in amniotic fluid from normal and diabetic pregnant women.
Topics: Amniotic Fluid; Arginine; C-Peptide; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucose; Humans; Insulin; Peptides; Pregnancy; Pregnancy in Diabetics | 1986 |
Effect of charge on hepatic specific nature of vesicle encapsulated insulin in conscious dogs.
Topics: Animals; Blood Glucose; C-Peptide; Dogs; Electrochemistry; Glucagon; Glucose; Insulin; Kinetics; Liposomes; Liver | 1986 |
Plasma and urinary C-peptide in the classification of adult diabetics.
Topics: Adolescent; Adult; Aged; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Glucagon; Humans; Insulin; Insulin Secretion; Middle Aged | 1986 |
Altered C-peptide/insulin molar ratios and glucose turnover rates after stimulation in nondiabetic offsprings of type II diabetic patients.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Liver; Metabolic Clearance Rate; Time Factors | 1987 |
Polyacrylamide gel electrophoretic preparation of labeled and non-labeled peptides for radioimmunoassay.
Topics: C-Peptide; Electrophoresis, Disc; Electrophoresis, Polyacrylamide Gel; Glucagon; Growth Hormone; Hormones; Humans; Insulin; Iodine Radioisotopes; Proinsulin; Radioimmunoassay | 1986 |
Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Fasting; Female; Glucagon; Humans; Insulin; Male; Metabolic Clearance Rate; Middle Aged; Obesity, Morbid | 1987 |
Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Lactates; Lactic Acid; Male; Norepinephrine | 1987 |
Insulin action in aging man: evidence for tissue-specific differences at low physiologic insulin levels.
Topics: Adult; Aged; Aging; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Lipolysis; Liver; Male | 1987 |
Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Glucagon; Glucose; Humans; Insulin; Insulin Resistance; Kinetics; Middle Aged; Obesity | 1987 |
Failure of human insulin to influence endogenous basal insulin secretion in mild diabetics.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged | 1987 |
Pancreatic beta-cell secretion after oral glucose and intravenous glucagon: different responses to dietary control of plasma glucose in newly diagnosed patients with NIDDM.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Male | 1987 |
Plasma C-peptide and insulin responses to intravenous glucagon stimulation in idiopathic haemochromatosis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Hemochromatosis; Humans; Insulin; Male; Middle Aged; Time Factors | 1987 |
Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
Topics: Adult; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Food; Glucagon; Humans; Islets of Langerhans; Male; Obesity | 1987 |
Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Kinetics; Liver; Male; Obesity | 1987 |
Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics.
Topics: Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged | 1986 |
Repeatability of C-peptide response in glucagon stimulation test.
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Injections, Intravenous; Male | 1987 |
Clinical characteristics in the discrimination between patients with low or high C-peptide level among middle-aged insulin-treated diabetics.
Topics: Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Male; Middle Aged; Sex Factors | 1987 |
C-peptide secretion in calcific tropical pancreatic diabetes.
Topics: C-Peptide; Calcinosis; Diabetes Mellitus; Glucagon; Glucose; Humans; Pancreas; Protein Deficiency | 1987 |
Fasting, postprandial and postprandial plus glucagon-stimulated plasma C-peptide levels in non-insulin-dependent diabetics and in control subjects.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Male; Middle Aged | 1987 |
Outcome of the glucagon test depends upon the prevailing blood glucose concentration in type I (insulin-dependent) diabetic patients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Food; Glucagon; Humans; Male | 1987 |
Practical aspects in performing the glucagon test in the measurement of C-peptide secretion in diabetic patients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Food; Glucagon; Humans; Male; Middle Aged | 1986 |
Congenital pancreatic hypoplasia: a syndrome of exocrine and endocrine pancreatic insufficiency.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; HLA Antigens; Humans; Male; Pancreas | 1986 |
Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.
Topics: Acromegaly; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Glucose-6-Phosphate; Glucosephosphates; Humans; Insulin Resistance; Liver; Male; Middle Aged | 1986 |
[Incretory changes in the pancreatic hormones in chronic pancreatitis].
Topics: C-Peptide; Chronic Disease; Glucagon; Humans; Insulin Antibodies; Pancreatic Hormones; Pancreatitis; Radioimmunoassay; Recurrence | 1986 |
Starvation enhances the ability of insulin to inhibit its own secretion.
Topics: Adult; Blood Glucose; C-Peptide; Feedback; Glucagon; Humans; Insulin; Insulin Secretion; Middle Aged; Obesity; Starvation | 1985 |
Effects of a new diuretic piretanide on glucose tolerance, insulin secretion and 125I-insulin binding.
Topics: Adult; Blood Glucose; C-Peptide; Diuretics; Glucagon; Glucose Tolerance Test; Humans; Hypertension; Insulin; Insulin Secretion; Male; Middle Aged; Receptor, Insulin; Sulfonamides; Time Factors | 1985 |
Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Magnesium | 1985 |
Maximal pancreatic beta-cell stimulation and the counter-regulatory hormonal responses in South African black and white obese subjects.
Topics: Adult; Black or African American; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Obesity; Time Factors; Tolbutamide; White People | 1985 |
Effects of hyperinsulinemia in the primate fetus.
Topics: Adipose Tissue; Amino Acids; Animals; Birth Weight; Blood Glucose; C-Peptide; Disease Models, Animal; Erythropoietin; Female; Fetal Blood; Fetal Hypoxia; Fetus; Glucagon; Hydrocortisone; Insulin; Macaca mulatta; Pregnancy; Pregnancy in Diabetics | 1985 |
Effect of serial test meals on plasma immunoreactive GIP in non-insulin dependent diabetic patients and non-diabetic controls.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Food; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Humans; Immune Sera; Insulin; Isoelectric Focusing; Male; Middle Aged; Radioimmunoassay | 1985 |
Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus.
Topics: Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Male; Middle Aged | 1985 |
Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Insulin; Male; Norepinephrine | 1985 |
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy.
Topics: Adenocarcinoma; Adult; Aged; Alanine; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Insulin Infusion Systems; Intraoperative Period; Lactates; Male; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Pyruvates | 1985 |
Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Eating; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Liver Cirrhosis; Male; Middle Aged | 1985 |
Inverse relationship of serum HDL and HDL2 cholesterol to C-peptide level in middle-aged insulin-treated diabetics.
Topics: Body Weight; C-Peptide; Cholesterol, HDL; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Insulin Secretion; Lipoproteins; Lipoproteins, HDL; Lipoproteins, HDL2; Lipoproteins, HDL3; Male; Middle Aged; Triglycerides | 1985 |
Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents.
Topics: Administration, Oral; Adult; Aged; Autoantibodies; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged | 1985 |
Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Middle Aged; Obesity; Receptor, Insulin | 1985 |
Plasma six-keto-prostaglandin F1 alpha and endocrine pancreatic function in the newborn infant of the diabetic mother.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Glucose; C-Peptide; Epoprostenol; Female; Glucagon; Humans; Infant, Newborn; Islets of Langerhans; Pregnancy; Pregnancy in Diabetics | 1985 |
[Changes in carbohydrate metabolism in hepatic cirrhosis].
Topics: Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Liver Cirrhosis; Male | 1985 |
C-peptide determination in the choice of treatment in diabetes mellitus.
Topics: Adolescent; Adult; Aged; Body Weight; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Middle Aged | 1985 |
[Glucagon test: criterion for insulin therapy in type II diabetes mellitus].
Topics: C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin | 1985 |
[Endocrine function of the pancreas in chronic pancreatitis].
Topics: Alcoholism; Blood Glucose; C-Peptide; Chronic Disease; Fatty Liver; Female; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreatitis; Proinsulin | 1985 |
[Biological effects of 2 different types of human insulin and monocomponent porcine insulin in normal subjects].
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin, Regular, Pork; Male | 1985 |
[Insulin resistance in chronic liver disease: the possible role of anti-insulin factors].
Topics: Adult; C-Peptide; Chronic Disease; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Insulin; Insulin Antagonists; Insulin Resistance; Liver Diseases; Male; Middle Aged | 1985 |
Glucagon-stimulated plasma C-peptide and insulin levels in active and non-active acromegalics.
Topics: Acromegaly; Adult; Aged; C-Peptide; Fasting; Female; Glucagon; Half-Life; Humans; Insulin; Male; Middle Aged; Stimulation, Chemical | 1985 |
A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Glucagon; Humans; Insulin; Kinetics; Sulfonylurea Compounds | 1985 |
Serum branched chain amino and keto acid response to fasting in humans.
Topics: 3-Hydroxybutyric Acid; Adult; Amino Acids, Branched-Chain; Blood Glucose; Blood Urea Nitrogen; C-Peptide; Fasting; Female; Glucagon; Humans; Hydroxybutyrates; Keto Acids; Male | 1985 |
The C-peptide response to glucagon injections in IDDM and NIDDM patients.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Glucagon; Humans | 1985 |
Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
Topics: Adult; Blood Glucose; C-Peptide; Constriction; Female; Glucagon; Growth Hormone; Humans; Insulin Resistance; Male; Middle Aged; Renal Dialysis; Uremia | 1985 |
Diabetes mellitus: customizing management.
Topics: Adult; Aging; Biguanides; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dietary Fiber; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Monitoring, Physiologic; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds | 1984 |
Immunoreactive somatostatin changes during insulin-induced hypoglycaemia and operative stress in man.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Middle Aged; Somatostatin; Stress, Physiological; Surgical Procedures, Operative | 1980 |
Further studies on the significance of circulating platelet aggregates induced by somatostatin in man.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Glucagon; Humans; Male; Middle Aged; Phentolamine; Platelet Aggregation; Platelet Count; Somatostatin | 1981 |
Effect of intraductal injection of neoprene on the canine pancreas.
Topics: Animals; Blood Glucose; C-Peptide; Dogs; Glucagon; Insulin; Islets of Langerhans; Ligation; Neoprene; Pancreas; Pancreatic Ducts; Polyenes; Rats; Somatostatin; Time Factors | 1980 |
The antiketogenic effect of alanine in normal man: evidence for an alanine-ketone body cycle.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adult; Alanine; Blood Glucose; C-Peptide; Glucagon; Humans; Hydroxybutyrates; Insulin; Keto Acids; Ketone Bodies; Kinetics; Male; Somatostatin | 1981 |
Evaluation of insulin resistance during inhibition of endogenous insulin and glucagon secretion by somatostatin in non-obese subjects with impaired glucose tolerance.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Male; Reference Values; Somatostatin | 1981 |
Absence of islet alpha cell function in pancreatectomized patients.
Topics: Adult; Arginine; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Islets of Langerhans; Male; Pancreatectomy; Pancreatic Function Tests; Pancreatitis; Somatostatin | 1982 |
Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity; Pancreatic Hormones; Radioimmunoassay; Somatostatin | 1982 |
Fluctuations in basal levels and effects of altered nutrition on plasma somatostatin.
Topics: Animals; Blood Glucose; C-Peptide; Diet; Glucagon; Humans; Hyperphagia; Insulin; Macaca mulatta; Male; Peptides; Somatostatin; Starvation | 1982 |
Hormonal and metabolic effects of near physiological increase of plasma immunoreactive somatostatin 14.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Glucagon; Humans; Insulin; Ketone Bodies; Kinetics; Male; Pancreatic Hormones; Peptides; Somatostatin | 1983 |
Oral glucose tolerance test and insulin sensitivity in low insulin responders.
Topics: Adult; Age Factors; Blood Glucose; Body Weight; C-Peptide; Computers; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Insulin Secretion; Male; Somatostatin | 1983 |
Insulin, C-peptide, glucagon, and somatostatin secretion in segmental pancreatic autotransplantation.
Topics: Aged; C-Peptide; Carcinoma, Intraductal, Noninfiltrating; Female; Glucagon; Graft Survival; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Pancreas; Pancreas Transplantation; Pancreatic Neoplasms; Radiation Dosage; Somatostatin; Transplantation, Autologous | 1984 |
Pancreatic hormone profiles and metabolism posthepatectomy in the dog. Evidence for a hepatotrophic role of insulin, glucagon, and pancreatic polypeptide.
Topics: Animals; Blood Glucose; C-Peptide; Dogs; Female; Glucagon; Hepatectomy; Insulin; Liver; Liver Regeneration; Male; Metabolic Clearance Rate; Pancreatic Polypeptide; Somatostatin; Time Factors | 1984 |
Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Drug Synergism; Fatty Acids, Nonesterified; Glucagon; Glycerol; Humans; Insulin Infusion Systems; Male; Middle Aged; Somatostatin; Tolbutamide | 1984 |
Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.
Topics: Amino Acids; Amino Acids, Branched-Chain; C-Peptide; Glucagon; Humans; Insulin; Liver Cirrhosis, Alcoholic; Male; Phenylalanine; Somatostatin; Tyrosine | 1984 |
Analysis of pancreatic peptide hormones by reversed-phase high-performance liquid chromatography.
Topics: Animals; C-Peptide; Chromatography, High Pressure Liquid; Glucagon; Hormones; Humans; Infant; Insulin; Pancreas; Pancreatic Polypeptide; Peptides; Proinsulin; Radioimmunoassay; Somatostatin; Swine; Thyrotropin-Releasing Hormone; Vasoactive Intestinal Peptide | 1984 |
Effect of three beta-blockers with different pharmacological properties on metabolic, cardiovascular and hormonal response to insulin-induced hypoglycemia in normal subjects.
Topics: Adrenergic beta-Antagonists; Adult; Blood Glucose; Blood Pressure; C-Peptide; Carteolol; Glucagon; Growth Hormone; Hemodynamics; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kinetics; Male; Metoprolol; Propranolol; Pulse | 1984 |
B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function.
Topics: Adult; Aged; Amylases; Bicarbonates; C-Peptide; Chronic Disease; Female; Glucagon; Glucose Tolerance Test; Humans; Islets of Langerhans; Lipase; Male; Middle Aged; Pancreas; Pancreatic Function Tests; Pancreatitis | 1982 |
[Radioimmunologic determination of gastrin, insulin, C-peptide, glucagon and trypsin in the combined radiotherapy of cervix cancer].
Topics: C-Peptide; Female; Gastrins; Glucagon; Humans; Insulin; Radioimmunoassay; Trypsin; Uterine Cervical Neoplasms | 1984 |
[Biosynthetic human insulin. Pharmacokinetic characteristics and activity in normal subjects].
Topics: Adult; Blood Glucose; C-Peptide; DNA, Recombinant; Female; Glucagon; Humans; Injections, Intravenous; Insulin; Kinetics; Male | 1984 |
[Disturbances in glycoregulation and plasma amino acids in alcoholic hepatopathies. Study using the arginine test].
Topics: Adult; Amino Acids; Arginine; Blood Glucose; C-Peptide; Fatty Liver, Alcoholic; Female; Glucagon; Humans; Insulin; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Male; Middle Aged | 1984 |
Hepatic gluconeogenic key enzymes in patients with hepatic cancer.
Topics: Adult; Aged; Animals; Blood Glucose; C-Peptide; Carcinoma, Hepatocellular; Female; Glucagon; Gluconeogenesis; Glucose-6-Phosphatase; Humans; Insulin; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Phosphoenolpyruvate Carboxykinase (GTP); Rats | 1980 |
[Blood levels of pancreatic hormones, gastrin and cyclic adenosine monophosphate in peptic ulcer].
Topics: Adolescent; Adult; Aged; C-Peptide; Cyclic AMP; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Glucagon; Humans; Insulin; Male; Middle Aged; Pancreatic Hormones; Stomach Ulcer | 1981 |
A case with glucagonoma syndrome--endocrine and metabolic studies.
Topics: Adenoma, Islet Cell; C-Peptide; Endocrine Glands; Female; Glucagon; Glucagonoma; Glucose Tolerance Test; Humans; Insulin; Liver Neoplasms; Middle Aged; Pancreatic Neoplasms; Tolbutamide | 1981 |
[Glucagonoma with diabetic ketoacidosis; case report].
Topics: Adenoma, Islet Cell; Aged; Blood Glucose; C-Peptide; Diabetic Ketoacidosis; Female; Glucagon; Glucagonoma; Humans; Pancreatic Neoplasms | 1982 |
Insulin and C-peptide in plasma and tumor of insulinoma patients.
Topics: Adenoma, Islet Cell; Adult; Aged; Blood Glucose; C-Peptide; Chromatography, Gel; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Peptides | 1983 |
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Humans; Insulin; Kinetics; Male; Norepinephrine; Phentolamine; Physical Exertion; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Tritium | 1984 |
Secretory granules in benign and malignant glucagonomas of the pancreas.
Topics: Adenoma, Islet Cell; Adult; C-Peptide; Cytoplasmic Granules; Glucagon; Glucagonoma; Humans; Insulinoma; Male; Neoplasm Metastasis; Neoplasms, Multiple Primary; Pancreatic Neoplasms; Radioimmunoassay | 1984 |
Effects of propranolol and hemodialysis on the response of glucose, insulin, C-peptide and cyclic AMP to glucagon challenge.
Topics: Adult; Blood Glucose; C-Peptide; Cyclic AMP; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Male; Middle Aged; Propranolol; Renal Dialysis; Time Factors | 1984 |
Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion.
Topics: Adolescent; Adult; Antibodies; Blood Glucose; Body Surface Area; Body Weight; C-Peptide; Diabetes Mellitus; Epinephrine; Glucagon; Humans; Hypoglycemia; Insulin; Islets of Langerhans | 1983 |
Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Humans; Infusions, Parenteral; Insulin; Insulin Secretion; Male | 1983 |
Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Insulin; Male; Metformin; Middle Aged; Peptides; Time Factors | 1983 |
[The diagnostic value of serum C-peptide determination].
Topics: Adolescent; Adult; Aged; C-Peptide; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Peptides | 1983 |
Studies of glucose intolerance in cirrhosis of the liver.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Monocytes | 1983 |
Insulin- and glucagonlike peptides in the brain.
Topics: Animals; Anura; Brain Chemistry; C-Peptide; Glucagon; Glucagon-Like Peptides; Humans; Immunologic Techniques; Insulin; Mice; Peptides; Radioimmunoassay; Rats; Somatomedins; Spinal Cord; Turtles | 1983 |
[Levels of insulin, C-peptide and glucagon in the neonatal period].
Topics: C-Peptide; Female; Fetal Blood; Fetal Distress; Glucagon; Glucose; Humans; Infant, Newborn; Insulin; Labor, Obstetric; Maternal-Fetal Exchange; Pregnancy | 1983 |
Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Lipids; Male | 1983 |
The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Hepatic Artery; Hepatic Veins; Humans; Insulin; Lactates; Lactic Acid; Liver Circulation; Male; Pancreatic Hormones; Pancreatic Polypeptide; Pyruvates; Pyruvic Acid; Splanchnic Circulation | 1983 |
Ultrastructural, immunohistological, and clinical findings in the pancreas in insulin-dependent diabetes mellitus (IDDM) of long duration.
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Islets of Langerhans; Male; Microscopy, Electron; Middle Aged; Pancreas | 1983 |
Normal insulin sensitivity of the islets of Langerhans in obese subjects with resistance to its glucoregulatory actions.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Insulin Infusion Systems; Insulin Resistance; Islets of Langerhans; Male; Obesity | 1984 |
Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man. Role of the beta cell and arterial hyperinsulinemia.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Humans; Hyperinsulinism; Hypoglycemia; Insulin; Islets of Langerhans | 1984 |
How does glucose regulate the human pancreatic A cell in vivo?
Topics: Adolescent; Adult; Arginine; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Radioimmunoassay | 1984 |
Effect of physical training on utilization of a glucose load given orally during exercise.
Topics: Administration, Oral; Adult; Blood Glucose; Body Weight; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Humans; Insulin; Lactates; Lactic Acid; Male; Norepinephrine; Physical Exertion; Physical Fitness; Potassium | 1984 |
Lack of effect of intravenous metformin on plasma concentrations of glucose, insulin, C-peptide, glucagon and growth hormone in non-diabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Growth Hormone; Humans; Injections, Intravenous; Insulin; Male; Metformin; Middle Aged | 1984 |
Effect of middle-term gliclazide treatment on insulin secretion in non-insulin dependent diabetics.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gliclazide; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Iodine Radioisotopes; Male; Middle Aged; Sulfonylurea Compounds; Time Factors | 1984 |
Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis.
Topics: 4-Aminobenzoic Acid; Aminobenzoates; Arginine; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Pancreas; Pancreatic Polypeptide; Pancreatitis; para-Aminobenzoates | 1984 |
A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.
Topics: Adult; Blood Glucose; C-Peptide; Drug Administration Schedule; Female; Glucagon; Humans; Hydrocortisone; Infusions, Parenteral; Insulin; Insulin Infusion Systems; Male; Obesity | 1984 |
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Topics: Adult; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Hemochromatosis; Humans; Hyperinsulinism; Insulin; Insulin Resistance; Liver; Male; Middle Aged | 1984 |
Factors influencing beta-cell function and insulin sensitivity in patients with type 2 (non-insulin-dependent) diabetes.
Topics: Adult; Age Factors; Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Male; Middle Aged | 1984 |
[The pancreatic reserve in diabetes mellitus by the determination of serum C-peptide using radioimmunoassay].
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Insulin; Male; Pancreas; Radioimmunoassay | 1984 |
Lack of negative feed-back regulation of insulin on the responses of gastric inhibitory polypeptide, insulin, glucagon and pancreatic polypeptide to a meal in insulin treated diabetics.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 1; Female; Food; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Homeostasis; Humans; Insulin; Male; Middle Aged; Pancreatic Polypeptide | 1984 |
[Hormonal status of diabetes mellitus patients with microcirculation disorders].
Topics: Adolescent; Adult; Aged; Blood Flow Velocity; Blood Viscosity; C-Peptide; Diabetic Angiopathies; Glucagon; Humans; Hydrocortisone; Insulin; Insulin Secretion; Middle Aged; Radioimmunoassay; Thyrotropin | 1984 |
Beta-cell function recovery is not the only factor responsible for remission in type I diabetics: evaluation of C-peptide secretion in diabetic children after first metabolic recompensation and at partial remission phase.
Topics: Adolescent; Arginine; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Time Factors | 1984 |
Calcitonin and the human endocrine pancreas.
Topics: Blood Glucose; C-Peptide; Calcitonin; Glucagon; Glucose Tolerance Test; Humans; Injections, Intramuscular; Insulin; Insulin Secretion; Islets of Langerhans; Time Factors | 1984 |
Relationship between insulin secretion and pancreas morphology in subjects with chronic pancreatitis.
Topics: Adult; Blood Glucose; C-Peptide; Chronic Disease; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Pancreas; Pancreatectomy; Pancreatitis | 1984 |
[Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Sulfonylurea Compounds | 1984 |
[Inhibition of arginine-stimulated pancreatic glucagon secretion with biosynthetic human insulin and swine insulin in healthy subjects and diabetics].
Topics: Animals; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Islets of Langerhans; Swine | 1983 |
[Use of fixed-combination preparations of regular BHI and basal BHI (NPH) in type I diabetics].
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Drug Combinations; Glucagon; Humans; Insulin, Isophane; Swine | 1983 |
Metabolic availability of glucose ingested 3 h before prolonged exercise in humans.
Topics: Adult; Blood Glucose; C-Peptide; Calorimetry, Indirect; Carbon Dioxide; Energy Metabolism; Fatty Acids, Nonesterified; Glucagon; Glucose Solution, Hypertonic; Glycerol; Humans; Insulin; Male; Physical Exertion | 1984 |
Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetic Coma; Diabetic Ketoacidosis; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hyperglycemia; Hyperglycemic Hyperosmolar Nonketotic Coma; Keto Acids; Male; Middle Aged; Models, Biological; Regression Analysis | 1984 |
Impaired plasma amino-acid clearance in patients with cirrhosis of the liver and portocaval shunt--its relation to insulin resistance.
Topics: 3-Hydroxybutyric Acid; Adult; Amino Acids; Blood Glucose; C-Peptide; Catecholamines; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Insulin Resistance; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical; Reference Values | 1984 |
Circulating glucagon after total pancreatectomy in man.
Topics: Adult; Aged; C-Peptide; Chronic Disease; Dietary Carbohydrates; Dietary Fats; Glucagon; Humans; Middle Aged; Pancreatectomy; Pancreatic Neoplasms; Pancreatitis | 1983 |
[Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
Topics: Acromegaly; Adult; Bromocriptine; C-Peptide; Carbohydrates; Diabetes Mellitus; Drug Evaluation; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Humans; Insulin Antibodies; Male; Middle Aged; Pancreas | 1984 |
Insulin resistance and decreased insulin response to glucose in lean type 2 diabetics.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 1982 |
[Effect of chronic insulin therapy on pancreatic A and B cell functions in type 2 diabetes].
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Time Factors | 1982 |
The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Male; Obesity; Peptides; Radioimmunoassay; Stimulation, Chemical; Time Factors | 1982 |
Glucose metabolism in patients receiving chronic calcitonin treatment.
Topics: Aged; Arginine; Blood Glucose; C-Peptide; Calcitonin; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Humans; Insulin; Male; Middle Aged; Osteitis Deformans; Osteoporosis | 1982 |
Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Glycerol; Humans; Insulin; Insulin Resistance; Kinetics; Male; Propranolol; Reference Values | 1982 |
Discrepant effect of the prostaglandin synthesis inhibitor acetylsalicylic acid on insulin and C-peptide response to glucose in man.
Topics: Adult; Aspirin; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerol; Growth Hormone; Humans; Insulin; Peptides | 1982 |
[Roles of endogenous insulin reserve and the counter-regulatory hormones in the various phases of juvenile diabetes mellitus].
Topics: Adolescent; Age Factors; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Humans; Hydrocortisone; Insulin; Insulin Secretion | 1982 |
The effect of hyperinsulinemia on glucose homeostasis during moderate exercise in man.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Insulin; Liver; Male; Norepinephrine; Physical Exertion | 1982 |
Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Topics: Adult; Aged; Arginine; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Liver Cirrhosis; Male; Middle Aged; Nephritis; Pancreatic Neoplasms; Peptides; Tolbutamide | 1982 |
Pancreatic endocrine function in leukemic children treated with L-asparaginase.
Topics: Asparaginase; Blood Glucose; C-Peptide; Child; Child, Preschool; Female; Glucagon; Humans; Infusions, Intravenous; Insulin; Islets of Langerhans; Leukemia; Male; Pancreas | 1981 |
Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Child; Diabetes Mellitus; Diabetic Ketoacidosis; Diabetic Neuropathies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Male; Phenylurea Compounds; Tolbutamide | 1980 |
Hormonal and metabolic effects of a pancreatic endocrine graft. Vascularized segmental transplantation in insulin-dependent diabetic patients.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Glucagon; Hormones; Humans; Hydroxybutyrates; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Urea | 1981 |
Polypeptides in the human brain.
Topics: Brain Chemistry; C-Peptide; Cerebral Cortex; Fluorescent Antibody Technique; Glucagon; Hippocampus; Humans; Hypothalamus; Insulin; Medulla Oblongata; Neurons; Peptides | 1982 |
C-peptide response to glucagon in black and Indian insulin-dependent diabetics.
Topics: Adolescent; B-Lymphocytes; Black or African American; Black People; C-Peptide; Child; Diabetes Mellitus; Female; Glucagon; Humans; India; Male; Peptides; South Africa | 1982 |
Human fetal pancreas: culture and function in vitro.
Topics: C-Peptide; Female; Fetus; Glucagon; Glucose; Histocytochemistry; Humans; Insulin; Insulin Secretion; Organ Culture Techniques; Pancreas; Perfusion; Pregnancy; Somatostatin; Theophylline | 1980 |
[Dynamics of the glucagon and C-peptide content in Itsenko-Cushing disease].
Topics: Adult; C-Peptide; Cushing Syndrome; Diabetes Mellitus; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Antibodies; Male; Middle Aged; Peptides; Time Factors | 1980 |
Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Topics: Adult; Blood Glucose; C-Peptide; Dietary Fats; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male | 1980 |
Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.
Topics: Alkaline Phosphatase; C-Peptide; Calcitonin; Chorionic Gonadotropin; Clinical Enzyme Tests; Clinical Laboratory Techniques; Evaluation Studies as Topic; Gastrins; Glucagon; Hormones; Humans; Insulin; Neoplasms; Pancreatic Neoplasms; Parathyroid Hormone; Prospective Studies; Ribonucleases | 1980 |
Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Topics: Adolescent; Adult; Alanine; Arginine; Aspirin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Growth Hormone; Hormones; Humans; Hydroxybutyrates; Insulin; Male; Middle Aged | 1980 |
Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
Topics: Adolescent; Adult; Amino Acids; Artificial Organs; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Food; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Middle Aged | 1980 |
Iodotyrosylation of peptides using tertiary-Butyloxycarbonyl-L-[125I]iodotyrosine N-hydroxysuccinimide ester.
Topics: C-Peptide; Chemical Phenomena; Chemistry; Electrophoresis, Polyacrylamide Gel; Glucagon; Insulin; Iodine Radioisotopes; Isotope Labeling; Monoiodotyrosine; Peptides; Radioimmunoassay; Succinimides | 1980 |
Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis.
Topics: Blood Chemical Analysis; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperplasia; Hypoglycemia; Insulin; Islets of Langerhans; Middle Aged; Portacaval Shunt, Surgical; Tolbutamide | 1980 |
Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Growth Hormone; Humans; Insulin; Insulin Antibodies; Peptides | 1980 |
Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy.
Topics: Adult; Aged; Arginine; C-Peptide; Chronic Disease; Female; Glucagon; Glucagon-Like Peptides; Humans; Insulin; Male; Middle Aged; Pancreas; Pancreatectomy; Pancreatitis; Peptides; Radioimmunoassay | 1980 |
C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Kinetics; Male; Peptides; Tolbutamide | 1980 |
[Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Topics: Adult; Aged; Ascites; C-Peptide; Female; Glucagon; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Liver Cirrhosis; Male; Middle Aged; Peptides | 1980 |
Failure of exogenous insulin to inhibit C-peptide release from the perfused rat pancreas.
Topics: Animals; Arginine; C-Peptide; Glucagon; Glucose; Insulin; Male; Pancreas; Peptides; Perfusion; Rats; Tolbutamide | 1980 |
[Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
Topics: Adolescent; Adult; C-Peptide; Child; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Obesity; Peptides; Stimulation, Chemical | 1980 |
Pancreatic B-cell function and abnormal urinary peptides in a boy with lipoatrophic diabetes and stenosis of the aqueduct of Sylvius.
Topics: Adolescent; Blood Glucose; C-Peptide; Cerebral Aqueduct; Chromatography, Gel; Constriction, Pathologic; Diabetes Mellitus, Lipoatrophic; Diet, Diabetic; Glucagon; Humans; Immunoglobulin G; Islets of Langerhans; Male; Peptides; Proinsulin | 1980 |
The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects.
Topics: Adult; Aged; Arginine; Aspirin; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Kinetics; Male; Middle Aged | 1981 |
Parallel dysfunctions of pancreatic A, B and PP cells in insulin dependent diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Pancreatic Polypeptide | 1980 |
Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
Topics: Adult; Aged; C-Peptide; Chlorpropamide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Kinetics; Male; Middle Aged; Peptides | 1981 |
Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Kinetics; Male; Middle Aged; Models, Biological; Peptides; Proinsulin | 1981 |
In vivo inhibition of glucagon secretion by paracrine beta cell activity in man.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Pancreas | 1981 |
Effects of calcium and calcitonin on circulating levels of glucagon and glucose in diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Calcitonin; Calcium; Diabetes Mellitus; Glucagon; Humans; Insulin | 1981 |
Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Indomethacin; Insulin; Islets of Langerhans; Male; Middle Aged; Peptides | 1981 |
Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus; Fasting; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Peptides | 1981 |
Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Fatty Acids, Nonesterified; Glucagon; Humans; Hydroxybutyrates; Insulin; Oxidation-Reduction; Physical Exertion | 1981 |
Relationship of glycosylated haemoglobin to C-peptide secretory status and antibody binding of insulin in insulin-dependent diabetes.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Antibodies; Male; Peptides | 1981 |
Effects of pharmacologic hyperglucagonemia on plasma amino acid concentrations in normal and diabetic man.
Topics: Amino Acids; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Humans; Insulin; Male; Time Factors | 1981 |
[Changes in plasma glucagon, insulin, C-peptide and amino acids during the intravenous induced hyperammonemia test in the cirrhotic].
Topics: Amino Acids; Ammonia; Ammonium Chloride; C-Peptide; Female; Glucagon; Humans; Infusions, Parenteral; Insulin; Liver Cirrhosis; Male; Middle Aged | 1981 |
Pancreatic islet cell and thyroid antibodies, and islet cell function in diabetic patients of Mexican-American origin.
Topics: Adolescent; Adult; Aged; Autoantibodies; C-Peptide; Child; Child, Preschool; Diabetes Mellitus; Female; Glucagon; Hispanic or Latino; Humans; Islets of Langerhans; Male; Mexico; Middle Aged; Thyroid Gland | 1982 |
[Evaluation of immunoreactive serum levels of insulin, C peptide and glucagon in patients with acute pancreatitis and acute abdominal pain of non-pancreatic origin (author's transl)].
Topics: Abdomen, Acute; Acute Disease; Adult; Aged; C-Peptide; Female; Glucagon; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Pancreatitis; Peptides | 1982 |
Immunoreactive insulin and C-peptide responses to various insulin secretory stimuli in subjects with type 2 diabetes and in control subjects during continuous glucose monitoring.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Food; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Peptides; Secretory Rate; Terbutaline | 1981 |
Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
Topics: C-Peptide; Diabetes Mellitus; Glucagon; Glucose; Humans; Insulin; Obesity; Peptides | 1982 |
Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity.
Topics: Adult; Blood Glucose; C-Peptide; Feedback; Female; Glucagon; Humans; Indians, North American; Insulin; Insulin Secretion; Islets of Langerhans; Male; Obesity | 1982 |
[Incidence of clinical remission and residual beta function during early stages of diabetes mellitus type I (author's transl)].
Topics: Adolescent; Adult; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Peptides | 1982 |
Residual pancreatic function in insulin dependent diabetics.
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Insulin Antibodies; Islets of Langerhans; Male; Middle Aged | 1982 |
Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Obesity | 1982 |
Endocrine pancreatic response of children with onset of insulin-requiring diabetes before age 3 and after age 5.
Topics: Arginine; Blood Glucose; C-Peptide; Child; Child, Preschool; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Gastric Inhibitory Polypeptide; Glucagon; Humans; Hypoglycemia; Infant; Infusions, Parenteral; Insulin; Islets of Langerhans; Male; Pancreatic Polypeptide; Time Factors | 1982 |
[Plasma insulin, C-peptide and pancreatic glucagon responses to oral glucose load in chronic liver diseases (author's transl)].
Topics: C-Peptide; Chronic Disease; Glucagon; Glucose Tolerance Test; Humans; Insulin; Islets of Langerhans; Liver Diseases; Peptides | 1982 |
[Incretory function of the pancreas in obesity].
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Obesity | 1982 |
Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Kinetics; Male; Middle Aged; Tolbutamide | 1982 |
Correlation between the routine 6-min. C-peptide value and the AUC after I.V. glucagon injection in NIDDM patients.
Topics: C-Peptide; Diabetes Mellitus; Female; Glucagon; Humans; Male; Peptides; Time Factors | 1982 |
Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
Topics: Adult; Albuterol; Aspirin; Blood Glucose; C-Peptide; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydroxybutyrates; Kinetics; Male; Middle Aged | 1981 |
A study of the physiological role of glucagon. Passive immunization with antiserum specific for pancreatic glucagon in rats.
Topics: Animals; Antibodies; Blood Glucose; C-Peptide; Glucagon; Male; Pancreas; Rabbits; Rats | 1980 |
Glucose, insulin, and glucagon levels during exercise in pancreas transplant recipients.
Topics: Adult; Analysis of Variance; Blood Gas Analysis; Blood Glucose; C-Peptide; Exercise; Female; Glucagon; Humans; Insulin; Male; Oxygen Consumption; Pancreas Transplantation | 1995 |
[Multiple endocrine neoplasia type 1. Digestive hormones in the screening].
Topics: Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Child; Female; Gastrins; Glucagon; Humans; Insulin; Male; Middle Aged; Multiple Endocrine Neoplasia; Pancreatic Neoplasms; Pancreatic Polypeptide; Pituitary Neoplasms; Risk Factors; Substance P; Ultrasonography; Vasoactive Intestinal Peptide | 1993 |
[Glucagon peptide--new treatment for late-onset diabetes?].
Topics: C-Peptide; Diabetes Mellitus, Type 2; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptides; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Pancreatic Hormones; Peptides; Protein Precursors | 1994 |
Hyperinsulinemia in children and adolescents after bone marrow transplantation.
Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Glucose; Bone Marrow Transplantation; C-Peptide; Child; Child, Preschool; Female; Glucagon; Glycated Hemoglobin; Growth Hormone; Humans; Hypogonadism; Hypothyroidism; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Leukemia; Lymphoma, Non-Hodgkin; Male; Prospective Studies; Radiation Injuries; Radioisotope Teletherapy; Whole-Body Irradiation | 1995 |
Chronic calcific pancreatitis of the tropics (CCPT): spectrum and correlates of exocrine and endocrine pancreatic dysfunction.
Topics: Adolescent; Adult; Age of Onset; Analysis of Variance; Blood Glucose; C-Peptide; Calcinosis; Chronic Disease; Chymotrypsin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Islets of Langerhans; Male; Pancreas; Pancreatitis; Reference Values; Tropical Climate; Ultrasonography | 1995 |
Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment.
Topics: Adult; Aged; C-Peptide; Carbohydrate Metabolism; Circadian Rhythm; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoxia; Insulin; Lipid Metabolism; Male; Middle Aged; Polysomnography; Positive-Pressure Respiration; Sleep Apnea Syndromes | 1995 |
Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects.
Topics: Adult; Analysis of Variance; C-Peptide; Dose-Response Relationship, Drug; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Male; Peptide Fragments; Reference Values; Time Factors | 1995 |
Highly increased insulin secretion in a patient with postprandial hypoglycemia: role of glucagon-like peptide-1 (7-36) amide.
Topics: Adult; C-Peptide; Fasting; Food; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Secretion; Male; Peptide Fragments; Proinsulin | 1995 |
Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon.
Topics: Blood Glucose; C-Peptide; Female; Glucagon; Growth Hormone; Humans; Hypoglycemia; Insulin; Middle Aged; Octreotide; Pancreatic Neoplasms; Proinsulin | 1995 |
Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Humans; Insulin; Insulin Secretion; Kidney Transplantation; Kinetics; Middle Aged; Pancreas Transplantation; Somatostatin | 1995 |
C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Regression Analysis; Sulfonylurea Compounds | 1994 |
Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Deuterium; Glucagon; Glucose; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Liver; Male; Middle Aged; Radioisotope Dilution Technique; Reference Values; Somatostatin | 1995 |
Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia.
Topics: 3-Hydroxybutyric Acid; Analysis of Variance; Blood Glucose; Body Mass Index; C-Peptide; Child; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glycerol; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Obesity; Reference Values; Triglycerides | 1995 |
Insulin secretion and plasma levels of glucose-dependent insulinotropic peptide and glucagon-like peptide 1 [7-36 amide] after oral glucose in cirrhosis.
Topics: Adult; Blood Glucose; C-Peptide; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Male; Middle Aged; Peptide Fragments | 1995 |
Diabetes mellitus carrying a mutation in the mitochondrial tRNA(Leu(UUR)) gene.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Base Sequence; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Genetic Variation; Glucagon; Humans; Male; MELAS Syndrome; Middle Aged; Mitochondria; Molecular Sequence Data; Pedigree; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Transfer, Leu | 1995 |
Gene therapy for diabetes mellitus in rats by hepatic expression of insulin.
Topics: Animals; Base Sequence; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Gene Expression; Genetic Therapy; Genetic Vectors; Glucagon; Insulin; Ketones; Liver; Male; Molecular Sequence Data; Rats; Recombinant Proteins; Retroviridae; Streptozocin; Survival Analysis; Transduction, Genetic | 1995 |
Natural course of insulin sensitivity and insulin reserve in early insulin-dependent diabetes mellitus.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Longitudinal Studies; Male; Reference Values; Regression Analysis; Time Factors | 1995 |
Forearm substrate exchange during hyperinsulinaemic hypoglycaemia in normal man.
Topics: Adult; Alanine; Analysis of Variance; Blood Glucose; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Forearm; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glycerol; Growth Hormone; Humans; Infusions, Intravenous; Insulin; Kinetics; Lactates; Male; Muscle, Skeletal; Norepinephrine; Recombinant Proteins; Reference Values; Time Factors | 1995 |
Implications of host pancreatic hormones in the restart of grafted liver.
Topics: Adolescent; Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Bile; Blood Glucose; C-Peptide; Factor V; Fatty Acids, Nonesterified; Female; Glucagon; Graft Survival; Humans; Insulin; Insulin Secretion; Ketone Bodies; Liver Transplantation; Male; Middle Aged; Mitochondria, Liver; Reperfusion; Time Factors; Treatment Outcome | 1995 |
Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Peptide Fragments; Protein Precursors | 1995 |
Diabetic ketoacidosis in obese African-Americans.
Topics: Adult; Black People; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetic Ketoacidosis; Female; Georgia; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Reference Values; Thinness | 1995 |
Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance.
Topics: Administration, Oral; Adolescent; Adult; C-Peptide; Cystic Fibrosis; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Tolbutamide | 1995 |
Effect of endurance training on hepatic glycogenolysis and gluconeogenesis during prolonged exercise in men.
Topics: Adult; Alanine; Blood Glucose; C-Peptide; Epinephrine; Exercise; Glucagon; Gluconeogenesis; Glycerol; Glycogen; Humans; Insulin; Kinetics; Lactates; Lactic Acid; Liver; Male; Norepinephrine; Oxygen Consumption; Physical Endurance | 1995 |
Hyperinsulinemia decreases second-phase but not first-phase arginine-induced insulin release in humans.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Glucagon; Glucose Clamp Technique; Humans; Hyperinsulinism; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Male; Reference Values; Somatostatin; Time Factors | 1994 |
Opioid antagonism alters blood glucose homeostasis during exercise in humans.
Topics: Adult; Bicycling; Blood Glucose; C-Peptide; Endorphins; Epinephrine; Exercise; Glucagon; Homeostasis; Humans; Insulin; Male; Naloxone; Norepinephrine; Oxygen Consumption | 1994 |
[Neurohumoral regulation of gastric secretion in postvagotomy syndromes].
Topics: C-Peptide; Constriction, Pathologic; Diarrhea; Dumping Syndrome; Gastric Acid; Gastrins; Glucagon; Growth Hormone; Humans; Insulin; Insulin Secretion; Neurotransmitter Agents; Peptic Ulcer; Postoperative Complications; Recurrence; Somatostatin; Stomach Diseases; Syndrome; Vagotomy, Proximal Gastric | 1994 |
The differential effects of body fat distribution on insulin and glucose metabolism during pregnancy.
Topics: Adipose Tissue; Adult; Analysis of Variance; Body Constitution; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Longitudinal Studies; Obesity; Pregnancy; Pregnancy Complications; Regression Analysis | 1994 |
Turnover of human muscle glycogen with low-intensity exercise.
Topics: Adult; Blood Glucose; C-Peptide; Carbon; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glycogen; Humans; Insulin; Lactates; Magnetic Resonance Spectroscopy; Male; Muscle Contraction; Muscle, Skeletal; Physical Exertion | 1994 |
Glucagon stimulation test: assessment of beta-cell function in gestational diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes, Gestational; Fasting; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Kinetics; Pregnancy; Risk Factors | 1994 |
Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.
Topics: Adult; Autonomic Nervous System; Blood Glucose; C-Peptide; Cognition; Cognition Disorders; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Hormones; Humans; Hydrocortisone; Hypoglycemia; Insulin; Insulin Secretion; Male; Norepinephrine; Pancreatic Polypeptide; Reference Values; Sex Factors; Time Factors | 1994 |
Beta-cell function in pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Adult; C-Peptide; Female; Glucagon; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1994 |
[Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog].
Topics: Aged; Blood Glucose; C-Peptide; Combined Modality Therapy; Female; Glucagon; Humans; Insulin; Insulinoma; Octreotide; Pancreatic Neoplasms | 1994 |
Short cycles of very low calorie diet in the therapy of obese type II diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Reducing; Energy Intake; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Receptor, Insulin; Weight Loss | 1994 |
An improved method for the determination of islet amyloid polypeptide levels in plasma.
Topics: Amyloid; C-Peptide; Cross Reactions; Diabetes Mellitus, Type 1; Glucagon; Humans; Injections, Intravenous; Islet Amyloid Polypeptide; Islets of Langerhans; Radioimmunoassay | 1994 |
Secretion of glucagon-like peptide-1 and reactive hypoglycemia after partial gastrectomy.
Topics: Administration, Oral; Adult; Blood Glucose; C-Peptide; Chromatography, Gel; Data Interpretation, Statistical; Female; Gastrectomy; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemia; Insulin; Insulin Secretion; Male; Middle Aged; Peptide Fragments; Protein Precursors; Radioimmunoassay | 1994 |
[Changes in levels of glucose, insulin, c-peptide, glucagon and potassium in serum of patients with bronchial asthma during stimulation with b2-adrenergic fenoterol].
Topics: Adolescent; Adult; Asthma; Blood Glucose; C-Peptide; Female; Fenoterol; Glucagon; Humans; Insulin; Male; Middle Aged; Potassium | 1994 |
Hormonal enteroinsular axis in newborn infants of insulin-treated diabetic mothers.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Digestive System; Enteral Nutrition; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptides; Humans; Infant, Newborn; Insulin; Islets of Langerhans; Male; Milk, Human; Pancreas; Pregnancy; Pregnancy in Diabetics | 1993 |
Insulin resistance in microvascular angina (syndrome X)
Topics: Alanine; Angina Pectoris; Basal Metabolism; Blood Glucose; C-Peptide; Chest Pain; Coronary Circulation; Energy Metabolism; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Growth Hormone; Humans; Insulin; Insulin Resistance; Lactates; Male; Microcirculation; Middle Aged; Regional Blood Flow; Syndrome | 1993 |
Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Chronic Disease; Female; Glucagon; Glucose Tolerance Test; Homeostasis; Humans; Insulin; Kinetics; Male; Middle Aged; Pancreas; Pancreatic Polypeptide; Pancreatitis; Prospective Studies | 1994 |
Feedback inhibition of insulin and glucagon secretion by insulin is altered in abdominal obesity with normal or impaired glucose tolerance.
Topics: Adult; Blood Glucose; C-Peptide; Feedback; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Humans; Insulin; Insulin Secretion; Male; Obesity; Reference Values | 1993 |
Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans.
Topics: Activity Cycles; Adult; Analysis of Variance; Blood Glucose; Brain; C-Peptide; Cerebrovascular Circulation; Electroencephalography; Female; Glucagon; Glucose; Growth Hormone; Humans; Insulin; Male; Oxygen Consumption; Reference Values; Regional Blood Flow; Sleep; Sleep Stages | 1994 |
[Effects of insular hormones on the secretion of atrial natriuretic factor].
Topics: Adolescent; Adult; Atrial Natriuretic Factor; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperinsulinism; Insulin; Male; Middle Aged; Obesity; Potassium; Secretory Rate; Sodium | 1993 |
Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.
Topics: Adult; Age Factors; Aged; C-Peptide; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Glucagon; Glucose; Humans; Insulin; Insulin-Like Growth Factor I; Middle Aged; Recombinant Proteins | 1994 |
Postprandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels.
Topics: Adult; Apolipoproteins B; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Eating; Fasting; Female; Glucagon; Humans; Hyperlipidemias; Insulin; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides | 1994 |
Pancreas transplantation in diabetic humans normalizes hepatic glucose production during hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Humans; Hypoglycemia; Immunosuppressive Agents; Infusions, Intravenous; Insulin; Kidney Transplantation; Liver; Male; Pancreas Transplantation; Reference Values | 1994 |
Case report: defective beta and alpha cell regulation in patients with hyperinsulinemia and acanthosis nigricans.
Topics: Acanthosis Nigricans; Adolescent; Adult; C-Peptide; Child; Female; Glucagon; Glucose Tolerance Test; Hirsutism; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Islets of Langerhans; Male; Octreotide; Pancreas | 1994 |
Metabolic effects of rhIGF-1 in normal human subjects.
Topics: Adult; Animals; Awareness; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Heart Rate; Humans; Hypoglycemia; Insulin; Insulin-Like Growth Factor I; Liver; Male; Norepinephrine; Rats; Recombinant Proteins | 1993 |
Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Analysis of Variance; Autonomic Nervous System; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Lactates; Male; Norepinephrine; Oxygen Consumption; Pancreatic Polypeptide; Physical Exertion; Posture; Reference Values; Time Factors | 1994 |
Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subject.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Exercise; Fatty Acids, Nonesterified; Glucagon; Growth Hormone; Heart Rate; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Lactates; Liver; Male; Pancreatic Polypeptide; Physical Fitness; Reference Values; Sports | 1994 |
[A study on the mechanism of hyperinsulinemia in essential hypertension].
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperinsulinism; Hypertension; Insulin; Insulin Resistance; Male; Middle Aged | 1993 |
Glucose and urea production and leucine, ketoisocaproate and alanine fluxes at supraphysiological plasma adrenaline concentrations in volunteers.
Topics: Adult; Alanine; Amino Acids; Blood Glucose; C-Peptide; Caproates; Critical Illness; Epinephrine; Gas Chromatography-Mass Spectrometry; Glucagon; Gluconeogenesis; Humans; Infusions, Intravenous; Insulin; Keto Acids; Leucine; Liver; Male; Metabolic Clearance Rate; Oxygen Consumption; Proteins; Time Factors; Urea | 1994 |
Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Female; Glucagon; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Male; Metyrapone; Palmitates; Periodicity; Sleep | 1993 |
Time course and variability of the endocrine and metabolic response to severe sepsis.
Topics: Adult; Aged; Aged, 80 and over; C-Peptide; Energy Metabolism; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Infections; Insulin; Insulin-Like Growth Factor I; Male; Methylhistidines; Middle Aged; Nitrogen | 1993 |
Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Atropine; Autonomic Nervous System; Awareness; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Heart Rate; Hormones; Humans; Hydrocortisone; Hydroxybutyrates; Hypoglycemia; Insulin; Lactates; Lactic Acid; Male; Norepinephrine; Pancreatic Polypeptide; Phentolamine; Propranolol; Receptors, Adrenergic, beta; Reference Values; Time Factors | 1993 |
Effects of glucose, galactose, and lactose ingestion on the plasma glucose and insulin response in persons with non-insulin-dependent diabetes mellitus.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Eating; Fatty Acids, Nonesterified; Galactose; Glucagon; Glucose; Humans; Insulin; Kinetics; Lactose; Male; Middle Aged; Time Factors | 1993 |
Hepatic glucose production during intraperitoneal and intravenous closed-loop insulin regulation of blood glucose in type 1 (insulin-dependent) diabetic patients.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycerol; Growth Hormone; Homeostasis; Humans; Hydrocortisone; Hydroxybutyrates; Insulin; Insulin Infusion Systems; Liver; Male; Middle Aged | 1993 |
[C-peptide levels in secondary sulfonylurea resistant diabetics].
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucagon; Glyburide; Humans; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1993 |
Evidence that fasting hyperproinsulinemia after combined pancreas-kidney transplantation diminishes over time.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Fasting; Female; Glucagon; Humans; Insulin; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Proinsulin; Time Factors | 1993 |
Lack of effect of hyperglycemia on lipolysis in humans.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Clamp Technique; Growth Hormone; Humans; Hyperglycemia; Insulin; Lipolysis; Male; Palmitic Acid; Palmitic Acids; Radioimmunoassay; Time Factors | 1993 |
Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
Topics: Adolescent; Adult; Amino Acids; Blood Glucose; C-Peptide; Carbon Isotopes; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin-Like Growth Factor I; Kinetics; Leucine; Male; Recombinant Proteins; Reference Values; Time Factors; Tritium | 1993 |
Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
Topics: Blood Glucose; C-Peptide; Carbon Radioisotopes; Diabetes Mellitus, Type 2; Eating; Female; Forearm; Glucagon; Glucose; Humans; Insulin; Lactates; Liver; Male; Middle Aged; Palmitic Acid; Palmitic Acids; Reference Values; Time Factors | 1994 |
Octreotide: a long-acting inhibitor of endogenous hormone secretion for human metabolic investigations.
Topics: Adult; Analysis of Variance; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Female; Glucagon; Growth Hormone; Humans; Hyperglycemia; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Octreotide; Radioimmunoassay; Time Factors | 1994 |
Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Glycogen; Humans; Insulin; Liver; Liver Cirrhosis; Male; Middle Aged; Molecular Weight; Time Factors | 1994 |
[Diabetes mellitus in patients with chronic alcoholic pancreatitis].
Topics: Adult; Alcoholism; Blood Glucose; C-Peptide; Chronic Disease; Diabetes Mellitus; Female; Glucagon; Glucose; Humans; Insulin; Islets of Langerhans; Male; Pancreatitis; Time Factors | 1993 |
Physiological, symptomatic and hormonal responses to acute hypoglycaemia in type 1 diabetic patients with autonomic neuropathy.
Topics: Adult; Awareness; Blood Glucose; C-Peptide; Cardiovascular System; Cognition; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diarrhea; Epinephrine; Female; Glucagon; Glycated Hemoglobin; Heart Rate; Humans; Hypoglycemia; Hypotension, Orthostatic; Insulin; Male; Middle Aged; Pancreatic Polypeptide; Reaction Time; Sweating; Valsalva Maneuver | 1993 |
Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
Topics: Aged; Blood Glucose; Butter; C-Peptide; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Reference Values; Solanum tuberosum; Time Factors; Triglycerides | 1993 |
Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
Topics: Adolescent; Adult; Age Factors; Autoantibodies; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Middle Aged; Reference Values; Time Factors | 1993 |
Transient state of NIDDM in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Glyburide; Humans; Insulin; Male; Pentamidine; Proinsulin | 1993 |
The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Insulin-Like Growth Factor I; Male; Recombinant Proteins | 1993 |
No pharmacokinetic effect of retaining the infusion site up to four days during continuous subcutaneous insulin infusion therapy.
Topics: Adult; Blood Glucose; C-Peptide; Catheters, Indwelling; Diabetes Mellitus, Type 1; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Infusion Systems; Middle Aged; Time Factors | 1993 |
Fructose utilization during exercise in men: rapid conversion of ingested fructose to circulating glucose.
Topics: Adult; Blood Glucose; C-Peptide; Carbon Dioxide; Carbon Isotopes; Energy Metabolism; Exercise; Fatty Acids, Nonesterified; Fructose; Glucagon; Glucose; Glycerol; Humans; Insulin; Lipid Metabolism; Male; Proteins; Pulmonary Gas Exchange; Respiration | 1993 |
Glucose resistance contributes to diabetes mellitus in cirrhosis.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Diabetes Mellitus; Drug Resistance; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Humans; Insulin; Lactates; Lactic Acid; Liver; Liver Cirrhosis; Male; Middle Aged; Osmolar Concentration; Oxidation-Reduction | 1993 |
Insulin surrogates in insulinoma.
Topics: 3-Hydroxybutyric Acid; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Hydroxybutyrates; Insulin; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms | 1993 |
Intracellular glucose metabolism after long term metabolic control with glyburide: improved glucose oxidation with unchanged glycogen synthase activity.
Topics: Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Calorimetry, Indirect; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glyburide; Glycogen Synthase; Humans; Insulin; Male; Middle Aged; Muscles; Obesity; Oxidation-Reduction; Pyruvate Dehydrogenase Complex | 1993 |
Quantitative evaluation of the effect of low-intensity exercise on insulin secretion in man.
Topics: Adult; Blood Glucose; C-Peptide; Exercise; Female; Glucagon; Humans; Insulin; Insulin Secretion; Male; Metabolic Clearance Rate | 1993 |
Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Albuminuria; Blood Glucose; Blood Pressure; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycated Hemoglobin; Humans; Hypertension; Insulin; Insulin Resistance; Lipids; Liver; Middle Aged; Reference Values; Triglycerides | 1993 |
Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemia; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Middle Aged; Reference Values; Time Factors | 1993 |
Very low calorie diet-induced weight loss reverses exaggerated insulin secretion in response to glucose, arginine and glucagon in obesity.
Topics: Adolescent; Adult; Arginine; Blood Glucose; Body Mass Index; C-Peptide; Energy Intake; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Kinetics; Male; Obesity; Weight Loss | 1993 |
The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus.
Topics: Autoantibodies; C-Peptide; Cytomegalovirus; Cytomegalovirus Infections; Diabetes Mellitus, Type 1; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Humans; Infant, Newborn; Islets of Langerhans; Male; Prevalence; Sweden | 1993 |
Restoration of fuel homeostasis in IDDM patients during pregnancy by an open-loop insulin infusion system.
Topics: Adult; Blood Glucose; C-Peptide; Calorimetry; Carbohydrate Metabolism; Diabetes Mellitus, Type 1; Energy Metabolism; Female; Glucagon; Homeostasis; Humans; Insulin; Insulin Infusion Systems; Ketone Bodies; Lactates; Pregnancy; Pregnancy in Diabetics; Pregnancy Trimester, First; Pyruvates | 1993 |
Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.
Topics: Adult; Analysis of Variance; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Glucagon; Glucose; Glucose Clamp Technique; Growth Hormone; Heart Rate; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Insulin-Like Growth Factor I; Kinetics; Norepinephrine; Recombinant Proteins; Time Factors | 1993 |
[Pulsatile insulin secretion into the portal vein in liver cirrhosis].
Topics: Aged; Blood Glucose; C-Peptide; Catheterization, Peripheral; Female; Glucagon; Glucose; Hepatitis; Humans; Insulin; Insulin Secretion; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Portal Vein; Pulsatile Flow; Radiography, Interventional; Time Factors | 1993 |
Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Danish-Swedish Study Group of Metabolic Effect of Pancreas Transplantation (DSSGMEPT).
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Eating; Fasting; Glucagon; Glycated Hemoglobin; Humans; Islets of Langerhans; Kidney Transplantation; Middle Aged; Pancreas Transplantation; Reference Values; Tolbutamide | 1993 |
Loss of potentiating effect of hypoglycemia on the glucagon response to hyperaminoacidemia in IDDM.
Topics: Adult; Amino Acids; Amino Acids, Essential; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Insulin Infusion Systems; Male; Reference Values | 1993 |
The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Islets of Langerhans; Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone | 1993 |
Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error.
Topics: Adult; Blood Glucose; C-Peptide; Carbon Radioisotopes; Female; Glucagon; Glucose; Homeostasis; Humans; Infusions, Intravenous; Insulin; Kinetics; Liver; Male; Radioisotope Dilution Technique; Reference Values; Time Factors; Tritium | 1993 |
Evidence for increased sensitivity of fuel mobilization to growth hormone during short-term fasting in humans.
Topics: Adult; C-Peptide; Energy Metabolism; Fasting; Glucagon; Gluconeogenesis; Glucose; Growth Hormone; Humans; Insulin; Lipid Mobilization; Male | 1993 |
Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Topics: Administration, Oral; Adult; C-Peptide; Cystic Fibrosis; Diabetes Complications; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Hormones; Humans; Injections, Intravenous; Insulin; Intestinal Mucosa; Intestines; Male; Middle Aged; Pancreas; Pancreatic Polypeptide; Peptide Fragments; Proinsulin; Protein Precursors; Time Factors | 1993 |
Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Secretion; Male; Peptide Fragments; Structure-Activity Relationship; Time Factors | 1993 |
Impaired glucose tolerance after endurance exercise is associated with reduced insulin secretion rather than altered insulin sensitivity.
Topics: Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Electronic Data Processing; Exercise; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Resistance; Middle Aged; Norepinephrine; Physical Endurance; Radioimmunoassay; Rest; Running; Time Factors | 1993 |
Plasma concentration of islet amyloid polypeptide in healthy children and patients with insulin-dependent diabetes mellitus.
Topics: Adolescent; Amyloid; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Humans; Islet Amyloid Polypeptide; Male | 1993 |
Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
Topics: Adult; Aged; Amyloid; Body Mass Index; C-Peptide; Creatinine; Diabetes Mellitus, Type 2; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Islet Amyloid Polypeptide; Male; Middle Aged; Reference Values | 1993 |
Human fetal islet transplantation in IDDM patients: an 8-year experience.
Topics: Biomarkers; C-Peptide; CD4-CD8 Ratio; Diabetes Mellitus, Type 1; Fetal Tissue Transplantation; Glucagon; Glycated Hemoglobin; Graft Rejection; Humans; Insulin; Insulin Secretion; Interleukin-2; Islets of Langerhans Transplantation; Time Factors | 1995 |
Gastric emptying and release of incretin hormones after glucose ingestion in humans.
Topics: Adult; Blood Glucose; C-Peptide; Duodenum; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastric Mucosa; Gastrointestinal Hormones; Gastrointestinal Motility; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Humans; Insulin; Insulin Secretion; Male; Peptide Fragments | 1996 |
Changes in immunoreactive insulin, C-peptide immunoreactivity, and immunoreactive glucagon in acute viral hepatitis.
Topics: Acute Disease; Adolescent; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Hepatitis, Viral, Human; Humans; Insulin; Male; Middle Aged; Transaminases | 1995 |
Inhibition of muscle glycogen synthase activity and non-oxidative glucose disposal during hypoglycaemia in normal man.
Topics: Adult; Biopsy; Blood Glucose; C-Peptide; Calorimetry, Indirect; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Glycogen Synthase; Glycolysis; Growth Hormone; Humans; Hypoglycemia; Infusions, Intravenous; Insulin; Kinetics; Male; Muscle, Skeletal; Reference Values; Time Factors | 1996 |
The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people.
Topics: Adult; beta-Endorphin; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Insulin; Kinetics; Male; Obesity; Opioid Peptides | 1996 |
Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Glucagon; Glucose; Glucose Clamp Technique; Homeostasis; Humans; Infusions, Intravenous; Insulin; Islets of Langerhans Transplantation; Kidney Transplantation; Liver; Liver Transplantation; Male; Middle Aged; Uveitis | 1996 |
Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
Topics: Adult; Aged; C-Peptide; Colectomy; Crohn Disease; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Insulin; Intestine, Large; Intestine, Small; Male; Middle Aged; Peptide Fragments; Postoperative Complications | 1996 |
Glutamine and alanine metabolism in NIDDM.
Topics: Alanine; Blood Glucose; C-Peptide; Carbon Radioisotopes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Glucose; Glutamine; Humans; Insulin; Male; Middle Aged; Phenylalanine; Radioisotope Dilution Technique; Reference Values; Tritium | 1996 |
Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Progression; Female; Food; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Linear Models; Male; Middle Aged; Obesity; Stimulation, Chemical; Treatment Outcome | 1996 |
Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Danazol; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Liver; Male; Middle Aged; Thrombocytopenia | 1995 |
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Drug Administration Schedule; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Hypoglycemia; Injections, Subcutaneous; Insulin; Insulin Lispro; Islets of Langerhans; Lactates; Male; Recombinant Proteins; Reference Values; Time Factors | 1995 |
The possible role of insulin release in cardiovascular morbidity and mortality in NIDDM patients.
Topics: Age Factors; Aged; Analysis of Variance; Blood Pressure; Body Mass Index; C-Peptide; Cardiovascular Diseases; Creatinine; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Follow-Up Studies; Glucagon; Humans; Insulin; Insulin Secretion; Male; Morbidity; Myocardial Ischemia; Obesity; Risk Factors; Sex Factors | 1995 |
Oral sensory stimulation improves glucose tolerance in humans: effects on insulin, C-peptide, and glucagon.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucose; Glucose Intolerance; Humans; Insulin; Intubation, Gastrointestinal; Male; Mouth; Sensation; Stimulation, Chemical | 1996 |
Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact.
Topics: Abortion, Induced; Animals; C-Peptide; Cell Aggregation; Cell Communication; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Epithelial Cells; Epithelium; Extracellular Matrix; Female; Fetal Tissue Transplantation; Glucagon; Graft Survival; Hepatocyte Growth Factor; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Mice; Mice, Nude; Niacinamide; Pregnancy; Transcription, Genetic; Transplantation, Heterologous | 1996 |
Contribution of amino acids and insulin to protein anabolism during meal absorption.
Topics: Administration, Oral; Adult; Amino Acids; Antithrombin III; Blood Glucose; C-Peptide; Carbon Radioisotopes; Eating; Fatty Acids, Nonesterified; Female; Fibrinogen; Glucagon; Glucose; Humans; Hyperinsulinism; Immunoglobulin G; Insulin; Intestinal Absorption; Keto Acids; Kinetics; Leucine; Lipid Metabolism; Lipids; Male; Protein Biosynthesis; Proteins; Radioisotope Dilution Technique; Serum Albumin | 1996 |
Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.
Topics: Adult; alpha-Amylases; Analysis of Variance; Biomarkers; Blood Glucose; Blood Group Incompatibility; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up Studies; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppressive Agents; Insulin; Insulin Secretion; Kidney Transplantation; Male; Pancreas Transplantation; Reference Values; Regression Analysis; Time Factors | 1996 |
The entero-insular axis in polycystic ovarian syndrome.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Neurotransmitter Agents; Peptide Fragments; Polycystic Ovary Syndrome; Proinsulin | 1996 |
Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cognition; Dose-Response Relationship, Drug; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Hemodynamics; Humans; Hypoglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin, Regular, Pork; Male; Reaction Time; Recombinant Proteins; Sweating; Tolbutamide; Tremor | 1996 |
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Insulin Lispro; Insulin, Isophane; Lactates; Male; Postprandial Period; Recombinant Proteins | 1996 |
Frequency of insulin-dependent diabetes mellitus in Turkish adult-onset diabetic population.
Topics: Adult; Age Factors; Age of Onset; Autoantibodies; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glucagon; Humans; Incidence; Insulin Antibodies; Islets of Langerhans; Male; Medical Records; Middle Aged; Turkey | 1996 |
Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
Topics: Adolescent; Adult; Antigens, CD; Autoantibodies; Biomarkers; Body Mass Index; C-Peptide; CD8 Antigens; Child; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Histocompatibility Testing; HLA-DR3 Antigen; Humans; Insulin; Islets of Langerhans; Male; Predictive Value of Tests; Prospective Studies | 1996 |
Effect of dietary protein intake on insulin secretion and glucose metabolism in insulin-dependent diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diet Records; Dietary Proteins; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Insulin Secretion; Liver; Male | 1996 |
Modulation of glucose production by indomethacin and pentoxifylline in healthy humans.
Topics: Adult; Blood Glucose; C-Peptide; Cytokines; Glucagon; Humans; Indomethacin; Insulin; Liver; Male; Norepinephrine; Pentoxifylline | 1996 |
Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
Topics: Adult; Age of Onset; Body Mass Index; Body Weight; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Male; Obesity | 1996 |
[Endocrine function of the pancreas in patients with organic hyperinsulinism syndrome].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Hyperinsulinism; Insulin; Insulinoma; Islets of Langerhans; Male; Middle Aged; Pancreatic Neoplasms; Radioimmunoassay | 1996 |
Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis.
Topics: Adult; Aged; Amylases; Bicarbonates; C-Peptide; Chronic Disease; Diabetes Mellitus; Glucagon; Humans; Insulin; Islets of Langerhans; Middle Aged; Pancreas; Pancreatitis | 1996 |
Insulin resistance prevented by portal delivery of insulin in rats with renal subcapsular islet grafts.
Topics: Anastomosis, Surgical; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Glucagon; Glucose Clamp Technique; Hyperinsulinism; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans Transplantation; Liver; Male; Mesenteric Veins; Organ Size; Rats; Rats, Inbred Lew; Renal Veins | 1997 |
Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men.
Topics: Adult; Aged; Aging; Blood Glucose; Blood Pressure; C-Peptide; Cognition; Cohort Studies; Epinephrine; Glucagon; Glucose Clamp Technique; Heart Rate; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Middle Aged; Psychomotor Performance | 1997 |
The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study.
Topics: Adolescent; Adult; Age of Onset; Algorithms; Biomarkers; C-Peptide; Child; Child, Preschool; Cohort Studies; Diabetes Mellitus; Female; Follow-Up Studies; Glucagon; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies | 1997 |
Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Drug Synergism; Glucagon; Glucose; Humans; Insulin; Liver; Liver Circulation; Male; Tolbutamide | 1997 |
Regulation of gluconeogenesis by glutamine in normal postabsorptive humans.
Topics: Alanine; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Forearm; Glucagon; Gluconeogenesis; Glutamates; Glutamine; Humans; Insulin; Intestinal Absorption; Male; Metabolic Clearance Rate; Middle Aged; Proteins | 1997 |
Effect of C-peptide on insulin and glucagon release by isolated perfused rat pancreas.
Topics: Animals; C-Peptide; Female; Glucagon; Glucose; In Vitro Techniques; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Kinetics; Perfusion; Rats; Rats, Wistar | 1997 |
The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Kinetics; Male; Tolbutamide | 1997 |
Abnormal myocardial kinetics of 123I-heptadecanoic acid in subjects with impaired glucose tolerance.
Topics: Adult; Analysis of Variance; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Echocardiography; Fatty Acids; Fatty Acids, Nonesterified; Glucagon; Glucose Intolerance; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Models, Cardiovascular; Myocardium; Reference Values; Tissue Distribution; Tomography, Emission-Computed; Ventricular Function, Left | 1997 |
Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.
Topics: Adult; C-Peptide; Cohort Studies; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Heparin; Humans; Hyperinsulinism; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Liver; Male; Time Factors; Tolbutamide; Triglycerides; Tritium | 1997 |
Metabolism of oral glucose in pancreas transplant recipients with normal and impaired glucose tolerance.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreas; Pancreas Transplantation; Time Factors | 1997 |
Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
Topics: Animals; Body Weight; C-Peptide; Glucagon; Hyperinsulinism; Insulin; Liver; Liver Circulation; Liver Transplantation; Metabolic Clearance Rate; Regional Blood Flow; Swine | 1997 |
Influence of circulating epinephrine and norepinephrine on insulin-like growth factor binding protein-1 in humans.
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Epinephrine; Glucagon; Heart Rate; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Kinetics; Male; Norepinephrine | 1997 |
Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans.
Topics: Blood Glucose; C-Peptide; Chromatography; Female; Glucagon; Humans; Insulin; Insulin Secretion; Middle Aged; Neuropeptides; Neurotransmitter Agents; Osmolar Concentration; Pancreas; Pituitary Adenylate Cyclase-Activating Polypeptide | 1997 |
Beta-endorphin infusion alters pancreatic hormone and glucose levels during exercise in rats.
Topics: Animals; beta-Endorphin; Blood Glucose; C-Peptide; Glucagon; Kinetics; Lactic Acid; Male; Naloxone; Pancreatic Hormones; Physical Exertion; Rats; Rats, Sprague-Dawley | 1997 |
A physiological level of rhubarb fiber increases proglucagon gene expression and modulates intestinal glucose uptake in rats.
Topics: Animals; C-Peptide; Cellulose; Dietary Fiber; Gene Expression Regulation; Glucagon; Glucose; Homeostasis; Insulin; Intestinal Absorption; Intestine, Small; Male; Plants, Medicinal; Proglucagon; Protein Precursors; Rats; Rats, Sprague-Dawley; Rheum; RNA, Messenger; Up-Regulation | 1997 |
Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Topics: Animals; Blood Glucose; Blood Pressure; C-Peptide; Catecholamines; Glucagon; Glucose; Glucose Clamp Technique; Glycolysis; Heart Rate; Hyperinsulinism; Hypertension; Insulin Resistance; Liver; Male; Rats; Rats, Sprague-Dawley; Sodium | 1997 |
Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis.
Topics: Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Human Growth Hormone; Humans; Insulin; Kinetics; Lactic Acid; Liver; Male; Middle Aged | 1997 |
Dose-dependent effects of recombinant human interleukin-6 on glucose regulation.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Glucagon; Humans; Injections, Subcutaneous; Insulin; Interleukin-6; Male; Recombinant Proteins | 1997 |
Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.
Topics: Administration, Oral; Adult; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Humans; Insulin; Male; Splanchnic Circulation | 1997 |
Effects of glucagon on postprandial carbohydrate metabolism in nondiabetic humans.
Topics: Blood Glucose; C-Peptide; Carbohydrate Metabolism; Female; Food; Gastric Emptying; Gastrointestinal Hormones; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Postprandial Period; Xylose | 1998 |
Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Topics: Adult; Aged; Arginine; Basal Metabolism; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Complications; Diabetes Mellitus; Dose-Response Relationship, Drug; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Liver Cirrhosis, Alcoholic; Middle Aged; Secretory Rate | 1998 |
Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects.
Topics: Adult; Amyloid; Blood Glucose; C-Peptide; Gastric Emptying; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Islet Amyloid Polypeptide; Male; Pentetic Acid; Peptide Fragments; Protein Precursors; Radiopharmaceuticals; Reference Values; Technetium; Time Factors | 1998 |
Effects of glucagon-like peptide 1 (7-36 amide) on glucose kinetics during somatostatin-induced suppression of insulin secretion in healthy men.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Male; Peptide Fragments; Proinsulin; Somatostatin | 1998 |
Insulin secretion rates estimated by two mathematical methods in pancreas-kidney transplant recipients.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Kidney Transplantation; Kinetics; Male; Mathematics; Middle Aged; Pancreas Transplantation | 1998 |
Impact of family history of diabetes on the assessment of beta-cell function.
Topics: Adolescent; Adult; Age Factors; Aged; Biomarkers; Blood Glucose; Body Constitution; Body Mass Index; C-Peptide; Data Interpretation, Statistical; Diabetes Mellitus, Type 2; Family Health; Fasting; Female; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Linear Models; Male; Middle Aged | 1998 |
Expression pattern for adrenomedullin during pancreatic development in the rat reveals a common precursor with other endocrine cell types.
Topics: Adrenomedullin; Animals; C-Peptide; Female; Fetus; Glucagon; Insulin; Pancreas; Pancreatic Polypeptide; Peptides; Pregnancy; Rats; Rats, Sprague-Dawley; Somatostatin; Stem Cells; Vasodilator Agents | 1998 |
Glucose turnover and insulin sensitivity in rats with pancreatic islet transplants.
Topics: Anastomosis, Surgical; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Food; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Insulin Resistance; Islets of Langerhans Transplantation; Kidney; Liver; Male; Mesenteric Veins; Rats; Rats, Inbred Lew; Renal Veins | 1998 |
Hypoglycaemia following pancreatic allograft transplantation.
Topics: Adult; Blood Glucose; C-Peptide; Glucagon; Growth Hormone; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Pancreas Transplantation; Transplantation, Homologous | 1998 |
Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity.
Topics: Age Factors; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin Resistance; Male; Middle Aged; Obesity; Reference Values; Sex Characteristics; Tumor Necrosis Factor-alpha | 1998 |
Perioperative insulin and glucose infusion maintains normal insulin sensitivity after surgery.
Topics: Arthroplasty, Replacement, Hip; Blood Glucose; C-Peptide; Calorimetry, Indirect; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Intraoperative Period; Lactates; Male; Middle Aged; Postoperative Period | 1998 |
Effect of residual endogenous insulin secretion on the abnormal oxytocin response to hypoglycaemia in insulin-dependent diabetics.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 1; Glucagon; Humans; Hypoglycemia; Injections, Intravenous; Insulin; Insulin Secretion; Male; Oxytocin | 1998 |
Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose Clamp Technique; Glycogen; Glycolysis; Human Growth Hormone; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Middle Aged; Somatostatin; Sulfonylurea Compounds | 1998 |
Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man.
Topics: Adult; Aging; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Kinetics; Leptin; Liver; Male; Middle Aged; Pancreatic Polypeptide; Proteins | 1998 |
Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning.
Topics: Adult; Blood Glucose; C-Peptide; Circadian Rhythm; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Gastrointestinal Agents; Glucagon; Gluconeogenesis; Human Growth Hormone; Humans; Hydrocortisone; Lactic Acid; Male; Octreotide; Oxidation-Reduction; Postprandial Period; Reference Values; Sleep; Xylose | 1998 |
Somatostatin release in response to glucose is impaired in chronic renal failure.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Kidney Failure, Chronic; Male; Middle Aged; Somatostatin; Uremia | 1998 |
Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake.
Topics: Blood Glucose; C-Peptide; Carbon Dioxide; Carbon Radioisotopes; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycosuria; Human Growth Hormone; Humans; Insulin; Kinetics; Male; Middle Aged; Tritium | 1998 |
Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
Topics: Adult; Blood Glucose; C-Peptide; Dumping Syndrome; Female; Gastrectomy; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemia; Kinetics; Male; Peptide Fragments; Protein Precursors | 1998 |
Forearm norepinephrine spillover during standing, hyperinsulinemia, and hypoglycemia.
Topics: Adult; Blood Pressure; C-Peptide; Chromaffin System; Female; Forearm; Glucagon; Glucose Clamp Technique; Heart Rate; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hyperinsulinism; Hypoglycemia; Infusions, Intravenous; Insulin; Male; Muscle, Skeletal; Norepinephrine; Pancreatic Polypeptide; Posture; Regional Blood Flow; Sympathetic Nervous System | 1998 |
Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency.
Topics: Adult; Binding Sites; Body Mass Index; C-Peptide; Female; Glucagon; Humans; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Kidney Failure, Chronic; Leptin; Male; Middle Aged; Proteins; Radioimmunoassay; Receptor, IGF Type 1; Receptors, Leptin; Recombinant Proteins | 1998 |
Elevated serum tumor necrosis factor-alpha concentrations and bioactivity in Type 2 diabetics and patients with android type obesity.
Topics: Adipose Tissue; Aged; Biomarkers; Body Mass Index; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Male; Middle Aged; Obesity; Reference Values; Tumor Necrosis Factor-alpha | 1998 |
Initiation of increased pancreatic islet growth in young normoglycemic mice (Umeå +/?).
Topics: 5-Hydroxytryptophan; Animals; Blood Glucose; C-Peptide; Cell Division; Culture Techniques; Glucagon; Glucagon-Like Peptide 1; Hypoglycemic Agents; Insulin; Islets of Langerhans; Mice; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide | 1999 |
Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
Topics: Adult; Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dogs; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Liver; Male; Middle Aged; Portal System; Tolbutamide | 1999 |
Protein metabolism in glucagonoma.
Topics: Adult; Amino Acids; Blood Glucose; C-Peptide; Deuterium; Female; Glucagon; Glucagonoma; Humans; Infusions, Intravenous; Insulin; Leucine; Male; Middle Aged; Pancreatic Neoplasms; Phenylalanine; Protein Biosynthesis; Proteins; Reference Values; Tyrosine | 1999 |
Euglycaemic hyperinsulinaemia does not affect gastric emptying in type I and type II diabetes mellitus.
Topics: Adult; Amyloid; Blood Glucose; C-Peptide; Cholecystokinin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hyperinsulinism; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Islet Amyloid Polypeptide; Male; Peptide Fragments; Protein Precursors | 1999 |
Within- and between-subject variation in commonly measured anthropometric and biochemical variables.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adult; Blood Glucose; C-Peptide; Chemistry, Clinical; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Individuality; Insulin; Lactic Acid; Male; Radioimmunoassay; Reference Values; Triglycerides | 1999 |
Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
Topics: Body Mass Index; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Fasting; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Obesity; Proinsulin; Radioimmunoassay | 1999 |
Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Topics: C-Peptide; Case-Control Studies; Chronic Disease; Diabetes Mellitus; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Pancreatitis; Peptide Fragments; Protein Precursors; Time Factors | 1999 |
Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
Topics: Adult; Antidepressive Agents, Second-Generation; Blood Glucose; C-Peptide; Depressive Disorder; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Maprotiline | 1999 |
Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization.
Topics: Adult; Arginine; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; DNA; DNA-Binding Proteins; Female; Glucagon; Glucose Tolerance Test; Hepatocyte Nuclear Factor 1; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Transcription Factors | 1999 |
Effect of subcutaneous pancreatic tissue transplants on streptozotocin-induced diabetes in rats. II. Endocrine and metabolic functions.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; C-Peptide; Cholesterol; Diabetes Mellitus, Experimental; Endocrine System; Female; Glucagon; Glycated Hemoglobin; Insulin; Male; Pancreas Transplantation; Rats; Rats, Wistar; Skin; Transplantation, Heterologous | 1999 |
Effect of overnight restoration of euglycemia on glucose effectiveness in type 2 diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glucose; Human Growth Hormone; Humans; Insulin; Kinetics; Lactic Acid; Male; Middle Aged; Somatostatin | 1999 |
Lack of acute zinc effects in glucose metabolism in healthy and insulin-dependent diabetes mellitus patients.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose; Humans; Hydrocortisone; Male; Zinc | 1999 |
Insulin resistance in HIV protease inhibitor-associated diabetes.
Topics: Adult; Animals; Anti-HIV Agents; C-Peptide; Cells, Cultured; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Glucagon; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Insulin; Insulin Resistance; Islets of Langerhans; Male; Phospholipases A; Proinsulin; Rats; Rats, Sprague-Dawley | 1999 |
Impact of lack of suppression of glucagon on glucose tolerance in humans.
Topics: Adult; Blood Glucose; C-Peptide; Carbon Dioxide; Female; Glucagon; Glucose; Glucose Intolerance; Human Growth Hormone; Humans; Insulin; Male | 1999 |
Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Glyburide; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Kinetics; Male; Middle Aged | 1999 |
Enhancement of B-cell secretion by blood glucose normalization in type 2 diabetes is associated with fasting C-peptide levels.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Middle Aged | 1997 |
Insulin action during variable hyperglycemic-hyperinsulinemic infusions in hyperandrogenic anovulatory patients and healthy women.
Topics: Adolescent; Adrenal Glands; Adult; Anovulation; Blood Glucose; Body Composition; C-Peptide; Female; Glucagon; Human Growth Hormone; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Leuprolide; Middle Aged; Ovary; Prospective Studies; Steroids | 1999 |
Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
Topics: Adult; Blood; Blood Glucose; C-Peptide; Circadian Rhythm; Diabetes Mellitus, Type 2; Eating; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Intestinal Mucosa; Male; Middle Aged; Peptide Fragments; Proinsulin; Reference Values | 1999 |
Metabolic and hormonal responses to exercise in type 1 diabetic patients during continuous subcutaneous, as compared to continuous intraperitoneal, insulin infusion.
Topics: Adult; Blood Glucose; Blood Pressure; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Equipment Design; Exercise; Female; Glucagon; Glycated Hemoglobin; Human Growth Hormone; Humans; Hydrocortisone; Insulin Infusion Systems; Male; Middle Aged; Norepinephrine; Pulse | 1999 |
Insulin sensitivity predicts glycemia after a protein load.
Topics: Adult; Blood Glucose; C-Peptide; Dietary Proteins; Female; Glucagon; Glucose; Glucose Clamp Technique; Humans; Insulin; Male; Regression Analysis; White People | 2000 |
Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations.
Topics: Autoimmunity; Biopsy; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Graft Rejection; Graft Survival; Humans; Islets of Langerhans Transplantation; Liver; Pancreatectomy; Transplantation, Autologous; Transplantation, Homologous | 2000 |
Beta-cell function of the pancreas after necrotizing pancreatitis.
Topics: C-Peptide; Diabetes Mellitus; Female; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Pancreatitis, Acute Necrotizing; Postoperative Complications | 1999 |
Young Chinese adults with new onset of diabetic ketoacidosis--clinical course, autoimmune status and progression of pancreatic beta-cell function.
Topics: Adult; Asian People; Autoantibodies; Blood Glucose; C-Peptide; China; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Follow-Up Studies; Glucagon; Glutamate Decarboxylase; Hong Kong; Humans; Islets of Langerhans; Male | 2000 |
Evaluation of beta-cell secretory capacity using glucagon-like peptide 1.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Peptide Fragments; Postprandial Period; Protein Precursors; Reference Values; Time Factors | 2000 |
The effects of carbohydrate variation in isocaloric diets on glycogenolysis and gluconeogenesis in healthy men.
Topics: Adult; Blood Glucose; C-Peptide; Deuterium; Dietary Carbohydrates; Energy Intake; Epinephrine; Glucagon; Gluconeogenesis; Glucose; Glycogen; Hormones; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Male; Middle Aged; Norepinephrine; Reference Values | 2000 |
Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 gene.
Topics: Adult; Amyloid; Arginine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Female; Glucagon; Hepatocyte Nuclear Factor 4; Humans; Hypoglycemia; Insulin; Islet Amyloid Polypeptide; Male; Mutation; Pancreatic Polypeptide; Phosphoproteins; Transcription Factors | 2000 |
Determinants of within-subject variation of fasting serum leptin concentrations in healthy subjects.
Topics: 3-Hydroxybutyric Acid; Adult; Alcohol Drinking; Blood Glucose; Body Constitution; Body Weight; C-Peptide; Diet; Exercise; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Insulin; Leptin; Male; Reference Values; Regression Analysis; Reproducibility of Results; Sex Characteristics; Time Factors; Triglycerides | 2000 |
Does glucagon stimulation predict oral glucose tolerance in patients after simultaneous pancreas-kidney transplantation?
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Female; Glucagon; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation | 2000 |
Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Fasting; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Glucose Intolerance; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Peptide Fragments; Reference Values | 2000 |
Functional rest through intensive treatment with insulin and potassium channel openers preserves residual beta-cell function and mass in acutely diabetic BB rats.
Topics: Animals; Arginine; Blood Glucose; C-Peptide; Cells, Cultured; Diabetes Mellitus, Type 1; Diazoxide; Glucagon; Glucose Tolerance Test; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Potassium Channels; Rats; Rats, Inbred BB; Rats, Inbred WF | 2000 |
The circulating hormonal milieu of the endocrine pancreas in healthy individuals, organ donors, and the isolated perfused human pancreas.
Topics: Adult; C-Peptide; Female; Glucagon; Hormones; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Pancreatic Polypeptide; Perfusion; Portal Vein; Radial Artery; Radioimmunoassay; Splenic Vein; Tissue Donors | 2000 |
A probing dose of phenylacetate does not affect glucose production and gluconeogenesis in humans.
Topics: Aged; C-Peptide; Citric Acid Cycle; Deuterium; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Insulin; Kinetics; Male; Middle Aged; Phenylacetates | 2000 |
Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene).
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Glucagon; Glucose Clamp Technique; Heterozygote; Homeodomain Proteins; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Metabolic Clearance Rate; Mutation; Pancreas; Pedigree; Trans-Activators | 2000 |
Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Galactose; Glucagon; Glycogen; Human Growth Hormone; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged; Postprandial Period | 2000 |
Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting.
Topics: Adult; Aged; B-Lymphocytes; Blood Glucose; Body Mass Index; C-Peptide; Chemistry, Clinical; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hyperinsulinism; Hypoglycemia; Insulin; Male; Middle Aged; Norepinephrine; Peptides; Proinsulin; Reference Values; Serum Albumin; Sex Factors | 2001 |
[Dynamics of changes in levels of insulin, glucagon, and C-peptide during glucose tolerance test in patients with coronary atherosclerosis].
Topics: C-Peptide; Coronary Artery Disease; Glucagon; Glucose Tolerance Test; Humans; Insulin; Myocardial Infarction | 2000 |
Lipid-dependent control of hepatic glycogen stores in healthy humans.
Topics: Adult; Blood Glucose; C-Peptide; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Gluconeogenesis; Glucose; Glycerol; Glycogen; Humans; Hydrocortisone; Insulin; Liver; Male | 2001 |
Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Duodenum; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Human Growth Hormone; Hydrocortisone; Hypoglycemic Agents; Insulin; Intubation; Osmolar Concentration; Peptide Fragments; Viscera | 2001 |
Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Osmolar Concentration; Peptide Fragments; Postprandial Period; Protein Precursors; Reference Values | 2001 |
No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemia; Hypoglycemic Agents; Infusions, Intravenous; Injections, Subcutaneous; Insulin; Kinetics; Male; Middle Aged; Peptide Fragments; Protein Precursors; Reference Values | 2001 |
Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glycogen; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Time Factors | 2001 |
C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus.
Topics: Adolescent; Adult; Black People; Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 2; Eating; Food, Formulated; Glucagon; Glycated Hemoglobin; Hispanic or Latino; Humans; Reference Values; Time Factors; White People | 2001 |
Peripheral blood mitochondrial DNA content is inversely correlated with insulin secretion during hyperglycemic clamp studies in healthy young men.
Topics: Adult; Anthropometry; C-Peptide; DNA, Mitochondrial; Glucagon; Glucose Clamp Technique; Homeostasis; Humans; Hyperglycemia; Insulin; Insulin Resistance; Insulin Secretion; Leukocytes; Male; Reference Values | 2001 |
Glucose-dependent insulinotropic hormone potentiates the hypoglycemic effect of glibenclamide in healthy volunteers: evidence for an effect on insulin extraction.
Topics: Adult; Blood Glucose; C-Peptide; Drug Synergism; Female; Gastric Inhibitory Polypeptide; Glucagon; Glyburide; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Male | 2001 |
Physiological levels of glucagon do not influence lipolysis in abdominal adipose tissue as assessed by microdialysis.
Topics: Abdomen; Adipose Tissue; Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glycerol; Humans; Lipolysis; Male; Microdialysis | 2001 |
Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Peptide Fragments; Peptides | 2001 |
Renal handling of zinc in insulin-dependent diabetes mellitus patients.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Creatinine; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Glucagon; Glycosuria; Humans; Hydrocortisone; Kidney; Kidney Tubules; Male; Zinc | 2001 |
Enhanced maturation of porcine neonatal pancreatic cell clusters with growth factors fails to improve transplantation outcome.
Topics: Animals; Animals, Newborn; Blood Glucose; C-Peptide; Cattle; Cell Culture Techniques; Culture Media; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucagon; Glucokinase; Glucose Transporter Type 2; Growth Substances; Humans; Insulin; Insulin-Like Growth Factor I; Islets of Langerhans; Islets of Langerhans Transplantation; Monosaccharide Transport Proteins; Niacinamide; Pancreas; Polymerase Chain Reaction; Recombinant Proteins; Somatostatin; Swine; Treatment Outcome | 2001 |
Assessment of hepatic insulin action in obese type 2 diabetic patients.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Humans; Insulin; Liver; Middle Aged; Obesity | 2001 |
No influence of C-peptide, insulin, and glucagon on blood viscosity in vitro in healthy humans and patients with diabetes mellitus.
Topics: Adult; Aged; Blood Proteins; Blood Viscosity; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Erythrocyte Indices; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged | 2001 |
Peritoneal implantation of macroencapsulated porcine pancreatic islets in diabetic rats ameliorates severe hyperglycemia and prevents retraction and simplification of hippocampal dendrites.
Topics: Animals; Blood Glucose; Body Weight; C-Peptide; Capsules; Dendrites; Diabetes Mellitus, Experimental; Glucagon; Graft Survival; Hippocampus; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Male; Nerve Degeneration; Peritoneum; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Swine; Treatment Outcome | 2001 |
Insulin sensitivity and beta-cell secretion after liver transplantation in patients with acute liver failure.
Topics: Acute Disease; Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Liver Failure; Liver Transplantation; Male; Reference Values | 2001 |
Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
Topics: Adult; Arginine; Blood Glucose; C-Peptide; Deafness; Diabetes Complications; Diabetes Mellitus; DNA, Mitochondrial; Female; Genomic Imprinting; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Nuclear Family; Pedigree; Point Mutation; Reference Values; RNA; RNA, Mitochondrial; RNA, Transfer, Leu; Time Factors | 2001 |
Temporal changes in insulin sensitivity following the development of acute liver failure secondary to acetaminophen.
Topics: Acetaminophen; Adult; Blood Glucose; C-Peptide; Fatal Outcome; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Insulin-Like Growth Factor I; Kinetics; Liver Failure, Acute; Male; Metabolic Clearance Rate; Middle Aged; Multiple Organ Failure | 2001 |
High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.
Topics: Adult; Aged; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Glucose Tolerance Test; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Islets of Langerhans; Kinetics; Male; Membrane Proteins; Middle Aged; Nerve Tissue Proteins; Prospective Studies; Receptor-Like Protein Tyrosine Phosphatases, Class 8; ROC Curve; Sensitivity and Specificity | 2001 |
Insulin secretion and glucose kinetics during exercise with and without pharmacological alpha(1)- and alpha(2)-receptor blockade.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Blood Glucose; Blood Pressure; C-Peptide; Cross-Over Studies; Epinephrine; Exercise; Fatty Acids, Nonesterified; Glucagon; Glycerol; Heart Rate; Hemodynamics; Humans; Insulin; Insulin Secretion; Kinetics; Lactates; Male; Physical Exertion; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Time Factors; Tritium; Yohimbine | 2001 |
Influence of age on clinical and immunological characteristics of newly diagnosed type 1 diabetic patients.
Topics: Adult; Aging; Autoantibodies; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Female; Glucagon; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Islets of Langerhans; Male; Pancreas; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Protein Tyrosine Phosphatases | 2001 |
Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
Topics: Analysis of Variance; Autoantibodies; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Fatty Acids, Nonesterified; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Intolerance; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Pancreatic Polypeptide; Peptide Fragments; Peptides; Protein Precursors; Reference Values | 2001 |
Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes.
Topics: Area Under Curve; Autoantibodies; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dipeptidyl Peptidase 4; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Like Peptide 1; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Infusions, Intravenous; Insulin; Islets of Langerhans; Isoenzymes; Male; Middle Aged; Peptide Fragments; Protein Precursors; Regression Analysis | 2001 |
Hormone metabolism in the pulmonary circulation.
Topics: Aged; C-Peptide; Endothelium, Vascular; Female; Follicle Stimulating Hormone; Glucagon; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor I; Luteinizing Hormone; Male; Middle Aged; Prolactin; Pulmonary Artery; Pulmonary Circulation; Radial Artery; Reference Values; Thyroid Hormones | 2001 |
Urinary excretion of glucagon-like peptide 1 (GLP-1) 7-36 amide in human type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Aged; Albuminuria; Body Mass Index; C-Peptide; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peptide Fragments | 2001 |
Failure to develop diabetic ketoacidosis in a newly presenting type 1 diabetic patient.
Topics: Addison Disease; Adolescent; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glucagon; Humans; Triglycerides | 2001 |
Insulin independence and normalization of oral glucose tolerance test after islet cell allotransplantation.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans Transplantation; Reference Values; Time Factors; Transplantation, Homologous | 2001 |
Splanchnic blood flow and hepatic glucose production in exercising humans: role of renin-angiotensin system.
Topics: Adrenocorticotropic Hormone; Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; C-Peptide; Cross-Over Studies; Enalapril; Exercise; Fatty Acids, Nonesterified; Glucagon; Hemodynamics; Human Growth Hormone; Humans; Insulin; Liver; Male; Oxygen Consumption; Reference Values; Regional Blood Flow; Renin-Angiotensin System; Splanchnic Circulation; Tilt-Table Test | 2001 |
Is the process of beta-cell destruction in type 1 diabetes at time of diagnosis more extensive in females than in males?
Topics: Adolescent; Adult; Body Mass Index; C-Peptide; Child; Diabetes Mellitus, Type 1; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Male; Puberty; Sex Characteristics | 2001 |
Glucose production and gluconeogenesis in adults with cerebral malaria.
Topics: Adult; C-Peptide; Case-Control Studies; Epinephrine; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Hydrocortisone; Insulin; Malaria, Cerebral; Male; Norepinephrine; Statistics, Nonparametric | 2001 |
Metabolic adaptation to feeding and fasting during lactation in humans.
Topics: 3-Hydroxybutyric Acid; Adaptation, Physiological; Adult; Blood Glucose; C-Peptide; Carbon Isotopes; Eating; Fasting; Fatty Acids; Female; Glucagon; Glucose; Glycerol; Humans; Insulin; Lactation; Lactic Acid; Milk, Human; Postpartum Period; Time Factors | 2002 |
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Topics: Adult; Autonomic Nervous System; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hypoglycemia; Insulin; Kinetics; Male; Middle Aged; Norepinephrine | 2002 |
Basal and postglucagon C-peptide levels in Ethiopians with diabetes.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Ethiopia; Female; Glucagon; Humans; Insulin; Male; Reference Values; Socioeconomic Factors | 2002 |
Energy metabolism in diabetic and nondiabetic heart transplant recipients.
Topics: Adult; Albuminuria; Blood Glucose; C-Peptide; Cholesterol; Diabetes Mellitus; Diabetic Neuropathies; Energy Metabolism; Female; Follow-Up Studies; Glucagon; Glucose Clamp Technique; Heart Transplantation; Humans; Insulin; Lipids; Male; Middle Aged; Neural Conduction | 2002 |
Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia.
Topics: 3-Hydroxybutyric Acid; Adrenal Medulla; Adult; C-Peptide; Cosyntropin; Epinephrine; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Male; Neurosecretory Systems; Norepinephrine; Pancreatic Polypeptide; Parasympathetic Nervous System | 2002 |
Urea synthesis in patients with chronic pancreatitis: relation to glucagon secretion and dietary protein intake.
Topics: Adaptation, Physiological; Adult; Alanine; Blood Glucose; C-Peptide; Chronic Disease; Dietary Proteins; Female; Glucagon; Humans; Insulin; Liver Function Tests; Male; Middle Aged; Nitrogen; Pancreatitis; Urea | 2001 |
Glutamic acid decarboxylase antibody positivity is associated with an impaired insulin response to glucose and arginine in nondiabetic patients with autoimmune thyroiditis.
Topics: Adult; Aged; Antibodies; Arginine; C-Peptide; Chronic Disease; Female; Follow-Up Studies; Glucagon; Glucose; Glutamate Decarboxylase; Humans; Injections, Intravenous; Insulin; Insulin Resistance; Islets of Langerhans; Male; Middle Aged; Thyroiditis, Autoimmune | 2002 |
Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.
Topics: Blood Glucose; C-Peptide; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Lipolysis; Middle Aged; Postmenopause; Prospective Studies | 1999 |
Fructose amplifies counterregulatory responses to hypoglycemia in humans.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Fructose; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Homeostasis; Human Growth Hormone; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Male; Norepinephrine; Reference Values | 2002 |
Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight.
Topics: 3-Hydroxybutyric Acid; Alanine; Birth Weight; Blood Glucose; C-Peptide; Denmark; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glycerol; Humans; Hyperinsulinism; Infant, Low Birth Weight; Infant, Newborn; Insulin; Insulin Secretion; Lactates; Male; Reference Values; Registries; White People | 2002 |
Stimulation of nerves innervating the dog's pancreas.
Topics: Animals; C-Peptide; Dogs; Electric Stimulation; Electrodes, Implanted; Glucagon; Insulin; Insulin Secretion; Microelectrodes; Pancreas; Splanchnic Nerves; Vagus Nerve | 2002 |
Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study.
Topics: Acute-Phase Reaction; Adult; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Glucagon; Gluconeogenesis; Humans; Hydrocortisone; Insulin; Interleukin-6; Leucine; Lung Neoplasms; Middle Aged; Triiodothyronine; Tumor Necrosis Factor-alpha | 2002 |
Transient neonatal diabetes mellitus, type 4, type 1 diabetes mellitus, or MODY: which disease is it, anyway?
Topics: Adult; Arginine; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Humans; Infant; Insulin; Insulin Secretion; Islets of Langerhans; Male; Tolbutamide | 2002 |
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Drug Synergism; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Hypoglycemic Agents; Injections, Intravenous; Insulin; Male; Middle Aged; Obesity; Peptide Fragments; Protein Precursors; Reference Values; Time Factors | 2002 |
A case of fulminant type 1 diabetes with graves' disease.
Topics: Adult; Amylases; Autoantibodies; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Graves Disease; Humans; Ketone Bodies; Lipase; Pregnancy; Pregnancy in Diabetics | 2002 |
Reduction of hepatic glycogen synthesis and breakdown in patients with agenesis of the dorsal pancreas.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose Tolerance Test; Glycogen; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Resistance; Insulin Secretion; Kinetics; Leptin; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Norepinephrine; Pancreas | 2002 |
Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.
Topics: Adult; Autonomic Nervous System; Blood Glucose; C-Peptide; Data Interpretation, Statistical; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Infusions, Intravenous; Injections, Subcutaneous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Pancreatic Polypeptide; Radioimmunoassay; Time Factors | 2002 |
Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans.
Topics: Adult; Animals; Biotransformation; Blood Glucose; Body Mass Index; C-Peptide; Dipeptidyl Peptidase 4; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Human Growth Hormone; Humans; Hydrocortisone; Infusions, Intravenous; Insulin; Kinetics; Lizards; Peptide Fragments; Peptides; Reference Values; Venoms | 2002 |
Reduction of plasma leptin concentrations by arginine but not lipid infusion in humans.
Topics: Adult; Arginine; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Glucagon; Glycerol; Heparin; Humans; Insulin; Kinetics; Leptin; Male; Middle Aged; Somatostatin | 2002 |
Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Hormones; Humans; Hypoglycemia; Insulin; Islets of Langerhans Transplantation; Liver; Male; Middle Aged | 2002 |
Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Dietary Proteins; Energy Intake; Exercise; Fasting; Fatty Acids; Female; Glucagon; Glucose Clamp Technique; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertriglyceridemia; Insulin; Insulin Secretion; Male; Middle Aged; Obesity; Proinsulin; Pyrazines | 2003 |
The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
Topics: Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Peptide Fragments; Protein Precursors; Reference Values | 2003 |
A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes.
Topics: Adolescent; Adult; Aging; Autoantibodies; C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Humans; Islets of Langerhans; Male; Mathematics; Models, Biological; Time Factors | 2002 |
Residual C-peptide secretion and endothelial function in patients with Type II diabetes.
Topics: Aged; Analysis of Variance; Area Under Curve; Brachial Artery; C-Peptide; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glucagon; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Nitroglycerin; Oxidative Stress; Regional Blood Flow; Thiobarbituric Acid Reactive Substances; Ultrasonography; Vasodilator Agents | 2003 |
Effects of inducing physiological hyperglucagonemia on metabolic responses to exercise.
Topics: 3-Hydroxybutyric Acid; Animals; Ankle; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glycerol; Glycogen; Hyperglycemia; Infusions, Intravenous; Insulin; Liver Glycogen; Male; Muscle, Skeletal; Norepinephrine; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Reference Values | 2003 |
Increased insulin sensitivity is associated with reduced insulin and glucagon secretion and increased insulin clearance in man.
Topics: Adult; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Humans; Insulin; Islets of Langerhans; Male; Metabolic Clearance Rate | 2003 |
Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Glucose Clamp Technique; Growth Hormone; Hormone Antagonists; Humans; Hyperglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Male; Somatostatin | 2003 |
Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens.
Topics: Adipose Tissue; Adult; Blood Glucose; Body Composition; Body Constitution; C-Peptide; CD4 Lymphocyte Count; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Glucose Intolerance; Glycated Hemoglobin; Glycerol; HIV Infections; HIV Protease Inhibitors; Homeostasis; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Lipids; Liver; Male; Middle Aged; Muscle, Skeletal; Proinsulin; Viral Load | 2003 |
Metabolic, endocrine and mood responses to nocturnal eating in men are affected by sources of dietary energy.
Topics: Adult; Affect; Blood Glucose; Blood Pressure; Body Temperature; C-Peptide; Calorimetry, Indirect; Chromogranin A; Chromogranins; Circadian Rhythm; Dietary Carbohydrates; Dietary Fats; Endocrine System; Energy Metabolism; Fatty Acids, Nonesterified; Feeding Behavior; Glucagon; Heart Rate; Humans; Hydrocortisone; Insulin; Leptin; Male; Oxidation-Reduction; Pancreatic Polypeptide; Skin Temperature; Thyroid Hormones; Triglycerides | 2002 |
Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Topics: Adult; Aged; Blood Glucose; Body Weight; C-Peptide; Case-Control Studies; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Feeding Behavior; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Middle Aged; Obesity; Peptide Fragments; Protein Precursors; Random Allocation | 2003 |
Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance.
Topics: Adult; Aged; Aging; Blood Glucose; Body Mass Index; C-Peptide; Dehydroepiandrosterone Sulfate; Eating; Fatty Acids, Nonesterified; Glucagon; Glucose; Glucose Tolerance Test; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Insulin Secretion; Palmitic Acid | 2003 |
Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Male; Peptide Fragments; Postprandial Period; Protein Precursors; Reference Values | 2003 |
Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia.
Topics: Adult; Blood Glucose; C-Peptide; Deuterium; Duodenum; Fasting; Female; Glucagon; Glucose; Humans; Infusions, Intravenous; Insulin; Intubation, Gastrointestinal; Kinetics; Male; Tritium | 2003 |
Insulin-sparing effects of troglitazone in rat pancreatic islets.
Topics: Animals; C-Peptide; Chromans; Gene Expression Regulation; Glucagon; Glucose; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Proglucagon; Proinsulin; Protein Precursors; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Troglitazone | 2003 |
Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.
Topics: Adult; Alanine Transaminase; Analysis of Variance; Autoantibodies; Blood Glucose; C-Peptide; Chi-Square Distribution; Diabetes Mellitus, Type 1; DNA, Viral; Female; Glucagon; Glucose Tolerance Test; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatitis C, Chronic; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Interferon-alpha; Islets of Langerhans; Male; Middle Aged | 2003 |
Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Clamp Technique; Humans; Insulin; Insulin Infusion Systems; Male; Obesity; Predictive Value of Tests; Statistics, Nonparametric | 2003 |
Contrasting metabolic effects of antihypertensive agents.
Topics: Adrenergic alpha-Agonists; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; C-Peptide; Cholesterol; Eating; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Homeostasis; Imidazoline Receptors; Insulin; Lipid Metabolism; Male; Metabolism; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha-2; Receptors, Drug; Sympathetic Nervous System; Triglycerides; Vascular Resistance | 2003 |
A fall in portal vein insulin does not cause the alpha-cell response to mild, non-insulin-induced hypoglycemia in conscious dogs.
Topics: Animals; Biosensing Techniques; Blood Glucose; C-Peptide; Dogs; Female; Glucagon; Glycogen Phosphorylase; Hypoglycemia; Insulin; Islets of Langerhans; Male; Norepinephrine; Portal Vein | 2003 |
Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
Topics: Adult; Anastomosis, Roux-en-Y; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Hydrocortisone; Insulin; Male; Middle Aged; Obesity, Morbid; Peptide Fragments; Protein Precursors | 2004 |
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Topics: Administration, Oral; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Case-Control Studies; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Liver; Middle Aged; Peptide Fragments; Protein Precursors; Regression Analysis; Time Factors | 2004 |
Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity.
Topics: Autoantibodies; Autoimmunity; C-Peptide; Child; Chylomicrons; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Glucose Clamp Technique; Humans; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Islets of Langerhans; Lipoprotein Lipase | 2004 |
Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes.
Topics: Biological Transport; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucagon; Glycolysis; Humans; Insulin; Kinetics; Reference Values; Splanchnic Circulation | 2004 |
Endocrine pancreatic dysfunction in HIV-infected children: association with growth alterations.
Topics: Blood Glucose; C-Peptide; Child; Female; Glucagon; Growth Disorders; HIV Infections; Homeostasis; Hormones; Humans; Insulin; Lipids; Male; Pancreas; Prospective Studies | 2004 |
Effects of insulin--like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement.
Topics: Animals; Blood Glucose; Body Weight; C-Peptide; Fluorescent Antibody Technique; Glucagon; Growth Hormone; Hypophysectomy; Insulin; Insulin-Like Growth Factor I; Islets of Langerhans; Male; Organ Size; Pituitary Diseases; Rats; Rats, Wistar; RNA, Messenger | 2004 |
Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential.
Topics: Acetylcysteine; Adenoviridae; Adult; Albumins; alpha-Amylases; C-Peptide; Cell Aggregation; Cell Differentiation; Cell Separation; Cells, Cultured; Chromones; Culture Media; Culture Media, Serum-Free; Exenatide; Gene Expression Regulation; Genetic Vectors; Glucagon; Homeodomain Proteins; Humans; Insulin; Intermediate Filament Proteins; Intracellular Fluid; Islets of Langerhans; Morpholines; Nerve Tissue Proteins; Nestin; Niacinamide; Oxidation-Reduction; Peptides; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin; Stem Cells; Trans-Activators; Transcription Factors; Venoms; Vimentin | 2004 |
Insulin feedback actions: complex effects involving isoforms of islet nitric oxide synthase.
Topics: Androstadienes; Animals; C-Peptide; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Feedback, Physiological; Female; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Insulin; Insulin Secretion; Islets of Langerhans; Isoenzymes; Mice; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Precursors; Wortmannin | 2004 |
Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Diet; Energy Intake; Family; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Linear Models; Male; Models, Biological; Multivariate Analysis; Peptide Fragments; Protein Precursors | 2005 |
Adult pancreas generates multipotent stem cells and pancreatic and nonpancreatic progeny.
Topics: Animals; Apoptosis; Bromodeoxyuridine; C-Peptide; Cell Differentiation; Cell Line; Cell Lineage; Cell Proliferation; Cells, Cultured; Glucagon; Immunohistochemistry; Insulin; Islets of Langerhans; Isoelectric Focusing; Mice; Mice, Inbred C57BL; Neurons; Pancreas; Phenotype; Rats; Reverse Transcriptase Polymerase Chain Reaction; Somatostatin; Stem Cells; Time Factors | 2004 |
A case of type 2 diabetes with high levels of plasma and urinary C-peptide.
Topics: Adult; Biomarkers; C-Peptide; Diabetes Mellitus, Type 2; Fatty Liver; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Kidney; Male; Radiography | 2004 |
Committing embryonic stem cells to early endocrine pancreas in vitro.
Topics: Animals; C-Peptide; Cell Culture Techniques; Cell Differentiation; Culture Media, Serum-Free; DNA Primers; Embryo, Mammalian; Flow Cytometry; Glucagon; Immunohistochemistry; Insulin; Islets of Langerhans; Kinetics; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microscopy, Fluorescence; Neurons; Pancreas; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells; Time Factors | 2004 |
Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome.
Topics: Adult; Appetite Regulation; Blood Glucose; Body Mass Index; Bulimia; C-Peptide; Cholecystokinin; Female; Food; Food Preferences; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Insulin; Polycystic Ovary Syndrome; Satiation; Sex Hormone-Binding Globulin; Testosterone | 2004 |
Enhanced glucagon-like peptide-1 (GLP-1) response to oral glucose in glucose-intolerant HIV-infected patients on antiretroviral therapy.
Topics: Adult; Analysis of Variance; Antiretroviral Therapy, Highly Active; Antiviral Agents; Area Under Curve; Blood Glucose; Body Composition; C-Peptide; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Intolerance; Glucose Tolerance Test; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Peptide Fragments; Protein Precursors | 2005 |
Fasting hyperglucagonemia in patients with transjugular intrahepatic portosystemic shunts (TIPS).
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Complications; Female; Glucagon; Glycated Hemoglobin; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic | 2005 |
Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Cisapride; Domperidone; Eating; Erythromycin; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Humans; Infusions, Intravenous; Insulin; Male; Metoclopramide; Peptide Fragments; Placebos; Protein Precursors; Reference Values | 2005 |
Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Female; Food; Glucagon; Glucose; Glycerol; Humans; Hypolipidemic Agents; Insulin; Kinetics; Lipolysis; Liver; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxidation-Reduction; Placebos; Pyrazines; Triglycerides | 2005 |
Glucagon-like peptide-1 enhances production of insulin in insulin-producing cells derived from mouse embryonic stem cells.
Topics: Animals; C-Peptide; Cell Differentiation; Cell Line; Exenatide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Immunohistochemistry; Insulin; Insulin Secretion; Mice; Peptide Fragments; Peptides; Protein Precursors; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction; Stem Cells; Venoms | 2005 |
Pathophysiology of ketoacidosis in Type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Antibodies; C-Peptide; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Human Growth Hormone; Humans; Hydrocortisone; Hypoglycemic Agents; Insulin; Islets of Langerhans; Ketones; Middle Aged; Norepinephrine | 2005 |
Insulin sensitivity and counter-regulatory hormones in hypothyroidism and during thyroid hormone replacement therapy.
Topics: Adult; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Hormones; Human Growth Hormone; Humans; Hydrocortisone; Hypothyroidism; Insulin; Insulin Resistance; Insulin Secretion; Thyroid Hormones | 2005 |
Growth and functional maturation of beta-cells in implants of endocrine cells purified from prenatal porcine pancreas.
Topics: Animals; Animals, Newborn; Blood Glucose; C-Peptide; Cell Division; Glucagon; Insulin; Islets of Langerhans Transplantation; Mice; Mice, Nude; Pancreas; Swine; Synaptophysin; Time Factors; Transplantation, Heterologous | 2005 |
Characterization of human islet-like structures generated from pancreatic precursor cells in culture.
Topics: 1-Methyl-3-isobutylxanthine; C-Peptide; Cell Count; Cell Proliferation; Cells, Cultured; Culture Media; Culture Media, Serum-Free; Gene Expression; Glucagon; Glucose; Homeodomain Proteins; Humans; Insulin; Islets of Langerhans; Pancreatic Polypeptide; Reverse Transcriptase Polymerase Chain Reaction; Somatostatin; Stem Cells; Tissue Culture Techniques; Tissue Engineering; Trans-Activators | 2006 |
Glucose-stimulated prehepatic insulin secretion is associated with circulating alanine, triglyceride, glucagon, lactate and TNF-alpha in patients with HIV-lipodystrophy.
Topics: Adult; Alanine; C-Peptide; Case-Control Studies; Glucagon; Glucose; Glucose Clamp Technique; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Lactates; Male; Middle Aged; Stimulation, Chemical; Triglycerides; Tumor Necrosis Factor-alpha | 2006 |
Two-dimensional reverse phase-reverse phase chromatography: A simple and robust platform for sensitive quantitative analysis of peptides by LC/MS. Hardware design.
Topics: C-Peptide; Chromatography, Liquid; Equipment Design; Glucagon; Humans; Insulin; Peptides; Plasma; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2006 |
Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice.
Topics: Animals; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Diet; Eating; Genistein; Glucagon; Glucose; Glucose Tolerance Test; Glycated Hemoglobin; Insulin; Isoflavones; Leptin; Lipid Metabolism; Liver; Liver Glycogen; Mice; Mice, Inbred C57BL; Phytoestrogens; Receptors, Cell Surface; Receptors, Leptin | 2006 |
Hypoglycemic and hypolipidemic action of Du-zhong (Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ-db/db mice.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Eucommiaceae; Glucagon; Gluconeogenesis; Glucose; Glucose Tolerance Test; Glycolysis; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Lipid Metabolism; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pancreas; Plant Leaves; Time Factors | 2006 |
Glucagon-like peptide 2 inhibits ghrelin secretion in humans.
Topics: Adult; Blood Glucose; C-Peptide; Ghrelin; Glucagon; Glucagon-Like Peptide 2; Humans; Infusions, Intravenous; Insulin; Kinetics; Male; Peptide Hormones | 2006 |
Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
Topics: Adolescent; Adult; Biomarkers; Body Mass Index; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Early Diagnosis; Female; Glucagon; Glycated Hemoglobin; Hormones; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Multivariate Analysis; Prognosis; Radioimmunoassay | 2006 |
Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Fasting; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Male; Middle Aged; Postprandial Period; Prediabetic State; Reference Values | 2006 |
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemia.
Topics: Adolescent; Adult; Alanine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Homeostasis; Humans; Hyperglycemia; Hypoglycemia; Male; Middle Aged; Norepinephrine; Reference Values | 2007 |
[Study of relationship between stress hyperglycemia and insulin-resistance related factors].
Topics: Adult; Aged; C-Peptide; Critical Illness; Female; Glucagon; Humans; Hydrocortisone; Hyperglycemia; Insulin; Insulin Resistance; Intensive Care Units; Male; Middle Aged; Stress, Physiological; Tumor Necrosis Factor-alpha; Young Adult | 2006 |
Zinc, not insulin, regulates the rat alpha-cell response to hypoglycemia in vivo.
Topics: Animals; Blood Glucose; C-Peptide; Glucagon; Glucagon-Secreting Cells; Hyperglycemia; Hypoglycemia; Insulin; Male; Rats; Rats, Wistar; Streptozocin; Zinc | 2007 |
Fasting hyperglycemia impairs glucose- but not insulin-mediated suppression of glucagon secretion.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Male; Mexican Americans | 2007 |
Limited capacity of human adult islets expanded in vitro to redifferentiate into insulin-producing beta-cells.
Topics: Animals; C-Peptide; Cell Culture Techniques; Cell Differentiation; Cell Proliferation; Gene Expression Regulation; Glucagon; Glucose; Humans; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Nude | 2007 |
Isolation and characterization of human CXCR4-positive pancreatic cells.
Topics: Adult; Aged; C-Peptide; Cell Differentiation; Cell Separation; Cells, Cultured; Fluorescent Antibody Technique; Gene Expression Regulation; Glucagon; Humans; Insulin; Intermediate Filament Proteins; Leukemia Inhibitory Factor Receptor alpha Subunit; Middle Aged; Nerve Tissue Proteins; Nestin; Pancreas; Receptors, CXCR4; RNA, Messenger | 2007 |
The Mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man.
Topics: Adult; Amino Acids; Biological Transport; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose; Human Growth Hormone; Humans; Insulin; Male; Protein Kinases; Reference Values; Sirolimus; TOR Serine-Threonine Kinases | 2007 |
Reversal of defective glucagon responses to hypoglycemia in insulin-dependent autoimmune diabetic BB rats.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Hypoglycemia; Insulin; Male; Rats; Rats, Inbred BB; Rats, Wistar | 2007 |
Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis.
Topics: Adipose Tissue; Blood Glucose; Body Mass Index; C-Peptide; Fasting; Female; Glucagon; Gluconeogenesis; Glucose Intolerance; Humans; Hyperglycemia; Insulin Resistance; Liver; Male; Middle Aged; Reference Values | 2007 |
Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Prediabetic State | 2007 |
Impaired first-phase insulin response predicts postprandial blood glucose increment in patients with recently diagnosed type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Middle Aged; Postprandial Period; Predictive Value of Tests; Reference Values; Sensitivity and Specificity | 2007 |
Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1.
Topics: Amylases; Animals; Betacellulin; Biomarkers; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Gene Expression; Genetic Therapy; Glucagon; Homeodomain Proteins; Insulin; Intercellular Signaling Peptides and Proteins; Male; Microbubbles; Pancreas, Exocrine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Ultrasonics | 2007 |
T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
Topics: Adult; Aged; Antigens; Autoantibodies; C-Peptide; Cell Proliferation; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose; Humans; Islets of Langerhans; Male; Middle Aged; Phenotype; T-Lymphocytes | 2007 |
Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glutaminase; Homeostasis; Humans; Insulin; Insulin Secretion; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Models, Biological | 2007 |
Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes.
Topics: Adolescent; ATP-Binding Cassette Transporters; Blood Glucose; C-Peptide; Child; Cohort Studies; Diabetes Mellitus, Type 1; Eating; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Immunohistochemistry; Insulin-Secreting Cells; Male; Postprandial Period; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors | 2007 |
Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
Topics: Adolescent; ATP-Binding Cassette Transporters; Blotting, Western; C-Peptide; Child; Diabetes Mellitus, Type 1; Eating; Female; Gastric Inhibitory Polypeptide; Genotype; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Ileum; Immunohistochemistry; Insulin; Islets of Langerhans; Male; Polymorphism, Restriction Fragment Length; Potassium Channels; Potassium Channels, Inwardly Rectifying; Receptors, Drug; Sulfonylurea Receptors | 2007 |
Glucagon, in concert with insulin, supports the postabsorptive plasma glucose concentration in humans.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucose; Human Growth Hormone; Humans; Infusions, Intravenous; Insulin; Intestinal Absorption; Kinetics; Male; Octreotide; Reference Values | 2007 |
Systematic analysis of the insulinotropic and glucagonotropic potency of saturated and monounsaturated fatty acid mixtures in rat pancreatic islets.
Topics: Animals; C-Peptide; Fatty Acids, Monounsaturated; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Rats; Rats, Wistar | 2007 |
Oral glucose tolerance test in the assessment of glucose-tolerance in the elderly people.
Topics: Adult; Aged; Aged, 80 and over; Aging; Blood Glucose; C-Peptide; Case-Control Studies; Female; Geriatric Assessment; Glucagon; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged | 2007 |
Editorial: The role of glucagon in postprandial hyperglycemia--the jury's still out.
Topics: Blood Glucose; C-Peptide; Child; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Postprandial Period; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Sulfonylurea Compounds | 2007 |
Susceptibility to oxidative stress, insulin resistance, and insulin secretory response in the development of diabetes from obesity.
Topics: Adult; Antioxidants; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin Resistance; Insulin Secretion; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Obesity; Oxidative Stress | 2007 |
The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Male; Middle Aged; Pancreatitis, Chronic | 2007 |
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
Topics: Adult; Aged; Blood Glucose; Body Mass Index; C-Peptide; Eating; Female; Food; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemia; Incretins; Insulin; Insulin Resistance; Male; Middle Aged; Obesity; Obesity, Morbid; Postoperative Complications | 2007 |
Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: implications for translation into clinical practice.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Female; Glucagon; Insulin; Islets of Langerhans Transplantation; Macaca fascicularis; Male; Metabolism; Sus scrofa; Time Factors; Transplantation, Heterologous; Treatment Outcome | 2008 |
Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes.
Topics: Adult; Anovulation; Basic Helix-Loop-Helix Transcription Factors; Biomarkers; Black People; C-Peptide; Case-Control Studies; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Female; Gene Expression; Genotype; Glucagon; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Nerve Tissue Proteins; Promoter Regions, Genetic; Sex Factors | 2008 |
Independent measures of insulin secretion and insulin sensitivity during the same test: the glucagon-insulin tolerance test.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Glucose Tolerance Test; Hormones; Humans; Insulin; Insulin Resistance; Insulin Secretion; Male; Middle Aged; Reproducibility of Results | 2008 |
Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Drainage; Female; Glucagon; Glucose Tolerance Test; Human Growth Hormone; Humans; Insulin; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Middle Aged; Pancreas Transplantation; Portal Vein | 2008 |
A comparison of protocols used to generate insulin-producing cell clusters from mouse embryonic stem cells.
Topics: Animals; C-Peptide; Cell Aggregation; Cell Culture Techniques; Cell Differentiation; Cell Survival; Embryonic Stem Cells; Fluorescent Antibody Technique; Gene Expression Profiling; Glucagon; Glucose; Insulin; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Mice; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.
Topics: Administration, Oral; Adult; Amino Acids; Area Under Curve; Blood Glucose; C-Peptide; Cognition; Diabetes Mellitus, Type 1; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Norepinephrine; Pancreatic Polypeptide; Reference Values; Surveys and Questionnaires; Trail Making Test | 2008 |
In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells.
Topics: Blotting, Western; C-Peptide; Cell Aggregation; Cell Culture Techniques; Cell Differentiation; Cell Separation; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation; Glucagon; Glucose; Humans; Immunophenotyping; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Mesenchymal Stem Cells; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Cord | 2008 |
Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes.
Topics: Adolescent; Age of Onset; C-Peptide; Child; Child, Preschool; Diabetes Mellitus, Type 1; Eating; Fasting; Female; Follow-Up Studies; Glucagon; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male | 2008 |
The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
Topics: Adult; Amyloid; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Exenatide; Feasibility Studies; Glucagon; Graft Rejection; Graft Survival; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Islet Amyloid Polypeptide; Islets of Langerhans Transplantation; Middle Aged; Peptides; Prospective Studies; Time Factors; Transplantation, Homologous; Treatment Outcome; Venoms | 2008 |
Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes.
Topics: Adolescent; Adult; Age of Onset; Biomarkers; C-Peptide; Child; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diet, Diabetic; Fasting; Glucagon; Humans; Insulin-Secreting Cells; Racial Groups; Random Allocation; Sensitivity and Specificity | 2008 |
Effects of glucagon on islet beta cell function in patients with diabetes mellitus.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Male; Middle Aged | 2008 |
Extracellular matrix gel is necessary for in vitro cultivation of insulin producing cells from human umbilical cord blood derived mesenchymal stem cells.
Topics: C-Peptide; Cell Differentiation; Cell Separation; Cells, Cultured; Extracellular Matrix; Fetal Blood; Flow Cytometry; Fluorescent Antibody Technique; Glucagon; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Mesenchymal Stem Cells; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Glucagon stimulation test for estimating endogenous insulin secretion in dogs.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Dog Diseases; Dogs; Female; Fructosamine; Glucagon; Glucose Tolerance Test; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Treatment Outcome | 2008 |
Effects of pioglitazone and metformin on NEFA-induced insulin resistance in type 2 diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fat Emulsions, Intravenous; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycerol; Heparin; Humans; Insulin; Insulin Resistance; Male; Metformin; Middle Aged; Pioglitazone; Thiazolidinediones | 2008 |
Human feeder cells support establishment and definitive endoderm differentiation of human embryonic stem cells.
Topics: Activins; Animals; C-Peptide; Cell Differentiation; Cells, Cultured; Coculture Techniques; DNA-Binding Proteins; Embryo, Mammalian; Embryonic Stem Cells; Endoderm; Fibroblasts; Glucagon; High Mobility Group Proteins; HMGB Proteins; Humans; Islets of Langerhans; Mice; Mice, Inbred ICR; SOXF Transcription Factors; Transcription Factors | 2008 |
A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Exocrine Pancreatic Insufficiency; Glucagon; Humans; Insulin; Male; Middle Aged | 2008 |
Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans.
Topics: Adult; Body Mass Index; C-Peptide; Cholesterol, HDL; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Hyperglycemia; Kidney Function Tests; Liver Function Tests; Male; Postprandial Period; Reference Values; Young Adult | 2009 |
[Pancreatic function assessment in type 1 diabetes mellitus patients according to disease duration].
Topics: Adolescent; C-Peptide; Chi-Square Distribution; Diabetes Mellitus, Type 1; Female; Glucagon; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Insulin; Insulin Secretion; Male; Pancreas; Time Factors; Young Adult | 2009 |
Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes.
Topics: Aged; Blood Glucose; Body Mass Index; C-Peptide; Deuterium; Diabetes Mellitus, Type 2; Galactose; Glucagon; Gluconeogenesis; Humans; Insulin; Isotope Labeling; Middle Aged; Obesity; Reference Values; Transaldolase; Triose-Phosphate Isomerase | 2009 |
The second-meal phenomenon in type 2 diabetes.
Topics: Arginine; Blood Glucose; C-Peptide; Catecholamines; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Feeding Behavior; Glucagon; Humans; Insulin; Postprandial Period | 2009 |
Differential islet and incretin hormone responses in morning versus afternoon after standardized meal in healthy men.
Topics: Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Gastric Inhibitory Polypeptide; Glucagon; Humans; Incretins; Insulin; Islets of Langerhans; Male; Postprandial Period; Time Factors | 2009 |
Impaired glucose-induced glucagon suppression after partial pancreatectomy.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucagon-Secreting Cells; Glucose; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Pancreatectomy | 2009 |
[Indicators for insulin therapy in late elderly patients with type 2 diabetes mellitus--the relationship between plasma C-peptide on glucagon load test and insulin therapy].
Topics: Aged; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Insulin; Sensitivity and Specificity | 2009 |
Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade.
Topics: Adult; Autonomic Nervous System Diseases; beta-Endorphin; Blood Glucose; C-Peptide; Epinephrine; Female; Glucagon; Gluconeogenesis; Humans; Hypoglycemia; Insulin; Male; Naloxone; Narcotic Antagonists; Norepinephrine; Receptors, Opioid; Syndrome | 2009 |
Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
Topics: Aged; Blood Glucose; C-Peptide; Case-Control Studies; Cognition; Diabetes Mellitus, Type 2; Epinephrine; Fasting; Glucagon; Glucose Clamp Technique; Humans; Hydrocortisone; Hypoglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Middle Aged; Norepinephrine; Sulfonylurea Compounds; Tremor | 2009 |
Mechanisms to conserve glucose in lactating women during a 42-h fast.
Topics: Adult; Algorithms; Blood Glucose; C-Peptide; Calorimetry, Indirect; Diet; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Gluconeogenesis; Glucose; Hexoses; Humans; Insulin; Insulin Resistance; Isotope Labeling; Ketone Bodies; Kinetics; Lactates; Lactation; Milk, Human; Oxidation-Reduction | 2009 |
Beta-cell-mediated signaling predominates over direct alpha-cell signaling in the regulation of glucagon secretion in humans.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Eating; Epinephrine; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Glucagon-Secreting Cells; Homeostasis; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Reference Values; Signal Transduction; Sulfonylurea Compounds | 2009 |
Mild sleep restriction acutely reduces plasma glucagon levels in healthy men.
Topics: Adult; Blood Glucose; C-Peptide; Cross-Over Studies; Glucagon; Hormones; Humans; Insulin; Male; Sleep Deprivation; Young Adult | 2009 |
Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report.
Topics: Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Enteral Nutrition; Fatty Acids, Nonesterified; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Male; Middle Aged; Obesity, Morbid; Peptide YY; Postoperative Period; Postprandial Period | 2010 |
The effect of branched chain amino acids on skeletal muscle mitochondrial function in young and elderly adults.
Topics: Adenosine Triphosphate; Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Blood Glucose; C-Peptide; DNA, Mitochondrial; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Male; Mitochondria, Muscle; Muscle, Skeletal; Young Adult | 2010 |
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptides; Glucose; Glucose Tolerance Test; Humans; Infusions, Intravenous; Male; Young Adult | 2010 |
A model of GLP-1 action on insulin secretion in nondiabetic subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Models, Biological | 2010 |
Effect of glucagon-like peptide-1 on alpha- and beta-cell function in C-peptide-negative type 1 diabetic patients.
Topics: Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Humans; Hyperglycemia; Insulin-Secreting Cells; Serum Albumin | 2010 |
Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.
Topics: Adipocytes; Adipose Tissue; Animals; Blood Glucose; C-Peptide; Down-Regulation; Fatty Acids, Nonesterified; Glucagon; Glucose Intolerance; Hyperlipidemias; Immunosuppressive Agents; Insulin; Liver; Male; Mice; Muscle, Skeletal; Polymerase Chain Reaction; Pyruvates; Rats; Rats, Sprague-Dawley; RNA; Sirolimus; Triglycerides | 2010 |
Glucose flux in controlled hyperglycaemia before and after oral glucose ingestion in men with mild type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin; Male; Middle Aged; Statistics, Nonparametric | 2010 |
Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs.
Topics: Animals; C-Peptide; Chromatography, Liquid; Dose-Response Relationship, Drug; Glucagon; Glucose; Glucose Clamp Technique; Hydrocortisone; Insulin; Insulin Resistance; Kinetics; Liver; Male; Swine; Tandem Mass Spectrometry | 2010 |
Detection of surreptitious administration of analog insulin to an 8-week-old infant.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Diagnosis, Differential; Emergency Service, Hospital; Female; Glucagon; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Infant; Insulin; Insulin Aspart; Male; Munchausen Syndrome by Proxy; Pregnancy; Pregnancy in Diabetics; Recurrence | 2010 |
Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
Topics: Adult; Area Under Curve; Blood Glucose; Body Weight; C-Peptide; Diet; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Motor Activity; Prednisolone | 2010 |
Insulin sensitivity and body composition in cirrhosis: changes after TIPS.
Topics: Body Composition; C-Peptide; Diabetes Mellitus; Energy Metabolism; Fatty Acids, Nonesterified; Female; Glucagon; Glucose; Glucose Clamp Technique; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Predictive Value of Tests; Rest | 2010 |
Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.
Topics: Aged; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Male; Middle Aged; Postprandial Period | 2010 |
Combination peroxisome proliferator-activated receptor gamma and alpha agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content.
Topics: Abdominal Muscles; Adult; Aged; Bezafibrate; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Insulin Resistance; Liver; Middle Aged; Pioglitazone; PPAR alpha; PPAR gamma; Thiazolidinediones; Triglycerides | 2010 |
[GADA persistence and detectable C peptide in patients with long standing diabetes mellitus type 1].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Biomarkers; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glucagon; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male | 2010 |
Focal congenital hyperinsulinism in a patient with septo-optic dysplasia.
Topics: 3-Hydroxybutyric Acid; Blood Glucose; C-Peptide; Congenital Hyperinsulinism; Glucagon; Glucose; Humans; Hydrocortisone; Hypopituitarism; Infant; Insulin; Loss of Heterozygosity; Male; Pancreas; Pituitary Hormones; Septo-Optic Dysplasia | 2010 |
Basal alpha-cell up-regulation in obese insulin-resistant adolescents.
Topics: Adolescent; Analysis of Variance; Area Under Curve; Blood Glucose; C-Peptide; Glucagon; Glucagon-Secreting Cells; Glucose Clamp Technique; Humans; Insulin; Insulin Resistance; Obesity; Regression Analysis; Up-Regulation; Young Adult | 2011 |
Induction of insulin-producing cells derived from endometrial mesenchymal stem-like cells.
Topics: Adipocytes; Adult; Animals; Antigens, CD; Apoptosis; Blood Glucose; C-Peptide; Cell Differentiation; Chondrocytes; Diabetes Mellitus, Experimental; Down-Regulation; Endometrium; Female; Fibroblasts; Gene Expression; Glucagon; Glucose; Glutathione; Homeobox Protein Nkx-2.2; Homeodomain Proteins; Humans; Insulin; Insulin-Secreting Cells; Interleukin-1beta; Mesenchymal Stem Cells; Mice; Mice, SCID; Middle Aged; Neurons; Nuclear Proteins; Osteocytes; Reactive Oxygen Species; Spheroids, Cellular; Transcription Factors; Transplantation, Heterologous; Up-Regulation | 2010 |
Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Diet; Energy Intake; Fasting; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Motor Activity; Postprandial Period; Prednisolone; Young Adult | 2011 |
Transaldolase exchange and its effects on measurements of gluconeogenesis in humans.
Topics: Acetates; Adult; Blood Glucose; C-Peptide; Carbon Radioisotopes; Deuterium Oxide; Female; Glucagon; Gluconeogenesis; Glucose; Glyceraldehyde 3-Phosphate; Humans; Insulin; Isotope Labeling; Magnetic Resonance Spectroscopy; Male; Middle Aged; Transaldolase | 2011 |
Insulin-producing cells from human pancreatic islet-derived progenitor cells following transplantation in mice.
Topics: Animals; C-Peptide; Cell Differentiation; Cells, Cultured; Gene Expression; Glucagon; Glucose; Humans; Insulin; Insulin-Secreting Cells; Male; Mice; Mice, Inbred NOD; RNA, Messenger; Stem Cell Transplantation; Stem Cells; Transplantation, Heterologous | 2011 |
β-cell function and metabolic control in latent autoimmune diabetes in adults with early insulin versus conventional treatment: a 3-year follow-up.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; C-Peptide; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Regression Analysis; Sweden; Treatment Outcome | 2011 |
Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.
Topics: Adolescent; Adult; Biomarkers; C-Peptide; Diabetes Mellitus, Type 1; Disease Progression; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin Resistance; Male; Proinsulin; Prospective Studies; Reference Values; Remission Induction; Young Adult | 2011 |
Pancreatic volume and endocrine and exocrine functions in patients with diabetes.
Topics: Adult; Aged; Atrophy; C-Peptide; Chymotrypsin; Cohort Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Feces; Female; Glucagon; Humans; Islets of Langerhans; Male; Middle Aged; Organ Size; Pancreas; Pancreas, Exocrine; Pancreatic Elastase; Tomography, X-Ray Computed | 2011 |
Effects of physiological variations in circulating insulin levels on bone turnover in humans.
Topics: Absorptiometry, Photon; Biomarkers; Blood Glucose; Bone and Bones; C-Peptide; Diabetes Mellitus; Endpoint Determination; Female; Glucagon; Glucose Clamp Technique; Human Growth Hormone; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Osteocalcin; Osteoprotegerin; Peptide Fragments; Procollagen; Prospective Studies | 2011 |
Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader-Willi syndrome.
Topics: Animals; Blood Glucose; C-Peptide; Caspase 3; Cell Proliferation; Female; Gene Deletion; Glucagon; Glucagon-Secreting Cells; Immunohistochemistry; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Knockout; Microarray Analysis; Prader-Willi Syndrome; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Somatostatin | 2011 |
Disturbed glucoregulatory response to food intake after moderate sleep restriction.
Topics: Adrenocorticotropic Hormone; Adult; Blood Glucose; C-Peptide; Eating; Glucagon; Glucose; Glucose Tolerance Test; Humans; Hydrocortisone; Insulin; Interleukin-6; Male; Polysomnography; Sleep Deprivation; Young Adult | 2011 |
The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Peptides | 2011 |
The message for MODY.
Topics: Autoantibodies; C-Peptide; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Genetic Predisposition to Disease; Glucagon; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Immunologic Factors; Male; Mutation; RNA, Messenger; Transcription, Genetic | 2011 |
Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes.
Topics: Age of Onset; Aged; C-Peptide; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Male; Middle Aged; Sensitivity and Specificity | 2011 |
Metabolic function of a suboptimal transplanted islet mass in nonhuman primates on rapamycin monotherapy.
Topics: Animals; Arginine; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Glucagon; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans Transplantation; Macaca fascicularis; Sirolimus | 2012 |
Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes.
Topics: Adolescent; Age of Onset; Blood Glucose; C-Peptide; Child; Child, Preschool; Cohort Studies; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Glucagon-Like Peptide 1; Humans; Infant; Infant, Newborn; Male; Proinsulin; Remission, Spontaneous | 2012 |
Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Obesity | 2012 |
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Topics: Adult; Appetite; C-Peptide; Cholecystokinin; Confounding Factors, Epidemiologic; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Leptin; Male; Middle Aged; Obesity, Morbid; Pancreatic Polypeptide; Peptide YY; Postprandial Period; Somatostatin; Time Factors; Weight Loss | 2012 |
Increased action of pulsatile compared to non-pulsatile insulin delivery during a meal-like glucose exposure simulated by computerized infusion in healthy humans.
Topics: Adult; Biomarkers; Blood Glucose; C-Peptide; Computer Simulation; Diabetes Mellitus, Type 2; Eating; Fatty Acids, Nonesterified; Female; Glucagon; Human Growth Hormone; Humans; Hypoglycemic Agents; Incretins; Insulin; Insulin Infusion Systems; Insulin Secretion; Male; Pancreatic Hormones; Pituitary Hormones; Postprandial Period; Pulsatile Flow; Research Design; Time Factors | 2012 |
Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Genetic Predisposition to Disease; Genetic Variation; Genotype; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Humans; Hyperglycemia; Insulin; Insulin-Secreting Cells; KCNQ1 Potassium Channel; Membrane Proteins; Transcription Factor 7-Like 2 Protein | 2012 |
Does glucagon stimulation test help to predict autoimmunity in newly diagnosed non obese adults with diabetes?
Topics: Adult; Autoantibodies; Body Mass Index; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glutamate Decarboxylase; Humans; Male; Middle Aged | 2012 |
β- and α-cell dysfunctions in africans with ketosis-prone atypical diabetes during near-normoglycemic remission.
Topics: Adult; Black People; C-Peptide; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Female; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Insulin; Insulin-Secreting Cells; Male; Middle Aged | 2013 |
C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment.
Topics: Adult; Aged; C-Peptide; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Liraglutide; Male; Middle Aged; Receptors, Glucagon | 2012 |
Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Humans; Insulin; Kidney Transplantation; Liver Glycogen; Male; Middle Aged; Pancreas Transplantation; Postprandial Period; Radioimmunoassay | 2014 |
Pathogenesis of prediabetes: role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Carbon Isotopes; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glucose Intolerance; Glycogenolysis; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Liver; Male; Middle Aged; Prediabetic State | 2013 |
GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Male; Middle Aged; Peptide Fragments | 2013 |
Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: a long-term follow-up study.
Topics: Aged; Aged, 80 and over; Asian People; C-Peptide; Diabetes Mellitus, Type 2; Diagnostic Techniques, Endocrine; Disease Progression; Female; Follow-Up Studies; Glucagon; Humans; Injections; Insulin; Insulin Secretion; Male; Middle Aged; Treatment Outcome; Up-Regulation | 2013 |
Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Obesity | 2013 |
The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.
Topics: Adult; Asian People; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Secretion; Male; Middle Aged; Republic of Korea | 2014 |
Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
Topics: Adult; Area Under Curve; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Diabetes, Gestational; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Homeostasis; Humans; Insulin; Insulin Resistance; Insulin Secretion; Postpartum Period; Postprandial Period; Pregnancy | 2013 |
Residual C-peptide in patients with Type 1 diabetes and multiethnic backgrounds.
Topics: Adolescent; Adult; C-Peptide; Diabetes Mellitus, Type 1; Epidemiologic Methods; Female; Glucagon; Humans; Luminescence; Male; Sex Factors; Time Factors; Young Adult | 2013 |
GLP-1 and the long-term outcome of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery in morbidly obese subjects.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Blood Glucose; Body Composition; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Gastric Bypass; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Obesity, Morbid; Treatment Outcome | 2013 |
Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.
Topics: Adult; Aged; Aged, 80 and over; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Secretion; Male; Middle Aged | 2013 |
Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats.
Topics: Animals; C-Peptide; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Streptozocin; Treatment Outcome; Triazoles; Umbilical Cord | 2014 |
Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
Topics: Administration, Intravenous; Animals; Blood Glucose; Bone Marrow; C-Peptide; Culture Media, Conditioned; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucagon; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Streptozocin | 2013 |
Postprandial glucose fluxes and insulin sensitivity during exercise: a study in healthy individuals.
Topics: Activities of Daily Living; Adult; Algorithms; Blood Glucose; C-Peptide; Carbon Radioisotopes; Deuterium; Feasibility Studies; Female; Glucagon; Gluconeogenesis; Glucose; Humans; Infusions, Intravenous; Insulin; Insulin Resistance; Male; Middle Aged; Models, Biological; Motor Activity; Postprandial Period; Tritium; Young Adult | 2013 |
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Secreting Cells; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Prediabetic State | 2014 |
Glucagon/insulin ratio in preoperative screening before pancreatic surgery: correlation with hemoglobin A1C in subjects with and without pancreatic cancer.
Topics: Aged; Blood Glucose; C-Peptide; Female; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Pancreas; Pancreatic Neoplasms; Preoperative Period | 2014 |
Development of an improved time-resolved fluoroimmunoassay for simultaneous quantification of C-peptide and insulin in human serum.
Topics: Antibodies; C-Peptide; Calibration; Diabetes Mellitus; Fluoroimmunoassay; Glucagon; Humans; Insulin; Limit of Detection; Magnetic Phenomena; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 2014 |
Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes.
Topics: Animals; Blood Glucose; Body Mass Index; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Gene Expression Regulation; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Incretins; Insulin; Male | 2014 |
Utility of glucagon stimulation test in type 1 diabetes after pancreas transplantation.
Topics: C-Peptide; Diabetes Mellitus, Type 1; Glucagon; Humans; Insulin; Pancreas Transplantation | 2014 |
A new approach for pancreatic tissue engineering: human endometrial stem cells encapsulated in fibrin gel can differentiate to pancreatic islet beta-cell.
Topics: C-Peptide; Cell Culture Techniques; Cell Differentiation; Cell Survival; Cells, Cultured; Endometrium; Female; Fibrin; Gels; Gene Expression; Glucagon; Homeodomain Proteins; Humans; Insulin; Insulin-Secreting Cells; Pancreas; Stem Cells; Tissue Engineering; Trans-Activators; Young Adult | 2014 |
Defective glucagon secretion during hypoglycemia after intrahepatic but not nonhepatic islet autotransplantation.
Topics: Adult; Arginine; Autografts; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Liver; Male; Pancreatectomy; Pancreatic Diseases; Pancreatic Ducts; Pancreatitis; Treatment Outcome | 2014 |
Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function.
Topics: Adolescent; Adult; Algorithms; Blood Glucose; C-Peptide; Female; Food; Gastric Emptying; Glucagon; Glucose; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Kinetics; Male; Middle Aged; Young Adult | 2014 |
Arginine is preferred to glucagon for stimulation testing of β-cell function.
Topics: Adult; Aged; Arginine; Blood Glucose; Body Mass Index; C-Peptide; Female; Glucagon; Humans; Hyperglycemia; Infusions, Intravenous; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kinetics; Male; Middle Aged; Mouth Mucosa; Nausea; Obesity; Paresthesia; Reproducibility of Results | 2014 |
Glucometabolic hormones and cardiovascular risk markers in antipsychotic-treated patients.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; C-Peptide; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cross-Sectional Studies; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Ghrelin; Glucagon; Glucose Metabolism Disorders; Humans; Insulin; Interleukin-6; Leptin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Proinsulin; Risk Factors; Tumor Necrosis Factor-alpha; Young Adult | 2014 |
Incretin and islet hormone responses to meals of increasing size in healthy subjects.
Topics: Adult; Blood Glucose; C-Peptide; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Healthy Volunteers; Humans; Insulin; Male; Meals; Postprandial Period; Young Adult | 2015 |
Overexpression of PAX4 reduces glucagon expression in differentiating hESCs.
Topics: Adenoviridae; C-Peptide; Cell Differentiation; Cells, Cultured; Embryonic Stem Cells; Gene Dosage; Gene Expression; Genetic Vectors; Glucagon; Homeodomain Proteins; Humans; Insulin; Insulin Secretion; Paired Box Transcription Factors; Recombination, Genetic; RNA; Transcription Factors; Up-Regulation | 2014 |
Patients with psoriasis are insulin resistant.
Topics: Adult; Anthropometry; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Gluconeogenesis; Glucose Clamp Technique; Glucose Intolerance; Humans; Hyperinsulinism; Inflammation; Insulin; Insulin Resistance; Male; Middle Aged; Prediabetic State; Psoriasis; Risk | 2015 |
Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests.
Topics: Aged; Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Biomarkers; C-Peptide; Creatinine; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Multivariate Analysis; Peptide Hormones; Stimulation, Chemical; Time Factors | 2015 |
Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
Topics: Aged; Blood Glucose; C-Peptide; Cell Count; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged | 2015 |
The effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant model.
Topics: Animals; Apoptosis; Blood Glucose; C-Peptide; Cell Count; Diabetes Mellitus, Experimental; Exenatide; Fasting; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Graft Survival; Humans; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice, Inbred BALB C; Models, Animal; Peptides; Venoms | 2015 |
Incretin secretion in obese Korean children and adolescents with newly diagnosed type 2 diabetes.
Topics: Adolescent; Analysis of Variance; Asian People; Blood Glucose; Body Mass Index; C-Peptide; Case-Control Studies; Child; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin Resistance; Male; Obesity; Republic of Korea | 2016 |
Glucose metabolism alterations in patients with bipolar disorder.
Topics: Biomarkers; Bipolar Disorder; Blood Glucose; C-Peptide; Case-Control Studies; Female; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Leptin; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Plasminogen Activator Inhibitor 1; Resistin | 2015 |
Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Caloric Restriction; Diabetes Mellitus, Type 2; Energy Intake; Fasting; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Postprandial Period; Time Factors | 2015 |
Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.
Topics: Adult; Aged; Body Mass Index; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Disease Progression; Female; Glucagon; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Longitudinal Studies; Male; Middle Aged; Overweight; Regression Analysis; Thinness; Triglycerides | 2015 |
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Dietary Fats; Dietary Proteins; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Healthy Volunteers; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Meals; Middle Aged; Postprandial Period | 2016 |
Microvesicles but Not Exosomes from Pathfinder Cells Stimulate Functional Recovery of the Pancreas in a Mouse Streptozotocin-Induced Diabetes Model.
Topics: Animals; Biomarkers; Blood Glucose; C-Peptide; Cell- and Tissue-Based Therapy; Cell-Derived Microparticles; Diabetes Mellitus, Experimental; Exosomes; Female; Glucagon; Insulin; Mice, Inbred C57BL; Pancreas; Paracrine Communication; Rats; Recovery of Function; Regeneration; Signal Transduction; Streptozocin; Time Factors | 2016 |
Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus.
Topics: Adult; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glucagon; Glucose Tolerance Test; Humans; Male; Models, Statistical; Young Adult | 2015 |
The effect of 8 days of strict bed rest on the incretin effect in healthy volunteers.
Topics: Adolescent; Adult; Bed Rest; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Glucose Tolerance Test; Healthy Volunteers; Humans; Incretins; Insulin; Insulin Resistance; Male; Young Adult | 2016 |
Are basal and glucagon-stimulated C-peptide values predictors of response to GLP-1 receptor agonists in type 2 diabetic patients?
Topics: Adult; Aged; Biomarkers; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Male; Middle Aged; Predictive Value of Tests | 2016 |
Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus; Disease Progression; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreatitis, Chronic | 2016 |
Differential Effects of Oral and Intravenous Lipid Administration on Key Molecules Related to Energy Homeostasis.
Topics: Adiponectin; Administration, Oral; Adult; alpha-2-HS-Glycoprotein; Blood Glucose; C-Peptide; Cytokines; Energy Metabolism; Fatty Acids, Nonesterified; Female; Fibroblast Growth Factors; Fibronectins; Ghrelin; Glucagon; GPI-Linked Proteins; Homeostasis; Humans; Incretins; Infusions, Intravenous; Insulin; Lectins; Lipids; Male; Middle Aged; Peptide YY; Young Adult | 2016 |
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.
Topics: Adult; Aged; Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Female; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Immunoglobulin Fc Fragments; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Metformin; Middle Aged; Postprandial Period; Recombinant Fusion Proteins; Treatment Outcome | 2016 |
Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency.
Topics: Area Under Curve; C-Peptide; Case-Control Studies; Child; Child, Preschool; Fasting; Female; Glucagon; Glucose Tolerance Test; Hormones; Human Growth Hormone; Humans; Hypopituitarism; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Like Growth Factor I; Insulin-Secreting Cells; Male; Prospective Studies | 2016 |
The Shape of the Glucose Response Curve During an Oral Glucose Tolerance Test Heralds Biomarkers of Type 2 Diabetes Risk in Obese Youth.
Topics: Adiposity; Adolescent; Biomarkers; Blood Glucose; Body Composition; Body Mass Index; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin Secretion; Male; Pediatric Obesity; Risk Factors | 2016 |
Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
Topics: Adolescent; Adult; C-Peptide; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Middle Aged; Pancreas; Proinsulin; Young Adult | 2017 |
Oxytocin Improves β-Cell Responsivity and Glucose Tolerance in Healthy Men.
Topics: Adrenocorticotropic Hormone; Adult; Blood Glucose; C-Peptide; Fatty Acids, Nonesterified; Glucagon; Glucose Tolerance Test; Healthy Volunteers; Humans; Hydrocortisone; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Oxytocics; Oxytocin; Young Adult | 2017 |
Insulin resistance, glucagon-like peptide-1 and factors influencing glucose homeostasis in neonates.
Topics: Blood Glucose; C-Peptide; Female; Glucagon; Glucagon-Like Peptide 1; Homeostasis; Humans; Infant, Newborn; Infant, Premature; Insulin; Insulin Resistance; Intensive Care Units, Neonatal; Male; New Zealand | 2017 |
Glucagon increases insulin levels by stimulating insulin secretion without effect on insulin clearance in mice.
Topics: Animals; Blood Glucose; C-Peptide; Glucagon; Glucose; Hyperinsulinism; Injections, Intravenous; Insulin; Insulin Secretion; Kinetics; Mice | 2017 |
Neu5Gc and α1-3 GAL Xenoantigen Knockout Does Not Affect Glycemia Homeostasis and Insulin Secretion in Pigs.
Topics: Animals; Antigens, Heterophile; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Galactose; Gene Knockout Techniques; Glucagon; Glucose; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Neuraminic Acids; Pancreas; Purinergic P1 Receptor Antagonists; Swine; Theophylline; Transplantation, Heterologous | 2017 |
Plasma Irisin Modestly Increases during Moderate and High-Intensity Afternoon Exercise in Obese Females.
Topics: Adult; Blood Glucose; Body Mass Index; C-Peptide; Exercise; Female; Fibronectins; Gene Expression; Glucagon; Humans; Insulin; Lactic Acid; Obesity; Oxygen Consumption; Random Allocation; Time Factors | 2017 |
Diagnostic Performance of 48-Hour Fasting Test and Insulin Surrogates in Patients With Suspected Insulinoma.
Topics: 3-Hydroxybutyric Acid; Adult; Aged; Blood Glucose; C-Peptide; Fasting; Fatty Acids, Nonesterified; Female; Glucagon; Humans; Insulin; Insulinoma; Male; Middle Aged; Pancreatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Time Factors | 2017 |
In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin).
Topics: Adolescent; Animals; Blotting, Western; C-Peptide; Cell Line; Cricetinae; Diabetes Mellitus; Female; Glucagon; Humans; Insulin; Islet Amyloid Polypeptide; Proinsulin; Rats; Receptor, Insulin | 2017 |
Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.
Topics: Blood Glucose; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Male; Middle Aged; Postprandial Period; Retrospective Studies; Sensitivity and Specificity | 2018 |
Increased Incretin But Not Insulin Response after Oral versus Intravenous Branched Chain Amino Acids.
Topics: Administration, Intravenous; Administration, Oral; Adult; Amino Acids, Branched-Chain; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Incretins; Insulin; Isoleucine; Leucine; Male; Valine; Young Adult | 2017 |
The Effect of Ingested Glucose Dose on the Suppression of Endogenous Glucose Production in Humans.
Topics: Adult; Blood Glucose; C-Peptide; Dose-Response Relationship, Drug; Fatty Acids, Nonesterified; Glucagon; Glucose; Homeostasis; Humans; Insulin; Male; Postprandial Period | 2017 |
Defects in α-Cell Function in Patients With Diabetes Due to Chronic Pancreatitis Compared With Patients With Type 2 Diabetes and Healthy Individuals.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Pancreatitis, Chronic | 2017 |
Effects of three major amino acids found in Japanese broth on glucose metabolism and gastric emptying.
Topics: Adult; Amino Acids; Animals; Aspartic Acid; Blood Glucose; C-Peptide; Cross-Over Studies; Diet; Female; Fishes; Food, Preserved; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glutamic Acid; Histidine; Humans; Insulin; Japan; Kelp; Male; Oryza | 2018 |
Complete loss of insulin secretion capacity in type 1A diabetes patients during long-term follow up.
Topics: Adult; Age of Onset; Asian People; C-Peptide; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glucagon; Humans; Insulin; Insulin Secretion; Japan; Male; Retrospective Studies; Young Adult | 2018 |
Differential associations of lower cardiac vagal tone with insulin resistance and insulin secretion in recently diagnosed type 1 and type 2 diabetes.
Topics: Adolescent; Adult; Aged; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Clamp Technique; Heart; Heart Rate; Humans; Insulin; Insulin Resistance; Lipids; Male; Middle Aged; Vagus Nerve; Young Adult | 2018 |
Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans.
Topics: Biomarkers; Blood Glucose; C-Peptide; Cross-Sectional Studies; Female; Follow-Up Studies; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Prediabetic State; Prognosis | 2018 |
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.
Topics: Adult; Awareness; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Drug Administration Schedule; Epinephrine; Female; Glucagon; Glucose Clamp Technique; Humans; Hypoglycemia; Insulin; Male; Middle Aged; Norepinephrine; Young Adult | 2018 |
Short-term changes in pancreatic α-cell function after the onset of fulminant type 1 diabetes.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucagon-Secreting Cells; Humans | 2018 |
Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations.
Topics: Adolescent; Adult; Blood Glucose; Blood Glucose Self-Monitoring; C-Peptide; Diabetes Mellitus, Type 1; Fasting; Female; Glucagon; Humans; Insulin; Male; Middle Aged; Time Factors; Young Adult | 2018 |
Effects of starvation and short-term refeeding on gastric emptying and postprandial blood glucose regulation in adolescent girls with anorexia nervosa.
Topics: 3-O-Methylglucose; Adolescent; Anorexia Nervosa; Blood Glucose; Breath Tests; C-Peptide; Caprylates; Carbon Isotopes; Case-Control Studies; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Postprandial Period; Starvation; Young Adult | 2018 |
Association between serum somatostatin levels and glucose-lipid metabolism in the Jino ethnic minority and Han Chinese population.
Topics: Adult; Asian People; C-Peptide; China; Cholesterol, HDL; Fasting; Female; Glucagon; Glucose; Humans; Hyperglycemia; Insulin; Insulin-Secreting Cells; Lipid Metabolism; Middle Aged; Somatostatin | 2018 |
Paradigm Shifts in Nocturnal Glucose Control in Type 2 Diabetes.
Topics: Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Body Mass Index; C-Peptide; Case-Control Studies; Circadian Rhythm; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Glucagon; Homeostasis; Humans; Insulin; Male; Middle Aged; Prognosis; Sleep | 2018 |
Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide.
Topics: Adult; Area Under Curve; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucose Tolerance Test; Humans; Incretins; Insulin; Insulin-Secreting Cells; Male; Young Adult | 2019 |
The characteristics of blood glucose fluctuations in patients with fulminant type 1 diabetes mellitus in the stable stage.
Topics: Adult; Blood Glucose; Blood Glucose Self-Monitoring; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 1; Female; Glucagon; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Reference Values; Retrospective Studies; Statistics, Nonparametric | 2018 |
Mild Physiologic Hyperglycemia Induces Hepatic Insulin Resistance in Healthy Normal Glucose-Tolerant Participants.
Topics: Adult; Blood Glucose; C-Peptide; Female; Glucagon; Gluconeogenesis; Glucose; Glucose Clamp Technique; Glycogenolysis; Healthy Volunteers; Humans; Hyperglycemia; Insulin; Insulin Resistance; Liver; Male; Middle Aged; Tritium | 2019 |
Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients.
Topics: Adipose Tissue; Aged; Biomarkers; C-Peptide; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fatty Liver; Female; Follow-Up Studies; Gastrointestinal Agents; Glucagon; Glucose Tolerance Test; Humans; Longitudinal Studies; Male; Pancreatic Diseases; Prognosis | 2020 |
Proinsulin associates with poor β-cell function, glucose-dependent insulinotropic peptide, and insulin resistance in persistent type 2 diabetes after Roux-en-Y gastric bypass in humans.
Topics: Adult; Blood Glucose; Body Weight; C-Peptide; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Middle Aged; Recurrence | 2020 |
Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.
Topics: Adolescent; Area Under Curve; Blood Glucose; C-Peptide; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Humans; Hypoglycemia; Incretins; Insulin; Insulin Secretion; Male; Young Adult | 2020 |
Childhood trauma and glucose metabolism in patients with first-episode psychosis.
Topics: Adult; Adverse Childhood Experiences; Antipsychotic Agents; Biomarkers; C-Peptide; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Resistance; Leptin; Male; Middle Aged; Nicotinamide Phosphoribosyltransferase; Plasminogen Activator Inhibitor 1; Psychotic Disorders; Resistin | 2020 |
Fasting glucagon concentrations are associated with longitudinal decline of β-cell function in non-diabetic humans.
Topics: Adult; Blood Glucose; C-Peptide; Fasting; Female; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin-Secreting Cells; Longitudinal Studies; Male; Middle Aged; Pancreas; Postprandial Period; Prediabetic State | 2020 |
The counterregulatory response to hypoglycaemia in the pig.
Topics: Animals; Blood Glucose; C-Peptide; Catecholamines; Epinephrine; Female; Glucagon; Glucose; Growth Hormone; Humans; Hydrocortisone; Hypoglycemia; Insulin; Models, Animal; Norepinephrine; Swine | 2020 |
Functional β-Cell Differentiation of Small-Tail Han Sheep Pancreatic Mesenchymal Stem Cells and the Therapeutic Potential in Type 1 Diabetic Mice.
Topics: Animals; Blood Glucose; Body Weight; C-Peptide; Cell Differentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Sheep | 2020 |
Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Case-Control Studies; Child; Cystic Fibrosis; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Male; Time Factors; Young Adult | 2020 |
Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
Topics: Adult; Bile Acids and Salts; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged | 2020 |
Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Endocrine Cells; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Glucosides; Insulin; Insulin-Secreting Cells; Male; Mice; Proprotein Convertase 1; Regeneration; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Glucagon stimulation test as a possible predictor of residual β-cell function.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Infant, Newborn; Insulin; Insulin-Secreting Cells; Male; Retrospective Studies | 2021 |
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition.
Topics: Benzhydryl Compounds; Biphenyl Compounds; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Energy Metabolism; Gastric Emptying; Glucagon; Glucosides; Glycerol; Half-Life; Humans; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Incretins in fibrocalculous pancreatic diabetes: A unique subtype of pancreatogenic diabetes.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; C-Peptide; Calcinosis; Case-Control Studies; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Female; Fibrosis; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Insulin; Male; Middle Aged; Pancreatitis, Chronic; Time Factors; Young Adult | 2021 |
Salivary concentrations of cytokines and other analytes in healthy children.
Topics: Adiponectin; Age Factors; Body Height; C-Peptide; Child; Cytokines; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Interleukin-13; Interleukin-2; Leptin; Male; Multivariate Analysis; Nicotinamide Phosphoribosyltransferase; Reference Values; Saliva | 2021 |
Impact of glucagon response on early postprandial glucose excursions irrespective of residual β-cell function in type 1 diabetes: A cross-sectional study using a mixed meal tolerance test.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Cohort Studies; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose Tolerance Test; Humans; Hyperglycemia; Insulin-Secreting Cells; Male; Meals; Middle Aged; Prospective Studies | 2021 |
Glucagon blockade restores functional β-cell mass in type 1 diabetic mice and enhances function of human islets.
Topics: Animals; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cell Lineage; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gene Expression; Glucagon; Glucagon-Secreting Cells; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Organ Size; Receptors, Glucagon; Treatment Outcome | 2021 |
Food intake rather than blood glucose levels affects the pharmacokinetic profile of insulin aspart in pigs.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus; Eating; Glucagon; Glucose Clamp Technique; Hypoglycemic Agents; Insulin; Insulin Aspart; Male; Swine | 2021 |
Metabolic effects of 1-week binge drinking and fast food intake during Roskilde Festival in young healthy male adults.
Topics: Adult; Aspartate Aminotransferases; Binge Drinking; Blood Glucose; C-Peptide; C-Reactive Protein; Denmark; Diet; Elasticity Imaging Techniques; Fast Foods; Fatty Liver; Fibroblast Growth Factors; Glucagon; Glucose Tolerance Test; Growth Differentiation Factor 15; Holidays; Humans; Insulin Resistance; Liver; Male; Young Adult | 2021 |
C-peptide enhances glucagon secretion in response to hyperinsulinemia under euglycemic and hypoglycemic conditions.
Topics: Animals; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Dogs; Female; Glucagon; Hyperinsulinism; Hypoglycemia; Hypoglycemic Agents; Male | 2021 |
Pronounced proliferation of non-beta cells in response to beta-cell mitogens in isolated human islets of Langerhans.
Topics: C-Peptide; Cell Division; Cell Proliferation; Epidermal Growth Factor; Female; Glucagon; Glucose; Harmine; Heparin-binding EGF-like Growth Factor; Humans; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Male; Mitogens; Pancreatic Ducts; Primary Cell Culture; Signal Transduction | 2021 |
Comparative Effects of the Branched-Chain Amino Acids, Leucine, Isoleucine and Valine, on Gastric Emptying, Plasma Glucose, C-Peptide and Glucagon in Healthy Men.
Topics: Adult; Amino Acids, Branched-Chain; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Gastric Emptying; Gastric Inhibitory Polypeptide; Glucagon; Humans; Insulin; Isoleucine; Leucine; Male; Middle Aged; Postprandial Period; Valine; Whey Proteins; Young Adult | 2021 |
Entero-Pancreatic Hormone Secretion, Gastric Emptying, and Glucose Absorption After Frequently Sampled Meal Tests.
Topics: Adult; Biomarkers; C-Peptide; Cholecystokinin; Follow-Up Studies; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Male; Meals; Pancreatic Hormones; Prognosis; Prospective Studies; Young Adult | 2022 |
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Pancreatitis, Chronic; Peptide YY | 2022 |
Pancreatic cancer-associated diabetes mellitus is characterized by reduced β-cell secretory capacity, rather than insulin resistance.
Topics: Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Insulin Resistance; Pancreatic Neoplasms | 2022 |
Satiety, glycemic profiles, total antioxidant capacity, and postprandial glycemic responses to different sugars in healthy Malaysian adults.
Topics: Adult; Antioxidants; Blood Glucose; C-Peptide; Cross-Over Studies; Glucagon; Glucose; Glycemic Index; Humans; Insulin; Postprandial Period; Single-Blind Method; Sugars; Tyrosine | 2022 |
Elevated islet prohormone ratios as indicators of insulin dependency in auto-islet transplant recipients.
Topics: Animals; C-Peptide; Glucagon; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Proinsulin; Retrospective Studies | 2022 |
Incretin Response to Mixed Meal Challenge in Active Cushing's Disease and after Pasireotide Therapy.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Incretins; Insulin; Insulin Resistance; Meals; Pituitary ACTH Hypersecretion; Somatostatin | 2022 |
Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.
Topics: C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Humans; Hyperglycemia; Insulin | 2022 |
The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Glucose; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Kinetics; Male; Prediabetic State; Receptor, Melatonin, MT2 | 2022 |
Analysis of the transcriptome and metabolome of pancreatic spheroids derived from human induced pluripotent stem cells and matured in an organ-on-a-chip.
Topics: C-Peptide; Calcium; Cell Differentiation; Fatty Acids; Glucagon; Glycerol; Humans; Induced Pluripotent Stem Cells; Lab-On-A-Chip Devices; Lipids; Metabolome; Pancreas; Phosphates; Serotonin; Transcription Factors; Transcriptome | 2022 |
Prolonged insulin-induced hypoglycaemia reduces ß-cell activity rather than number in pancreatic islets in non-diabetic rats.
Topics: Animals; Blood Glucose; C-Peptide; Female; Glucagon; Humans; Hypoglycemia; Insulin; Islets of Langerhans; Male; Rats | 2022 |
An Examination of Donor Factors That Impact the Results of the Glucagon Stimulation Test as an Assessment of the Pancreatic Graft Endocrine Function.
Topics: C-Peptide; C-Reactive Protein; Creatinine; Glucagon; Glycated Hemoglobin; Humans; Insulin; Middle Aged; Sodium | 2022 |
The Levels of Ghrelin, Glucagon, Visfatin and Glp-1 Are Decreased in the Peritoneal Fluid of Women with Endometriosis along with the Increased Expression of the CD10 Protease by the Macrophages.
Topics: Ascitic Fluid; Biomarkers; C-Peptide; Dipeptidyl Peptidase 4; Endometriosis; Female; Ghrelin; Glucagon; Glucagon-Like Peptide 1; Humans; Leptin; Macrophages; Nicotinamide Phosphoribosyltransferase; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Resistin | 2022 |
Lipid droplet accumulation in β cells in patients with type 2 diabetes is associated with insulin resistance, hyperglycemia and β cell dysfunction involving decreased insulin granules.
Topics: Blood Glucose; Boron Compounds; C-Peptide; Diabetes Mellitus, Type 2; Glucagon; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hyperglycemia; Insulin; Insulin Resistance; Lipid Droplets | 2022 |
Blood Adipokines/Cytokines in Young People with Chronic Bronchitis and Abdominal Obesity.
Topics: Adipokines; Adiponectin; Adolescent; Bronchitis, Chronic; C-Peptide; Complement Factor D; Cytokines; Ghrelin; Glucagon; Humans; Interleukin-6; Islet Amyloid Polypeptide; Lipocalin-2; Obesity; Obesity, Abdominal; Resistin | 2022 |
Alterations of adipokines, pancreatic hormones and incretins in acute and convalescent COVID-19 children.
Topics: Adipokines; Adiponectin; C-Peptide; Child; Complement Factor D; COVID-19; Cytokines; Diabetes Mellitus, Type 2; Ghrelin; Glucagon; Granulocyte Colony-Stimulating Factor; Humans; Incretins; Interleukin-12; Interleukin-17; Interleukin-6; Leptin; Pancreatic Hormones; SARS-CoV-2; Tumor Necrosis Factor-alpha | 2023 |
Nonlinear Mixed Effects Modeling of Glucagon Kinetics in Healthy Subjects.
Topics: Blood Glucose; C-Peptide; Glucagon; Healthy Volunteers; Humans; Insulin; Kinetics | 2023 |
Influence of general anaesthesia on circulating biomarkers of glucose metabolism in pigs.
Topics: Anesthesia, General; Anesthetics; Animals; C-Peptide; Glucagon; Glucose; Glycerol; Ketamine; Medetomidine; Propofol; Swine; Tiletamine; Triglycerides | 2023 |
Serum alanine transaminase is predictive of fasting and postprandial insulin and glucagon concentrations in type 2 diabetes.
Topics: Alanine Transaminase; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Fasting; Glucagon; Glucose; Humans; Insulin | 2023 |